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Summary 
Research aim 
This project continues a programme of work led by the NNRU that has sought to explore the 
relationship between workforce configuration in the health service and patient outcomes. In a nutshell 
we seek to address: what difference does it make who provides care and treatment to patients? The 
ramifications of different workforce models have been more thoroughly investigated in the acute 
sector, but there has been far less research undertaken to determine the impact of employing 
different combinations of staff in primary care.  
As part of the Policy Research Programme funded by the Department of Health the NNRU began 
research in this field by using secondary data to see if the level of practice nurses employed bore any 
relationship with the quality of care provided in GP practices, as measured by the Quality and 
Outcomes Framework (QOF). Findings suggested that there was an association between level of 
practice nurse staffing and performance based on Doran’s composite diabetes measure and certain 
QOF Diabetes Indicators (HbA1c ≤ 7.4%, HbA1c ≤ 10%, Total cholesterol ≤ 193mg/dl), (Griffiths et al, 
2010b).  
This led to an interest in pursuing the research further, focusing in depth on one particular condition 
using patient level data (as opposed to practice level quality scores) and more detailed workforce 
data. Thus the current study was commissioned to examine whether different workforce 
configurations (and activity) in primary care are associated with variation in control of diabetes as 
measured by haemoglobin A1c (HbA1c) level, a recognised and commonly used measure of diabetes 
control. We focussed in particular on the extent to which people with diabetes received care from 
nurses, as opposed to general practitioners, because there is strong advocacy for a ‘policy’ shift at 
provider level to pass much ‘routine’ chronic disease care from doctors to nurses. 
Background: focus on diabetes 
Diabetes is an important condition to focus on – not least because of the hugely increasing 
prevalence over the last ten years (described by some as an ‘epidemic’) and the cost associated with 
treating it. It is estimated to affect 3.6 million people in the UK and cost the NHS at least £10 billion a 
year. Understanding the ways in which the nursing contribution has impacted on the management of 
patients with diabetes has implications for the delivery of diabetes care in the future, and potentially 
the management of other chronic conditions in primary care.  
To address this question, we needed to find ways of quantifying both inputs (in terms of who is doing 
what and the balance between nurses and doctors) and outcomes (variation in control of diabetes). 
Neither are straight forward. 
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Identifying outcome measures  
After examination of the literature and discussion with clinical colleagues on the project team, 
glycaemic control (measured by Hb1Ac) was identified as a key outcome measure, in that it reflects 
how well controlled an individual’s diabetes is, but also because poor control is associated with higher 
risk of complications and adverse health (such as Coronary Heart Disease, stroke, renal failure, visual 
impairment and neuropathy). To get a sense of how well a practice is doing in managing diabetes, the 
proportion of their patients with diabetes achieving a certain level of control is measured. A number of 
HbA1c thresholds have been used as performance metrics since QOF was introduced in 2004. These 
have included ≤ 7%, ≤ 7.4%, ≤ 8%, ≤ 9% and ≤ 10%.  We chose the lower and upper thresholds for 
use in this study (≤ 7%, ≤ 10%). To make fair comparisons of the level of successful control between 
practices with different workforce configurations the many factors that affect the glycaemic control of 
diabetes patients need to be accounted for – hence the analyses needed to adjust for individual and 
population differences. To do this required us to use data generated directly from patient records to 
produce a ‘case-mix’ adjusted measure of glycaemic control achievement per practice population. We 
used ‘THIN’ data supplied by CEDEGIM which gives complete consultation records extracted from the 
database of a nationally representative sample of 556 general practices.     
As well as capturing glycaemic control, the THIN data also provides details of each consultation 
patients received. These data were used to tell us about the number of consultations, who they were 
with, the proportion with nurses or doctors, and the types of activities undertaken.  
Differences in glycaemic control were explored in two ways:  
- by comparing change over time. We have a data set generated from patient records that 
spans ten years, from 2002 to 2012, and so can explore differences in glycaemic control over 
the years in relation to any differences observed in the proportions of consultations 
undertaken by different staff, or changes in the types of activity undertaken.   
- by comparing practices within the current year: we examined how glycaemic control varies 
between practices and how much variation is associated with differences in the workforce 
configurations (staffing levels and mix). For 2012 we were able to identify the healthcare 
professional (GPs, practice nurses or specialist practice nurses) who typically lead the 
management of diabetes in each practice, through a survey undertaken in the spring of 2012 
(covering 249 practices).  
Glycaemic control is partly determined by a person’s individual characteristics and partly by the way 
care is delivered in each practice. A multilevel modelling approach was therefore used to ascertain 
individual (through risk adjustment) and practice level (including workforce) effects upon control of 
diabetes. 
The table below summarises the key measures this study uses and the data sources they are drawn 
from.     
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Table 1. Data sources used for quantifying inputs and outcomes 
 Question How measured Source 
Outcome How well do practices 
manage patients with 
diabetes?  
Proportion of patients with diabetes 
achieving glycaemic control (at two 
different levels) – adjusted to account for 
practice (e.g. location, postcode (socio-
economic) variable indicators, 
prevalence) and individual differences 
(e.g. age, co-morbidity, obesity) 
THIN patient 
records 2002-
2012  
Inputs Staffing levels and mix Size of workforce (patients per GP, 
patients per practice nurse), and mix 
(practice nurses as proportion of clinical 
workforce)  
Practice survey 
2012 
 How much care is 
provided to patients 
with diabetes? 
Number of consultations per year 
 
THIN 
 Who do patients see – 
GPs or practice 
nurses? 
Average number of consultations per year 
by GPs and by practice nurses  
Proportion of all consultations that are 
held with practice nurses 
THIN 
 
THIN 
 Is specialist nursing 
input available? 
Employing nurses with postgraduate 
qualification in diabetes 
Practice survey 
 What activities are 
undertaken (by 
whom)? 
Activities coded within the consultation THIN 
 Who leads 
management of 
diabetes? 
GPs or practice nurses (with or without 
specialist knowledge), shared with 
hospital/community based specialists 
Practice survey 
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Key Findings 
Diabetes and its management in the last ten years 
Our data shows the prevalence of diabetes has increased by 66% over the last decade reflecting 
other national statistics. The average number of patients with diabetes in each practice has increased 
from 237 in 2002, to 375 in 2012. As a proportion of all patients, those with diabetes account for an 
average of 4.9% of total list size now, compared with 3.0% in 2002.   
Important in understanding what this means for practice activity, is the fact that the clinical 
identification of patients with diabetes has also changed - people with diabetes are detected at a 
much earlier stage than in the past (because of more rigorous and regular review such as annual 
health checks) so there is an increased proportion of the ‘diabetic’ patient population that have less 
severe diabetes now, and are being helped to manage their diabetes earlier. 
Glycaemic control (that is the percentage of patients with diabetes that have an Hb1Ac level below a 
certain threshold) improved considerably between 2002 and 2004.  Since then improvement slowed 
and then plateaued in 2005 for the upper threshold (≤10% - reflecting ‘loose’ control of diabetes) and 
in 2009 for the lower (≤ 7% reflecting tighter control) of the two thresholds. 
Primary care activity over the last ten years 
Across all staff groups there has been an increase in activity, in that the annual number of 
consultations undertaken with patients with diabetes has increased by 13%. Practice nurses have 
increased their activity much more than doctors during this period – a 20% increase in annual 
consultations with people with diabetes compared with just 1% increase amongst GPs.  The overall 
effect of these changes means that whilst in 2002 70% of consultations were undertaken by doctors, 
this has fallen to 64% in 2011/12. Meanwhile the average proportion of consultations undertaken by 
nurses in each practice has increased slightly (from 31% to 32%) and those by other healthcare 
professionals from less than 3% to 8%.    
However, the amount of activity has not increased as sharply as the number of patients, so although 
both doctors and practice nurses are doing more consultations each year with people with diabetes 
patients, each person with diabetes is actually getting fewer consultations per year now than in 2002 
(the average has fallen from 16 per year to 11.5).  Practices with lower staffing levels (e.g. more 
patients per whole time equivalent GP or per whole time equivalent registered nurse) undertook fewer 
consultations with each individual person that had diabetes.  
How does glycaemic control vary? 
Glycaemic control is now much more uniformly achieved across practices, than was the case ten 
years ago. The amount of variation due to differences between practices as a proportion of all 
variation (people and practices) fell from 14% to 9% for HbA1c ≤ 7% and from 21% to 11% for HbA1c 
≤ 10% from 2002 to 2011. Much of the variation that appears to exist between practices in ability to 
achieve glycaemic control is therefore related to differences in the patient populations served. 
Practice variation was even smaller for the 2011/12 patient (people with diabetes) data linked to the 
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practice survey (166 practices). This placed limitations on what could be achieved statistically in terms 
of testing associations between workforce variables from the practice survey and glycaemic control, 
however a consistent picture emerged over the ten-year period from the analysis of The Health 
Information Network (THIN) data. Practices where practice nurses delivered a high proportion of the 
diabetes care performed as well as those practices where doctors delivered most of the care. Indeed 
optimised DM care is just as good when predominantly provided by nurses compared to care which is 
mainly provided by GPs. 
The primary care workforce  
A key part of this research has been to establish in more detail the composition of the primary care 
workforce, and determine who is doing what in relation to care of patients with diabetes. Do practices 
vary in how they are staffed, and the way in which they manage and provide diabetes care?   
Our survey (undertaken in Spring 2012, n=249 practices) showed that practices vary in the size and 
composition of their workforce. A ‘typical’ practice employs an average of 4 GPs, 2 registered nurses 
(RNs), 1 care support worker/assistant, a practice manager and 7 receptionists/admin staff (whole 
time equivalents). Nurses make up a third of the trained clinical staff (e.g. total GPs and RNs), but this 
varies considerably: 5% of practices have no registered nurses whilst in 12% of practices RNs make 
up more than half of the clinical staff.  
Larger practices (5 or more WTE GPs) are more likely to employ experienced nurses (on higher pay-
bands) and to employ nurses with post-graduate qualifications in diabetes, compared with smaller 
ones (less than 3 GPs). 84% of nurses in larger practices hold a post graduate qualification in 
diabetes compared with 44% in practices with less than 3 WTE GPs. 
Who manages care of patients with diabetes in primary care? 
A nurse (or nurses) who specialises in diabetes leads the management of care of people with 
diabetes in 58% of practices, and non-specialist practice nurses lead care in 11% of practices. 18% of 
practices say that the GP leads management of diabetes patients. 89% of practices that employ a 
nurse with postgraduate specialist qualification in diabetes report that care of patients with diabetes is 
generally managed by a nurses (or nurses) who is specialised in diabetes.  
Smaller practices are more likely to say management of care is shared with hospital or community 
consultants (22% vs. 5% in medium or large), are slightly less likely to use their own practice nurses 
(61% vs. 71% of medium sized), and are less likely to have care in the hands of a designated GP or 
practice nurse with specialist knowledge (51% vs. 83% in larger practices).  
In practices where nurses hold specialist postgraduate qualifications, the majority of diabetes care is 
provided through regularly held clinics specifically for people with diabetes (74% compared to 41% of 
cases where there is no specialist postgraduate trained diabetes nurse).  
Practices in which nurses undertake a larger proportion of consultations with patients with diabetes 
(as defined from the patient records data) are more likely to report that nurses lead the management 
of diabetes care.  In practices where nurses see a larger proportion of diabetes patients, doctors 
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spend nine minutes less a year (61 minutes vs. 70), but patients have 27 minute more contact time in 
total (132 minutes vs. 105 in the low nurse contact group).    
What range of activities do staff undertake in consultations? 
What activities staff undertake during consultations with patients with diabetes has also changed over 
the last ten years. Practice nurses have been doing a larger number and range of activities; in 2012 
they were making 2.7 times more entries on patient records than doctors. Much more activity is 
focused on ‘annual review’ now than ten years ago, particularly by practice nurses.  Statistical 
modelling suggests that where diabetes review and monitoring is happening more often, then 
glycaemic control is more likely to be achieved. 
What difference does it make who manages diabetes care? 
Whilst there has been an overall reduction in the number of consultations per patient, glycaemic 
control has been maintained. The changes were greatest between 2002 and 2005. After applying risk 
adjustment at the patient and practice level, practices in which people with diabetes had a higher 
proportion of practice nurse contact had significantly more patients meeting both the lower threshold 
(≤7%) and higher thresholds (≤10%) thresholds in 2003. The difference was close to significance in 
2005 for the lower threshold only. 
The more often people had their diabetes reviewed the greater the likelihood of glycaemic control 
being achieved. It did not seem to matter whether it is a doctor or practice nurse undertaking the 
review however the percentage of diabetes reviews undertaken by practice nurses has increased 
from 53% in 2002 to 65% in 2011. Therefore the role of practice nurses in the delivery of diabetes 
review could become a key factor in the further reduction of HbA1c levels and the achievement of 
diabetes control. 
What are the cost implications? 
The study findings indicate that whether doctors or practice nurses take the lead in delivery diabetes 
care (or whether they are specialists in diabetes care) has no discernible effect on the probability of a 
person reaching good diabetes control. The absence of a strong relationship, either positive or 
negative, indicates that practices which primarily use GPs to manage diabetes care could release 
significant resources by switching their service configuration towards nurse-led care. Practice nurses 
undertake more diabetes review, which is associated with better glycaemic control and practices may 
therefore wish to make even greater use of practice nurses. Currently practices that deliver a higher 
proportion of care for people with diabetes by nurses save on doctors’ time but savings are not 
sufficient to cover the costs of additional nurse consultation time. Nurses are therefore providing an 
extra resource. The opportunity costs of using GPs to deliver additional care would be high as would 
be the costs of delivering the additional care in secondary settings. However, the benefits of the 
additional care are not demonstrated in terms of HbA1C control. The costs and benefits associated 
with changes remain uncertain and it should be borne in mind that confining an economic analysis to 
a short time window may not reveal all the costs going forward. 
7 
 
Conclusion 
As diabetes has become increasingly prevalent, more care is being delivered and managed by 
practice nurses. The roles of doctors and nurses have changed: people with diabetes have fewer 
consultations per year, but more of them are undertaken by nurses, who increasingly do review 
activities (monitoring, follow-up, annual review). Regular diabetes review is associated with improved 
glycaemic control, and during the last decade glycaemic control across the practices has improved.   
However whether looking longitudinally or within the latest year’s data, little of the variation in 
practices’ performance is found to relate specifically to differences in the way in which practices are 
organised or staffed. The vast majority of variation relates to differences between people with 
diabetes.   
The study shows that where practice nurses undertake a higher proportion of consultations with 
diabetes patients, practices perform the same (in terms of glycaemic control) as practices where more 
of the consultations are done by doctors.  
In this study practices that made more use of nurses reduced the amount of time patients spent with 
doctors but also delivered more care (as measured by consultation time) overall with equivalent 
outcomes. The savings in doctors’ time does not appear to be offset by the additional costs of time 
spent with other practitioners, predominantly nurses. However there are opportunity costs associated 
with the use of GPs or secondary care to provide additional services. There is considerable scope to 
substitute nurses for GPs in delivering care for people with diabetes and to use nurses as a means of 
delivering enhanced care. The costs and benefits of this strategy remain uncertain but there is no 
evidence of harm. Indeed it is fair to say that optimised diabetes care is just as good when 
predominantly provided by nurses compared to care which is mainly provided by GPs. Other research 
suggests that patient satisfaction may be improved. 
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 1. Introduction and background 
1.1 Introduction 
As the population ages, there is a pressing need to cost-effectively manage the care of increasing 
numbers of people with long-term conditions, and prevent unnecessary hospitalisation. Pressure to 
find cost-efficient solutions to the delivery of health care have been intensified by the recent global 
and national financial crisis.  
Currently, it is estimated that as many as 3,636,000 people in the United Kingdom (excluding 
Northern Ireland) live with diabetes (Kanavos et al 2012). For some groups in the population, (for 
example black Caribbean and Indian men) the prevalence is over 10% (NICE 2008). The figure is 
rising as the incidence of type II diabetes mellitus, by far the most common form, increases. A 
diagnosis of Type II Diabetes Mellitus is associated with a significant increase in the utilisation of 
healthcare resources (Gulliford et al, 2008). The costs of diabetes are significant: a recent report 
estimated that approximately 10% of the NHS budget (£10 billion) was spent on diabetes in 2011 
(Hex et al, 2012). A large proportion of this (66%) results from hospital care and treatment for 
complications that arise including CHD, stroke, renal failure, visual impairment and  neuropathy 
(Kanavos et al 2012).  
With good diabetes control many of these complications could be prevented or onset delayed 
(Burden, 2003) but the proportion of patients achieving tight control, as measured by HbA1C 
(glycosylated haemoglobin) ≤6.5% is low, and significant numbers do not achieve less tight but ‘good’ 
levels of control (HbA1C ≤7.5%) (Kanavos et al 2012). Primary care has become the focal point with 
more diabetes care now taking place in GP practices (NICE 2008 Forbes et al 2011).  
In order to improve the quality of chronic disease management in primary care, a pay for performance 
scheme, the quality and outcomes framework (QOF), was introduced in 2004/5. This included targets 
and incentives for improving the quality of care for people with diabetes. In many practices much of 
the work involved in delivering results against the QOF indicators has been delegated by GPs to 
nurses (Leese, 2006) and over recent years there has been a steady increase in both the number of 
nurses employed in general practice and the proportion of consultations that are undertaken by them 
(Hippisley-Cox et al., 2007, The Information Centre, 2008), although increases in staff numbers have 
tailed off more recently.   
Models of nurse-led diabetes care have been advocated and positively evaluated in a range of 
settings including primary care (Vrijhoef et al., 2002) and there is evidence of similar outcomes when 
people with diabetes are managed by non-specialist nurse practitioners in primary care (Mundinger et 
al., 2000). Some have argued that there is considerable scope to further increase the amount of 
primary care delivered by nurses (Sibbald, 2008a, Sibbald, 2008b) but the potential extent and 
desirability of substitution is contested (Knight, 2008). Evidence of the impact on the quality of 
diabetes care of a widespread and routine increased nursing contribution is scant and there is little if 
any data on which to plan optimal skill mix between nurses and GPs in general practice. 
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Researchers have previously attempted to quantify the impact of nurse staffing policies on patient 
outcomes (Rafferty et al 2007, Aiken et al., 2002, al-Haider and Wan, 1991, Blegen et al., 1998, Hartz 
et al., 1989, Knaus et al., 1986, Sochalski, 2001). The majority of studies have been performed within 
acute care (e.g. hospital setting) and report adverse patient outcomes and quality of care (Blegen et 
al., 1998, Sochalski, 2001). The types of adverse patient outcomes examined included medication 
errors, patient falls, infections, patient complaints and mortality. 
A systematic review and meta-analysis of 96 studies confirmed these findings; increased nurse 
staffing was associated with lower odds of hospital related mortality and adverse patient outcomes 
(Kane, Shamliyan et al., 2007). The odds of hospital related mortality was 9 to 16% lower for each 
additional full time registered nurse per patient day while a curvilinear association between staffing 
and outcomes was demonstrated. Within the hospital setting, there appears to be consistent evidence 
that nurse staffing affects patient outcomes.  
As part of the current programme of research we demonstrated that higher levels of practice nurse 
staffing is associated with improved practice performance (as measured by QOF) for certain long-term 
conditions including diabetes (Griffiths et al., 2010a). Our research suggested that the effect of 
practice nurse staffing remains after controlling for patient, practice, practitioner, and organisational 
factors (Griffiths et al., 2011) although practices with higher levels of nurse staffing are also 
associated with higher levels of admissions for diabetes, but not other conditions (Griffiths et al., 
2010b). 
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1.2 Background 
Diabetes and its management  
Between 2006 and 2011 in England, there was a 25% increase in the number of people diagnosed 
with diabetes and it is estimated that there are 850,000 people with undiagnosed diabetes (Diabetes 
UK, 2012). If these current trends continue, it is anticipated that by 2025 there will be 5 million people 
in the UK with diabetes (Diabetes UK, 2012).  
Diabetes is associated with significant mortality and morbidity. It can lead to cardiovascular disease 
(coronary heart disease and stroke), renal failure, retinopathy, peripheral neuropathy and limb 
amputation. For example, those with diabetes are 48% more likely to have a myocardial infarction 
than the rest of the population (Diabetes UK, 2012). Managing potentially preventable complications 
consumes as much as 80% of the money allocated to diabetes care. There is an increasing emphasis 
on the prevention of diabetes-related complications through screening and assessment services in 
the primary care environment. For example to minimise risk of coronary heart disease and stroke, 
regular cholesterol and blood pressure checks are advised (Diabetes UK, 2012).  
Primary care can successfully manage chronic diseases such as diabetes and potentially reduce the 
need for hospitalisation due to complications (Basu et al., 2002, Zhan et al., 2004). However, the 
numbers of admissions for people with diabetes appears to be increasing in England (Bardsley et al., 
2013). 
Those with diabetes require on-going optimal management to ensure their diabetes is well-controlled 
and enable early detection of associated complications. A 6 to 20 year reduction in life expectancy is 
observed in those with poorly controlled diabetes (Seshasai et al., 2011). Hence the prevention of 
complications is closely linked to good glycaemic control.  
Nine Key Care Processes were derived from the National Service Framework (NSF) and the National 
Institute for Health and Clinical Excellence (NICE) and aimed to enable healthcare professionals to 
agree actions with individuals on managing their diabetes. The agreed standards relate to: 
Blood glucose level measurement 
Blood pressure measurement 
Cholesterol level measurement 
Retinal screening 
Foot and leg check 
Kidney function testing (urine) 
Kidney function testing (blood) 
Weight check 
Smoking status check 
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Two landmark studies, the Diabetes Control and Complications Trial (DCCT) and United Kingdom 
Prospective Diabetes Study (UKPDS) demonstrated that complications associated with diabetes are 
preventable or delayed through intensive glycaemic management (The Diabetes Control and 
Complications Trial Research Group (DCCT), 1993, UK Prospective Diabetes Study Group (UKPDS), 
1998). However, the tight glycaemic control needed is not consistently replicated in clinical practice 
(Speight, 2013). One of the explanations put forward is the relatively low number of patients being 
offered structured diabetes education (Speight, 2012).  
Although tight glycaemic control is not universally achieved, investigators have documented 
reductions in HbA1c in conjunction with blood pressure and plasma cholesterol reduction in several 
European studies (Cooper et al., 2009, Kloos et al., 2011, Mata-Cases et al., 2012). However in 
England there is large variation in the standard of care achieved against the nine standards of care 
set out by NICE. For example the proportion of individuals receiving their annual health checks 
ranged from 6% in some areas to 69% in others (NHS Information Centre for Health and Social Care,  
2011). The majority of those with diabetes (91%) have their annual blood pressure checks but a 
recent audit reveals that 1.4 million have hypertension with only between 41 and 61% of people 
achieving the recommended levels.  
Role of practice nurses 
General Practices provide primary healthcare to the community usually employing general 
practitioners, practice nurses and other staff including administrative staff, phlebotomists, 
psychologists and other healthcare professionals. Practices vary in size from a single GP to large 
practices with five or six GPs and several practice nurses. As in acute care, some research attention 
has focussed on the efficacy (and cost-effectiveness) of different staffing configurations. A key 
question has been: can practice nurses deliver some aspects of care to levels comparative to general 
practitioners?  
Several studies have outlined the changes to practice nurses’ workload and their increased role in 
caring for those with chronic conditions such as diabetes (Gemmell et al., 2009, Laurant et al., 2005, 
Richardson, 1999). The findings suggest that nurses provide comparable high quality care that is 
complementary to that of their medical colleagues. One review stated that extending nursing roles 
within general practice was feasible at improving service capacity with no compromise of quality of 
care or health outcomes (Sibbald et al., 2006). However these studies typically focussed on nurse 
practitioners specifically as opposed to practice nurses and all examined services delivered within the 
tightly controlled parameters of clinical trials.   
The workload of practice nurses has reportedly changed over the past decade with nursing now 
dealing with more complex patient care (Gemmell et al., 2009). Nurses are now more likely to provide 
patient care via a range of nurse-led clinics that allows for health promotion and surveillance of 
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chronic disease such as asthma, diabetes and chronic obstructive pulmonary disease (COPD). The 
cost implications of these changes however remain unclear (Laurant et al., 2005, Richardson, 1999)  
Developments in the NHS 
Over recent years the NHS has undergone radical reorganisation. The role of general practice in 
commissioning has been significantly increased and the nature of general practice itself is subject to 
substantial change with new opportunities for a range of providers to provide general practice 
services. While much of the management of people with diabetes has shifted from hospital based 
ambulatory settings to primary care management, with the support of community or hospital based 
specialists, the optimum model of care provision both within general practice the optimal method of 
delivering care remains unclear for both commissioners and providers.  
Quality and Outcomes Framework (QOF)  
The quality of primary care was difficult to quantify prior to the introduction of a new system of 
reimbursement linked to performance indicators known as the Quality and Outcomes Framework 
(QOF). Since the introduction of QOF in 2004, detailed descriptive information is now available 
(National Health Service Confederation, 2006). In 2004 QOF consisted of a total of 146 indicators that 
include measures on chronic disease management (76 indictors covering 11 chronic diseases 
including diabetes), practice organisation (56 indicators), patient experience (4 indicators) and 
additional services (10 indictors) and one indicator on access. The points are weighted and a score 
calculated for each practice with a maximum score of 1050 points (Department of Health, 2006). The 
QOF has allowed researchers to describe the quality of primary care and the relationship between 
social deprivation and other factors, such as practice characteristics (Ashworth and Armstrong, 2006). 
The study revealed that three variables were associated with higher QOF score: training practices, 
group practices and practices in less socially deprived areas. The conclusion was that practices in 
areas of higher social deprivation had a lower quality of care when measured using the QOF.  
There is some evidence that higher QOF scores are associated with improved outcomes such as  
reductions in mortality, morbidity, hospital referrals and non-elective admissions (Bottle et al., 2008a, 
Bottle et al., 2008b, Downing et al., 2007, Srirangalingam et al., 2006).  
One study used the GP Research Database to examine the quality of diabetes care at patient level 
from pre QOF (2000/01) to post QOF implementation (2006/07) in 148 practices  (Kontopantelis et al., 
2013). The authors recorded improvement in the first year post incentive compared to pre-incentive at 
14.2%; this dropped to 7.3% in the third year but remained statistically significant. The variation in 
care between population groups decreased over time but in some instances remained substantial. 
Levels of care varied according to gender, age, years of previous care, co-morbidities and practice 
diabetes prevalence. The financial incentives for practices are significant. If diabetes targets are met, 
the average practice could earn £7,500 in the first year and £12,500 in subsequent years (NHS 
Information Centre for Health and Social Care, 2007) . Interestingly Kontopantelis and colleagues 
(2013) reported a decrease in emergency hospital admissions but this effect was not sustained. 
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Unfortunately, the paper did not provide details on which members of the practice undertook patient 
care. 
Previous research by the National Nursing Research Unit used the Quality Outcomes Framework to  
examine long-term conditions such as diabetes, and found that higher levels of practice nurse staffing 
were associated with improved practice performance (Griffiths et al., 2010b). However, practices with 
more nurses also had higher rates of unplanned admission among people with diabetes.  
But findings based on practice level data are constrained. Aggregated data can hide important 
relationships. There is limited ability to control for individual patient characteristics and no indication 
how the workforce is actually deployed to care for people with a particular condition. Thus there is no 
guarantee that findings based on aggregated data (e.g. practice) will be replicated when data 
(patients) are disaggregated.  This led to an interest in pursuing the research further, focusing in 
depth in this study on one particular condition using patient level data (as opposed to practice level 
quality scores) and more detailed workforce data.  
1.3  Aim 
The aim of the current study is to examine whether different workforce configurations (and activity) in 
primary care are associated with variation in control of diabetes. We focussed in particular on the 
extent to which people with diabetes received care from practice nurses, as opposed to general 
practitioners, to explore the impact of the more general shift of chronic disease care from doctors to 
practice nurses in primary care. 
Specifically the study seeks to address the following research questions: 
What types of (diabetes related) activities are undertaken by doctors, practice nurses and other 
healthcare professionals; to what degree does this vary across practices and over time? 
Do practices where practice nurses undertake a higher proportion of consultations with diabetes 
patients perform worse, the same, or better in terms of glycaemic control than practices where there 
is a different pattern of consultations amongst practice staff? 
Are relationships previously found between practice nurse staffing and performance under QOF for 
diabetes replicated using patient level data? 
Which workforce attributes (e.g. nurse led, specialism in diabetes) offer the most effective provision of 
care for people with diabetes in terms of health outcomes and costs?  
Chapter 1 Summary 
Diabetes is seen as an important condition to focus on due to its increasing prevalence over the last 
ten years and the costs associated with treating it: it is estimated to affect 3.6 million people in the UK 
and cost the NHS £10 billion a year.  
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Several studies have outlined the changes to practice nurses’ workload and their increased role in 
caring for those with chronic conditions such as diabetes (Gemmell et al., 2009, Laurant et al., 2005, 
Richardson, 1999). 
Understanding what difference increasing the nursing contribution has on the management of patients 
with diabetes may have implications for other conditions in primary care.  
Previous research by the National Nursing Research Unit used the Quality Outcomes Framework to 
examine long-term conditions such as diabetes, and found that higher levels of practice nurse staffing 
were associated with improved practice performance. 
The aim of the study is to examine whether different workforce configurations (and activity) in primary 
care are associated with variation in control of diabetes.  
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2. Methods 
 
As set out in Chapter 1, the study aims to examine the nature of relationship between workforce 
configurations (and activity) in primary care and outcomes of patients with diabetes (as measured at 
the patient level).  
The approach taken draws on two main data sources: 
Patient level data on consultations with 319,649 people with diabetes from a nationally representative 
sample of 556 practices that indicates activities undertaken, who consultations were with, and 
outcomes. (The Health Information Network (THIN) data each year from 2002 to May 2012). 
A survey of 249 practices contributing to the THIN database to profile their workforce and activities 
relating to management of diabetes. 
These data are hierarchical. Medical records over time are nested within patients who are nested 
within practice. Data will therefore be analysed using a multilevel modelling approach (Goldstein, 
1995). The amount of care delivered by practice nurses (and doctors) will be estimated by the 
proportion of consultations undertaken by practice nurses, and this will be related to the attainment of 
HbA1C targets and workforce configuration.  
2.1 Patient level data set (THIN data set) 
THIN Data is supplied by Cegedim Strategic Data Medical Research UK (CSD) and currently covers 
more than 3.7 million active patients (6.2% of all UK Patients) from 556 GP Practices in the United 
Kingdom (UK). 
THIN data consists of anonymised data on the following: diagnoses, anonymised commentary written 
by the health physician, symptoms, prescriptions issued, tests and results, measurements and 
readings taken in the practice, demographic information, dates of entry in and out of the database 
such as information on death and outcomes of conditions and treatments. Medical conditions are 
recorded using the Read Clinical Classification Version 2 and 75% of THIN practices are now 
electronically linked to pathology laboratories and receive test results electronically. 
THIN Data are gathered from practices that use an electronic clinical system called Vision for 
managing patients’ data (http://www.inps4.co.uk/vision/vision/). Data are extracted using unobtrusive 
anonymous data collection software written by CSD’s sister company, INPS. New practices joining 
THIN undergo a Full Data Collection, which includes all retrospective data. Incremental data are then 
downloaded automatically each month. Data collection commenced in November 2002.  
England, Scotland, Wales and Northern Ireland all contribute GP practices to THIN although the 
majority are from England (Appendix A2.1). THIN Patients have a similar age, gender and medical 
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conditions profile to that found in the UK population. A Comparison of demographics, deprivation 
(Townsend), Quality and Outcomes Framework condition prevalence and deaths from THIN with 
national and QOF 2006/7 data found that demographics were similar although THIN had fewer people 
aged less than 25 years. Diabetes prevalence was similar (THIN 3.5% vs. National 3.7%). THIN 
patients tended live in more affluent areas (THIN 24% vs. National 20%). Adjusting for demographic 
and deprivation the 2006 THIN death rate was close to the national death rate (9.1 per 1000 vs. 9.4 
per 1000)(Blak et al, 2011). 
Patient records are regularly updated and therefore it is possible to track a patient longitudinally whilst 
they remain on the Vision system and registered in the same practice.  Figure 2.1 Structure of the 
THIN Data 
 
Source: THIN Data Guide for Researchers Version 2.6: 28 March 2013 (Cegedim Strategic Data 
Market Research UK) 
Data can be linked across the three main THIN clinical datasets (Medical records, Additional Health 
Details, Therapy) using the practice, patient and the consultation IDs. Patient level postcode variable 
indicators for each patient can be linked to these datasets using the practice ID and patient ID.  
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Members of the practice staff can be linked to records on the three main datasets using the Staff ID. 
The Staff file contains the roles of each member of staff so it is possible to identify the role of the 
person (e.g. doctor, practice nurse, administrator) who entered or made a change to the patient’s 
record. The Vision System allocates ‘ownership’ of the consultation record to one member of staff, 
usually the person who opens the record for the first time. It is possible that one or more other 
members of staff may add or make changes to the record. For example a practice nurse may see a 
patient initially but a doctor then subsequently prescribes a therapy. It is possible for more than one 
type of healthcare professional to be involved in a consultation.  
The practice file holds information on three key dates: use of Vision, Computerisation and compliance 
with “Acceptable Mortality Reporting” (AMR). To enable the analyses to be undertaken, a dataset 
needed to be generated from the THIN database, selecting eligible patients and practices.  
Patient and practice selection 
Stage 1 
Patients who fulfilled the following criteria were selected for inclusion into the study dataset: 
 Be flagged with an A (Acceptable record) or C (Acceptable: transferred out deceased without 
additional death information) code on the patient file thereby confirming the patient is suitable 
for research. 
 Have a code from the list of 612 Diabetes Readcodes in either their Additional Health Details 
or Medical Records files. 
 The code must have been entered after the registration, Acceptable Mortality Reporting or 
Vision date. 
The list of 612 diabetes ‘Readcodes’ (see Appendix A2.2) was created from pre-existing lists (CSD; 
Public Health Sciences, King’s College London) and from an inspection of THIN Readcodes access 
database (supplied by CSD). These criteria resulted in 406,362 patients being selected from 556 GP 
practices. The size of the various datasets is shown in Table 2.1 below. 
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Table 2.1 Diabetes THIN datasets 
File Records 
Patients 406,362 
Medical 84,447,383 
Additional Health Details 173,058,295 
Therapy 199,877,160 
Consultations 158,520,984 
Postcode variable indicator 444,309 
Staff 1,339,829 
 
Stage 2 
Patients with a Readcode that indicated gestational diabetes were excluded if they had no other 
diabetes Readcode in their patient record (n=168) reducing the population down to 406,195. 
A second algorithm was then applied to the patient record to identify patients where the medical 
record, additional health details and therapy record gave a strong indication that the person was 
diabetic. This necessitated the classification of Readcodes into seven groups (A to G)(Appendix 
A2.3). Only groups A (diagnostic and label codes) and B (Annual review) were used in the algorithm 
for selection of people with diabetes. All groups were used when we compared medical record Vision 
system entries made by doctors and practice nurses to the medical record (section 4.3). 
Algorithm for selecting people with diabetes 
A person was included if they satisfied one, or more, of the following criteria applied in the sequence 1 
to 6 (Note a person is only included in the first group they are allocated to. They may also have 
satisfied one or more of the other criteria further down the sequence): 
1. One or more codes from Group A and one or more diabetic treatment prescribed (n= 
273,169, 67.3%) 
2. One or more codes from Group A and at least two from Group B with different event dates 
(n=33,431, 8.2%) 
3. One or more diabetic treatments prescribed and at least two from Group B with different event 
dates (n=3,856, 1.0%) 
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4. One or more codes from Group A and two HbA1c measurements at least 30 months apart 
(n=545, 0.1%) 
5. A HbA1c value 6.5% or higher (n=7,657, 1.9%) 
6. Two codes from Group A recorded at different dates (n=986, 0.2%) 
(Criteria 5 and 6 were added after an initial review) 
This captured 319,649 (79%) patients. Those people not selected have been grouped by whether 
they had a diagnosis Readcode, an annual review Readcode, had received diabetic therapy and had 
two HbA1c measurement less than 30 months apart (Table 2.2). 
 
Table 2.2 People not selected by the algorithm 
Diagnosis 
readcode
Annual review 
readcode
Diabetic 
Treatment 
code
Months between Hba1c 
measurement
No. %
30 months or more 2397 2.8
less than 30 months 27897 32.2
No measurement 31542 36.4
30 months or more 182 0.2
less than 30 months 1300 1.5
No measurement 2161 2.5
30 months or more 2209 2.6
less than 30 months 5454 6.3
No measurement 9012 10.4
less than 30 months 1430 1.7
No measurement 2967 3.4
All 86551 100.0
Present Absent Absent
Absent Absent Absent
Present
Present Absent
 
 
Those patients not selected were subject to a further review. We sampled 10 patients from each 
category to see whether we were excluding certain patients unnecessarily. We were not, and based 
on this review we decided to not add any further categories. For the majority of these patients diabetic 
treatment, diagnosis of diabetes and annual review of diabetes was absent from their records. HbA1c 
may therefore have been measured for other reasons for example as part of an annual health check. 
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Stage 3: Selection of practices 
1. No practice was included prior to it joining the Vision System. 
2. No practice was included prior to AMR being attained. 
3. 90% (or more) of all HbA1c measurements had to be recorded in, or could be transformed 
into, percentage units. 
4. 90% (or more) of consultations could be associated with a member of practice staff whose 
staff role was known and was something other than administration. (In earlier periods, before 
the year 2000, records were entered more often by administrative staff on behalf of their 
healthcare professional colleagues) 
The number of THIN practices meeting the eligibility criteria increased from 247 in 2002 to 471 in 
2009. Since 2009 there has been fall to 434 in 2011/12 (see Appendix A2.1). 
2.2 Defining staff consultations using THIN data  
Each time a patient has a consultation with a healthcare professional a new record is opened on the 
Vision system. A member of practice staff can only open a record, or make changes to a record, if 
they are authorised to do so. Some of the records opened by practice staff do not necessarily relate to 
direct patient contact, for example the record might indicate that a letter has been written. We 
therefore restricted our definition of a consultation, or direct contact, to activities that took place in the 
GP surgery, or where there was contact with a healthcare professional outside of the surgery (e.g. a 
home visit). Phone conversations with a patient were also included in this definition. Below we have 
listed the types of contact (which may relate also to location of the contact) used:  
 Surgery consultation 
 Clinic (often by nurse) 
 Follow-up/routine visit 
 Home visit 
 Acute Visit by GP to patients home, usually during normal working hours 
 Night Visit (e.g. by practice doctor,  locum GP, colleague, or deputising service) - often an 
emergency 
 Out of Hours visit by practice doctor, often an emergency 
 Telephone call to patient 
 Co-op surgery consultation or home visit (collaborative out-of hours service by local GPs) 
 Telephone consultation 
 Children's home visit 
 Twilight visit 
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The type of contact or location that is allocated when a consultation record is first opened remains 
consistent across the consultation, medical, additional health details and therapy datasets. Each 
member of practice staff allowed to enter records has their own unique staff ID. The Vision system 
allocates ‘ownership’ of the initial consultation record to one person. That person’s staff ID, and no 
other, will appear in the consultations dataset for that consultation. Each time staff make changes to a 
patient’s record (this could be to the medical, additional health details and therapy records) their staff 
ID is added. The medical, additional health details and therapy record for a consultation all share the 
same consultation ID. Therefore it is possible to link records from the same consultation and ascertain 
whether more than one member of staff has been involved. Although the consultation dataset holds a 
record of the duration of each consultation (i.e. the time between opening and closing the consultation 
record) it was not possible to apportion time between healthcare professionals when a consultation is 
shared.  
Each staff ID can be linked to a staff group (e.g. doctor, practice nurse, pharmacist) using a lookup 
file. The depth of occupational coding has improved since 2002; the percentage of records coded to 
missing or administration has decreased for all four datasets (Medical record: 4.3% to 0.8%, 
Additional Heath Details: 7.0% to 1.2%, Therapy Record: 0.9% to 0.1%, Consultation file: 6.2% to 
4.3%). We included administration in the calculation of this percentage because in the past 
administrators were often used to enter data on behalf of their medically trained colleagues, 
particularly doctors. As will become evident below this practice appears to have diminished over time. 
In Table 2.3 we show how the staff group derived from the medical, AHD and therapy records, which 
could involve one or more members of staff compares with the single role allocated by the Vision 
system that appears on the consultations dataset only, for those consultations taking place in one of 
the locations listed above for 2002 and 2011 (Note this dataset also includes patients that were not 
selected by the algorithm in Stage 2 Section 2.1 above). The congruence between the two sources 
for staff group is good. 
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Table 2.3 Occupational group allocation to consultations 
Occupational Group No. % No. % No. %
Doctor 1634241 66.4 1631217 99.8 1818004 73.9
Practice Nurse 543476 22.1 526797 96.9 542612 22.0
Other nurses, midwives 40845 1.7 37106 90.8 38862 1.6
Other healthcare professionals 120692 4.9 113228 93.8 124425 5.1
Administration 120070 4.9 84580 70.4 96627 3.9
Unknown 1793 0.1 n/a n/a n/a n/a
All 2461117 100.0
Doctor 1478345 55.6 1474846 99.8 1678551 63.1
Practice Nurse 811421 30.5 797831 98.3 811541 30.5
Other nurses, midwives 64628 2.4 59713 92.4 61118 2.3
Other healthcare professionals 253049 9.5 233411 92.2 241434 9.1
Administration 51687 1.9 5077 9.8 7922 0.3
Unknown 1099 <0.01 n/a n/a n/a n/a
All 2660229 100.0
Vision allocated 
role group from the 
consultations file
Vision allocated 
role group also 
appears in either 
the medical, AHD or 
therapy record
Role group appears 
in either the 
medical, AHD or 
therapy record on its 
own or with other 
role groups
 
Measures of workforce activity 
The activity of staff was calculated on the basis of all consultations undertaken in relation to the 
person with a diagnosis of diabetes, rather than restricting our study solely to activities that that were 
explicitly related to diabetes care. This approach was adopted to take account of the multiple system 
and diagnoses that are affected by diabetes (as shown in the literature). All consultations, tests, 
checks and treatments relating to comorbidites associated with diabetes were captured; for example 
hypertension, discussions about weight loss, diet, exercise etc. A considerable amount of care 
received by a person with diabetes may be directly, or indirectly, related to their diabetes, and is likely 
to be a factor in much of their care, even when it is not the primary activity coded to their consultation. 
We were able to calculate the number of all types of consultation per annum for each person with 
diabetes, and the number of times they were seen by doctors, practice nurses and all healthcare 
professionals in total. We used two main measures of workforce activity: the average number of times 
people with diabetes were seen by a healthcare professional (per annum) and the percentage of 
consultations in that year involving practice nurses, divided into three levels: low (less than 26%), 
medium (26-35%) and high (over 35%) based on tertiles (three groups of equal or near equal size) 
derived from data for 2002 (the reference year). The percentage of diabetes reviews undertaken by 
practice nurses were similarly grouped into low (less than 34%), medium (35-77%), and high (over 
77%). 
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2.3 Choice of outcome measure: using HbA1c as a measure of diabetes 
control 
As the literature shows, good glycaemic control is key to managing diabetes and preventing 
complications.  Glucose attaches to haemoglobin during the life span of a blood cell. HbA1c reflects 
average plasma glucose over 8 to 12 weeks and is widely used in the management of diabetes. Blood 
for the purposes of testing HbA1c can be taken at any time of day; fasting is not required.  
Since 2002 HbA1c has been measured in % units (previously HbA1c was often measured using other 
units such as ‘international units’. The unit of measurement is now changing to mmol/mol. There has 
been a transition period where Hba1c has been measured in both % and mmol/mol units. However, to 
enable consistency across the time period studies, the measurement as a percentage has been 
adopted. The thresholds against which glycaemic control is monitored have varied – both between 
organisations reporting it and over time. Nearly all practices (>98%) were using %HbA1c to measure 
glucose levels from 2003 onwards, making it a feasible indicator for this research.  
The nearest HbA1c reading to the 1
st
 July (mid point of the year) was selected for each person with 
diabetes for each calendar year from 2002 to 2011. When two Hba1c measures were equidistant 
either side of 1
st
 July their mean was taken. For the 2011/12 analysis dataset the value nearest to the 
16
th
 May 2012 was chosen, in order to coincide with timing of the Practice Survey (undertaken in May 
2012 to July 2012). Each percentage HbA1c reading was then categorised according to whether the 
particular threshold was met. We chose thresholds that spanned the full range previously used for 
QOF ( ≤ 7%, ≤ 8%, ≤ 9%, ≤ 10%) 
2.4 Defining other variables  
In order to examine the possible relationship between staffing inputs (in terms of workforce attributes 
and activity by staff group) and health outcomes for people with diabetes (glycaemic control as 
measured by HbA1c), a number of variables needed to be included in the analysis. The source and 
definition of each are outlined below. 
Year of birth and gender for each person with diabetes was obtained from the THIN Patients file. The 
Townsend Score (socio-deprivation measure), ethnicity (percent white) and urban-rural classification 
were all taken from the THIN Postcode Variable Indicators (PVI) file. PVIs could alter if a person’s 
place of residence changed. The most recent PVI, prior to the HbA1c reading was linked to that 
reading. Practice size was obtained from the midyear counts, available by calendar year from CSD. 
The UK nation (England, Northern Ireland, Scotland, Wales) in which the practice was located was 
taken from the THIN Practice file which also included ‘Vision Date’, ‘Computerisation Date’ and 
‘Acceptable Mortality Reporting Date’. 
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a) Age: Year of birth was used to calculate the age of the person at the time of their HbA1c readings. 
b) Estimated date of diagnosis: Was based on either the date a person first received a diagnostic 
Readcode, when their first diabetic therapy was prescribed or when they first received an HbA1c 
reading ≥ 6.5%, whichever came first. Our study was confined to the period 2002 onwards. Not 
surprisingly very few people before 2002 had an HbA1c reading ≥ 6.5% that preceded their first 
diagnosis Readcode or first diabetic therapy. The estimated diagnosis date for 80% of people was 
determined from their first diagnosis Readcode (Table 2.4). Approximately equal proportions of 
estimated diagnosis dates were determined from either the person’s first diabetic prescription or when 
HbA1c ≥ 6.5% for the first time, 10% and 9% respectively. On current trends HbA1c ≥ 6.5% could 
soon overtake the diagnosis Readcode in determining estimated diagnosis date based on this 
approach.  
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Table 2.4 Estimated year of diagnosis by source of diagnosis date 
Estimated year of 
diagnosis
Diagnosis 
readcode
Diabetic therapy HbA1c ≥ 6.5% No. %
No. 118991 16162 2722 137875 (43.1%)
(%) (86.3%) (11.7%) (2.0%)
No. 15116 2131 1172 18419 (5.8%)
(%) (82.1%) (11.6%) (6.4%)
No. 15200 1826 1633 18659 (5.8%)
(%) (81.5%) (9.8%) (8.8%)
No. 15628 1688 2053 19369 (6.1%)
(%) (80.7%) (8.7%) (10.6%)
No. 15257 1451 2100 18808 (5.9%)
(%) (81.1%) (7.7%) (11.2%)
No. 14560 1512 2134 18206 (5.7%)
(%) (80.0%) (8.3%) (11.7%)
No. 13953 1417 2218 17588 (5.5%)
(%) (79.3%) (8.1%) (12.6%)
No. 13514 1352 2402 17268 (5.4%)
(%) (78.3%) (7.8%) (13.9%)
No. 13035 1380 2797 17212 (5.4%)
(%) (75.7%) (8.0%) (16.3%)
No. 11415 1313 3505 16233 (5.1%)
(%) (70.3%) (8.1%) (21.6%)
No. 9354 1176 4414 14944 (4.7%)
(%) (62.6%) (7.9%) (29.5%)
No. 2555 330 2035 4920 (1.5%)
(%) (51.9%) (6.7%) (41.4%)
No. 148 0 0 148 (0.0%)
(%) (100.0%) (0.0%) (0.0%)
Total No. 258726 31738 29185 319649 (100.0%)
(%) (80.9%) (9.9%) (9.1%) (100.0%)
2004
Source of diagnosis date Total
before 2002
2002
2003
2011
2012
Missing
2005
2006
2007
2008
2009
2010
 
†Data for 2012 covers the period up to 16
th
May 
 
c) Prevalence: Estimated date of diagnosis, date of registration, date of transfer out or death were 
used to calculate the number of person years of diabetes for each GP practice for the period 2002 
onwards by calendar year. These figures were divided by the practice list size for each GP practice to 
obtain prevalence. 
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2.5 Adjusting for co-morbidities  
A primary care equivalent of the Charlson index was used as our measure of comorbidity (Khan et al, 
2010). This index was time varying, and would increase as people acquired new conditions. 
Alongside this measure a time varying obesity indicator was derived. This was based on the QOF rule 
set for obesity. All records with inconceivable BMI measurements (age ≥ 16 and BMI <13 or BMI 
>150), where the weight was missing, the weight was zero or less and missing measurement dates 
were removed. An algorithm (see Appendix 5) for identifying outliers was applied to the data finishing 
with a final visual inspection of remaining suspected outliers. This process reduced the number of 
useable weight measurements by 3.7% from 4,706,621 to 4,534,221. 
Under QOF, obesity has an age based exclusion rule and lapse in weight measurement rule is set at 
15 months. The age rule excludes anybody under 16 however we did carry weight (BMI) 
measurements forward. For example if a person aged 15 years and 9 months had their weight 
measured and their BMI was 30 or over this was carried forward to their 17
th
 birthday. If by their 
seventeenth birthday they had not been weighed again (to calculate BMI) they would no longer be 
classified as obese, since there would have been a lapse of 15 months since the last weight 
measurement. 
A lapse in weight measurement at the end person’s medical history could mean that the condition was 
no longer indicated. The last consultation date for that person was used to ascertain whether the time 
lapse since the last weight measurement (obesity) was 15 months or more. 
2.6 Analytical approach (model) 
The hierarchical nature of the data lends itself to a multilevel modelling approach. Each person with 
diabetes is registered with a single practice and has HbA1c measurements for all, or some of, the 
years during the period 2002 to 2011. Consideration was given to modelling the data over the full 
period. This required us to specify a three level hierarchical model: GP practice> person with 
diabetes>yearly HbA1c measurements for that person.  
Each model included the same set of patient and practice level independent variables. These were as 
follows (the variable label used in the analysis tables is highlighted in bold): 
Patient level 
Age (calculated from date of birth on the THIN Patient File) 
Gender (1 = Female, 0 = Male) 
Primary care equivalent of the Charlson Index 
Obesity (1= BMI > 30, 0=BMI ≤ 30) 
Townsend score (Nationally derived quintiles 1=least deprived, 5=most deprived) 
Percent White (Nationally derived quintiles 1=lowest, 5=highest) 
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Postcode indicator variables (Townsend, Percent white, Urban-rural classification) were derived 
for each census output area (~ 150 households) using 2001 census data and matched to the 
postcode of the patient. 
Practice level 
Practice list size (from the mid-year count supplied by CSD) 
Prevalence (derived from the THIN data) 
UK Country (in which the practice is located) 
Workforce activity variables (practice level)  
Average number of times a person had a consultation with a healthcare professional annually (label 
shortened to Consultations per healthcare professional) 
Nurse contact; the percentage of all consultations involving or attributable to practice nurses 
categorised into tertiles: low, medium, high (See Section 2.2 Measures of workforce activity). 
Average number of diabetic Reviews with a healthcare professional (annually) 
% Practice nurse reviews; the percentage of all diabetic reviews involving or attributable to practice 
nurses categorised into tertiles: low, medium, high. 
 
The following variables were used in the model in their standardised form (mean zero, standard 
deviation of one): Age, Charslon, Practice List Size, Prevalence, Consultations per healthcare 
professional and Reviews with a healthcare professional. 
Before proceeding a test was performed to see whether the effect of the independent variables upon 
the outcome remained invariant over time. We attempted to fit this model - all independent variables 
and their interactions (multiplicative effects) with time (e.g. age x year, gender x year etc.) - using SAS 
Procedure GLIMMIX but this model failed to converge. It was also not possible to test individual 
interactions on a one-by-one basis using GLIMMIX due to model convergence issues. However we 
were able to test individual interactions using the package MLwiN. Nearly all interactions (see Table 
2.5) were significant suggesting that effects were not time invariant therefore the data should be 
modelled separately for each year of the study. Another reason for analysing data for each year 
separately was because the nature of the population was changing over time due to earlier diagnosis 
and treatment. The model was also fitted the data covering the period 2011/12 using the HbA1c 
measurement closest to 16
th
 May 2012. Models were fitted to a lower (≤ 7%) and upper (≤ 10%) 
HbA1c threshold, using a multilevel logistic regression model with random intercepts. 
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Table 2.5 Tests of interaction with Year (2002-2011) 
Interaction with year 2
Degrees 
of 
Freedom p 2
Degrees 
of 
Freedom p
Age(linear) x Year 563.1 9 <.001 236.8 9 <.001
Age(quadratic) x Year 32.8 9 <.001 28.6 9 <.001
Gender x Year 105.9 9 <.001 8.7 9 .46
Charlson x Year 208.9 9 <.001 37.3 9 <.001
Obesity x Year 64.4 9 <.001 208.3 9 <.001
Townsend x Year 83.3 45 <.001 75.0 45 .003
Ethnicity x Year 194.6 45 <.001 141.2 45 <.001
Urban-Rural Classification x Year 149.9 54 <.001 150.4 54 <.001
Practice List Size x Year 29.3 9 <.001 18.7 9 0.028
Prevalence x Year 126.9 9 <.001 29.6 9 <.001
Country x Year 193.1 27 <.001 120.9 27 <.001
Consultations per healthcare professional x Year 185.4 9 <.001 377.0 9 <.001
Nurse contact x Year 94.3 18 <.001 80.9 18 <.001
HbA1c ≤ 7% HbA1c ≤ 10%
 
 
2.7 Classification of diabetes Readcodes for the activity analysis 
The aim of the classification of diabetic Readcodes was to see what doctors and nurses were doing in 
relation to diabetes care and more specifically to find out who was changing medication and 
performing the annual reviews. We also sought to identify how many people with diabetes in a 
practice were being referred onto specialist care or were part of intermediate/shared care. This 
classification was undertaken by a diabetes nurse on the project team and went through a number of 
iterations that resulted in fewer categories (e.g.  eye screening, which was initially a separate 
category, was amalgamated with diabetes review)(see Appendix A2.3 ‘Readcode’ classification). This 
allowed us to look at activity in broad terms and to identify trends both at the level of the category and 
by individual Readcode. 
2.8 Ethics 
Based on the information we provided to National Research Ethics Service (NRES), we were advised 
that this project was not considered to be research according to the NRES guidance and therefore it 
did not require ethical review by a NHS Research Ethics Committee. 
Cegedim periodically audits it practices for administrative information. The instrument and database 
for the audit had previously received ethical approval. Inclusion of the additional questions (for the 
practice survey) did not require further ethical approval. 
 
 
Chapter 2 Summary 
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The proportion of a practice’s diabetic population that achieved glycaemic control (as defined at the 
7% and 10% levels) was used as the main outcome measure, using data from patient records (THIN 
data covering approximately 320 thousand patients in 400 practices).  
Differences in outcome (glycaemic control) were explored in two ways:  
- by comparing change over time. We used data from 2002 to 2012, to explore variation in 
glycaemic control over the years in relation to any differences observed in the proportions of 
consultations undertaken by different staff (recorded by staff on patient records in THIN), or 
changes in the types of activity undertaken (coded under different groupings)  
- by comparing practices within the current year to see how much glycaemic control varies 
between practices and what, if any variation relates to differences in the practices’ – their 
workforce, and who leads management of diabetes. These variables were derived from a 
survey of practices undertaken in the spring of 2012 (covering 249 practices)  
Workforce activity was captured through consultations as:  
- the average number of times people with diabetes were seen by a healthcare professional 
(per annum) 
- the percentage of consultations per year involving practice nurses, divided into three levels: 
low (less than 26%), medium (26-35%) and high (over 35%)  
A multilevel modelling approach was used to explain variation in glycaemic control attributable to 
characteristics of the person (age, gender, comorbidity) and the practice (size, diabetes prevalence 
workforce activity measures). 
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3. Survey of practices in 2012 (workforce and diabetes care)    
Between May and June of 2012, the THIN data supplier (CSD) undertook to survey practices to 
collect generic data on the practices they covered, and on behalf of the NNRU, also collected more 
detailed workforce data relating to how diabetes care was organised (see the Appendix 6 for the 
questionnaire). The survey was administered by CSD, who obtained responses from 249 practices. 
The survey asked background questions about the size and location of practices, and also covered 
questions on the total workforce (including nursing and support staff) and approaches to managing 
diabetes.  
3.1 Background: practice size, location and type 
Before we describe the nature of the nursing workforce available to provide care for people with 
diabetes, we start with some background information on the practices themselves.    
243 out of 249 practices provided details of the number of whole time equivalent (WTE) GPs. The 
total ranged from one GP in 15 practices to 10 or more in five practices. The total number of GPs 
practicing across the 243 practices covered is just under 1000 with an average (mean) practice of 4.1 
WTE GPs (median of 3.8). Practices have been grouped into ‘small’ (less than 3 WTE GPs), ‘medium’ 
(4-4.99 WTE GPs) and ‘large’ practices (5 or more WTE GPs). Figure 3.1 summarises these data. 
Just under a third of practices (30%) are in rural locations, 54% in urban locations, and 12% in inner 
city locations; 3% describe their location as ‘combination’ (perhaps where a practice has more than 
one surgery). Large practices are more likely to be found in urban locations (61% compared to 44% of 
small and 55% of medium practices). Larger proportions of small practices are found in inner city 
locations: 20%, compared to 11% of medium and 7% of large practices.   
Nine in ten (89%) indicated that they are a ‘dispensing’ practice and this did not vary by size of 
practice. However, practices located in urban or inner city areas are more likely to be dispensing 
practices (99% compared to 70% of rural practices).  
Just over half (56%), of all practices indicated that they are training practices. Large practices are 
more likely to be training practices than smaller ones; 24% of ‘small’ practices are training practices 
compared to 80% of ‘large’ practices. 
3.2 Practice workforce 
This section presents data on the total number of staff and the skill mix among GP practices covered 
in the survey. Only practices that were able to provide data for number of WTE staff and GPs are 
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included
1
 (n=232). The total number of all staff (including GPs themselves) ranges from 3 to 54 WTE 
with a mean of 15.35. The average for ‘small’ practices is 8.4 WTE, for ‘medium’ is 14.0 WTE and in 
‘large’ practices the mean is 29.6 WTE.  Typically, GPs represent 27% of all practice staff and this 
figure varies from 11% of all staff to 84% of all staff. Table 3.1 and Figure 3.1 summarise these data.   
 
Table 3.1. Workforce in GP practices: mean numbers and percentages (232 cases) 
Whole time equivalents (WTE) Mean no. staff Total % of all staff 
Total GPs  4.10 950 27% 
Total number of other staff (not GPs) 11.26 2612 73% 
    
Practice nurses 1.85 429 12 
Consultant nurse  0.01 1 <1 
Nurse practitioner 0.24 56 2 
Advanced nurse practitioner 0.08 18 1 
Other registered nurse 0.08 18 1 
Total RNs 2.26 522 15% 
Total nursing assistant/HCA/support worker 0.78 180 5% 
Dispensers  0.15 35 1 
Phlebotomists/pharmacists  0.08 20 1 
Total other clinical 0.23 55 2% 
Practice manager (clinical)  0.08 17 <1 
Practice manager (non-clinical)  0.95 221 6 
Total Practice management 1.03 238 7% 
Receptionist  5.41 1254 35 
Other staff not specified  0.16 38 1 
Admin staff (IT/assistant managers/secretaries)  1.36 316 9 
Cleaners  0.03 6 <1 
Total admin and other staff 6.96 1614 44% 
All staff (inc. GPs) 15.35 3562 100% 
                                                     
1
 If details of WTE equivalent for some staff groups are provided, ‘blank’ responses were treated as no staff 
employed. If all the staffing questions were blank, the responses are treated as missing and excluded from the 
analyses    
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Registered nurses (practice nurses, consultant nurses, nurse practitioners and advanced nurse 
practitioners and other registered nurses) account for 15% of all practice staff or 2.3 WTE on average. 
The average number of patients per RN is 3,800 with a minimum of 720 and maximum of 11,200.    
 
Figure 3.1 GP workforce summary: Mean number WTEs, percentage of all staff 
  
There is little difference between types of practice in the proportion of different staff groups employed 
in the practices covered by the survey. Larger practices tend to have slightly smaller proportions 
employed as practice management (5% compared to 12% in ‘small’ practices) and higher proportion 
employed as GPs (30% compared to 24% in ‘small’ practices).  Dispensing practices are more likely 
to have higher proportion of clinical support workers (including pharmacists and phlebotomists – 14% 
compared to 5% in practices that are not dispensing).  
Registered nurses account for 15% of the total primary care workforce. Whilst in relation to the clinical 
workforce (that is GPs and registered nurses together), RNs make up a third of the clinical workforce. 
Put another way, on average there is a ratio of one nurse to every two GPs. But this varies 
considerably, as shown in Figure 3.2. One in 20 practices report having no practice nurses whilst in 
12% of practices, RNs make up more than half of the total clinical staff.       
Number of GPs, 4.1, 
27%
Total Nursing 
support, 1.0, 7%
Total RNs, 2.3, 15%
Total Practice 
managers, 1.0, 7%
Total Admin staff, 
7.0, 44%
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Figure 3.2 Registered Nurses as a percentage of all RNs and GPs 
 
 
Most nursing staff (42%) are employed on Band 6, 24% are on Band 7 or 8 and 15% Band 5. One in 
five (20%) of staff are paid on the equivalent of Band 4 or lower (see Figure 3.3).  
 
Figure 3.3 Nursing staff (RNs and assistants) by equivalent AFC pay band 
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Grade mix of registered nurses varies by size of practice, with larger practices being more likely to 
employ nurses on Band 7/8 (33% compared to 21% in ‘medium’ sized practices and 15% in ‘small’ 
practices). Among the 207 practices providing data, 59% indicated that some nurses providing care to 
patients with diabetes hold a post graduate qualification relating to diabetic care from a higher 
education institute. One per cent of practices did not know whether or not they employed nurses with 
postgraduate qualifications in diabetes care. ’Large’ practices (5 or more GPs) are more likely to 
employ nurses holding postgraduate qualifications in diabetes care: 84% do compared with  52% and 
44% in ‘medium’ and ‘small’ practices respectively.  
 
Figure 3.4 Percentage of practices who employ nurses holding postgraduate diabetes 
qualifications 
  
3.3 Approach to diabetes care 
This section looks at how practices approach diabetes care. Figure 3.5 shows that the most frequently 
cited approach to diabetes care management is using nurse(s) specialised in diabetes care (73%). In 
practices that have nurses with postgraduate diabetes qualifications, this figure rises to 89%. In more 
than half of cases (57%) care is managed by GP(s) specialised in diabetes care and a similar 
proportion of respondents (54%) indicated that management of care is shared between the practice 
and hospital/community based consultants. In a third of cases (32%) care is managed by GP(s) with 
no diabetes specialism. 
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Figure 3.5 How care is managed by practices: percentages
2
 
  
Large practices are where care is most likely to managed by diabetes specialists, be they GPs or 
nurses and in small practices it is more likely to be managed by GPs and nurses that are not 
specialised in diabetes. For example, in 88% of ‘large’ practices, employing 5 or more GPs care is 
managed by nurses with specialist diabetes training compared to 56% of ‘small’ practices.  
When asked to indicate which is the main approach to managing care of people with diabetes using a 
‘designated nurse or nurses who specialises in diabetes’ was indicated by more than half of all 
respondents (58%; this includes 5% that said they use a combination of GPs and nurses both 
specialised in diabetes care). In a further 11% of cases care is managed by nurses (but not 
specialists). (See Figure 3.6).  
 
                                                     
2
 Respondents were allowed to indicate more than one management approach hence figures do not add up to 
100%.  
3
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Figure 3.6 How care is managed by practices (main approach): percentages 
  
Smaller practices are more likely to say management of care is shared with hospital or community 
consultants (22% vs. 5% in medium or large), rather than led by their own nurse (61% vs. 71% of 
medium sized), and are less likely to have care in the hands of a designated GP or practice nurse 
with specialist knowledge (51% vs. 83% in larger practices).   
In practices that have nurses with postgraduate qualifications in diabetes, 70% report the nurse 
specialists manage diabetes care, compared to 33% of practices where there are no nurses 
specialised in diabetes. However, this is still the most frequently used approach in these practices. 
Large practices are more likely to report that specialist diabetes nurses lead diabetes care 
management than smaller and medium sized practices.  
People with diabetes typically receive most of their diabetes related care and assessment via 
regularly held clinics specifically for diabetic patients (61%) or through routinely scheduled 
appointments (52%). A third of practices say that they provide appointments as and when needed 
(32%) and five per cent use other approaches (again it should be noted that respondents could 
indicate more than one approach) to care provision.  
Insulin treatment is initiated by a range of different practitioners. In 46% of cases the GP initiates 
treatment, in 36% of practices the practice nurse initiates treatment, in 32% of practices a community 
diabetic nurse specialist initiates treatment and in 40% of practices outpatient diabetes mellitus clinics 
initiate insulin treatment (8% of respondents indicated that other people or organisations initiate 
treatment).  
In just over half the cases (53%) a single approach is used while in a third (34%) two strategies are 
deployed and in 13% of cases three or more approaches are used to initiate insulin treatment. Where 
a single approach is used, it is most likely to be using diabetes mellitus outpatient clinics.   
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In practices where nurses hold specialist postgraduate qualifications the majority of diabetes care is 
provided through regularly held clinics specifically for diabetic patients (74% compared to 41% of 
cases where there is no specialist postgraduate trained diabetic nurse). Larger practices are more 
likely to provide care in this way.  
In large practices insulin treatment is more likely to be initiated by practice nurses (47% compared to 
39% in medium sized practices and 19% in small practices) while small practices are more likely to 
use outpatient diabetes mellitus clinics (58% compared to 36% of medium sized practices and 29% of 
large practices).  
Chapter 3 Summary 
 A survey of 249 practices undertaken in Spring 2012 found that a  ‘typical’ practice employs 
an average of 4 GPs, 2 registered nurses (RNs), 1 care support worker/assistant, a practice 
manager and 7 receptionists/admin staff (whole time equivalents).   
 The findings show that overall there is substantial variation between practices in the 
composition of their workforce, how they deliver care to people with diabetes, and who leads 
that care.  
 Nurses make up a third of the trained clinical staff (e.g. total GPs and RNs), but this varies 
considerably: 5% of practices have no registered nurses whilst in 12% RNs make up more 
than half of the clinical staff.  
 Larger practices (5 or more WTE GPs) are more likely to employ experienced nurses (on 
higher pay-bands), and nurses that hold a post-graduate qualification in diabetes (84% do, 
compared with 44% in small practices (less than 3 WTE GPs)). 
 A nurse (or nurses) who specialises in diabetes leads the management of care of patients 
with diabetes in 58% of practices, and generalist practice nurses lead care in 11% of 
practices.   
 About one in five (18%) practices say that the GP leads management of diabetes patients.  
89% of practices that employ a nurse with postgraduate specialist qualification in diabetes 
report that care of patients with diabetes is generally managed by a nurses (or nurses) who is 
specialised in diabetes.  
 In practices where nurses hold specialist postgraduate qualifications the majority of diabetes 
care is provided through regularly held clinics specifically for diabetic patients (74% compared 
to 41% of cases where there is no specialist postgraduate trained diabetic nurse).  
 In 46% of practices the GP generally initiates insulin treatment, and in 36% of practices the 
practice nurse initiates treatment. 
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4. Staff consultations and patient outcomes  
 
This chapter presents analysis of primary care medical records from the THIN practices during the 
period 2002 to 2012. The number of practices included in the analysis increased over time, varying 
from 247 to 471. We start by profiling the patient population to consider factors that need to be taken 
into account when looking at the relationship between workforce and outcomes for people with 
diabetes. We then describe each of the two key areas of interest: 
1. Outcomes in relation to their diabetes:  
a) What is the incidence and prevalence of diabetes in the THIN practice populations? 
b) How well controlled is their diabetes?  
2. Staff activity related to diabetes care: based on the activities coded as part of their 
consultation with individual patients.  
a) Who is doing what (based on consultations)?  
b) What are the ‘typical’ mix of activities undertaken by doctors and nurses in treating and 
caring for people with diabetes in primary care?  
c) Does the nature of the roles performed by nurses and doctors vary between practices? 
d) How have these patterns of activity changed over the last ten years? 
4.1 Patient Profile 
Below we briefly describe the patient profile of those people with diabetes registered in the practices 
that met the study selection criteria.  
 There has been a shift towards people with diabetes being older than they were ten years 
ago. In 2002, 8.4% were aged under 40, which has fallen to 6.6% in 2011/12. Conversely 
there has been an increase in the proportion of those people aged 80 and over from 12.5% in 
2002 to 14.6% in 2011/12.  
 There were more men with diabetes than women (55.2% vs. 44.8% in 2011/12).  
 Using the Townsend score to measure socio-deprivation, the overall profile distribution has 
remained stable across the study period. The study population was less deprived than the 
national population. 
 There were more people in the study sample who lived in areas where individuals described 
themselves as ‘White’ than is the national average.  
 The majority of people in the study population lived in less sparse urban areas. 
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CSD has over the last decade acquired more THIN practices from the all four UK nations. The 
majority are from England although recent acquisition of practices has happened at a far faster rate 
for Scotland (Appendix A2.1). The proportion of practices that met the criteria for inclusion based on 
the Vision and AMR dates in 2011/12 by nation was England (336, 72%), Scotland (71, 15%), Wales 
(37, 8%) and Northern Ireland (22, 5%). In the study population the proportion of people registered 
with practices in Scotland has increased from 2.7% in 2002 to 13.8% in 2011/12. 
There has been a steady increase in the proportion of people who have one or more comorbidities 
alongside their diabetes. In 2002 52.2% had one or more comorbidities. This figure has risen to 
60.0% in 2011/12. The percentage of people with 5 or more comorbidities, at any one time, has risen 
from 2.3% to 6.5% over the study period. 
Obesity has also increased considerably between 2002 and 2011/12 (Table 4.1). In 2002 fewer than 
30% of all people with diabetes were morbidly obese; this has risen to almost 47% by 2011/12. 
 
Table 4.1 Obesity (BMI ≥ 30) 2002 – 2011/12 
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
No. 36219 53062 55478 63436 67758 71169 76285 80026 82239 81730 79487
% 70.3 67.6 63.9 61.4 59.4 57.6 56.3 55.8 55.5 54.5 53.3
No. 15274 25440 31360 39955 46281 52335 59135 63303 65982 68293 69548
% 29.7 32.4 36.1 38.6 40.6 42.4 43.7 44.2 44.5 45.5 46.7
Total No. 51493 78502 86838 103391 114039 123504 135420 143329 148221 150023 149035
Obesity
Year
Absent
Present
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
4.2 Prevalence of diabetes in the THIN practices 2002-2012  
Table 4.2 describes the number of people with diabetes in each year since 2002 (as a number and as 
a proportion of all people). Whilst the average total number of patients registered per practice has 
changed little (from 8,617 patient in 2002 to 7,877 in 2011/12), the average number of patients with 
diabetes per practice has increased by 58% in the same period, and now account for one in 20 
patients (4.9% vs. 3.0% in 2002).  While national estimates of diabetes prevalence vary somewhat 
this figure is consistent with a recent estimate of 4.3% based on the QOF for 2010 (Kanavos et al., 
2012), and 5.8% prevalence from QOF in 2011/12 (NHS Information Centre for Health and Social 
Care, 2012). These figures reveal the extent of the growing burden of care that has been placed on 
GP Practices. 
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Table 4.2 Practice registers and diabetes prevalence 
Year
Practices 
(no.)
Mean SD Range Mean SD Range Mean SD Range
2002 247 8162 3878 1498 - 28455 237 115 40 - 719 3.0 0.6 1.0 - 5.7
2003 375 7541 3747 1482 - 28219 236 120 15 - 781 3.2 0.8 0.8 - 6.3
2004 386 7523 3826 1317 - 28373 254 132 31 - 841 3.4 0.8 0.9 - 6.6
2005 427 7525 3893 1333 - 28562 270 142 40 - 895 3.7 0.9 0.9 - 7.6
2006 441 7587 3951 1313 - 28856 288 153 47 - 957 3.9 0.9 1.0 - 7.5
2007 448 7686 3937 1349 - 29357 306 159 51 - 1003 4.1 0.9 1.2 - 7.9
2008 470 7655 3984 518 - 29929 318 167 10 - 1065 4.3 1.0 1.3 - 8.3
2009 471 7723 4033 1009 - 30440 335 176 20 - 1125 4.4 1.0 1.3 - 8.6
2010 466 7749 4073 1228 - 31157 350 185 37 - 1177 4.6 1.1 1.5 - 8.9
2011 445 7869 4130 1273 - 31441 370 194 57 - 1230 4.8 1.1 1.5 - 9.1
2011/20121 434 7877 4111 1273 - 31441 375 197 60 - 1249 4.9 1.1 1.5 - 9.2
%Change -3.5% 58.3% 66.1%
Estimated diabetic register size PrevalencePractice (Mid-year count)
1
 Uses mid-year count for 2011 to calculate prevalence 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
4.3 Staff activity  
Doctor and nurse consultation rates  
We start by describing some of the key trends in care of people with diabetes that have taken place 
over the last ten years (2002 to 2011/12) in THIN GP practices.  
There has been an increase in activity (across staff groups) as the numbers of patients with diabetes 
has increased. The average total number of consultations per practice of any type (e.g. both diabetic 
and non-diabetic care) involving a healthcare professional (based on the Vision system allocated role 
group) with people with diabetes has increased by 14% between 2002 and 2011/12. The equivalent 
figures for average total number of practice consultations derived from the medical, additional health 
details and therapy records are very similar, with an increase of 13% since 2002 (see Table 4.3). The 
increase in activity – as measured by consultations - is substantially lower than the increase in 
prevalence (66%). 
Table 4.3 shows figures on consultations that involve one or more staff groups from the practice 
healthcare team. So, for example, we count any consultation that involves just a doctor and any that 
doctors shared with a healthcare professional from another staff role group (e.g. practice nurse, 
pharmacist). An alternative means of capturing consultation by staff group is to base it on either the 
Vision system allocation, or restrict consultations to those that belong exclusively to a single staff 
group – e.g. only doctor or only nurse. These alternatives were explored and any key differences are 
reported in the text below. (Full results using these approaches are found in the appendices along 
with a footnote defining the levels of nurse contact) 
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Table 4.3 Average number of consultations per practice of patients with diabetes 
Year Practices (no.) Mean SD Range Mean SD Range Mean SD Range
2002 247 3900 2339 52 - 11641 2673 1539 21 - 8739 1205 857 0 - 4418
2003 375 3694 2403 3 - 14262 2515 1597 0 - 10698 1133 831 0 - 5094
2004 386 3874 2493 171 - 13850 2597 1605 107 - 10542 1202 894 1 - 5992
2005 427 3938 2541 350 - 15309 2590 1581 208 - 10929 1234 923 0 - 6576
2006 441 4043 2598 270 - 14412 2615 1561 72 - 9295 1277 968 0 - 5780
2007 448 4273 2734 133 - 14317 2700 1604 111 - 8289 1382 1055 0 - 6034
2008 470 4241 2724 53 - 14334 2654 1594 42 - 8497 1358 1051 0 - 6374
2009 471 4338 2788 215 - 15538 2659 1573 133 - 8569 1401 1088 0 - 7147
2010 466 4279 2759 246 - 15367 2641 1567 220 - 8469 1375 1076 0 - 6677
2011 445 4376 2805 219 - 15589 2662 1601 208 - 8703 1441 1095 0 - 6882
2011/2012 434 4423 2833 251 - 15674 2703 1628 246 - 9218 1449 1102 0 - 6561
% Change 13.4% 1.1% 20.2%
Doctors (Any contact) Practice nurses (Any contact)All healthcare professionals (Derived1)
 
1
 Derived from the medical, AHD and therapy records 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
It appears that the increase in consultations with diabetic patients has largely been delivered by 
practice nurses.  In the average GP practice, doctors were involved in 2673 consultations in 2002 
which rose only marginally to 2703 in 2011/12 representing a 1% increase over then ten-year period. 
Over the same period there has been a 20% increase in the consultations involving practice nurses. 
Looking at practice nurse only consultations (no other staff group involved) suggests there has been 
an increase of 23% between 2002 and 2012. For both staff role groups there was a fall between 2002 
and 2003 which coincides with an increase in eligible practices from 247 to 375. If 2003 is used as the 
reference year the increases were 7% and 27% respectively. Whichever figures are used, practice 
nurses have borne more of the increased workload than doctors based on this particular measure. 
The proportion of consultations undertaken by each group has changed only slightly. Table 4.4 
expresses the number of consultations by the two main staff role groups (Doctors, practice nurses) in 
terms of percentages. In 2002 70% of all consultations with people with diabetes were undertaken by 
doctors. By 2011/12 this had fallen to 64%. Amongst practice nurses there was a small increase from 
31% to 32%. During this period the proportion of consultations involving healthcare professionals who 
were neither doctors nor nurses, increased from 3.4% to around 7.6%. The staff role of these entries 
was often recorded simply as ‘Other Healthcare Professional’, rather than to something more specific 
(e.g. pharmacist, dietician).  
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Table 4.4 Proportion of consultations with doctors and practice nurses (as a percentage of all 
healthcare professional staff  
 
Practices 
(no.)
Mean SD Range Mean SD Range
2002 247 69.8 12.5 13.1 - 100.0 30.7 12.8 0.0 - 88.1
2003 375 69.1 13.0 0.0 - 99.9 31.0 13.5 0.0 - 100.0
2004 386 68.9 13.2 21.9 - 100.0 30.7 13.7 0.1 - 87.4
2005 427 68.0 13.4 35.4 - 99.9 30.9 13.9 0.0 - 76.5
2006 441 67.3 14.4 9.5 - 100.0 30.6 14.4 0.0 - 91.7
2007 448 66.2 14.7 18.5 - 100.0 31.2 14.5 0.0 - 92.2
2008 470 65.3 14.2 28.2 - 100.0 31.2 14.0 0.0 - 88.0
2009 471 64.4 14.9 10.9 - 99.8 31.5 14.5 0.0 - 96.7
2010 466 65.0 14.4 25.2 - 100.0 31.1 14.3 0.0 - 83.7
2011 445 63.8 14.3 29.7 - 100.0 32.2 14.1 0.0 - 77.0
2011/2012 434 63.9 14.3 31.0 - 100.0 32.0 14.2 0.0 - 71.6
% Change -8.4% 4.1%
Doctors (Any contact) Practice nurses (Any contact)
 
1
 Derived from the medical, AHD and therapy records 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
Figure 4.1 presents the data graphically. The modal group based upon ten-percent banding is 30-39% 
for practice nurses for both 2002 and 2011/12. There are proportionally more practices in 40-49% 
(19.4% vs. 13.8%) and 50-59% bands (7.6% vs. 6.1%) than in 2002 for consultations involving any 
contact with a practice nurse. The modal band for doctors was 60-69% in 2002 and 50-59% in 
2011/12. There are fewer practices in the 70-79% (18.2% vs. 29.6%) and 80-89% (7.4% vs. 16.2%) 
bands in 2011/12 than in 2002 for consultations involving any contact with a doctor however there has 
been a proportionate increase in the very highest band (90%+) from 2.5% to 5.2%. The percentage of 
all consultations involving practice nurses was subsequently categorised into low, medium and high 
(tertiles) for analysis purposes using 2002 as the reference year. 
  
43 
 
Figure 4.1 Consultations involving doctors and practice nurses 2002 vs. 2011/12 
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Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
The average number of consultations a person with diabetes had with a healthcare professional on an 
annual basis has dropped by 28% from 16.0 per annum in 2002 to 11.5 per annum in 2011/12 (Table 
4.5). The average number of consultations with doctors fell by 36% from 11.1 to 7.1 and for practice 
nurses by 24% from 5.0 to 3.8 per annum over the same period. 
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Table 4.5 Number of consultations per person with diabetes (per annum) with all healthcare 
professionals, doctors and practice nurses 
Year
Practices 
(no.)
Mean SD Range Mean SD Range Mean SD Range
2002 247 16.0 5.4 0.6 - 35.4 11.1 3.5 0.2 - 23.8 5.0 2.7 0.0 - 15.2
2003 375 15.3 5.1 0.0 - 32.9 10.4 3.3 0.0 - 22.4 4.8 2.6 0.0 - 14.2
2004 386 14.9 4.6 1.6 - 32.2 10.1 2.9 1.4 - 22.0 4.7 2.5 0.0 - 15.0
2005 427 14.3 4.3 4.1 - 32.4 9.5 2.8 2.9 - 24.1 4.6 2.5 0.0 - 15.0
2006 441 13.8 4.2 2.1 - 30.6 9.1 2.6 0.4 - 24.5 4.4 2.4 0.0 - 12.3
2007 448 13.7 4.2 1.2 - 29.1 8.8 2.6 0.7 - 25.0 4.5 2.4 0.0 - 12.7
2008 470 13.1 4.2 0.4 - 44.3 8.3 2.5 0.3 - 23.0 4.3 2.5 0.0 - 25.6
2009 471 12.7 4.0 2.0 - 35.5 7.9 2.2 1.0 - 18.3 4.2 2.5 0.0 - 19.9
2010 466 12.0 3.6 3.5 - 22.8 7.5 2.1 2.2 - 18.6 3.9 2.2 0.0 - 12.6
2011 445 11.6 3.4 2.6 - 21.6 7.1 2.0 2.5 - 18.9 3.9 2.1 0.0 - 11.9
2011/2012 434 11.5 3.3 2.7 - 21.2 7.1 2.0 2.7 - 18.8 3.8 2.1 0.0 - 11.8
% Change -28.3% -35.6% -23.9%
Doctors (Any contact) Practice nurses (Any contact)All healthcare professionals
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
The shift towards fewer consultations with doctors and practice nurses is shown graphically in Figure 
4.2. People with diabetes are therefore seeing professionals from both these two groups less often in 
2011/12 than they were a decade earlier in 2002. 
 
Figure 4.2 Number of times people with diabetes are seen by doctors and practice nurses, 
2002 vs. 2011/12 
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Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
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The number of times people with diabetes saw a doctor in 2011/12 was negatively, and significantly, 
correlated (Pearson correlation -0.22, n==210, p=.001) with the list size per GP (that is the number of 
patients registered with a practice per WTE general practitioner). Similarly there was a negative 
correlation between number of people seeing a practice nurse (Pearson correlation, -0.22, n=207, 
p=.002) and list size per practice nurse. So as might be expected, the more people doctors and 
practice nurses had to care for, the less often people with diabetes received consultations.  
We can conclude from these tables that there has been sharp increase in the prevalence of diabetes. 
The additional burden of care has been absorbed primarily by practice nurses and other healthcare 
professionals, rather than doctors, and people with diabetes are seeing healthcare professionals less 
often than in the past. 
Types of activity undertaken by doctors and nurses 
Since 2002 practice nurses have increasingly been recording more activities about those people with 
diabetes who they have contact with than doctors.  Table 4.6 shows the average number of entries 
made by doctors and practice nurses that appear in the THIN medical records dataset. Individual 
Readcodes have been grouped according to the classification in Appendix A2.3.  In 2002 the average 
number of entries per practice for both doctors and practice nurses (228 vs. 232). By 2011/2012 
practice nurses were making 2.7 times as many entries as doctors. 
 
Table 4.6 Activity categories 2002 - 2011/12: mean frequency per practice  
Role Group Readcode classification 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Diagnosis or label 95.7 87.5 81.5 70.3 67.1 59.9 56.8 54.6 52.5 51.8 50.6
Diabetes review 131.3 137.4 145.0 128.5 115.3 114.1 114.8 122.9 128.3 179.0 204.1
Medication review 0.6 1.7 5.7 5.1 5.1 4.9 4.1 5.2 7.1 5.8 5.3
Referral to another party 0.4 0.4 0.3 0.9 0.7 0.7 1.0 1.2 1.2 1.3 1.3
Care for by secondary clinic 0.3 0.7 4.9 8.1 4.6 3.2 3.2 3.2 3.0 2.5 2.5
Exemption codes 0.0 0.2 4.6 6.0 5.5 4.8 3.6 3.0 4.1 3.3 3.3
Other 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1
All 228.4 227.9 242.0 218.9 198.3 187.8 183.8 190.2 196.3 243.8 267.10.00.0
Diagnosis or label 25.2 31.7 33.8 28.4 30.9 30.1 29.4 30.9 27.6 31.0 32.1
Diabetes review 206.1 201.7 230.4 242.4 251.9 261.3 275.6 294.0 344.3 572.1 656.2
Medication review 0.4 0.4 2.8 2.9 2.7 3.7 4.0 3.2 3.4 3.6 3.3
Referral to another party 0.2 0.2 0.3 2.8 3.0 2.7 3.8 4.5 4.5 4.9 5.0
Care for by secondary clinic 0.2 1.4 11.6 20.9 19.9 21.7 19.0 18.6 16.5 15.9 14.8
Exemption codes 0.0 0.1 3.0 4.2 3.9 4.5 4.3 3.8 3.2 3.4 3.1
Other 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.30.0
All 232.0 235.5 281.7 301.6 312.2 324.0 336.2 355.1 399.6 631.2 714.8
Practice 
Nurse
Doctor
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
A higher proportion of entries made by doctors relate to diagnosis or labelling than is the case for 
practice nurses (Table 4.7). In both groups the category “diagnosis or label” as a proportion of all 
entries has declined from 42% to 19% for doctors and from 11% to 4% for practice nurses.  More 
entries made by doctors relate to annual review now than in the past rising from 58% of all doctors 
entries in 2002 to 76% in 2011/12. In particular there has been a dramatic increase in entries 
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concerning foot screening/examination from 0.1% in 2002 to 32% in 2011/12 (Appendix 4.1b). Entries 
for care or management plans have increased eightfold from 0.5% in 2002 to 4% in 2011/12.  
Annual review has always been the dominant category for entries made by practice nurses 
representing consistently over 80% of all entries. The proportion fell from 89% in 2002 to 80% in 
2005, but has steadily increased since then to 92% in 2011/12. Foot screening, examination or 
assessment entries have increased from 0% in 2002 to 43% in 2011/12 and care or management 
plans entries from 0.2% in 2002 to 2.2% in 2011/12 (Appendix 4.2b). 
 
Table 4.7 Activity code classification: percentages for doctors and practice nurses 
Role Group Readcode classification 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/1
Diagnosis or label 41.9 38.4 33.7 32.1 33.8 31.9 30.9 28.7 26.8 21.3 18.9
Diabetes review 57.5 60.3 59.9 58.7 58.1 60.8 62.4 64.6 65.4 73.4 76.4
Medication review 0.3 0.7 2.4 2.3 2.6 2.6 2.2 2.7 3.6 2.4 2.0
Referral to another party 0.2 0.2 0.1 0.4 0.4 0.4 0.5 0.6 0.6 0.5 0.5
Care for by secondary clinic 0.1 0.3 2.0 3.7 2.3 1.7 1.7 1.7 1.5 1.0 0.9
Exemption codes 0.0 0.1 1.9 2.7 2.8 2.5 2.0 1.6 2.1 1.4 1.2
Other 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0
All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Diagnosis or label 10.9 13.5 12.0 9.4 9.9 9.3 8.7 8.7 6.9 4.9 4.5
Diabetes review 88.8 85.6 81.8 80.4 80.7 80.6 82.0 82.8 86.2 90.6 91.8
Medication review 0.2 0.2 1.0 1.0 0.9 1.2 1.2 0.9 0.9 0.6 0.5
Referral to another party 0.1 0.1 0.1 0.9 0.9 0.8 1.1 1.3 1.1 0.8 0.7
Care for by secondary clinic 0.1 0.6 4.1 6.9 6.4 6.7 5.6 5.2 4.1 2.5 2.1
Exemption codes 0.0 0.0 1.1 1.4 1.2 1.4 1.3 1.1 0.8 0.5 0.4
Other 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0
All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Doctor
Practice 
Nurse
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
Further analysis was undertaken to explore activities coded under diabetic review in greater detail and 
to model the relationship between average number of reviews (per person) at the practice level and 
diabetes control. In Table 4.8 we can see the average number of diabetic reviews performed by 
practices over the period 2002 to 2011/12. 
Table 4.8 Average number of total reviews undertaken by practices 2002 - 2011/12 
Year Practice (No.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 300 256 0 - 1188 117 138 0 - 724 175 192 0 - 907 53 34 0 -100
2003 375 298 281 0 - 1681 120 169 0 - 1616 172 196 0 -1083 54 34 0 -100
2004 386 330 318 1 - 1851 128 186 0 - 1839 195 220 0 -1209 56 34 0 -100
2005 427 332 333 0 - 2042 115 181 0 - 1792 205 229 0 -1253 57 34 0 -100
2006 441 335 344 0 - 2093 104 172 0 - 1710 216 247 0 -1439 58 35 0 -100
2007 448 342 345 0 - 1968 101 165 0 - 1387 225 258 0 - 1562 60 35 0 -100
2008 470 352 358 0 - 2262 100 165 0 - 1316 233 265 0 - 1454 60 35 0 -100
2009 471 372 372 0 - 2383 107 171 0 - 1350 240 269 0 - 1440 59 35 0 -100
2010 466 402 377 0 - 2290 109 174 0 - 1750 266 272 0 - 1413 62 34 0 -100
2011 445 496 406 1 - 2571 126 187 0 - 1828 334 302 0 - 1531 65 32 0 -100
2011/12 434 513 417 0 - 2481 131 191 0 - 1709 342 306 0 - 1579 65 32 0 -100
All reviews with a healthcare 
professional (No.) Doctor reviews (No.) Practice nurse reviews (No.) % reviews by practice nurses1
1
 only calculated for practices with one or more reviews; the maximum number of practices with no 
reviews in a particular year was 4. 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
47 
 
The average number of reviews per practice with a healthcare professional has increased by 69% 
from 300 in 2002 to 513 in 2011/12. This measure of activity varies considerably between practices, 
perhaps not surprising because practice characteristics, e.g. practice list size, people on the diabetic 
register, deprivation etc. are heterogeneous. The degree of variation (as measured by the standard 
deviation) has increased over the period of the study (from 256 to 417). The trends are however 
different for doctors and practice nurses.  
Total number of reviews reached a peak for doctors in 2004, and then declined before rising again in 
2009. For practice nurses’ total number of reviews has risen every year, except for 2003, over the 
period from 175 in 2002 to 342 in 2011/12. The standard deviation has also increased over the 
period. In percentage terms practice nurses are undertaking proportionately more of the reviews than 
in the past increasing from 53% in 2002 to 65% in 2011/12. Variation between practices in the 
percentage of reviews undertaken by practice nurses, has remained quite stable (SD around 34-35%) 
although this has decreased since 2009.  
What has been described so far however does not reveal how often, on average, people with 
diabetes were seen each year for a diabetic review in their practice. These figures are shown in Table 
4.9. 
Table 4.9 Average number of times people with diabetes were reviewed by practices 2002 - 
2011/12 
Year Practice (No.) Mean SD Range Mean SD Range Mean SD Range
2002 247 1.23 0.86 0.01 - 4.52 0.48 0.49 0.01 - 2.11 0.72 0.73 0.00 - 3.89
2003 375 1.18 0.84 0.01 - 4.60 0.46 0.52 0.00 - 2.92 0.70 0.68 0.00 - 3.54
2004 386 1.20 0.85 0.00 - 4.66 0.45 0.51 0.00 - 3.00 0.72 0.69 0.00 - 4.23
2005 427 1.15 0.87 0.01 - 4.38 0.38 0.47 0.00 - 2.97 0.73 0.71 0.00 - 4.27
2006 441 1.09 0.85 0.01 - 4.48 0.33 0.43 0.00 - 2.93 0.72 0.70 0.00 - 3.96
2007 448 1.05 0.81 0.00 - 3.74 0.31 0.42 0.00 - 2.43 0.70 0.69 0.00 - 3.39
2008 470 1.05 0.82 0.00 - 4.32 0.30 0.42 0.00 - 2.46 0.71 0.70 0.00 - 4.31
2009 471 1.06 0.81 0.00 - 4.88 0.30 0.41 0.00 - 2.34 0.70 0.68 0.00 - 4.88
2010 466 1.11 0.78 0.00 - 4.23 0.30 0.41 0.00 - 2.74 0.74 0.64 0.00 - 4.21
2011 445 1.31 0.77 0.00 - 5.46 0.33 0.41 0.00 - 2.62 0.90 0.67 0.00 - 4.86
2011/12 434 1.32 0.73 0.00 - 5.39 0.34 0.40 0.00 - 2.38 0.90 0.65 0.00 - 4.76
All reviews with a healthcare 
professional Doctor reviews                           Practice nurse reviews             
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
The number of times people with diabetes were reviewed decreased from 1.23 times per year in 2002 
to 1.05 in 2007 before rising to 1.32 in 2011/12. The variability between practices as measured by the 
standard deviation has fallen over the study period from 0.86 to 0.73. Doctors are seeing people with 
diabetes less often than in the past for review purposes falling from 0.48 in 2002 to 0.30 in 2008 with 
a small increase since then to 0.34 in 2011/12. Between 2002 and 2010 the number of time patients 
were reviewed by a practice nurse remained relatively stable at around 0.70 - 0.74 times per year. In 
2011 this increased to 0.90. The standard deviation has been in the range 0.68 to 0.73 for most years 
except for 2010 and 2011/12 when it decreased to 0.64 and 0.65 respectively. Figure 4.3 shows how 
the distributions have shifted since 2002. The modal band in 2002 was 0.00 to 0.49 for reviews 
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undertaken by practice nurses, this had moved up one band by 2011/12. In 2002 63% of practices 
were in the lowest band for reviews by doctors. This percentage had increased to 75% by 2011/12. 
Figure 4.3 Number of times patients were reviewed by doctors and practice nurses, 2002 vs. 
2011/12 
0
10
20
30
40
50
60
70
80
0
.0
0
 -0
.4
9
0
.5
0
 -
0
.9
9
1
.0
0
 -1
.4
9
1
.5
0
 -
1
.9
9
2
.0
0
 -2
.4
9
2
.5
0
 -
2
.9
9
3
.0
0
 -3
.4
9
3
.5
0
 -
3
.9
9
4
.5
0
 -
4
.9
9
0
.0
0
 -0
.4
9
0
.5
0
 -
0
.9
9
1
.0
0
 -1
.4
9
1
.5
0
 -
1
.9
9
2
.0
0
 -2
.4
9
2
.5
0
 -
2
.9
9
3
.0
0
 -3
.4
9
4
.5
0
 -
4
.9
9
2002 2011/12
%
Doctors Practice Nurses
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
Turning now to medication reviews Table 4.10 shows that practices are undertaking more medication 
reviews now than in the past. 
Table 4.10 Average number of total medication reviews undertaken by practices 2002 - 2011/12 
Year Practice (No.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 1.0 4.0 0 - 41 0.6 3.1 0 - 41 0.3 2.3 0 - 27 23.9 39.8 0 -100
2003 375 2.2 6.4 0 - 68 1.6 4.7 0 - 61 0.4 2.3 0 - 34 14.7 30.2 0 -100
2004 386 8.3 22.0 0 - 244 5.5 15.2 0 - 218 2.7 15.1 0 - 241 23.3 36.4 0 -100
2005 427 8.1 26.2 0 - 337 4.9 16.0 0 - 266 2.9 17.9 0 - 329 26.4 39.1 0 -100
2006 441 7.7 29.4 0 - 394 5.0 18.9 0 - 250 2.6 18.4 0 - 334 25.8 38.9 0 -100
2007 448 8.6 35.7 0 - 500 4.8 19.2 0 - 298 3.7 25.4 0 - 410 27.4 39.3 0 -100
2008 470 8.1 35.8 0 - 518 4.0 15.9 0 - 242 3.9 27.8 0 - 404 28.8 40.7 0 -100
2009 471 8.3 32.6 0 - 574 5.1 20.6 0 - 276 3.1 16.8 0 - 298 31.7 41.0 0 -100
2010 466 10.5 35.5 0 - 661 7.0 26.4 0 - 464 3.4 13.6 0 - 197 31.9 41.3 0 -100
2011 445 9.4 40.8 0 - 810 5.7 26.3 0 - 503 3.6 17.0 0 - 307 38.0 42.1 0 -100
2011/12 434 8.5 40.4 0 - 804 5.2 25.2 0 - 481 3.2 17.0 0 - 323 38.9 43.1 0 -100
All medication reviews with a 
healthcare professional (No.) Doctor medication reviews (No.) Practice nurse reviews (No.)
% Medication reviews by 
practice nurses1
 
1
 only calculated for practices with one or more reviews; the number of practices with no medication 
reviews ranged from 106 to 198 over the study period. 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
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The average number of times people with diabetes had their medication reviewed by practices each 
year is shown in Table 4.11. There was a sharp increase in medication reviews from 0.004 to 0.031 
between 2002 and 2004. From 2005 onwards the average decreased but has remained around the 
same level, since 2006. However, as indicated by the range, there are a small number of practices 
that are now reviewing medications on a much more regular basis, on average, one or more 
medication reviews every year for each person with diabetes. 
 
Table 4.11 Average number of times people with diabetes had their medication reviewed by 
practices 2002 - 2011/12 
Year Practice (No.) Mean SD Range Mean SD Range Mean SD Range
2002 247 0.004 0.019 0.00 - 0.236 0.003 0.018 0.00 - 0.236 0.001 0.006 0.00 - 0.074
2003 375 0.010 0.026 0.00 - 0.250 0.007 0.021 0.00 - 0.250 0.002 0.008 0.00 - 0.104
2004 386 0.031 0.068 0.00 - 0.573 0.020 0.047 0.00 - 0.527 0.010 0.045 0.00 - 0.495
2005 427 0.028 0.076 0.00 - 0.798 0.017 0.043 0.00 - 0.594 0.009 0.045 0.00 - 0.642
2006 441 0.024 0.069 0.00 - 0.833 0.016 0.051 0.00 - 0.734 0.007 0.037 0.00 - 0.606
2007 448 0.024 0.078 0.00 - 0.975 0.014 0.052 0.00 - 0.861 0.009 0.049 0.00 - 0.720
2008 470 0.021 0.070 0.00 - 0.961 0.012 0.041 0.00 - 0.661 0.009 0.050 0.00 - 0.693
2009 471 0.021 0.063 0.00 - 0.999 0.013 0.044 0.00 - 0.503 0.007 0.031 0.00 - 0.519
2010 466 0.027 0.068 0.00 - 1.109 0.018 0.052 0.00 - 0.779 0.009 0.029 0.00 - 0.331
2011 445 0.023 0.071 0.00 - 1.289 0.014 0.046 0.00 - 0.801 0.010 0.034 0.00 - 0.489
2011/12 434 0.020 0.067 0.00 - 1.235 0.012 0.042 0.00 - 0.739 0.008 0.031 0.00 - 0.496
All reviews with a healthcare 
professional Doctor reviews                           Practice nurse reviews             
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
In 2002 there were two practices (0.8%) where doctors were reviewing the medications of one in 
every ten people with diabetes. This increased to seventeen practices (3.6%) in 2010 before falling to 
13 (2.9%) practices in 2011. For practice nurses no practices were reviewing the medications of at 
least one in ten people in 2002. By 2010 this had risen to eleven practices (2.3%) falling to ten in 
2011 (2.2%). The figures for the 2011/12 were noticeably lower for both doctors and practice nurses 
(7 and 4 practices respectively) which may be explained by the fact that 2011/12 data covers two 
QOF reporting periods. 
In 2002 doctors reviewed the medication of one or more people with diabetes in 41 (17%) practices. 
This increased to 259 (56%) of practices in 2010 falling to 214 (49%) in 2011/12. For practice nurses 
the corresponding figures were 16 (6%), 171 (38%) and 159 (37%) for 2002, 2010 and 2011/12 
respectively. 
Table 4.12 shows that practice nurses are becoming more involved in prescribing, although still at a 
low level. Almost 4% of consultations, where a therapy was prescribed that was described as ‘acute’ 
(e.g. not a repeat prescription), were undertaken by a practice nurse in 2011/12 compared to 0.1% in 
2002. For prescriptions that were specifically for the treatment of diabetes this figure was 8.5% in 
2011/12. (see Table 4.13). 
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Table 4.12 Consultations where an acute therapy (of any kind) was prescribed 
Year
Practices 
(no.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 246 1320 788 2 - 4552 1309 782 2 - 4552 1 20 0 - 304 0.1 1.1 0.0 - 16.4
2003 374 1186 791 19 - 5214 1176 787 19 - 5213 1 11 0 - 203 0.1 1.0 0.0 - 12.7
2004 386 1180 785 3 -5488 1169 779 3 -5488 2 18 0 - 209 0.1 1.1 0.0 - 15.0
2005 427 1190 792 7 - 5749 1177 784 7 - 5749 3 20 0 - 238 0.2 1.3 0.0 - 15.2
2006 441 1199 782 27 - 4740 1171 764 27 - 4740 17 51 0 - 414 1.2 3.1 0.0 - 20.5
2007 448 1261 819 28 - 4739 1215 785 28 - 4560 34 83 0 - 690 2.3 4.9 0.0 - 40.0
2008 470 1249 813 23 - 4889 1190 772 23 - 4889 47 100 0 - 681 3.3 6.7 0.0 - 70.7
2009 471 1235 785 32 - 4869 1174 745 24 - 4520 48 98 0 - 883 3.6 7.6 0.0 - 94.3
2010 466 1242 792 51 - 4714 1180 749 51 - 4318 53 100 0 - 829 3.6 6.2 0.0 - 38.3
2011 445 1255 794 43 - 4930 1192 751 43 - 4393 56 108 0 - 780 3.9 6.7 0.0 - 38.9
2011/12 434 1257 795 32 - 4914 1195 751 32 - 4522 56 109 0 - 841 3.9 6.6 0.0 - 40.1
Prescribed by a:
All healthcare professionals(No.) Doctor(No.) Practice nurse(No.) Practice nurse (%)
 
Table 4.13 Consultations where an acute diabetes therapy
1
 was prescribed 
Year
Practices 
(no.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 242 70 77 1 - 645 69 76 1 - 645 0 2 0 - 37 0.1 1.3 0.0 - 19.7
2003 370 57 79 1 - 782 56 79 1 - 782 0 3 0 - 49 0.2 1.8 0.0 - 25.0
2004 382 52 69 1 - 681 52 69 1 - 681 0 3 0 - 43 0.2 1.8 0.0 - 28.1
2005 424 55 77 1 - 844 54 76 1 - 844 0 4 0 - 66 0.4 3.5 0.0 - 57.9
2006 440 55 72 1 - 691 52 70 1 - 691 2 10 0 - 141 2.6 8.8 0.0 - 66.7
2007 442 60 78 1 - 814 55 74 0 - 808 4 16 0 - 222 5.1 13.2 0.0 - 84.4
2008 469 61 75 1 - 736 55 69 1 - 731 6 20 0 - 193 6.9 16.4 0.0 - 82.9
2009 471 66 77 1 - 801 58 69 1 - 800 7 24 0 - 292 7.2 16.8 0.0 - 97.3
2010 464 73 78 1 - 583 65 71 1 - 532 8 25 0 - 216 7.8 16.6 0.0 - 91.1
2011 444 74 77 1 - 612 65 68 1 - 539 9 29 0 - 358 8.5 17.8 0.0 - 90.7
2011/12 433 75 77 1 - 570 66 68 1 - 500 9 27 0 - 230 8.7 18.0 0.0 - 88.5
Prescribed by a:
All healthcare professionals(No.) Doctor(No.) Practice nurse(No.) Practice nurse (%)
1
 this may include equipment such as syringes; 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
Consultation duration and total contact time 
The THIN data allows the duration of each consultation to be calculated. The proportion of 
consultations, by year, where it was not possible to calculate duration varied from 6.1 to 7.6% across 
the period of the study. Whilst the annual number of consultations per patient has fallen, the duration 
has increased, for  both doctors (10.2 to 11.1 minutes) and practice nurses (11.2 to 13.0 minutes) 
over the period of the study and the duration is consistently lower for ‘other nurses / other healthcare 
professionals’ (since 2004 onwards) (Table 4.14). 
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Table 4.14 Duration (minutes) of consultations by staff group that first opened the consultation 
record on the Vision System 
Year Consultation with: No. Mean SD L95% U95% Median 25th 75th 
2002 Doctor 556820 10.2 20.3 10.2 10.3 8 5 13
Practice Nurse 284180 11.2 12.7 11.1 11.2 8 4 16
Other Nurse 19580 7.3 12.5 7.1 7.5 4 2 9
Other Healthcare Professional 39558 11.3 31.9 10.9 11.6 7 3 13
2003 Doctor 789606 10.4 23.6 10.3 10.4 8 5 13
Practice Nurse 406462 11.5 12.5 11.5 11.6 9 4 16
Other Nurse 32190 7.2 22.6 7.0 7.5 4 2 8
Other Healthcare Professional 59487 10.7 26.7 10.5 10.9 7 3 12
2004 Doctor 828214 10.6 23.3 10.5 10.6 9 5 13
Practice Nurse 445086 12.0 12.6 12.0 12.0 9 4 17
Other Nurse 37067 6.9 11.2 6.8 7.1 4 2 9
Other Healthcare Professional 75187 9.9 15.8 9.7 10.0 7 3 12
2005 Doctor 907039 10.4 18.2 10.4 10.4 9 5 13
Practice Nurse 497874 12.2 13.1 12.2 12.2 9 4 17
Other Nurse 41295 7.1 15.5 7.0 7.3 4 1 9
Other Healthcare Professional 104256 9.5 12.3 9.5 9.6 7 3 12
2006 Doctor 949879 10.5 17.3 10.4 10.5 9 5 13
Practice Nurse 529358 12.4 12.2 12.4 12.4 10 4 18
Other Nurse 48665 7.5 13.7 7.4 7.7 4 2 9
Other Healthcare Professional 120907 9.4 12.6 9.3 9.5 7 3 12
2007 Doctor 990854 10.5 16.6 10.5 10.5 9 5 13
Practice Nurse 583854 12.3 12.5 12.3 12.4 9 4 17
Other Nurse 54758 8.1 14.6 7.9 8.2 4 2 10
Other Healthcare Professional 141465 9.1 11.5 9.0 9.1 6 3 11
2008 Doctor 1028604 10.6 15.8 10.5 10.6 9 5 14
Practice Nurse 602084 12.6 13.0 12.5 12.6 10 4 18
Other Nurse 56228 8.2 14.3 8.0 8.3 5 2 10
Other Healthcare Professional 162280 9.1 14.1 9.0 9.2 7 4 11
2009 Doctor 1031518 10.7 17.5 10.6 10.7 9 5 14
Practice Nurse 619438 12.3 13.0 12.3 12.4 9 4 17
Other Nurse 52138 8.6 14.5 8.5 8.7 5 2 11
Other Healthcare Professional 181704 8.9 10.4 8.8 8.9 7 4 11
2010 Doctor 1016966 10.8 18.5 10.8 10.9 9 5 14
Practice Nurse 607544 12.7 13.2 12.7 12.7 10 4 18
Other Nurse 47856 8.8 19.1 8.6 9.0 5 2 11
Other Healthcare Professional 176392 9.0 11.7 8.9 9.0 7 4 11
2011 Doctor 979567 11.1 19.7 11.0 11.1 9 5 14
Practice Nurse 608791 12.8 14.0 12.8 12.9 10 4 18
Other Nurse 48058 8.9 14.5 8.8 9.0 5 2 11
Other Healthcare Professional 174945 9.0 19.9 8.9 9.1 7 4 11
2011/12 Doctor 968790 11.1 19.2 11.1 11.1 9 5 14
Practice Nurse 596775 13.0 13.3 12.9 13.0 10 4 18
Other Nurse 45846 9.1 14.6 8.9 9.2 5 2 11
Other Healthcare Professional 170361 9.0 13.9 8.9 9.0 7 4 11
Confidence Percentiles
 
 
Using the frequency of consultations and their duration, we can calculate the total time each patient 
with diabetes spent with practice staff (Table 4.15). In 2002, people with diabetes spent a total of 98 
minutes in consultation with a doctor, which reduced to 67 minutes in 2011/12, a fall of 32%. The total 
time spent in consultations with a practice nurse has decreased by 13%, from an average of 54 
minutes in 2002 to 47 minutes in 2011/12. 
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Table 4.15 Total annual amount of consultation time (minutes) per person with diabetes by 
year and staff role 
Year No. Mean SD Range Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 160.1 58.3 2.1 - 315.0 97.7 35.8 0.8 - 261.4 54.2 31.0 0.0 - 150.4 2.0 5.3 0.0 - 44.0 6.3 11.6 0.0 - 70.7
2003 375 154.7 59.1 0.3 - 493.0 92.2 38.7 0.0 - 412.1 53.9 31.0 0.0 - 152.2 2.4 6.5 0.0 - 49.9 6.1 12.1 0.0 - 94.8
2004 386 152.9 56.3 1.9 - 465.9 89.4 38.0 0.6 - 374.7 54.8 31.3 0.0 - 188.4 2.4 5.8 0.0 - 41.5 6.3 9.9 0.0 - 58.0
2005 427 145.8 51.1 3.9 - 301.6 83.3 32.5 0.0 - 269.8 53.1 31.4 0.0 - 180.4 2.2 6.1 0.0 - 55.3 7.2 10.0 0.0 -58.4
2006 441 142.0 48.5 18.8 - 297.5 79.6 29.6 0.2 - 229.5 52.1 30.4 0.0 - 174.6 2.6 8.0 0.0 - 104.4 7.7 10.5 0.0 - 56.3
2007 448 140.6 47.2 11.9 - 274.6 77.4 27.9 0.2 - 218.0 52.3 30.2 0.0 - 154.7 2.7 7.8 0.0 - 67.4 8.3 11.0 0.0 - 55.4
2008 470 136.8 50.7 3.1 - 586.7 74.1 27.7 0.0 - 268.6 51.4 32.3 0.0 - 320.1 2.6 6.7 0.0 - 49.7 8.7 11.8 0.0 - 84.9
2009 471 131.5 47.1 10.2 - 424.6 71.1 26.8 0.0 - 229.6 49.1 30.1 0.0 - 224.3 2.4 6.6 0.0 - 52.0 8.9 11.5 0.0 - 74.3
2010 466 126.8 44.4 1.3 - 407.1 69.1 25.7 1.1 - 187.3 47.1 27.6 0.0 - 192.1 2.1 6.2 0.0 - 55.2 8.5 10.5 0.0 - 53.1
2011 445 124.5 40.8 28.5 - 295.3 66.6 23.3 0.4 - 170.7 47.6 26.1 0.0 - 135.1 2.1 5.8 0.0 - 51.9 8.2 10.5 0.0 - 84.9
2011/12 434 124.1 39.6 12.1 - 276.7 66.6 23.2 0.0 - 174.4 47.3 25.8 0.0 - 142.1 2.1 6.1 0.0 - 54.9 8.1 10.1 0.0 - 53.9
Other Nurses Other Healthcare ProfessionalsAll Healthcare Professionals Doctors Practice Nurses
 
 
The net effect of these changes is that the proportion of consultation time with a doctor has fallen from 
61% (of a total of 160 minutes with all health care professionals) in 2002, to 54% (of 124 minutes) in 
2012. Whilst proportionally, the time with a practice nurse has increased from 33% to 37%, and with 
other staff (other nurses and other health care professionals) from 6% to 9%.  
Combining the times spent in consultation with all health care professionals, we can generate a total 
time per year per patient, and explore how contact time varies between practices, according to 
whether they have a low, medium or high level of nurse input (Table 4.16).    
 Table 4.16 Total annual amount of consultation time (minutes) per person with diabetes by 
staff role and nurse contact group, 2011/12 
Nurse contact 
(reference year 
2002) No. Mean SD Minimum Maximum
All Healthcare <26.0% 135 104.7 41.6 12.1 241.6
Professionals 26.0-35.3% 117 134.2 32.5 45.0 209.6
35.4% and over 182 131.9 37.3 44.9 276.7
Doctors <26.0% 135 69.9 26.6 10.9 174.4
26.0-35.3% 117 71.1 18.2 20.8 146.6
35.4% and over 182 61.4 22.4 0.0 142.5
Practice Nurses <26.0% 135 23.0 17.6 0.0 81.8
26.0-35.3% 117 50.3 17.4 16.5 94.0
35.4% and over 182 63.5 21.5 14.6 142.1
Other Nurses <26.0% 135 3.0 8.7 0.0 54.9
26.0-35.3% 117 2.2 6.0 0.0 44.1
35.4% and over 182 1.3 3.0 0.0 15.1
Other Healthcare <26.0% 135 8.9 11.3 0.0 53.9
Professionals 26.0-35.3% 117 10.6 10.5 0.0 39.7
35.4% and over 182 5.8 8.1 0.0 34.0  
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The level of input per year from GPs varies only slightly; people with diabetes see a GP about 7 times 
a year, for an average of 11 minutes, whether they are in a practice with more or less nurse input (as 
classified in the three bands). On average they spend 67 minutes a year in consultation with each 
person with diabetes. In practices where nurses see a larger proportion of diabetic patients, doctors 
spend nine minutes less per patient a year (61 minutes in the high nurse contact group as opposed 
70 in the low nurse contact group), but patients have 27 minutes per patient more contact time in total 
(132 minutes as opposed to 105 in the low nurse contact group).   The level of input from nurses 
varies much more between practices; from seeing patients a total of 23 minutes a year (in the 
practices with least nursing contact) through to 50 minutes for the average, and 64 minutes in the 
practices with most nurse contact.   
These findings imply that while there is some substitution of work between nurses and doctors in the 
‘high nurse contact’ practices there may also be enhanced care being delivered although we cannot 
discount lower productivity as a partial explanation. 
4.4 Practice population achievement of glycaemic control   
We used Haemoglobin A1c (HbA1c), the study measure for glucose intolerance, to gauge the extent 
to which a person’s diabetes is under control. The thresholds for QOF HbA1c indicators have ranged 
from 7% to 10% over the period of the study. At the start of QOF in 2004 there were two indicators for 
HbA1c level: 7.4% or less and 10% or less. The 10% threshold was last used as a QOF indicator in 
2008/9. An HbA1c value of 6.5% is often used now as a potential indicator of the presence of 
diabetes. Findings are presented for four thresholds ≤ 7%, ≤ 8%, ≤ 9% and ≤ 10%.  
We focus our attention on the upper (≤ 7%) and lower (≤ 10%) end of the QOF indicator range. The 
proportion of people meeting these thresholds increased noticeably during the early period in the last 
decade (see Table 4.17 and Figure 4.4). This has tapered off subsequently. The higher threshold (≤ 
10%) peaked in 2006 whereas there were still small gains in the lower threshold (≤ 7%) until 2009. 
However there has been a small decrease in the proportions meeting the four thresholds since 
2009/10. 
Table 4.17 Population achievement for HbA1c by threshold 
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
≤ 7% 30.7 35.0 37.6 38.9 42.2 42.4 43.2 43.5 43.5 42.7 41.7
≤ 8% 51.9 57.6 61.9 63.9 65.9 65.9 66.4 65.8 65.6 64.6 63.6
≤ 9% 64.8 71.0 75.4 77.1 77.6 77.4 77.8 77.3 77.3 76.4 75.6
≤ 10% 71.9 78.3 82.7 83.8 83.8 83.4 83.7 83.1 83.3 82.6 81.9
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
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Figure 4.4 Population achievement for HbA1c by threshold 
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The amount of variation between practices in meeting the four HbA1c thresholds ( ≤ 7%, ≤ 8%, ≤ 9%, 
≤ 10%) is shown in Table 4.18, and is further emphasised in Figures 4.5 and 4.6. 
The amount of variation between practices has decreased across all thresholds over time and more 
so for the highest threshold (≤10%). 
Table 4.18 Percentage population achievement by HbA1c threshold - variation across 
practices 2002-2011/12 
Year
Practice 
(no.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 30.1 10.0 0.0 - 54.6 51.1 13.8 0.0 - 75.2 63.9 15.8 0.0 - 85.7 71.1 16.9 0.0 - 92.6
2003 375 35.0 9.7 0.0 - 63.3 57.3 10.6 0.0 - 84.1 70.7 10.3 0.0 - 94.0 78.2 10.3 0.0 - 100.0
2004 386 37.4 9.4 0.0 - 67.5 61.6 9.1 0.0 - 82.0 75.2 8.2 0.0 - 92.9 82.6 7.5 0.0 - 97.3
2005 427 38.8 9.1 0.0 - 64.6 63.9 8.4 0.0 - 82.9 77.0 7.6 0.0 - 90.6 83.7 6.8 0.0 - 95.6
2006 441 42.3 9.2 0.0 - 68.6 65.9 8.3 0.0 - 83.2 77.6 7.4 0.0 - 93.3 83.8 6.9 0.0 - 96.0
2007 448 42.7 9.4 0.0 - 68.9 66.0 8.2 0.0 - 90.0 77.5 7.3 0.0 - 96.7 83.5 6.8 0.0 - 97.8
2008 470 43.3 9.2 0.0 - 71.6 66.3 8.2 0.0 - 83.3 77.8 7.0 0.0 - 92.5 83.8 6.6 0.0 - 100.0
2009 471 43.6 9.3 0.0 - 74.9 65.8 7.9 0.0 - 85.9 77.2 7.2 0.0 - 91.7 83.2 6.8 0.0 - 94.6
2010 466 43.8 8.6 0.0 - 72.2 65.6 7.5 0.0 - 83.3 77.4 6.8 0.0 - 90.0 83.4 6.4 0.0 - 94.7
2011 445 42.9 8.4 0.7 - 67.7 64.6 7.6 0.7 - 82.3 76.4 6.8 0.7 - 90.5 82.7 6.5 0.7 - 94.0
2011/12 434 41.9 8.3 0.3 - 66.2 63.5 7.6 0.3 - 83.4 75.5 7.1 0.3 - 91.0 81.9 6.7 0.3 - 94.5
≤ 9% ≤ 10%≤ 7% ≤ 8%
Note: all people in one practice failed to meet any threshold during the period 2002-2010; 2011/12 
covers the period May 17
th
 2011 to May 16
th
 2012 
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Figure 4.5 Percentage of practice population achieving HbA1c ≤ 7% (2002 vs. 2011/12) 
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Figure 4.6 Percentage of practice population achieving HbA1c ≤ 10% (2002 vs. 2011/12) 
0
10
20
30
40
50
60
70
0 -
<10%
10% -
<20%
20% -
<30%
30% -
<40%
40% -
<50%
50% -
<60%
60% -
<70%
70% -
<80%
80% -
<90%
90% +
%
2002 2011/12
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
56 
 
Chapter 4 Summary 
 The prevalence of diabetes has increased by 66% over the last decade and has increased 
steadily year on year (reflecting other national statistics). People with diabetes account for an 
average of 4.9% of average practice list now, compared with 3.0% in 2002.   
 Because of a change in the threshold used to define diabetes, there is an increased 
proportion of the ‘diabetic’ patient population that have less severe diabetes now, and are 
being helped to manage their diabetes earlier. 
 Glycaemic control (that is the percentage of patients with diabetes that have an Hb1Ac level 
below a certain threshold) improved considerably between 2002 and 2004. Since this time it 
has plateaued; roughly the same proportions of patients achieve control each year as the 
year before.  
 There has been a 13% increase in the annual number of consultations undertaken in 
practices with people with diabetes.  
 Practice nurses are doing more consultations each year, but as the increase in prevalence 
outstrips the increase in activity, each person is having fewer consultations now than in the 
past, although the average length of consultation with practice nurses is slightly longer (from 
11 minutes in 2002 to 13 minutes in 2011/12). 
 Practice nurses are increasingly undertaking more diabetes reviews and they are becoming 
more involved in prescribing. 
 People with diabetes in practices with larger caseloads (more patients per GP or RN) receive 
fewer consultations.  
 Nurses (and other healthcare professionals) have increased their activity much more than 
doctors during this period – a 20% increase in annual consultations by practice nurses 
compared with just 1% increase amongst GPs.  
 In practices where nurses see a larger proportion of people with diabetes, doctors spend nine 
minutes less a year (61 minutes vs. 70), but patients have 27 minute more contact time in 
total (132 minutes vs. 105 in the low nurse contact group).    
 Glycaemic control is now much more uniformly achieved in the population of people with 
diabetes across practices, than it was the case ten years ago.  
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5. Relationship between workforce and diabetes control 
 
In this section we consider specifically how population achievement of glycaemic control varies by 
level of nurse contact (low, medium, high) and whether this variation changes after risk adjustment 
both at the patient and practice level. The analyses focus on the upper(≤ 10%) and lower 
thresholds(≤7%) ob HbA1c.  
The contact with health professionals was captured through two variables: the average number of 
times people with diabetes were seen by a healthcare professional (of any sort) and the percentage of 
consultations involving practice nurses. For a more interpretable analysis we categorised the latter 
into tertiles (low – less than 26%, medium – 26-35%, and high – over 35%) using 2002 as our 
reference year (the start of the study period). 
5.1 Health professional contact   
The proportion of people attaining the tight (HbA1c ≤ 7%) and loose (HbA1c ≤ 10%) thresholds was 
consistently higher in practices with a high proportion of nurse contact for every year from 2002 to 
2007. However, in absolute terms the differences were generally small. The difference between the 
high and low practice nurse contact tertiles for the higher threshold (HbA1c ≤ 10%) was more 
apparent with maximum advantage of 3.5% (2003) and consistently in excess of 1%, before 2007. 
(Table 5.1 and Figure 5.1).  
 
Table 5.1 Population achievement for HbA1c by threshold and practice nurse contact (any 
involvement) 
HbA1c 
threshold
Practice 
nurse 
contact 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Low 30.8 33.9 37.5 37.7 42.2 41.8 43.6 42.9 43.0 42.5 41.4
≤ 7% Medium 30.3 34.6 37.3 38.6 41.2 42.6 43.1 43.9 43.7 42.0 41.6
High 31.0 36.6 38.1 40.3 43.1 42.8 42.8 43.6 43.8 43.4 42.0
Low 71.6 76.9 81.7 83.2 83.2 83.1 84.0 82.8 82.8 82.0 81.6
≤ 10% Medium 70.4 77.5 82.8 83.6 83.2 83.5 84.0 83.7 83.3 82.8 81.6
High 74.1 80.4 83.5 84.5 84.8 83.7 83.3 83.0 83.6 82.9 82.4
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
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Figure 5.1 Population achievement for HbA1c by threshold and level of practice nurse contact 
(any involvement) 
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
The previous chapter indicated that there has been an overall reduction in the number of 
consultations per person, but a larger proportion of them are undertaken by practice nurses, and that 
this has been accompanied by better glycaemic control. The changes were greatest between 2002 
and 2005, since which time levels of both activity and glycaemic control has plateaued. Multi-level 
modelling allowed the relationships between staffing activity and glycaemic control to be tested 
further, adjusting for the individual characteristics of the person and other socio-demographic factors. 
Table 5.2 shows that the amount of practice level variance as a proportion of the sum of both the 
person and practice level variance (known as the variance partition coefficient (VPC) or intra-class 
correlation coefficient), obtained by fitting the intercept only multi-level model, has fallen from 14% in 
2002 to 9% in 2011/12 for the HbA1c ≤7% threshold and from 21% to 11% for the HbA1c ≤10% 
threshold. Therefore most of the variation observed in these two variables is attributable to people 
with diabetes, although there is still variation between practices that requires explanation. 
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Table 5.2 Variation at the practice level 
Year
Residual 
variance VPC
Residual 
variance VPC
2002 0.530 14% 0.897 21%
2003 0.403 11% 0.552 14%
2004 0.384 10% 0.450 12%
2005 0.362 10% 0.405 11%
2006 0.362 10% 0.422 11%
2007 0.377 10% 0.419 11%
2008 0.355 10% 0.410 11%
2009 0.368 10% 0.419 11%
2010 0.338 9% 0.388 11%
2011 0.337 9% 0.392 11%
2011/12 0.333 9% 0.393 11%
≤ 7% ≤ 10%
 
Note: 2011/12 covers the period May 17
th
 2011 to May 16
th
 2012 
 
The results for the ≤7% level and ≤10% HbA1c thresholds, from the multi-level model, are presented 
in Tables 5.3 and 5.4. After risk adjustment at the person and practice level, practices in which people 
had a higher proportion of nurse contact had significantly more patients meeting the lower threshold 
of ≤7% in 2003. The difference was close to significance in 2005 (p=.052, full results are found in the 
Appendices A3.8 and A3.9). 
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Table 5.3 Multilevel model, HbA1c ≤ 7% - Findings for workforce variables (including nurse contact based on any involvement) 
 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.110 0.045 0.015 -0.047 0.024 0.047 -0.032 0.022 0.156 -0.035 0.020 0.080 -0.021 0.019 0.258
Nurse Contact - any involvement
  Low 0.042 0.091 0.646 -0.154 0.054 0.004 -0.047 0.051 0.360 -0.104 0.047 0.028 -0.032 0.047 0.493
  Medium -0.067 0.088 0.445 -0.113 0.056 0.045 -0.037 0.053 0.484 -0.090 0.047 0.054 -0.073 0.046 0.113
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.526 0.030 0.394 0.018 0.382 0.017 0.358 0.015 0.362 0.015
Global Test (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - any involvement (2df) 1.547 0.461 8.853 0.012 0.941 0.625 5.929 0.052 2.516 0.284
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional 0.005 0.021 0.827 0.017 0.015 0.263 0.022 0.015 0.147 0.030 0.017 0.066 0.043 0.018 0.020 0.027 0.017 0.110
Nurse Contact - any involvement
  Low -0.063 0.048 0.195 0.008 0.044 0.850 -0.064 0.046 0.158 -0.040 0.042 0.339 -0.051 0.042 0.227 -0.018 0.043 0.672
  Medium -0.018 0.047 0.701 0.010 0.045 0.831 0.012 0.046 0.800 -0.016 0.043 0.710 -0.048 0.043 0.266 -0.035 0.044 0.427
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.383 0.015 0.364 0.014 0.376 0.014 0.347 0.014 0.341 0.014 0.339 0.014
Global Test (degrees of freedom) χ
2
p χ
2
p χ
2
p χ
2
p χ
2
p χ
2
p
  Nurse Contact - any involvement (2df) 1.717 0.424 0.057 0.972 2.878 0.237 0.917 0.632 1.936 0.380 0.645 0.724
2002 2003 2004 2005 2006
2011/122007 2008 2009 2010 2011
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Table 5.4 Multilevel model, HbA1c ≤ 10% - Findings for workforce variables (including nurse contact based on any involvement) 
 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.192 0.071 0.007 -0.107 0.030 <.001 -0.042 0.025 0.090 -0.024 0.022 0.273 -0.015 0.022 0.490
Nurse Contact - any involvement
  Low -0.029 0.145 0.844 -0.189 0.070 0.007 -0.094 0.058 0.108 -0.070 0.052 0.176 -0.089 0.054 0.100
  Medium -0.191 0.140 0.174 -0.174 0.073 0.018 -0.035 0.060 0.563 -0.052 0.052 0.311 -0.081 0.053 0.130
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.865 0.044 0.518 0.023 0.421 0.019 0.379 0.017 0.405 0.017
Global Tests (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - any involvement (2df) 2.173 0.337 9.046 0.011 2.621 0.270 2.027 0.363 3.455 0.178
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.011 0.023 0.643 -0.001 0.017 0.938 -0.012 0.017 0.489 -0.008 0.018 0.657 0.005 0.021 0.813 -0.022 0.020 0.276
Nurse Contact - any involvement
  Low -0.011 0.053 0.834 0.043 0.050 0.382 0.000 0.050 0.993 -0.022 0.047 0.640 -0.052 0.048 0.284 -0.022 0.049 0.661
  Medium 0.023 0.052 0.664 0.073 0.050 0.142 0.069 0.050 0.169 0.014 0.047 0.761 -0.008 0.049 0.873 -0.060 0.050 0.232
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.405 0.017 0.391 0.016 0.400 0.016 0.371 0.016 0.378 0.016 0.382 0.016
Global Tests (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - any involvement (2df) 0.383 0.826 2.225 0.329 2.328 0.312 0.537 0.765 1.235 0.539 1.428 0.490
2011/12
2002 2003 2004 2005 2006
2007 2008 2009 2010 2011
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While there was some modest evidence of improved glycaemic control being associated with a high 
proportion of nurse contacts, the relationship between average the number of times people with 
diabetes were seen by any healthcare professional at the practice level (consultations per healthcare 
professional in Table 5.3) and meeting the threshold, was negative and statistically significant in 2002. 
However, towards the end of the period the relationship had become positive and statistically 
significant, or close to significance (2010, 2011). 
The residual variance that remained after fitting the model declined noticeably between 2002 and 
2003 from 0.526 to 0.394 but has not changed fundamentally since then, although there was a small 
step-down from 0.376 in 2009 to 0.347 in 2010. 
The findings at the higher threshold were similar; there was a statistically significant and positive 
association between the proportion of people meeting the threshold and a higher proportion of 
practice nurse contact in 2003 only. The average number of times people with diabetes were seen by 
a healthcare professional at the practice level was negatively associated with meeting the threshold 
for most years. For the first two years of the period (2002, 2003) this association was statistically 
significant. The residual variance decreased between 2002 and 2005 from 0.865 to 0.379, increasing 
to 0.405 in 2006 and has remained close to that level (0.371 to 0.400) since then. The inclusion of a 
person’s reading from the previous year (e.g. meeting the threshold or not) in the model did not 
change the main findings to any great degree nor did the using nurse contact based on sole 
involvement or Vision allocation (Appendices 3.4-3.7, 3.20-3.23). 
Restricting the analysis to practices who met the inclusion criteria for all years of the study period 
(n=183) also did not change the effect of nurse contact noticeably (Appendices 3.24-3.27).  For the 
higher threshold (≤ 10%), during the second half of the period (2008, 2009, 2011), practices with a 
medium level of practice nurse contact were more likely than those with a high level of contact to 
meet the threshold. The effect of consultations per healthcare professional was positive and stronger 
than for the unrestricted analysis for the lower threshold (≤ 7%) from 2007 onwards (except for 2010). 
5.2 Diabetic review    
The data on diabetic review have been modelled utilising most of the independent variables used 
previously except that consultations per healthcare professional has been replaced by average 
number of reviews with a healthcare professional, and practice nurse contact by percentage of 
reviews with a practice nurse where practice percentages have been categorised into low (less than 
34%), medium (35-77%), and high (over 77%). 
During the early part of the period (2002-2003) practices that reviewed and monitored people’s 
diabetes more often performed better in terms of meeting the HbA1c ≤ 7% threshold (Table 5.5). After 
2003, this effect was no longer as strong although it was statistically significant one final time in 2005. 
There was no significant association between the proportion of these reviews undertaken by nurses 
and the proportion of patients achieving the threshold, except in 2006 when the likelihood of meeting 
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the threshold was higher amongst those practices that made greater use of practice nurses in 
reviewing people’s diabetes. 
Similarly, practices that reviewed and monitored people’s diabetes more often performed better in 
terms of meeting the HbA1c ≤ 10% threshold (Table 5.6) in the early period (2002-2003) and although 
this effect was less strong after 2003, it has still remained statistically significant. Whether these 
reviews were undertaken more often by doctors or practice nurses was not significantly associated 
with patients achieving the threshold. 
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Table 5.5 Multilevel model, HbA1c ≤7% - effect of diabetic review 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Reviews with a healthcare professional 0.131 0.034 <.001 0.082 0.023 <.001 0.038 0.021 0.064 0.040 0.018 0.029 0.006 0.019 0.760
% Practice nurse reviews
  Low 0.139 0.087 0.113 -0.026 0.055 0.640 -0.046 0.054 0.393 -0.077 0.050 0.118 -0.133 0.049 0.006
  Medium 0.029 0.086 0.732 0.062 0.055 0.262 0.031 0.052 0.551 0.001 0.046 0.989 -0.090 0.045 0.044
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.501 0.029 0.389 0.018 0.379 0.017 0.356 0.015 0.360 0.015
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p
% Practice nurse reviews(2df) 2.729 0.256 2.481 0.289 1.982 0.371 3.028 0.220 8.593 0.014
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Reviews with a healthcare professional -0.021 0.020 0.285 -0.002 0.019 0.904 0.001 0.019 0.966 -0.009 0.019 0.617 -0.004 0.019 0.823 -0.004 0.020 0.842
% Practice nurse reviews
  Low -0.083 0.050 0.097 -0.042 0.047 0.362 -0.054 0.047 0.242 -0.005 0.044 0.901 -0.033 0.047 0.477 -0.041 0.046 0.375
  Medium -0.001 0.047 0.979 -0.032 0.044 0.462 -0.030 0.045 0.513 -0.056 0.042 0.180 -0.063 0.041 0.121 -0.072 0.040 0.073
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.383 0.015 0.365 0.014 0.378 0.015 0.347 0.014 0.342 0.014 0.336 0.014
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p 2 p
% Practice nurse reviews(2df) 3.174 0.205 1.014 0.602 1.413 0.493 1.917 0.383 2.459 0.292 3.307 0.191
2006
2011
2002 2003 2004 2005
2011/20122007 2008 2009 2010
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Table 5.6 Multilevel model, HbA1c ≤10% - effect of diabetic review 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Reviews with a healthcare professional 0.268 0.053 <.001 0.183 0.029 <.001 0.081 0.024 0.001 0.071 0.020 <.001 0.073 0.022 0.001
% Practice nurse reviews
  Low 0.110 0.136 0.419 0.029 0.070 0.677 0.006 0.061 0.922 0.058 0.054 0.288 0.008 0.056 0.890
  Medium -0.040 0.134 0.765 0.075 0.071 0.285 -0.021 0.058 0.724 0.006 0.050 0.911 0.008 0.051 0.877
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.809 0.043 0.497 0.022 0.416 0.019 0.372 0.017 0.398 0.017
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p
% Practice nurse reviews(2df) 1.255 0.534 1.149 0.563 0.213 0.899 1.285 0.526 0.031 0.984
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Reviews with a healthcare professional 0.064 0.022 0.004 0.074 0.021 <.001 0.092 0.021 <.001 0.056 0.021 0.007 0.082 0.021 <.001 0.091 0.023 <.001
% Practice nurse reviews
  Low 0.072 0.054 0.182 0.058 0.051 0.254 0.087 0.050 0.081 0.058 0.049 0.230 -0.043 0.052 0.402 -0.007 0.053 0.898
  Medium 0.048 0.051 0.346 0.072 0.048 0.136 0.056 0.049 0.250 0.022 0.046 0.638 -0.047 0.045 0.300 -0.026 0.046 0.574
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.401 0.017 0.386 0.016 0.391 0.016 0.368 0.016 0.369 0.015 0.375 0.016
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p 2 p
% Practice nurse reviews(2df) 2.003 0.367 2.611 0.271 3.305 0.192 1.449 0.485 1.353 0.508 0.321 0.852
2011/2012
2002 2003 2004 2005
2007
2006
2008 2009 2010 2011
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Chapter 5 Summary 
 Whilst there has been an overall reduction in the number of consultations per person, a larger 
proportion of them are undertaken by practice nurses, and this has been accompanied by 
better glycaemic control.  
 After risk adjustment at the person and practice level, multi-level modelling showed that 
practices in which people with diabetes had a higher proportion of nurse contact had 
significantly more people meeting the lower threshold of ≤7% in 2003. The difference was 
close to significance in 2005.  
 Overall however, after risk adjustment at the individual level, there is much less variation between 
practices in recent years (post QOF) than there was in 2003.  
 There was some practice level variation in the data but this diminished over time and was very low in 
the 2011/12 dataset that linked THIN data with the practice survey. Multilevel modelling indicates that 
most of the variation in likelihood of diabetes control is explained by person level characteristics rather 
than practice level characteristics. 
 There is evidence that those practices that place more effort on diabetes review have better 
performance in terms of control of diabetes. This activity is being increasingly undertaken by 
practice nurses. 
 In earlier years, just before, and soon after, QOF was introduced, there was some evidence 
that those practices where people with diabetes were most likely to be seen by a practice 
nurse had a higher proportion of people with good control, although the association was not 
strong and not consistently significant. 
67 
 
6. Service configurations and economic implications 
 
The purpose of this part of the analysis was to understand the effect of workforce variables and 
service configuration on the rate of diabetes control within primary care together with the economic or 
financial implications of these. To this end, additional data were collected by the NNRU from 249 GP 
practices through a practice survey (described in Chapter 3). The survey collected data on the size 
and mix of the workforce, and approach to the management of care for people with diabetes. For 
example, 73% of responding practices indicated that nurses (including those specially trained in 
diabetes care) were involved in the management of diabetes, and 58% of practices reported that 
nurses were primarily responsible for this care. A full set of descriptive statistics of this survey were 
presented in Chapter 3. In this section we report on the relationships between the workforce and 
service configuration variables and the management of diabetes, building upon the multilevel 
regression models used in Chapter 5.  
6.1 The data  
The NNRU practice survey dataset was successfully matched to THIN data for 222 GP practices 
surveyed, containing 74,143 patients. After removing practices with missing data for the variables of 
interest
3
 we were left with 166 practices and 55,037 diabetes patients. Included and excluded 
practices were compared and there was very little difference, none which was statistically significant, 
between the two sets of practices. As the NNRU practice survey was undertaken in May 2012, THIN 
data for the year 17
th
 May 2011 to 16
th
 May 2012, referred to subsequently as the 2011/12 data, were 
matched to the survey. Analysis of the 2011/12 THIN data are reported in chapters 4 and 5 alongside 
calendar years (2002 – 2011). As this analysis is based upon a subset of the data used in the rest of 
the report it is worthwhile to compare the descriptive statistics between this and the full sample. As 
Table 6.1 indicates, the data in the full 2011/12 dataset and the subset of practices which responded 
to the GP survey are similar in relation to the mean value of the key variables. Although not reported 
here, the standard deviations were also virtually identical. It appears that there was no selection bias 
for the sub-sample participating in the GP survey. 
Additional variables from the GP survey which were included in this analysis included: 
 Whether the practice employed any nursing staff with a postgraduate qualification in diabetes 
care from a higher education institution. 
                                                     
3
 The variables of interest for this section of the analysis relate to the service configuration and the workforce so 
practices were excluded if they had missing data for questions 18, 20 or 22. Please refer to the appendix for the 
complete questionnaire.  
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 Whether nurses commence insulin for patients with diabetes. 
 Who is primarily responsible for managing diabetes care in the practice. This was coded as a 
factor variable in two different ways. First, to capture whether the distinction between nurse, 
doctor or ‘other’ (usually secondary care referrals) was important. Second, whether the 
distinction between specialist, non-specialist or ‘other’ other’ (usually secondary care 
referrals) was important. 
 Nurse staffing levels as measured by all people registered with a practice (not just people with 
diabetes) per whole time equivalent registered nurse. 
 Doctor staffing levels as measured by all people registered with a practice (not just people 
with diabetes per whole time equivalent GP. 
Together these variables were chosen to reflect the service configuration and skill mix adopted by the 
practice for managing diabetes care. It captures the degree of staff specialism in diabetes care and 
the doctor/nurse split.  
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Table 6.1 Comparison of practices responding to the survey and all THIN practices (means) 
Variable Full Dataset 2011/12 
Practices participating 
in the survey 
Diabetic Control   
HBA1c < 10% 0.82 0.81 
HBA1c < 9% 0.76 0.75 
HBA1c < 8% 0.64 0.63 
HBA1c < 7% 0.42 0.42 
Patient Level Variables   
Townsend Index (quintiles) 3.07 2.76 
Age 64.57 64.78 
Charlson Score 1.53 1.57 
Obesity Index 0.47 0.46 
Male 0.55 0.56 
Country   
England 0.75 0.68 
Northern Ireland 0.03 0.04 
Scotland 0.14 0.19 
Wales 0.08 0.09 
Percent White - Quintiles   
Percent White – 1 0.19 0.24 
Percent White – 2 0.26 0.21 
Percent White – 3 0.19 0.19 
Percent White – 4 0.14 0.14 
Percent White - 5 0.11 0.10 
Percent White - Unknown 0.11 0.12 
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Urban-Rural Classification  
Urban - sparse 0.01 0.00 
Town & Fringe - sparse 0.06 0.00 
Village/Hamlet - sparse 0.05 0.00 
Urban - less sparse 0.65 0.63 
Town & Fringe - less sparse 0.09 0.08 
Village/Hamlet - less sparse 0.05 0.04 
Unknown 0.19 0.24 
Other Practice Level Variables  
Diabetes prevalence 5.01 5.00 
Practice List Size 9807.16 9442.34 
Patients per HCP 431.96 445.12 
Nurse Contact - Low Tertile 0.33 0.31 
Nurse Contact - Medium Tertile 0.36 0.34 
Nurse Contact - High Tertile 0.31 0.35 
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6.2 Analysis and results 
The baseline regression reported in column 1 of Table 6.2, is a simple intercept only hierarchical 
random effects model
4
 which nests patients within their practice. There are 55,037 people with 
diabetes patients nested within 166 practices with an average cluster of 332 people with diabetes 
patients in each practice (range: 63-899). The intercept (-0.393) represents the log-odds of diabetic 
compliance below the HbA1c ≤ 7% threshold, which can be exponentiated to give the odds of 
compliance as 0.72 to 1, which confirms the marginal probability of compliance of 0.42% across all 
people in all practices. This is the same result that was found in the full dataset for 2012 and indicates 
that there is no bias generated by dropping practices that did not complete the GP practice survey or 
those that returned the survey with missing data.  
In column 2 of Table 6.2, the person level fixed effects are included and in column 3 the practice level 
fixed effects are included, in columns 4-6, the variables from the GP survey are added.  
                                                     
4
 All analysis undertaken in this section used Stata 12 SE and xtmelogit, xtlogit and logit models. 
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Table 6.2 Multilevel Regression Model for HbA1c <7% 
 Model 1 Model 2 Model 3 Model 4a 
 
Model 4b Model 5 
 B (se) B (se) B (se) B (se) B (se) B (se) 
Patient Level Variables            
Age - linear  0.098*** 0.098*** 0.098*** 0.098*** 0.097*** 
  (<0.001) (<0.001) (<0.001) (<0.001) (<0.001) 
Age- Quadratic  -0.001*** -0.001*** -0.001*** -0.001*** -0.001*** 
  (<0.001) (<0.001) (<0.001) (<0.001) (<0.001) 
Male  -0.046* -0.046* -0.046* -0.046* -0.040* 
  (0.02) (0.02) (0.02) (0.02) (0.02) 
Charlson Score  -0.097*** -0.097*** -0.097*** -0.097*** -0.096*** 
  (0.01) (0.01) (0.01) (0.01) (0.01) 
Obesity Index  -0.114*** -0.114*** -0.114*** -0.114*** -0.115*** 
  (0.02) (0.02) (0.02) (0.02) (0.02) 
Townsend Quintiles       
1st  0.103 0.14 0.14 0.14 0.13 
  (0.065) (0.09) (0.09) (0.09) (0.09) 
2nd  0.061 0.098 0.098 0.098 0.077 
  (0.065) (0.09) (0.09) (0.09) (0.09) 
3rd  0.105 0.14 0.14 0.14 0.13 
  (0.064) (0.09) (0.09) (0.09) (0.09) 
4th  0.07 0.105 0.104 0.105 0.105 
  (0.064) (0.09) (0.09) (0.09) (0.09) 
5th  0.079 0.114 0.114 0.115 0.106 
  (0.066) -(0.09) (0.09) (0.09) (0.09) 
Practice Level Variables            
Percent White Quintiles       
1   -0.282* -0.279* -0.279* -0.269* 
   (0.14) (0.14) (0.14) (0.14) 
2   -0.175 -0.173 -0.175 -0.164 
   (0.14) (0.14) (0.14) (0.14) 
3   -0.144 -0.142 -0.145 -0.137 
   (0.14) (0.14) (0.14) (0.14) 
4   -0.137 -0.136 -0.138 -0.132 
   (0.14) (0.14) (0.14) (0.14) 
5   -0.076 -0.074 -0.077 -0.062 
   (0.14) (0.14) (0.14) (0.14) 
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Country       
Reference: England       
Northern Ireland   -0.247 -0.264 -0.288 -0.224 
   (0.18) (0.18) (0.18) (0.18) 
Scotland   -0.08 -0.065 -0.07 -0.121 
   (0.14) (0.14) (0.14) (0.15) 
Wales   0.078 0.079 0.085 0.097 
   (0.11) (0.11) (0.11) (0.11) 
Urban-Rural Classification       
Reference: Unknown       
Urban - sparse   0.016 0.035 0.028 0.006 
   (0.43) (0.43) (0.43) (0.43) 
Town & Fringe - sparse   -0.229 -0.215 -0.213 -0.257 
   (0.29) (0.29) (0.29) (0.29) 
Village or Hamlet - sparse   -0.294 -0.283 -0.273 -0.322 
   (0.28) (0.28) (0.28) (0.28) 
Urban - less sparse   0.145* 0.143* 0.144* 0.138* 
   (0.06) (0.06) (0.06) (0.06) 
Town & Fringe - less 
sparse   0.058 0.059 0.059 0.060 
   (0.06) (0.06) (0.06) (0.06) 
Village or Hamlet - less 
sparse   (Omitted) (Omitted) (Omitted) (Omitted) 
       
Diabetes Prevalence   0.006 0.008 0.002 0.001 
   (0.03) (0.03) (0.03) (0.03) 
Practice List Size   0.000 0.000 0.000 0.000 
   (<0.001) (<0.001) (<0.001) (<0.001) 
Consultations per HCP   0.000* 0.000* 0.000*   
   (<0.001) (<0.001) (<0.001)  
Proportion of 
consultations undertaken 
by a nurse        
Reference: Low (<26%)       
 Medium (26-35%)   0.033 0.044 0.031 0.022 
   (0.08) (0.08) (0.08) (0.08) 
High (over 35%)   0.057 0.075 0.07 0.02 
   (0.07) (0.07) (0.07) (0.08) 
Practice Survey Variables             
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Nurse with PG Education    -0.085 -0.063  
    (0.06) (0.07)  
Nurse starts Insulin    -0.013 -0.004  
    (0.06) (0.06) - 
Nurse Configuration       
Doctor primary lead    -0.103   
    (0.10)   
Nurse primary lead    -0.086   
    (0.08)   
Specialist Configuration       
Non-specialist primary 
lead     -0.038  
     (0.11)  
Specialist primary lead     -0.129  
     (0.09)  
People per WTE nurse      -66.5 
      (238.5) 
People per WTE GP      158.57 
      (188.08) 
 
 
Constant -0.328*** -4.288*** -4.343*** -4.269*** -4.228*** -4.209*** 
 (0.029) (0.15) (0.25) (0.25) (0.25) (0.26) 
Random Effect Variance 0.121 0.135 0.120 0.116 0.117 0.1126 
Log-Likelihood -36958 -35448 -35435 -35432 -35433 -34243 
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Understanding the variance at each level of analysis (patient vs. practice) is critical to understanding 
the contribution of this research to the literature. The practice level variance of 0.12 is relatively small 
which is confirmed by an interclass correlation coefficient (rho) of 3.6%. This indicates that almost all 
(96.4%) of the variation in diabetes control is explained at the individual person level rather than at the 
practice level. The variation in control rates across practices is ± 8.7% around the gross mean of 42%. 
Further evidence of the lack of practice level variation can be seen in Table 6.3 which compares the 
regression coefficients for a pooled and multilevel model. Altogether, this indicates that the data could 
be pooled without loss of generality and that a multilevel (hierarchical) or separated regression model 
will add little to our understanding. However, for completeness we continue to model the data as a 
simple two level (people nested in practices) multilevel mixed effects model with a random intercept 
and all other coefficients set as fixed effects.  
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Table 6.3 Regression Results Comparing Pooled and Multilevel Structure 
  Pooled Multilevel 
Age - linear 0.097 0.098 
Age- Quadratic -0.001 -0.001 
Male -0.045 -0.047 
Charlson Score -0.089 -0.097 
Obesity Index -0.093 -0.114 
Townsend Quintiles   
1 0.128 0.139 
2 0.115 0.097 
3 0.142 0.139 
4 0.127 0.103 
5 0.163 0.113 
Unknown 0.000 0.000 
Percent White Quintiles  
1 -0.392 -0.277 
2 -0.235 -0.171 
3 -0.281 -0.141 
4 -0.277 -0.135 
5 -0.144 -0.073 
Unknown 0.000 0.000 
Country   
Northern Ireland -0.318 -0.265 
Scotland -0.081 -0.060 
Wales 0.098 0.087 
England 0.000 0.000 
Urban-Rural Classification  
1 0.092 0.032 
2 -0.206 -0.222 
3 -0.265 -0.295 
4 0.235 0.144 
5 0.057 0.059 
6 (omitted) (omitted) 
Unknown 0.000 0.000 
Diabetes Prevalence 0.009 0.008 
Practice List Size 0.000 0.000 
Patients per HCP 0.000 0.000 
Nurse PG Education -0.082 -0.078 
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Nurse Starts Insulin -0.006 -0.006 
Nurse Configuration   
Doctor lead -0.115 -0.108 
Nurse lead -0.103 -0.084 
Other lead 0.000 0.000 
Constant -4.135 -4.222 
 
In each case a Chi-Squared test on the change in the deviance (LR test) shows that the models are 
an improvement on the previous model, although the inclusion of the GP survey variables provides a 
marginally statistically significant improvement in model fit (one-sided p=0.04). However, there is no 
statistically significant difference (p=0.15) in the deviance for the two different workforce configuration 
specifications – 4a (nurse vs. doctor) and 4b (specialist vs. non-specialist). This is supported by 
statistically insignificant coefficients in both formulations.  
One potential explanation may be the collinearity or association between the existing nurse staffing 
variable (nurse consultations as a proportion of all consultations with healthcare professionals) and 
the service configuration variable (Mainly managed by nurse, doctor or other). A Pearson Chi-
Squared test is reported in Table 6.4 and indicates that those practices with a higher level of nurse 
contact relative to all healthcare professional contact in the THIN data are more likely to report nurses 
managing diabetes care. Despite this strong association (p=0.001), dropping one of the two factor 
variables does not make the remaining variable statistically significant, nor does the deviance improve 
significantly.  
 
Table 6.4 Association between THIN Survey and GP Practice Survey Measures of Staffing and 
Configuration 
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Lowest 
Tertile 
2,633 3,700 10,623 16,956 
5% 7% 19% 31% 
Middle Tertile 
3,407 3,634 11,899 18,940 
6% 7% 22% 34% 
Highest 
Tertile 
2,741 2,499 13,901 19,141 
5% 5% 25% 35% 
Column 
Totals 
8,781 9,833 36,423 55,037 
16% 18% 66% 100% 
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The regression coefficients and their statistical significance are broadly similar to those reported for 
the full dataset in chapter 5 and this will not be duplicated here. The main difference being that the 
percentage of the local population that is white (recorded as quintiles) is not statistically significant in 
these models. While the regression coefficients are very close to those obtained using the full dataset, 
the standard errors are twice as large due to the much smaller dataset. The relatively small impact of 
the practice level variables in the model is evidenced by the lack of statistical significance on their 
regression coefficients and the relatively small reduction in the random effect (intercept) variance from 
0.12 in the null model (column 1) to 0.11 in the full model (columns 4a&b). This can be seen most 
clearly in Figure 6.1 which plots the combined mean intercept and random effect for each practice. 
There is relatively little variation in this unexplained practice level average ‘effect’ and the absolute 
size of these effects is very small. 
 
Figure 6.1: Practice level effect odds (intercept & random effect)   
 
 
We focus instead on the new variables included in models 4a and 4b. Model 4a and 4b both include 
the dummy variable for postgraduate training in diabetes care and the dummy variable for whether 
nurses start patients on insulin. The difference between models 4a and 4b are in relation to the 
service configuration variables. In model 4a, the model compares the performance of practices which 
manage care led by nurses and doctors in comparison to ‘others’. In model 4b, the comparison is 
between specialist, non-specialist and ‘others’. None of these variables are statistically significant. 
While the regression coefficients (and odds ratios) are quite small, they are similar in magnitude to the 
remainder of the variables in the models. However, the standard errors on these practice level 
variables are relatively large. This is likely the result of having only 166 practices in the dataset, and 
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this may go some way to explaining why the other practice level variables are also largely 
insignificant. It is interesting, however, that the signs on all of the survey related coefficients are 
negative which indicates odds ratios of less than one. This implies that, for example, having nurses 
trained in diabetes care would reduce, ceteris paribus, the likelihood of diabetic control. Given the 
statistical insignificance of these variables and the relatively small variation attributable to practice 
level characteristics, these findings are of little importance.  
Considering model 5, the general staffing levels of the practice are included through the inclusion of 
two new variables which measure the number of patients per WTE GP and nurse in each practice. 
The measures of service configuration (as used in models 4a and 4b) are excluded but the proportion 
of consultations undertaken by nurses is retained. Again, we see no statistically significant 
relationships between this staffing level variables and diabetes control as measured by HbA1c less 
than 7 % readings.  
The analysis was repeated using HbA1c of less than 10% which represents an extreme threshold 
above which patients (and their healthcare practitioners) are having severe difficulty controlling their 
diabetes. The results of this analysis are reported in Table 6.5 and they are broadly similar to those 
found when modelling HbA1c of less than 7%. We will therefore concentrate on the differences 
between the two sets of findings. 
While age, gender, Charlson score and obesity all remain strongly statistically significant predictors of 
diabetes control at the HbA1c 10% level, the coefficients are slightly weaker. However, more 
interestingly is that the first three quintiles of the Townsend score and the first two quintiles of the 
ethnicity variable (proportion of ethnically white people in the local population) are all statistically 
significant. Thus in comparison to patients from an area classified as “unknown deprivation”, being a 
patient from the first three most affluent areas increases the probability of compliance at the 10% 
level. Similarly, being from areas with relatively low proportions of ethnically white people reduces the 
probability of reaching the HbA1c of less than 10% threshold, when compared to “unknown.” 
Intuitively this makes sense: people with higher socioeconomic status are more likely to comply with 
medical instructions and less likely to engage in behaviour that is detrimental to their health. Finally, 
the coefficient on the number of people per GP is strongly statistically significant and has a large 
effect: having more people per WTE GP increases the likelihood of reaching the HbA1c of less than 
10% threshold. While this may appear counterintuitive as it implies lower GP staffing is better it may 
be capturing a ‘scale’ effect or ‘expertise’ effect which may occur in much larger practices. Given the 
lack of significance found among the plethora of staffing variables included in the many different 
regression models that have been run we must be cautious not to put too much emphasis on this 
singular finding. The remaining results are almost identical to those found for HbA1c less than 7%, 
and most importantly are also statistically insignificant. 
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Table 6.5 Multilevel Regression Model for HbA1c <10% 
 Model 1 Model 2 Model3 Model4a Model4b Model 5 
 b (SE) b (SE) b (SE) b (SE) b (SE) b (SE) 
Patient Level Variables             
Age - linear  0.086*** 0.086*** 0.086*** 0.086*** 0.084*** 
  (0.00) (0.00) (0.00) (0.00) (0.00) 
Age- Quadratic  -0.000*** -0.000*** -0.000*** -0.000*** -0.000*** 
  (0.00) (0.00) (0.00) (0.00) (0.00) 
Male  0.142*** 0.143*** 0.143*** 0.143*** 0.144*** 
  (0.02) (0.02) (0.02) (0.02) (0.02) 
Charlson Score  -0.053*** -0.053*** -0.052*** -0.053*** -0.053*** 
  (0.01) (0.01) (0.01) (0.01) (0.01) 
Obesity Index  0.057* 0.057* 0.057* 0.057* 0.051* 
  (0.02) (0.02) (0.02) (0.02) (0.02) 
Townsend Quintiles  0.000 0.000 0.000 0.000 0.000 
Reference: Unknown  (.) (.) (.) (.) (.) 
1st  0.364*** 0.463*** 0.461*** 0.462*** 0.453*** 
  (0.08) (0.10) (0.10) (0.10) (0.10) 
2nd  0.258*** 0.355*** 0.354*** 0.354*** 0.334** 
  (0.07) (0.10) (0.10) (0.10) (0.10) 
3rd  0.175* 0.270** 0.269** 0.269** 0.259* 
  (0.07) (0.10) (0.10) (0.10) (0.10) 
4th  0.094 0.189 0.188 0.188 0.180 
  (0.07) (0.10) (0.10) (0.10) (0.10) 
5th  -0.001 0.094 0.094 0.094 0.095 
  (0.08) (0.10) (0.10) (0.10) (0.10) 
Practice Level Variables             
Percent White Quintiles       
Reference: Unknown       
1   -0.424** -0.422** -0.419* -0.430** 
   (0.16) (0.16) (0.16) (0.17) 
2   -0.341* -0.338* -0.341* -0.349* 
   (0.16) (0.16) (0.16) (0.17) 
3   -0.275 -0.274 -0.276 -0.285 
   (0.16) (0.16) (0.16) (0.16) 
4   -0.247 -0.246 -0.249 -0.263 
   (0.16) (0.16) (0.16) (0.16) 
5   -0.149 -0.147 -0.149 -0.150 
   (0.16) (0.16) (0.16) (0.17) 
Country       
Reference: England       
Northern Ireland   -0.179 -0.190 -0.227 -0.155 
   (0.23) (0.23) (0.23) (0.23) 
Scotland   -0.170 -0.158 -0.153 -0.300 
   (0.17) (0.17) (0.17) (0.17) 
Wales   0.014 0.022 0.046 0.067 
   (0.15) (0.15) (0.15) (0.15) 
Urban-Rural Classification       
Reference: Unknown       
Urban - sparse   1.346 1.393 1.319 1.332 
   (1.08) (1.07) (1.08) (1.07) 
Town & Fringe - sparse   -0.137 -0.091 -0.149 -0.158 
   (0.38) (0.38) (0.38) (0.38) 
Village or Hamlet - sparse   0.029 0.076 0.030 0.014 
   (0.38) (0.37) (0.38) (0.37) 
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Urban - less sparse   0.158* 0.160* 0.158* 0.170* 
   (0.08) (0.08) (0.08) (0.08) 
Town & Fringe - less sparse   0.033 0.035 0.035 0.029 
   (0.08) (0.08) (0.08) (0.08) 
Village or Hamlet - less 
sparse   Omitted Omitted Omitted Omitted 
       
Diabetes Prevalence   -0.053 -0.056 -0.064 -0.055 
   (0.04) (0.04) (0.04) (0.04) 
Practice List Size   -0.000 -0.000 -0.000 0.000 
   (0.00) (0.00) (0.00) (0.00) 
People per HCP   0.000 0.000 0.000  
   (0.00) (0.00) (0.00)  
Proportion of Consultations undertaken by nurse - 
Tertiles     
Reference: Low       
Medium   -0.014 0.008 -0.008 -0.031 
   (0.11) (0.10) (0.10) (0.10) 
High   0.110 0.138 0.124 0.121 
   (0.10) (0.10) (0.10) (0.10) 
GP Practice Survey 
Variables             
Nurse with PG Education    -0.145 -0.113  
    (0.09) (0.09)  
Nurse starts Insulin    0.088 0.092  
    (0.09) (0.09)  
Nurse Configuration       
Reference: Other       
Doctor primary lead    0.049   
    (0.13)   
Nurse primary lead    -0.083   
    (0.11)   
Specialist Configuration       
Reference: other       
Non-specialist primary lead     0.089  
     (0.15)  
Specialist primary lead     -0.107  
     (0.12)  
       
People per WTE nurse      -236.576 
      (313.10) 
Patients per WTE GP      842.751*** 
      (253.73) 
Constant 1.535*** -2.116*** -1.805*** -1.736*** -1.704*** -2.140*** 
 (0.04) (0.13) (0.29) (0.29) (0.30) (0.30) 
Random Effect Variance 0.234 0.243 0.233 0.224 0.223  
Log-Likelihood -25706 -24469 -24457 -24454 -24454   
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6.3 Discussion 
 
The purpose of this section was to model the relationship between the workforce and diabetes control 
in primary care, including questions related to skill mix and service configuration. However, the 
multilevel modelling indicates  that  virtually all  (ca.  96%)  of  the  variation  in  diabetes  control  is 
explained by patient level characteristics rather than practice level characteristics. 
 
Practices in which nurses deliver higher proportions of the care of people with diabetes perform 
neither better nor worse, than those where nurse input is less. There is a similar finding for the use of 
nurses as the lead clinician for people with diabetes. Similarly, there appears to be no statistically 
significant return to the use of specialist healthcare professionals whether they be GPs or nurses 
although we were unable to ascertain the precise nature of training and preparation for specialism. 
 
The absence of a strong relationship, either positive or negative, indicates that practices which 
primarily use GPs to manage diabetes care could release significant resources by switching their 
service configuration towards nurse-led care. 
 
There are a number of limitations to the findings presented in this section of the study. Primarily, we 
have only one year of data and a small subset (166) of GP practices in this dataset. This has resulted 
in great uncertainty around the parameter estimates in the model and has limited the generalisability 
of the findings. It is also not possible to model the differences between getting a person below 
threshold and maintaining them below threshold. It seems plausible that the former is harder than the 
latter. This notwithstanding, it is interesting that very little variation is attributable to the practice level 
in the models. 
 
A more significant weakness is that although the survey provides additional information on service 
configurations, there remains limited data on exactly who does what within diabetes care. This makes 
it difficult to be certain about the effects of staffing and service configuration on diabetes outcomes, 
and more importantly to determine the true cost of different service configurations. 
 
However, the current findings indicate that service configuration has no effect on the probability of a 
person reaching diabetes control and therefore supports the supposition that cost savings in the care 
of diabetes can be achieved by substituting doctors for nurses. However, we observed in chapter 4 
that patients in practices where a high proportion of care is delivered by nurses receive 27 minutes 
more time in total with health care professionals in the practice each per year, whilst GPs spend 9 
minutes less per patient (per year) when compared to practices where a low proportion of care is 
delivered by nurses. This suggests that in addition to substitution for doctors there is also 
enhancement to care although lower productivity by nurses may also be a partial explanation as has 
been noted above and in the literature. 
 
Given the absence of any clear difference in outcome this has implications for cost effectiveness. It 
must be noted that we have only measured a single outcome here and enhancements in care may 
have other quantifiable benefits. Also there may be savings through lower use of secondary care. 
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Clearly releasing doctors to attend to other patients has a positive impact on opportunity costs which 
we cannot quantify.  
If unquantified benefits are ignored, in effect, 9 minutes of doctors time is ‘saved’ at the ‘expense’ of 
36 minutes of other professionals time, mainly practice nurses. The costs of the increased time spent 
on care is critically dependant on pay differentials. Because most GPs are not salaried it is not entirely 
straightforward to make comparisons. However, an approximation can be made by using pay rates for 
salaried GPs of between £53,781 and £81,158
5
. A band 6 nurse (the group most frequently 
employed) earns between £25,783 and £34,530. Taking the mid-point of each pay scale gives a 
salary differential of £30,156.5 for nurses compared to £67,469.5 for GPs. The actual differences are 
likely to be higher because of additional employment costs including pensions at 14% giving a 
difference of £34378.41 compared to £76915.23.  
This gives an approximate estimate that using doctors is 2.24 times more expensive than using 
nurses. Based on this it is clearly cheaper to use nurses to provide additional care than it is to use 
doctors. However the time saved by doctors (9 minutes) would only ‘pay’ for 20 minutes of nurse time 
whereas an ‘additional’ 36 minutes is being provided. While the figures provided here give a very 
rough estimate our assumptions would have to be significantly incorrect to change the basic 
conclusion. The cost of consultations (in terms of staff time) is likely to be higher in practices that 
provide a high proportion of care for people with diabetes but the opportunity costs of using GPs to 
deliver additional care would also be high as would be the costs of delivering the additional care in 
secondary settings.  
Chapter 6 Summary 
 Variation between practices within the 2011/12 data set were explored in relation to key 
workforce variables and approaches to the management of diabetes (from the practice 
survey).  
 Practices in which nurses undertake larger proportion of consultations with people with 
diabetes (as defined from the patient records data) are more likely to report that nurses lead 
the management of diabetes care (as captured in the survey).   
 Because of the low level of practice variation (coupled with relatively small sample), no 
distinct effect related to different workforce configurations, or approaches to managing 
diabetes have been discernible.   
 The absence of a strong relationship, either positive or negative, indicates that practices 
which primarily use GPs to manage diabetes care could release significant resources by 
switching their service configuration towards nurse-led care.  
                                                     
5
 http://www.nhscareers.nhs.uk/explore-by-career/doctors/pay-for-doctors/ 
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 Service configuration has no effect on the probability of a person’s diabetes being controlled. 
This therefore supports the supposition that, in relation to diabetes care, cost savings can be 
achieved by substituting doctors for nurses. 
 Currently practices that deliver a higher proportion of care for people with diabetes by nurses 
save on doctors’ time but savings are not sufficient to cover the costs of additional nurse 
consultation time. Nurses are providing an extra resource.  
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7. Discussion & Recommendations 
7.1 Introduction   
The contribution of practice nurses to chronic disease management has gained increasing attention 
over the last two decades. The introduction of a new GP contract in 1990 gave financial rewards for 
providing certain types of care, such as offering chronic disease clinics. In 2004 the revised GP 
contract rewarded practices for meeting specific targets, for example related to the management of 
long-term chronic conditions such as CHD, asthma, COPD, and diabetes. Nurse-led chronic disease 
clinics have been found to be as effective as hospital outpatient clinics and GP delivered care under 
the right conditions (Sibbald et al, 2006). This presented opportunities for increased delegation from 
doctors to nurses, and for nurses in primary care to lead care, for example, around the management 
of diabetes. As a result, GP practices increased the numbers of practice nurses they employed 
(Sibbald et al, 2006). The study reported here explores the impact of practice nurses in the 
management of chronic diseases in primary care. We focus specifically on diabetes for several 
reasons.  
Firstly, the prevalence of diabetes has been rising relentlessly particularly over the last decade not 
only in the UK but in many countries in the Western World. Around 10% of the NHS budget is now 
devoted to the treatment of people with diabetes and this burden on the NHS is expected to increase 
unless solutions are found. Bringing blood glucose down to safe levels has long-term benefits, and 
will delay and reduce the accumulation of both macro-vascular (e.g. stroke, myocardial infarction) and 
micro-vascular (retinopathy, neuropathy) comorbidities, the costs of which place a substantial burden 
on the NHS.  
Secondly, diabetes is one of the chronic conditions that practice nurses have an increasing level of 
involvement in. The new GP contract in 2004 brought with it new electronic database systems in GP 
practices. The use of these systems may have facilitated the delegation of certain types of work to 
non-medical colleagues who are “more bound and responsive to the ‘system’” (Checkland et al, 
2007). However, the detailed analysis of consultations presented here suggests that changes over the 
past decade have not been as dramatic as sometimes supposed and much of the change observed is 
because nurses are providing additional care in some practices, relative to those where nurses are 
used less. There is impetus behind wanting healthcare professionals to expand their skills to provide 
effective care to people with chronic conditions and previous research suggests that GP workload 
could be substantially reduced by delegating certain activities to nurses (Dubois and Singh, 2009). 
There is evidence here that this has occurred in some practices and our findings suggest there is no 
adverse effects for people with diabetes. 
Thirdly, diabetes has been regarded as a tracer condition for overall quality of care delivered by 
general practices and provides a potential model for other chronic conditions (Graffy and Griffin, 
2008).  
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Whilst a potential benefit of delegating routine care management activity to nurses is that it may free 
up doctors’ time that can be spent on more complex cases, there has nonetheless been concern as to 
whether nurses can deliver these activities to the same standard as GPs. In the USA it was argued 
that nurse practitioners would not replace doctors in primary care but would increase level of access 
to healthcare (The Board of Directors of the National Organization of Nurses Practitioner Faculties, 
2000). A systematic review in 2002 (Horrocks et al, 2002) suggested that nurses matched doctors in 
terms of quality of care provided and in some areas, e.g. patient satisfaction, they outperformed 
doctors. Our study was only able to explore a single outcome but confirms equivalent clinical outcome 
in terms of control of HbA1C. 
One of the success stories of QOF, has been the improvement of diabetes care (Heath et al, 2007). 
Previous work using routinely available QOF data found an association between level of practice 
nurse staffing and performance based on a composite QOF measure for diabetes and certain QOF 
Diabetes Indicators (HbA1c ≤ 7.4%, HbA1c ≤ 10%, total cholesterol ≤ 193mg/dl), (Griffiths et al, 
2010a).  
However this earlier work relied on using data aggregated at the practice level, rather than individual 
patient records. Flaws in using aggregated data have been widely discussed in the literature and is 
regularly referred to using a variety of different terms e.g. ecological fallacy, ecological bias, 
isomorphism (Arceneaux and Nickeson, 2009), aggregate bias and cross-level bias (Lancaster et al, 
2006). Robinson (1950) concluded that correlations calculated using data on individuals do not 
necessarily translate to the group level and vice versa. 
This study aimed to examine whether different workforce configurations (and activity) in primary care 
are associated with variation in the glycaemic control of patients with diabetes, using patient level 
data. 
7.2 Achievement of glycaemic control over the last 10 years 
There is some evidence that diabetes care was improving prior to QOF and after its introduction there 
was significant further improvement in performance that was above the pre-existing trend until 2005 
(Campbell et al, 2009). Our data shows that peak performance measured using the HbA1c ≤ 10% 
threshold was reached in 2005 but for the lower threshold (HbA1c ≤ 7%) there was continuing but 
slow improvement until 2009. Most of the improvement, in both cases, has taken place between 2002 
and 2004.  
Overall, in terms of QOF performance many practices that were predicted to get scores of 700-750 
were achieving scores of 950 very early on (Checkland et al, 2007). Changes to the pay-per-
performance scheme have occurred along the way with the introduction of higher thresholds. This 
was one of the reasons we have analysed the data for each year separately, to be able to examine 
the findings in relation to changes to crucial contextual factors since 2002. The HbA1c ≤ 10% 
threshold was last used by QOF in 2008/9, in subsequent years the highest threshold was ≤ 9%, and 
this may explain why our figures show a dip in performance with the percentage of people with 
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diabetes achieving that threshold falling from 83.7% in 2008 to 81.9% in 2011/12. There has been 
some criticism of the influence of QOF, in creating a more mechanistic approach that focuses on 
specific targets at the expense of overall care quality and continuity.  
The importance of diabetic review is made evident in the regression analysis which shows a positive 
association between average number of reviews per annum conducted by practices and the 
proportion of people meeting the QOF thresholds. This association was stronger for the higher 
(HbA1c ≤ 10%) than the lower threshold (HbA1c ≤ 7%) and in the earlier part of the study period 
(2002-2004), although for the higher threshold there is a suggestion that this association is starting to 
gain strength again. The importance of regular review, which is increasingly undertaken by practice 
nurses has workforce implications, if this level of activity is to be sustained and the occurrence of 
comorbidities minimised. 
7.3 Workforce activity in managing diabetes 
The proportion of people with diabetes seen by doctors in this study has fallen from 70% in 2002 to 
64% in 2011/12, but has hovered between 31% and 32% for practice nurses and increased from 3% 
to 8% for other healthcare professionals. In 2006 about 62% of consultations with all patients 
registered with a practice were undertaken by GPs and 34% by all types of nurses (Hippisley-Cox, 
Fenty and Heaps, 2007). This compares with 67% and 31% for doctors and practice nurses 
respectively found in this study for consultations specifically with people with diabetes.  
The amount of work (measured through total number of consultations) undertaken by practice nurses 
increased by 20% over the period of the study (2002 to 2011/12) whereas workload measured in 
these terms has remained static for doctors. Meanwhile prevalence continues to increase sharply, 
from 3.0% to 4.9% (based on the THIN Diabetes population), although some of this increase has 
been attributed to earlier diagnosis and the rise in obesity. 
In spite of this increase in the overall volume of consultations undertaken by practice nurses the 
number of times patients with diabetes were seen on average each year has declined from 16.0 to 
11.5 over the study period. This could be partly explained by the fact that people with diabetes are 
being diagnosed earlier, when the condition is less severe, is more treatable and therefore they do not 
need the same level of attention that more severe cases of diabetes require. GP practices may also 
have become better at dealing with multi-morbidity in a single but longer consultation. The regression 
models for the early part of the period found a negative relationship between this measure of 
workforce activity and achieving glycaemic control. One explanation is that some practices needed to 
devote more workforce capacity to meet the new QOF targets because the diabetes of people 
registered with their practice was less well controlled, whilst practices where diabetes was already 
better controlled could redirect their efforts to those who were more difficult to treat. This relationship 
became positive and significant for the lower HbA1c threshold (≤ 7%) in 2011. 
Practice nurses have made more entries in peoples’ medical records over this period. This might be 
because they are more responsive to the “system” but it may also reflect a greater involvement in 
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diabetes care. The proportion of consultation time with a doctor has gone from 61% (of a total of 160 
minutes with all health care professionals per person per year) in 2002, to 54% (of 124 minutes) in 
2012. Whilst proportionally the time spent with a practice nurse has increased from 33% to 37%, and 
with other staff (other nurses and other health care professionals) from 6% to 9%.  
Since 2002 practice nurses have undertaken more review activities (annual review, monitoring etc.) 
than doctors suggesting that their involvement had already become embedded, perhaps in 
preparation for QOF and by other initiatives prior to QOF. Doctors have become less involved in 
review, declining from an average of 0.49 reviews per person with diabetes in 2002 to 0.30 in 2008. 
This decline has now ceased and a small increase to 0.34 was observed in 2011/12. Review activity 
remained quite static for practice nurses until 2011 when it increased, primarily due to an increase in 
foot screening. Over the period, the proportion of reviews performed by practice nurses has increased 
from 64% to 73%.  
The role of nurses in 2012 is confirmed by the practice survey, which found that diabetes care was 
most frequently “managed by nurse (or nurses) specialised in diabetes”, and that this was more 
common than “care managed by doctor (or doctors) specialised in diabetes”. There are clear 
indications that practice nurses are taking the lead responsibility for the management of care for many 
people with diabetes.  
Specifically practice nurses are undertaking more of the diabetes reviews, which could be an 
indication that they are increasingly becoming the first point of contact. A quasi-experimental study in 
the Netherlands found that a shared care model resulted in improved glycaemic control with 
equivalent outcomes in other areas when compared to the GP as the main provider (Vrijhoef et al, 
2002).  
Other research has flagged the importance of practice staff being able to provide early diagnosis of 
people with diabetes, to treat them as quickly as possible and when oral diabetes drugs are no longer 
effective, to commence insulin at the earliest opportunity (Leibl, 2009). Our research suggests that 
practice nurses are becoming more involved in medication review although the absolute numbers of 
medication reviews recorded (by any staff group) is low. Although still on a very small scale in 
2011/12 practice nurses had reviewed the medication of one or more people with diabetes in 37% of 
practices (rising from 6% in 2002). The corresponding figures for doctors were an increase from 17% 
in 2002 to 49% in 2011/12. Converting to insulin therapy is known to have considerable benefits for 
people, yet in the past nurses reported fears around lack of training, support and litigation when 
converting patients from oral hyperglycaemic agents to injected insulin within primary care (Greaves 
et al, 2003). The fact that more practice nurses are now engaging in medication review suggests that 
some of these fears have lessened although evidence from this study suggests that there remains 
considerable scope to increase nurses’ role in medication review and initiation of insulin therapy, 
provided of course that there is proper training. In this study the practice survey found that in 46% of 
practices the GP generally initiates insulin treatment, and in 36% of practices the practice nurse 
initiates treatment. 
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While a majority (89%) of practices employed at least one nurse with a postgraduate qualification in 
diabetes care, roughly one it ten did not. Practice nurses play a pivotal role in making sure that, 
through the vehicle of annual health checks and other forms of medical review, people are diagnosed 
at an early stage. Recent research suggests that intensive treatment (e.g. insulin) on its own is not 
sufficient to reduce long-term risk of comorbidities because of the failure to achieve blood glucose 
control early on in the course of diabetes (Leibl, 2009).  
7.4 Performance and cost  
At the beginning of the last decade it was widely advocated that for certain chronic diseases 
(including diabetes) care that had traditionally been delivered by doctors, could be undertaken by staff 
with less training (Bagley, 2000). There is still an ongoing debate about whether primary care should 
be nurse led or not (Sibbald and Knight, 2008).  
Issues remain around economic efficiency. Some evidence suggests that nurses tend to hold longer 
consultations and instigate more investigations although both of these factors might result in better 
long-term outcomes for the person with diabetes. This study found that over the last decade nurse 
consultations have typically been one or two minutes longer than doctors (e.g. in 2011/12 the average 
GP consultation was 11 minutes compared to 13 minutes for practice nurses).    
There also may be hidden costs such as greater levels of unproductive time, lower capacity to act 
independently, and greater risks to the patient (Dubios and Singh, 2009). The economic benefits of 
substitution are critically dependent upon wage differentials (Goryakin et al, 2011), although large 
differentials between nurses’ salaries and GP income suggests that the case for substitution in the 
UK, is unlikely to be highly sensitive to differences in efficiency unless they are dramatic. A recent 
study found that higher practice nurse staffing was associated with higher admission rates for 
diabetes although the authors of that study advised against making simple causal interpretations 
(Griffiths et al, 2010b). 
In this study those GP practices where practice nurses had greater contact and involvement with 
people with diabetes performed as well as practices where most of the care was delivered by doctors 
based on HbA1c levels (≤ 7% and ≤ 10%). In the earlier years of the study there was some evidence 
that practices where practice nurse contact was high outperformed those where nurse contact was 
low. It appears that using practice nurses to provide higher proportions of care for people with 
diabetes is associated with the same level of performance as providing more care by doctors on this 
single, but highly important measure, of diabetes control. 
Previous research has found that nurse practitioners cost the same as GPs once clinical care and 
service costs are accounted for (Venning, 2000). There is also the issue of nurse practitioner training 
which is less well integrated, and perceived as inferior, to GP training (Burke, 2009). Despite this, 
nurse practitioner training typically produces a person who is able to deliver safe care. In the practice 
survey the average number of practice nurses was 1.85 per practice; the average was far lower for 
nurse practitioners at 0.24 but 73% of the diabetes care was managed by a nurse who specialised  in 
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diabetes. In this study, practices that made more use of nurses reduced the amount of time people 
spent with doctors but also delivered more care (as measured by consultation time) overall. The 
savings in doctors’ time does not appear to be offset by the additional costs of time spent with other 
practitioners, predominantly nurses. However there are opportunity costs associated with the use of 
GPs or secondary care to provide additional services. The costs and benefits associated with 
changes remain uncertain and it should be borne in mind that confining an economic analysis to a 
short time window may not reveal all the costs going forward. 
7.5 Strengths and limitations 
The initial selection of people with diabetes was based on a list of 612 Readcodes. A Readcode field 
appears both in the medical record and additional health details. Filtering by these THIN data fields 
will have captured most people who could have diabetes. It is possible however that we might have 
missed people with diabetes who did not have a diabetes Readcode anywhere in their THIN record, 
for example, people who were receiving a diabetic therapy or with a high HbA1c value (HbA1c > 
6.5%). The number of people to whom this applies is unlikely to be large. A further algorithm was 
applied to the THIN extract which reduced the sample by 21% suggesting that our initial list was, as 
intended, broadly inclusive. We are confident that we have captured most of the people with diabetes 
registered with THIN practices. 
In terms of consultations, we have constructed our own definition of a consultation based on where 
the contact with the person took place and using the THIN consultations dataset. Attribution of the 
consultation to a particular staff role group has been defined in two ways: 
 By the role group linked to the staff ID allocated by the Vision system to the ‘consultation’ 
record that appears in the THIN consultation dataset. 
 By the role group that links to the staff ID present on records from the medical, additional 
health details and therapy datasets which are all linked together via the same consultation ID. 
From the second definition we were able to ascertain whether a particular staff role group (e.g. 
practice nurses) shared the consultation with another staff role group (e.g. doctors) or whether they 
had sole ownership of the consultation record. So it was not possible for us to definitively ascribe 
overall ownership of the consultation to one person when more than one person was involved nor 
could we apportion consultation time between healthcare professionals when the consultation was 
shared between more than one person. 
As far as diabetes control: a single HbA1c value closest to July 1
st
 was selected for each person for 
each year they were registered with a practice (for 2011/12 we used the value closest to the 16
th
 May 
2012 to coincide with the practice survey). A single value may not in all cases provide a precise 
indication that a person’s diabetes is under control or not. In QOF the last HbA1c value in the 
preceding 15 months is always used so there are parallels between the two approaches except that 
we chose a date not wedded to the QOF reporting period (e.g. 1
st
 July rather than the 31
st
 March). 
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Further research is required to determine the reliability of single HbA1c measures as an indicator of 
diabetes control. When blood glucose is under control, fewer measurements will be taken and when it 
is not, more will be taken until that person’s diabetes is brought under control again. Therefore 
deciding what is meant by control under the latter circumstances is more complex. Nonetheless in a 
large sample the error induced by this variation is unlikely to dramatically affect estimates of control at 
a practice level or introduce measurement error sufficient to substantially limit the power of the study 
to demonstrate differences. 
We believe there was a sufficient conceptual match between our research questions and the data that 
were available to us to answer those questions.  Fortunately we were in a position to collect additional 
survey data via Cedegim - the company providing the THIN patient level data. Although this additional 
data collection was part of a routine audit and was thus limited in scale and scope, it did allow us to 
add and ask some specific questions about the management of diabetes care in those practices who 
participated. The survey was our only source for information about nursing qualifications in diabetes 
care and GP interest in diabetes. The THIN data currently only provides very limited information on 
each member of staff (role and gender). A significant limitation to this work is the absence of detailed 
information on the general practice workforce at a practice level. While information of numbers and 
demographic characteristics of doctors in general practice are readily available, no similar data on the 
numbers of other professionals are available from the Information Centre at the practice level. The 
ability to examine the general practice level workforce in detail, at the level of the practice, is vital for 
future work in this area.  Increasingly, diabetes care is taking place outside general practice through 
nurse led teams commissioned by CCGs who monitor their diabetes performance across all their 
practices. This work would not appear in our study. 
Our findings for prevalence and for consultation rates are in accord with those found by other 
researchers (Kanavos et al, 2012; Hippisley-Cox, Fenty and Heaps, 2007) and health information 
providers (NHS Information Centre for Health and Social Care, 2012). The proportion of people 
meeting the HbA1c thresholds for this study are lower than national figures 
(http://www.gpcontract.co.uk/ accessed 28
th
 March 2013) because we opted for population 
achievement, rather than reported achievement, therefore all people were included in the analysis 
and the denominators (i.e. there was no exception reporting). Our figures are closer to those reported 
by Calvert and colleagues who excluded diabetes exception reporting codes that did not give a 
reason for the exception (Calvert et al, 2009). 
The limitations of our economic analysis have been fully outlined on pages 88-89. In summary we 
have a small subset of data limited to 166 GP practices and one year of person level data. We are 
also limited in our understanding of service configurations – e.g. exactly who does what within 
diabetes care and we are therefore limited to the direct workforce implications of changes in 
consultation patterns and a single outcome at one point in time. Other outcomes, long term outcomes, 
other treatment costs, opportunity costs and savings occurring elsewhere in the health system have 
92 
 
not been considered. Judgements about the economic case are likely to be highly sensitive to these 
issues and further research is required. 
Previous work by NNRU found an association between practice nurse staffing and non-elective 
hospital admissions (Griffiths et al, 2010b). Providers of practice level data are now able to link GP 
practice data with Hospital Episodes Statistics creating a primary and secondary care medical history 
for each person. These data, once they become available, will allow researchers to study and more 
effectively understand the interface between primary and secondary care in relation to diabetes, and 
at the level of the individual, that would have not been possible in the past. This should also be a 
priority for future research. 
7.6 Conclusion 
This study aimed to examine whether different workforce configurations (and activity) in primary care 
are associated with variation in control of diabetes. We sought to determine whether the relationships 
previously found between practice nurse staffing and performance under QOF for diabetes, were still 
found when using person level data.   
The data shows that the prevalence of diabetes has increased year on year over the last ten years, 
and that there has been an increasing reliance on practice nurses. The role and activities of nurses in 
primary care in relation to diabetes has shifted: they undertake more of the consultations with people 
with diabetes and most practices now deliver care led by nurses. Practice nurses are increasingly 
undertaking review activities (monitoring, follow-up, annual review), which is linked to greater 
likelihood of glycaemic control.  During the last ten years glycaemic control has improved.   
However, whether looking longitudinally or within the latest year, there is little variation in glycaemic 
control that is found to relate specifically to differences in the way in which practices are organised or 
staffed (the vast majority of variation relates to differences between people with diabetes).  
The study shows that practices where practice nurses undertake a higher proportion of consultations 
with people with diabetes and where nurses are the lead clinician for managing diabetes perform the 
same (in terms of glycaemic control) as practices where there is a different pattern of consultations. 
Because there is relatively little variation between practices in terms of their glycaemic control, there 
is scope to substitute nurses for GPs in delivering care for people with diabetes and to use nurses as 
a means of delivering enhanced care. Given the salary differential, using nurses to deliver enhanced 
care appears to be an efficient strategy although more evidence is required to show long term 
benefits. The costs and benefits of this strategy remain uncertain but there is no evidence of harm. 
Indeed what we can say is that optimised diabetes care is just as good when predominantly provided 
by nurses compared to care which is mainly provided by GPs. Other research suggests that patient 
satisfaction may be improved. 
This conclusion can inform both commissioners and providers seeking to optimise care for people 
with diabetes. While the specific training of practitioners to provide care for people with diabetes is a 
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hugely important issue, it does not appear that the professional group of those providing routine care 
is a source of variable quality. Thus the available evidence suggests that moves toward the further 
development of nurse led services, with appropriate specialist support, are compatible with the 
delivery of quality diabetes care.  
The THIN data, and specific datasets that were created for this study, provide an extremely rich 
source of information about the population of people with diabetes in the UK, and avoids many of the 
limitations and pitfalls associated with using aggregate data. Further research on GP practice service 
and workforce configuration should focus on other diabetes related measures (e.g. blood pressure, 
cholesterol levels, foot and eye screening), diabetes related comorbidities both at the macro-vascular 
(stroke, myocardial infarction) and micro-vascular (neuropathy, retinopathy) level. The impact on 
nurse activity and diabetes structured patient education of the dramatic increase in people diagnosed 
with type 2 diabetes who are insulin dependent requires further consideration and research. . This list 
is not meant to be exhaustive because the potential of these data is vast. The ability of GP practices 
to identify diabetes at an earlier stage before the condition has become too severe, less easy and 
more expensive to treat will be crucial going forward. The obvious benefits will be longer life 
expectancy, fewer comorbidities and a reduced burden upon the state economically. Research on this 
topic should therefore be encouraged 
7.7 Recommendations 
From this research a number of recommendations can be identified, which relate to different 
communities. Key recommendations for each are:   
Research community: Further research is required regarding the following:  
 the economic analysis of substituting doctors for nurses which would need to take account of 
long term outcomes, other treatment costs, opportunity costs and savings occurring 
elsewhere in the health system. 
 the dramatic increase in people diagnosed with type 2 diabetes and impact on nurse activity 
and the effects of diabetes structured patient education.  
 the extent to which GP practices can identify diabetes at an early stage before the condition 
has become too severe. 
 the links between workforce and patient outcomes over time which includes other key 
outcome measures (BP, BMI, lipids etc.).  
 the management of other long-term conditions, and how this affects patient outcomes. 
Policy: the Quality and Outcomes Framework should continue to focus on specific care provided 
as well as the structural characteristics relating to training and competence.  
Policy: Health Education England and CfWi: Better general practice workforce data is needed. In 
particular systematic collection and collation of more detailed primary care workforce and skill-mix 
94 
 
data on nursing and non-nursing staff is required. We recommend that consideration is given to the 
implications for national minimum datasets to map and describe primary care workforce, to avoid 
piecemeal data collection (and assist policy and workforce planning).     
Policy: Health Education England: The requirements for post registration training in diabetes for 
doctors but also specifically for nurses (where historically budgets have been lower) needs to be 
addressed through educational commissioning. 
Health Education England and Higher Education Institutions:  
Nurses undertake most of the diabetes care so CPPD training in diabetes for practice nurses is 
essential to ensure a high standard of care and that QoF targets are achieved. 
Ensure practice and specialist nurses have competence training on foot assessment and collaborative 
care planning, for example, to ensure effective behaviour change and self-management are essential 
and may increase the proportion of patients achieving targets, reduce long term risk, ambulance call 
out rates and hospital admissions.  
 
Policy: CCGs and NHS England: responsibility for diabetes care is shared;  CCGs who are 
responsible for care in the community and via secondary care and NHS England for GP provided 
services. These organisations therefore need to work closely together to ensure joined up thinking in 
commissioning services and care delivery. 
Policy: CCGs and NHS England: should consider fully the implications of this research which 
suggests optimised diabetes care is just as good when predominantly provided by nurses compared 
to care which is mainly provided by GPs. The results of this study suggest there is scope to substitute 
nurses for GPs in delivering diabetes care and for nurses to deliver enhanced care and that this can 
result in cost savings. 
 
 
95 
 
References 
Aiken, L.H., Clarke, S.P., Sloane, D.M., Sochalski, J., Silber, J.H., 2002. Hospital nurse staffing and 
patient mortality, nurse burnout, and job dissatisfaction. JAMA 288 (16), 1987-1993. 
al-Haider, A.S., Wan, T.T., 1991. Modeling organizational determinants of hospital mortality. Health 
Serv Res 26 (3), 303-323. 
Arceneaux, K., Nickerson, D.W., 2009. Modeling certainty and clustered data: a comparison of 
methods. Political analysis, 17, 177-190. 
Ashworth, M., Armstrong, D., 2006. The relationship between general practice characteristics and 
quality of care: a national survey of quality indicators used in the UK Quality and Outcomes 
Framework, 2004-5. BMC family practice 7, 68. 
Bagley, B., 2000. Letter to the Editor. JAMA, 283, 19, 2521. 
Bardsley, M., Blunt, I., Davies, S., Dixon, J., 2013. Is secondary preventive care improving? 
Observational study of 10-year trends in emergency admissions for conditions amenable to 
ambulatory care. BMJ Open 3 (1). 
Basu, J., Friedman, B., Burstin, H., 2002. Primary care, HMO enrollment, and hospitalization for 
ambulatory care sensitive conditions: a new approach. Med Care 40 (12), 1260-1269. 
Blak B.T., Thompson M., Dattani H., Bourke A., 2011. Generalisability of The Health Improvement 
Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Informatics 
in Primary Care 2011; 19 (4), 251-255. 
Blegen, M.A., Goode, C.J., Reed, L., 1998. Nurse staffing and patient outcomes. Nurs Res 47 (1), 43-
50. 
Bottle, A., Gnani, S., Saxena, S., Aylin, P., Mainous, A.G., 3rd, Majeed, A., 2008a. Association 
between quality of primary care and hospitalization for coronary heart disease in England: national 
cross-sectional study. J Gen Intern Med 23 (2), 135-141. 
Bottle, A., Millett, C., Xie, Y., Saxena, S., Wachter, R.M., Majeed, A., 2008b. Quality of primary care 
and hospital admissions for diabetes mellitus in England. J Ambul Care Manage 31 (3), 226-238. 
Burden, M., 2003 Diabetes: treatment and complications- the nurse’s role. Nursing Times 99 (02) 
p30-32. 
Burke, L., 2009. Nurse practitioners and general practitioners, is there any difference? InnovAiT, 2, 
11, 687-688. 
Calvert, M., Shankar, A., McManus, R.J., Lester, H. and Freemantle, N., 2009. Effect of the quality 
and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ 
338:b1870doi:10.1136/bmj.b1870 
96 
 
Checkland, K., McDonald, R. and Harrison, S., 2007. Ticking boxes and changing the social world: 
data collection and the new UK General practice contract. Social Policy & Administration, 41, 7, 693-
710. 
Cooper, J.G., Claudi, T., Jenum, A.K., Thue, G., Hausken, M.F., Ingskog, W., Sandberg, S., 2009. 
Quality of care for patients with type 2 diabetes in primary care in Norway is improving: results of 
cross-sectional surveys of 33 general practices in 1995 and 2005. Diabetes Care 32 (1), 81-83. 
Department of Health, 2006. Investing in general practice- the new General Medical Services 
contract. Annex A. London. 
Diabetes UK, 2012. State of the Nation 2012 England. Diabetes UK, London. 
Downing, A., Rudge, G., Cheng, Y., Tu, Y.K., Keen, J., Gilthorpe, M.S., 2007. Do the UK 
government's new Quality and Outcomes Framework (QOF) scores adequately measure primary care 
performance? A cross-sectional survey of routine healthcare data. BMC Health Serv Res 7, 166. 
Forbes, A., While, A., Griffiths, P., Ismail, K., Heller, S., 2011. Organizing and delivering diabetes 
education and self-care support: findings of scoping project. Journal of Health Services Research and 
Policy 16 (suppl_1), 42-49. 
Gemmell, I., Campbell, S., Hann, M., Sibbald, B., 2009. Assessing workload in general practice in 
England before and after the introduction of the pay-for-performance contract. J Adv Nurs 65 (3), 509-
515. 
Goldstein, H., 1995. Multilevel statistical models. Arnold, London. 
Goryakin, Y., Griffiths, P., & Maben, J., 2011. Economic evaluation of nurse staffing and nurse 
substitution in health care: A scoping review. International Journal of Nursing Studies, 48(4), 501-512. 
doi: 10.1016/j.ijnurstu.2010.07.018 
Graffy, J. and Griffin, S. Review of the Quality and Outcomes Framework for Diabetes: Current 
Indicators 2007 - 2008. Manchester: National Primary Care Research and Development Centre.  
http://www.npcrdc.ac.uk/Publications/Diabetes_200708.pdf 
Greaves, C.J., Brown, P., Terry, R.T., Eiser, C., Lings, P. and Stead, J.W., 2003. Converting to insulin 
in primary care: an exploration of the needs of practice nurses. Journal of Advanced Nursing 42, 5, 
487-496. 
Griffiths, P., Murrells, T., Maben, J., Jones, S., Ashworth, M., 2010a. Nurse staffing and quality of care 
in UK general practice: cross-sectional study using routinely collected data. Br J Gen Pract 60 (570), 
36-48. 
Griffiths, P., Dawoud, D., Murrells, T., Jones, S., 2010b. Hospital admissions for asthma, diabetes and 
COPD: is there an association with practice nurse staffing? A cross sectional study using routinely 
collected data. BMC Health Sevices Research 10 (276), http://dx.doi.org/10.1186/1472-6963-1110-
1276. 
97 
 
Griffiths, P., Maben, J., Murrells, T., 2011. Organisational quality, nurse staffing and the quality of 
chronic disease management in primary care: Observational study using routinely collected data. 
International Journal of Nursing Studies 48 (10), 1199-1210. 
Gulliford, M.C., R. Latinovic, et al., 2008. "Diabetes diagnosis, resource utilization and health 
outcomes " American Journal of Managed Care 14(1): 32-38. 
Hartz, A.J., Krakauer, H., Kuhn, E.M., Young, M., Jacobsen, S.J., Gay, G., Muenz, L., Katzoff, M., 
Bailey, R.C., Rimm, A.A., 1989. Hospital characteristics and mortality rates. N Engl J Med 321 (25), 
1720-1725. 
Heath, I., Hippisley-Cox, J. and Smeeth, L., 2007. Measuring performance and missing the point. BMJ 
335; 1075-1076. 
Hex, N., Bartlett, C., Wright C., Taylor, D., Varley, D. 2012. Estimating the current and future costs of 
Type 1 and 2 diabetes in the United Kingdom including direct health costs and indirect 
Hippisley-Cox, J., Fenty, J., Heaps, M., 2007. Trends in Consultation Rates in General Practice 1995 
to 2006: Analysis of the QRESEARCH database. NHS Information Centre. 
Horrocks, S., Anderson, E., Salisbury, C., 2002. Systematic review of whether nurse practitioners 
working in primary care can provide equivalent care to doctors. BMJ 324 (7341), 819-823. 
Kanavos, P., van den Aardweg, S., Schurer, W., 2012. Diabetes expenditure, burden of disease and 
management in 5 EU countries. London School of Economics. 
Kane, R.L., Shamliyan, T.A., Mueller, C., Duval, S., Wilt, T.J., 2007. The association of registered 
nurse staffing levels and patient outcomes: systematic review and meta-analysis. Med Care. 
;45(12):1195-1204. 
Kloos, C., Muller, N., Wolf, G., Hartmann, P., Lehmann, T., Muller, U.A., 2011. Better HbA1c and 
blood pressure control in patients with diabetes mellitus treated at a primary health care level 10 
years after initiation of a diabetes quality improvement program. Experimental and clinical 
endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes 
Association 119 (8), 459-462. 
Knaus, W.A., Draper, E.A., Wagner, D.P., Zimmerman, J.E., 1986. An evaluation of outcome from 
intensive care in major medical centers. Ann Intern Med 104 (3), 410-418. 
Knight, R., 2008. Should primary care be nurse led? No. BMJ 337:39661.694572.59  
Kontopantelis, E., Reeves, D., Valderas, J.M., Campbell, S., Doran, T., 2013. Recorded quality of 
primary care for patients with diabetes in England before and after the introduction of a financial 
incentive scheme: a longitudinal observational study. BMJ Qual Saf 22 (1), 53-64. 
98 
 
Lancaster, G.A., Green, M. and Lane, S., 2006. Linkage of survey data with district-level lung cancer 
registrations: a method of bias reduction in ecological studies. Journal of Epidemiology and 
Community Health, 60, 1093-1098. 
Laurant, M., Reeves, D., Hermens, R., Braspenning, J., Grol, R., Sibbald, B., 2005. Substitution of 
doctors by nurses in primary care. Cochrane Database Syst Rev (2), CD001271. 
Leese, B., 2006. New opportunities for nurses and other healthcare professionals? A review of the 
potential impact of the new GMS contract on the primary care workforce. Journal of Health 
Organisation and  Management 20 (6), 525-536. 
Liebl, L., 2009. Insulin intensification – the rationale and the target. The International Journal of 
Clinical Practice, 63 (suppl. 164), 1-5. 
Mata-Cases, M., Roura-Olmeda, P., Berengue-Iglesias, M., Birules-Pons, M., Mundet-Tuduri, X., 
Franch-Nadal, J., Benito-Badorrey, B., Cano-Perez, J.F., 2012. Fifteen years of continuous 
improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain. 
International journal of clinical practice 66 (3), 289-298. 
Mundinger, M.O., Kane, R.L., Lenz, E.R., Totten, A.M., Tsai, W.Y., Cleary, P.D., Friedewald, W.T., 
Siu, A.L., Shelanski, M.L., 2000. Primary care outcomes in patients treated by nurse practitioners or 
physicians: a randomized trial. JAMA : the journal of the American Medical Association 283 (1), 59-
68. 
NHS Information Centre for Health and Social Care, 2007. National quality and outcomes framework 
statistics for England 2006/07. The Quality and Outcomes Framework National Health Service. 
NHS Information Centre for Health and Social Care, 2008. General and Personal Medical Services 
England 1997-2007. The Information Centre. 
NHS Information Centre for Health and Social Care, 2011. National Diabetes Audit Mortality Analysis 
2007-2008. Health and Social Care Information Centre, London. 
NHS Information Centre for Health and Social Care, 2012. Disease prevalence, Quality and 
Outcomes Framework (QOF) for April 2011 - March 2012, England (accessed on 28
th
 March 2013 
from http://www.ic.nhs.uk/catalogue/PUB08661). 
National Health Service Confederation, 2006. Investing in general practice- the new General Medical 
Service contract. 
National Institute for Health and Clinical Excellence (NICE), 2008. Type 2 diabetes: National clinical 
guideline for management in primary and secondary care (update), 2008, Royal College of Physicians 
O'Neil, E., Seago, J.A., 2002. Meeting the challenge of nursing and the nation's health. JAMA 288 
(16), 2040-2041. 
99 
 
Rafferty, A.M., Clarke, S.P., Coles, J., Ball, J., James, P., McKee, M. & Aiken, L.H., 2007. Outcomes 
of variation in hospital nurse staffing in English hospitals: Cross-sectional analysis of survey data and 
discharge records. International Journal of Nursing Studies, 44(2): 175-182  
Richardson, G., 1999. Identifying, evaluating and implementing cost-effective skill mix. J Nurs Manag 
7 (5), 265-270. 
Robinson, W.S., 1950. Ecological correlations and the behaviour of individuals. American Social Rev, 
15, 351-357. 
Seshasai, S.R., Kaptoge, S., Thompson, A., Di Angelantonio, E., Gao, P., Sarwar, N., Whincup, P.H., 
Mukamal, K.J., Gillum, R.F., Holme, I., Njolstad, I., Fletcher, A., Nilsson, P., Lewington, S., Collins, R., 
Gudnason, V., Thompson, S.G., Sattar, N., Selvin, E., Hu, F.B., Danesh, J., 2011. Diabetes mellitus, 
fasting glucose, and risk of cause-specific death. The New England journal of medicine 364 (9), 829-
841. 
Sibbald, B., Laurant, M.G. and Reeves, D., 2006. Advanced nurse roles in UK Primary care. Medical 
Journal of Australia, 185, 1 ,10-12. 
Sibbald, B., 2008a. Should primary care be nurse led? Yes. BMJ 337 (sep04_2), a1157-. 
Sibbald, B., 2008b. Who needs doctors in general practice? Quality in Primary Care 16, 73-74. 
Sibbald, B., Laurant, M.G., Reeves, D., 2006. Advanced nurse roles in UK primary care. Med J Aust 
185 (1), 10-12. 
Sochalski, J., 2001. Nursing's valued resources: critical issues in economics and nursing care. The 
Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres 33 
(1), 11-18. 
Speight, J., 2013. Managing diabetes and preventing complications: what makes the difference? Med 
J Aust 198 (1), 16-17. 
Speight, J., Browne, J.L., Homes-Truscott, E., 2012. Diabetes MILES-Australia 2011 survey report. 
Diabetes Australia, Canberra. 
Srirangalingam, U., Sahathevan, S.K., Lasker, S.S., Chowdhury, T.A., 2006. Changing pattern of 
referral to a diabetes clinic following implementation of the new UK GP contract. Br J Gen Pract 56 
(529), 624-626. 
The Board of Directors of the National Organization of Nurse Practitioner Faculties, 2000. Letter to the 
Editor. JAMA, 283, 19, 2523-2524. 
The Diabetes Control and Complications Trial Research Group (DCCT), 1993. The effect of intensive 
treatment of diabetes on the development and progression of long-term complications in insulin-
dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. The 
New England journal of medicine 329 (14), 977-986. 
100 
 
UK Prospective Diabetes Study Group (UKPDS), 1998. Intensive blood-glucose control with 
sulphonylureas or insulin compared with conventional treatment and risk of complications in patients 
with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 
(9131), 837-853. 
Venning, P., Durie, A., Roland, M., Roberts, C. and Leese, B., 2000. Randomised controlled trial 
comparing cost effectiveness of general practitioners and nurse practitioners in primary care. BMJ 
320(7241): 1048–1053. 
Vrijhoef, H.J.M., Diederiks, J.P.M., Spreeuwenberg, C., Wolffenbuttel, B.H.R., van Wilderen, L.J.G.P., 
2002. The nurse specialist as main care-provider for patients with type 2 diabetes in a primary care 
setting: effects on patient outcomes. International Journal of Nursing Studies 39 (4), 441-451. 
Zhan, C., Miller, M.R., Wong, H., Meyer, G.S., 2004. The effects of HMO penetration on preventable 
hospitalizations. Health Serv Res 39 (2), 345-361. 
 
 
 
101 
 
Appendix 1 Project group members 
 
Name  Organisation 
Dr Mark Ashworth Department of Primary Care & Public Health Sciences, King’s 
College London 
Jane Ball  National Nursing Research Unit, King’s College London 
Dr Graham Cookson Department of Management, King’s College London 
Professor Angus Forbes Florence Nightingale School of Nursing and Midwifery  King’s 
College London 
Professor Peter Griffiths Faculty of Health Sciences, University of Southampton 
Dr Geri Lee Florence Nightingale School of Nursing and Midwifery, King’s 
College London 
Professor Jill Maben National Nursing Research Unit, King’s College London 
Dr Henri Mulnier Florence Nightingale School of Nursing and Midwifery, King’s 
College London 
Trevor Murrells National Nursing Research Unit , King’s College London 
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Appendix 2 Technical details: THIN 
A2.1 Practices meeting the inclusion criteria by nation  
Year
England Northern 
Ireland
Scotland Wales Total England Northern 
Ireland
Scotland Wales Total England Northern 
Ireland
Scotland Wales Total
2002 312 17 24 22 375 220 6 7 14 247 71% 35% 29% 64% 66%
2003 337 20 31 25 413 308 18 27 22 375 91% 90% 87% 88% 91%
2004 345 21 32 30 428 312 18 28 28 386 90% 86% 88% 93% 90%
2005 374 23 33 33 463 346 21 30 30 427 93% 91% 91% 91% 92%
2006 380 23 35 35 473 353 22 32 34 441 93% 96% 91% 97% 93%
2007 382 23 43 35 483 350 21 43 34 448 92% 91% 100% 97% 93%
2008 383 21 62 38 504 353 19 61 37 470 92% 90% 98% 97% 93%
2009 374 22 69 38 503 346 20 68 37 471 93% 91% 99% 97% 94%
2010 362 23 70 39 494 337 21 70 38 466 93% 91% 100% 97% 94%
2011 348 23 73 37 481 317 21 73 34 445 91% 91% 100% 92% 93%
2011/12 336 22 71 37 466 308 21 71 34 434 92% 95% 100% 92% 93%
Meeting Vision date and AMR inclusion criteria
Meeting all the inclusion criteria including depth of staff 
coding and ≥90% use of %HbA1c units
Percentage of practices who met Vision date and AMR 
inclusion criteria who also met the additional criteria
 
Note: only practices that meet the criteria for a complete calendar year were included in the count 
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A2.2 Diabetes Readcodes used to identify people who may have diabetes 
READCODE Description READCODE Description
13AB.00 Diabetic lipid lowering diet 66A7100 Frequency of GP or paramedic treated hypoglycaemia
13AC.00 Diabetic weight reducing diet 66A8.00 Has seen dietician - diabetes
13B1.00 Diabetic diet 66A9.00 Understands diet - diabetes
1434.00 H/O: diabetes mellitus 66AA.11 Injection sites - diabetic
14F4.00 H/O: Admission in last year for diabetes foot problem 66AD.00 Fundoscopy - diabetic check
14P3.00 H/O: insulin therapy 66AG.00 Diabetic drug side effects
2BBF.00 Retinal abnormality - diabetes related 66AH.00 Diabetic treatment changed
2BBL.00 O/E - diabetic maculopathy present both eyes 66AH000 Conversion to insulin
2BBP.00 O/E - right eye background diabetic retinopathy 66AI.00 Diabetic - good control
2BBQ.00 O/E - left eye background diabetic retinopathy 66AJ.00 Diabetic - poor control
2BBR.00 O/E - right eye preproliferative diabetic retinopathy 66AJ.11 Unstable diabetes
2BBS.00 O/E - left eye preproliferative diabetic retinopathy 66AJ000 Chronic hyperglycaemia
2BBT.00 O/E - right eye proliferative diabetic retinopathy 66AJ100 Brittle diabetes
2BBV.00 O/E - left eye proliferative diabetic retinopathy 66AJ200 Loss of hypoglycaemic warning
2BBW.00 O/E - right eye diabetic maculopathy 66AJ300 Recurrent severe hypos
2BBX.00 O/E - left eye diabetic maculopathy 66AJz00 Diabetic - poor control NOS
2BBk.00 O/E - right eye stable treated prolif diabetic retinopathy 66AK.00 Diabetic - cooperative patient
2BBl.00 O/E - left eye stable treated prolif diabetic retinopathy 66AL.00 Diabetic-uncooperative patient
2BBo.00 O/E - sight threatening diabetic retinopathy 66AM.00 Diabetic - follow-up default
2G51000 Foot abnormality - diabetes related 66AN.00 Date diabetic treatment start
2G5A.00 O/E - Right diabetic foot at risk 66AO.00 Date diabetic treatment stopp.
2G5B.00 O/E - Left diabetic foot at risk 66AP.00 Diabetes: practice programme
2G5C.00 Foot abnormality - diabetes related 66AQ.00 Diabetes: shared care programme
2G5D.00 Foot abnormality - non-diabetes 66AR.00 Diabetes management plan given
2G5E.00 O/E - Right diabetic foot at low risk 66AS.00 Diabetic annual review
2G5F.00 O/E - Right diabetic foot at moderate risk 66AT.00 Annual diabetic blood test
2G5G.00 O/E - Right diabetic foot at high risk 66AU.00 Diabetes care by hospital only
2G5H.00 O/E - Right diabetic foot - ulcerated 66AV.00 Diabetic on insulin and oral treatment
2G5I.00 O/E - Left diabetic foot at low risk 66AW.00 Diabetic foot risk assessment
2G5J.00 O/E - Left diabetic foot at moderate risk 66AX.00 Diabetes: shared care in pregnancy - diabetol and obstet
2G5K.00 O/E - Left diabetic foot at high risk 66AY.00 Diabetic diet - good compliance
2G5L.00 O/E - Left diabetic foot - ulcerated 66AZ.00 Diabetic monitoring NOS
2G5V.00 O/E - right chronic diabetic foot ulcer 66Aa.00 Diabetic diet - poor compliance
2G5W.00 O/E - left chronic diabetic foot ulcer 66Ab.00 Diabetic foot examination
3881.00 Education score - diabetes 66Ac.00 Diabetic peripheral neuropathy screening
3882.00 Diabetes well being questionnaire 66Af.00 Patient diabetes education review
3883.00 Diabetes treatment satisfaction questionnaire 66Ag.00 Insulin needles changed daily
42W..00 Hb. A1C - diabetic control 66Ah.00 Insulin needles changed for each injection
42WZ.00 Hb. A1C - diabetic control NOS 66Ai.00 Diabetic 6 month review
42c..00 HbA1 - diabetic control 66Aj.00 Insulin needles changed less than once a day
43Gk.00 Insulin antibody level 66Ak.00 Diabetic monitoring - lower risk albumin excretion
43WQ.00 Insulin IgE antibody level 66Al.00 Diabetic monitoring - higher risk albumin excretion
43WR.00 Insulin IgG antibody level 66Am.00 Insulin dose changed
43Yu.00 Bovine insulin RAST test 66An.00 Diabetes type 1 review
43Yv.00 Human insulin RAST test 66Ao.00 Diabetes type 2 review
44V3.00 Glucose tol. test diabetic 66Ap.00 Insulin treatment initiated
66A..00 Diabetic monitoring 66Aq.00 Diabetic foot screen
66A1.00 Initial diabetic assessment 6761.00 Diabetic pre-pregnancy counselling
66A2.00 Follow-up diabetic assessment 679L.00 Health education - diabetes
66A3.00 Diabetic on diet only 679R.00 Patient offered diabetes structured education programme
66A4.00 Diabetic on oral treatment 68A7.00 Diabetic retinopathy screening
66A5.00 Diabetic on insulin 68A9.00 Diabetic retinopathy screening offered
66A7000 Frequency of hospital treated hypoglycaemia 68AB.00 Diabetic digital retinopathy screening offered  
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A2.2 Diabetes Readcodes used to identify people who could have diabetes  
)
READCODE Description READCODE Description
7276.00 Pan retinal photocoagulation for diabetes 9N1v.00 Seen in diabetic eye clinic
7L10000 Continuous subcutaneous infusion of insulin 9N2i.00 Seen by diabetic liaison nurse
7L19800 Subcutaneous injection of insulin 9N4I.00 DNA - Did not attend diabetic clinic
889A.00 Diab mellit insulin-glucose infus acute myocardial infarct 9N4p.00 Did not attend diabetic retinopathy clinic
8A12.00 Diabetic crisis monitoring 9NM0.00 Attending diabetes clinic
8A13.00 Diabetic stabilisation 9NN9.00 Under care of diabetes specialist nurse
8B3l.00 Diabetes medication review 9NND.00 Under care of diabetic foot screener
8BL2.00 Patient on maximal tolerated therapy for diabetes 9NiA.00 Did not attend diabetes structured education programme
8CA4100 Pt advised re diabetic diet 9NiC.00 Did not attend DAFNE diabetes structured education programme
8CE0.00 Diabetic leaflet given 9NiD.00 Did not attend DESMOND diabetes structured education program
8CP2.00 Transition of diabetes care options discussed 9NiE.00 Did not attend XPERT diabetes structured education programme
8CR2.00 Diabetes clinical management plan 9Nl4.00 Seen by general practitioner special interest in diabetes
8CS0.00 Diabetes care plan agreed 9OL..00 Diabetes monitoring admin.
8H2J.00 Admit diabetic emergency 9OL..11 Diabetes clinic administration
8H3O.00 Non-urgent diabetic admission 9OL1.00 Attends diabetes monitoring
8H4e.00 Referral to diabetes special interest general practitioner 9OL2.00 Refuses diabetes monitoring
8H7C.00 Refer, diabetic liaison nurse 9OL3.00 Diabetes monitoring default
8H7f.00 Referral to diabetes nurse 9OL4.00 Diabetes monitoring 1st letter
8H7r.00 Refer to diabetic foot screener 9OL5.00 Diabetes monitoring 2nd letter
8HBG.00 Diabetic retinopathy 12 month review 9OL6.00 Diabetes monitoring 3rd letter
8HBH.00 Diabetic retinopathy 6 month review 9OL7.00 Diabetes monitor.verbal invite
8HHy.00 Referral to diabetic register 9OL8.00 Diabetes monitor.phone invite
8HTe.00 Referral to diabetes preconception counselling clinic 9OL9.00 Diabetes monitoring deleted
8HTi.00 Referral to multidisciplinary diabetic clinic 9OLA.00 Diabetes monitor. check done
8HTk.00 Referral to diabetic eye clinic 9OLA.11 Diabetes monitored
8Hg4.00 Discharged from care of diabetes specialist nurse 9OLB.00 Attended diabetes structured education programme
8Hj0.00 Referral to diabetes structured education programme 9OLC.00 Family/carer attended diabetes structured education prog
8Hj1.00 Family/carer referral to diabetes structured education prog 9OLD.00 Diabetic patient unsuitable for digital retinal photography
8Hj3.00 Referral to DAFNE diabetes structured education programme 9OLF.00 Diabetes structured education programme completed
8Hj4.00 Referral to DESMOND diabetes structured education programme 9OLG.00 Attended XPERT diabetes structured education programme
8Hj5.00 Referral to XPERT diabetes structured education programme 9OLH.00 Attended DAFNE diabetes structured education programme
8Hl1.00 Referral for diabetic retinopathy screening 9OLJ.00 DAFNE diabetes structured education programme completed
8Hl4.00 Referral to community diabetes specialist nurse 9OLK.00 DESMOND diabetes structured education programme completed
8I3W.00 Diabetic foot examination declined 9OLL.00 XPERT diabetes structured education programme completed
8I3X.00 Diabetic retinopathy screening refused 9OLM.00 Diabetes structured education programme declined
8I3k.00 Insulin therapy declined 9OLZ.00 Diabetes monitoring admin.NOS
8I57.00 Patient held diabetic record declined 9Oy..00 Diabetes screening administration
8I6F.00 Diabetic retinopathy screening not indicated 9Oy0.00 Diabetes screening invitation
8I6G.00 Diabetic foot examination not indicated 9h4..00 Exception reporting: diabetes quality indicators
8I81.00 Did not complete diabetes structured education programme 9h41.00 Excepted from diabetes qual indicators: Patient unsuitable
8I82.00 Did not complete DAFNE diabetes structured education program 9h42.00 Excepted from diabetes quality indicators: Informed dissent
8I83.00 Did not complete DESMOND diabetes structured educat program 9kL..00 Insulin initiation - enhanced services administration
8I84.00 Did not complete XPERT diabetes structured education program 9m0..00 Diabetic retinopathy screening administrative status
9360.00 Patient held diabetic record issued 9m00.00 Eligible for diabetic retinopathy screening
93C4.00 Patient consent given for addition to diabetic register 9m01.00 Ineligible for diabetic retinopathy screening
9M00.00 Informed consent for diabetes national audit 9m04.00 Excluded from diabetic retinopathy screening
9M10.00 Informed dissent for diabetes national audit 9m05.00 Excluded from diabetic retinopathy screening as moved away
9N0m.00 Seen in diabetic nurse consultant clinic 9m0A.00 Declined diabetic retinop scrn
9N0n.00 Seen in community diabetes specialist clinic 9m0C.00 Excluded frm diabetic retinopathy screen as terminal illness
9N0o.00 Seen in community diabetic specialist nurse clinic 9m0D.00 Excluded from diabetic retinopthy screen as learn disability
9N1Q.00 Seen in diabetic clinic 9m0E.00 Excluded from diabetic retinopathy screen physical disorder
9N1i.00 Seen in diabetic foot clinic C10..00 Diabetes mellitus
9N1o.00 Seen in multidisciplinary diabetic clinic C100.00 Diabetes mellitus with no mention of complication   
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)
READCODE Description READCODE Description
C100000 Diabetes mellitus, juvenile type, no mention of complication C108000 Insulin-dependent diabetes mellitus with renal complications
C100011 Insulin dependent diabetes mellitus C108011 Type I diabetes mellitus with renal complications
C100100 Diabetes mellitus, adult onset, no mention of complication C108012 Type 1 diabetes mellitus with renal complications
C100111 Maturity onset diabetes C108100 Insulin-dependent diabetes mellitus with ophthalmic comps
C100112 Non-insulin dependent diabetes mellitus C108111 Type I diabetes mellitus with ophthalmic complications
C100z00 Diabetes mellitus NOS with no mention of complication C108112 Type 1 diabetes mellitus with ophthalmic complications
C101.00 Diabetes mellitus with ketoacidosis C108200 Insulin-dependent diabetes mellitus with neurological comps
C101000 Diabetes mellitus, juvenile type, with ketoacidosis C108211 Type I diabetes mellitus with neurological complications
C101100 Diabetes mellitus, adult onset, with ketoacidosis C108212 Type 1 diabetes mellitus with neurological complications
C101y00 Other specified diabetes mellitus with ketoacidosis C108300 Insulin dependent diabetes mellitus with multiple complicatn
C101z00 Diabetes mellitus NOS with ketoacidosis C108311 Type I diabetes mellitus with multiple complications
C102.00 Diabetes mellitus with hyperosmolar coma C108312 Type 1 diabetes mellitus with multiple complications
C102000 Diabetes mellitus, juvenile type, with hyperosmolar coma C108400 Unstable insulin dependent diabetes mellitus
C102100 Diabetes mellitus, adult onset, with hyperosmolar coma C108411 Unstable type I diabetes mellitus
C102z00 Diabetes mellitus NOS with hyperosmolar coma C108412 Unstable type 1 diabetes mellitus
C103.00 Diabetes mellitus with ketoacidotic coma C108500 Insulin dependent diabetes mellitus with ulcer
C103000 Diabetes mellitus, juvenile type, with ketoacidotic coma C108511 Type I diabetes mellitus with ulcer
C103100 Diabetes mellitus, adult onset, with ketoacidotic coma C108512 Type 1 diabetes mellitus with ulcer
C103y00 Other specified diabetes mellitus with coma C108600 Insulin dependent diabetes mellitus with gangrene
C103z00 Diabetes mellitus NOS with ketoacidotic coma C108611 Type I diabetes mellitus with gangrene
C104.00 Diabetes mellitus with renal manifestation C108612 Type 1 diabetes mellitus with gangrene
C104.11 Diabetic nephropathy C108700 Insulin dependent diabetes mellitus with retinopathy
C104000 Diabetes mellitus, juvenile type, with renal manifestation C108711 Type I diabetes mellitus with retinopathy
C104100 Diabetes mellitus, adult onset, with renal manifestation C108712 Type 1 diabetes mellitus with retinopathy
C104y00 Other specified diabetes mellitus with renal complications C108800 Insulin dependent diabetes mellitus - poor control
C104z00 Diabetes mellitis with nephropathy NOS C108811 Type I diabetes mellitus - poor control
C105.00 Diabetes mellitus with ophthalmic manifestation C108812 Type 1 diabetes mellitus - poor control
C105000 Diabetes mellitus, juvenile type, + ophthalmic manifestation C108900 Insulin dependent diabetes maturity onset
C105100 Diabetes mellitus, adult onset, + ophthalmic manifestation C108911 Type I diabetes mellitus maturity onset
C105y00 Other specified diabetes mellitus with ophthalmic complicatn C108912 Type 1 diabetes mellitus maturity onset
C105z00 Diabetes mellitus NOS with ophthalmic manifestation C108A00 Insulin-dependent diabetes without complication
C106.00 Diabetes mellitus with neurological manifestation C108A11 Type I diabetes mellitus without complication
C106.11 Diabetic amyotrophy C108A12 Type 1 diabetes mellitus without complication
C106.12 Diabetes mellitus with neuropathy C108B00 Insulin dependent diabetes mellitus with mononeuropathy
C106.13 Diabetes mellitus with polyneuropathy C108B11 Type I diabetes mellitus with mononeuropathy
C106000 Diabetes mellitus, juvenile, + neurological manifestation C108B12 Type 1 diabetes mellitus with mononeuropathy
C106100 Diabetes mellitus, adult onset, + neurological manifestation C108C00 Insulin dependent diabetes mellitus with polyneuropathy
C106y00 Other specified diabetes mellitus with neurological comps C108C11 Type I diabetes mellitus with polyneuropathy
C106z00 Diabetes mellitus NOS with neurological manifestation C108C12 Type 1 diabetes mellitus with polyneuropathy
C107.00 Diabetes mellitus with peripheral circulatory disorder C108D00 Insulin dependent diabetes mellitus with nephropathy
C107.11 Diabetes mellitus with gangrene C108D11 Type I diabetes mellitus with nephropathy
C107.12 Diabetes with gangrene C108D12 Type 1 diabetes mellitus with nephropathy
C107000 Diabetes mellitus, juvenile +peripheral circulatory disorder C108E00 Insulin dependent diabetes mellitus with hypoglycaemic coma
C107100 Diabetes mellitus, adult, + peripheral circulatory disorder C108E11 Type I diabetes mellitus with hypoglycaemic coma
C107200 Diabetes mellitus, adult with gangrene C108E12 Type 1 diabetes mellitus with hypoglycaemic coma
C107300 IDDM with peripheral circulatory disorder C108F00 Insulin dependent diabetes mellitus with diabetic cataract
C107400 NIDDM with peripheral circulatory disorder C108F11 Type I diabetes mellitus with diabetic cataract
C107y00 Other specified diabetes mellitus with periph circ comps C108F12 Type 1 diabetes mellitus with diabetic cataract
C107z00 Diabetes mellitus NOS with peripheral circulatory disorder C108G00 Insulin dependent diab mell with peripheral angiopathy
C108.00 Insulin dependent diabetes mellitus C108G11 Type I diabetes mellitus with peripheral angiopathy
C108.11 IDDM-Insulin dependent diabetes mellitus C108G12 Type 1 diabetes mellitus with peripheral angiopathy
C108.12 Type 1 diabetes mellitus C108H00 Insulin dependent diabetes mellitus with arthropathy
C108.13 Type I diabetes mellitus C108H11 Type I diabetes mellitus with arthropathy   
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A2.2 Diabetes Readcodes used to identify people who could have diabetes 
READCODE Description READCODE Description
C108H12 Type 1 diabetes mellitus with arthropathy C109F00 Non-insulin-dependent d m with peripheral angiopath
C108J00 Insulin dependent diab mell with neuropathic arthropathy C109F11 Type II diabetes mellitus with peripheral angiopathy
C108J11 Type I diabetes mellitus with neuropathic arthropathy C109F12 Type 2 diabetes mellitus with peripheral angiopathy
C108J12 Type 1 diabetes mellitus with neuropathic arthropathy C109G00 Non-insulin dependent diabetes mellitus with arthropathy
C108y00 Other specified diabetes mellitus with multiple comps C109G11 Type II diabetes mellitus with arthropathy
C108z00 Unspecified diabetes mellitus with multiple complications C109G12 Type 2 diabetes mellitus with arthropathy
C109.00 Non-insulin dependent diabetes mellitus C109H00 Non-insulin dependent d m with neuropathic arthropathy
C109.11 NIDDM - Non-insulin dependent diabetes mellitus C109H11 Type II diabetes mellitus with neuropathic arthropathy
C109.12 Type 2 diabetes mellitus C109H12 Type 2 diabetes mellitus with neuropathic arthropathy
C109.13 Type II diabetes mellitus C109J00 Insulin treated Type 2 diabetes mellitus
C109000 Non-insulin-dependent diabetes mellitus with renal comps C109J11 Insulin treated non-insulin dependent diabetes mellitus
C109011 Type II diabetes mellitus with renal complications C109J12 Insulin treated Type II diabetes mellitus
C109012 Type 2 diabetes mellitus with renal complications C109K00 Hyperosmolar non-ketotic state in type 2 diabetes mellitus
C109100 Non-insulin-dependent diabetes mellitus with ophthalm comps C10A.00 Malnutrition-related diabetes mellitus
C109111 Type II diabetes mellitus with ophthalmic complications C10A000 Malnutrition-related diabetes mellitus with coma
C109112 Type 2 diabetes mellitus with ophthalmic complications C10A100 Malnutrition-related diabetes mellitus with ketoacidosis
C109200 Non-insulin-dependent diabetes mellitus with neuro comps C10A200 Malnutrition-related diabetes mellitus with renal complicatn
C109211 Type II diabetes mellitus with neurological complications C10A300 Malnutrit-related diabetes mellitus wth ophthalmic complicat
C109212 Type 2 diabetes mellitus with neurological complications C10A400 Malnutrition-related diabetes mellitus wth neuro complicatns
C109300 Non-insulin-dependent diabetes mellitus with multiple comps C10A500 Malnutritn-relat diabetes melitus wth periph circul complctn
C109311 Type II diabetes mellitus with multiple complications C10A600 Malnutrition-related diabetes mellitus with multiple comps
C109312 Type 2 diabetes mellitus with multiple complications C10A700 Malnutrition-related diabetes mellitus without complications
C109400 Non-insulin dependent diabetes mellitus with ulcer C10AW00 Malnutrit-related diabetes mellitus with unspec complics
C109411 Type II diabetes mellitus with ulcer C10AX00 Malnutrit-relat diabetes mellitus with other spec comps
C109412 Type 2 diabetes mellitus with ulcer C10B.00 Diabetes mellitus induced by steroids
C109500 Non-insulin dependent diabetes mellitus with gangrene C10B000 Steroid induced diabetes mellitus without complication
C109511 Type II diabetes mellitus with gangrene C10C.00 Diabetes mellitus autosomal dominant
C109512 Type 2 diabetes mellitus with gangrene C10C.11 Maturity onset diabetes in youth
C109600 Non-insulin-dependent diabetes mellitus with retinopathy C10C.12 Maturity onset diabetes in youth type 1
C109611 Type II diabetes mellitus with retinopathy C10D.00 Diabetes mellitus autosomal dominant type 2
C109612 Type 2 diabetes mellitus with retinopathy C10D.11 Maturity onset diabetes in youth type 2
C109700 Non-insulin dependent diabetes mellitus - poor control C10E.00 Type 1 diabetes mellitus
C109711 Type II diabetes mellitus - poor control C10E.11 Type I diabetes mellitus
C109712 Type 2 diabetes mellitus - poor control C10E.12 Insulin dependent diabetes mellitus
C109800 Reaven's syndrome C10E000 Type 1 diabetes mellitus with renal complications
C109900 Non-insulin-dependent diabetes mellitus without complication C10E011 Type I diabetes mellitus with renal complications
C109911 Type II diabetes mellitus without complication C10E012 Insulin-dependent diabetes mellitus with renal complications
C109912 Type 2 diabetes mellitus without complication C10E100 Type 1 diabetes mellitus with ophthalmic complications
C109A00 Non-insulin dependent diabetes mellitus with mononeuropathy C10E111 Type I diabetes mellitus with ophthalmic complications
C109A11 Type II diabetes mellitus with mononeuropathy C10E112 Insulin-dependent diabetes mellitus with ophthalmic comps
C109A12 Type 2 diabetes mellitus with mononeuropathy C10E200 Type 1 diabetes mellitus with neurological complications
C109B00 Non-insulin dependent diabetes mellitus with polyneuropathy C10E211 Type I diabetes mellitus with neurological complications
C109B11 Type II diabetes mellitus with polyneuropathy C10E212 Insulin-dependent diabetes mellitus with neurological comps
C109B12 Type 2 diabetes mellitus with polyneuropathy C10E300 Type 1 diabetes mellitus with multiple complications
C109C00 Non-insulin dependent diabetes mellitus with nephropathy C10E311 Type I diabetes mellitus with multiple complications
C109C11 Type II diabetes mellitus with nephropathy C10E312 Insulin dependent diabetes mellitus with multiple complicat
C109C12 Type 2 diabetes mellitus with nephropathy C10E400 Unstable type 1 diabetes mellitus
C109D00 Non-insulin dependent diabetes mellitus with hypoglyca coma C10E411 Unstable type I diabetes mellitus
C109D11 Type II diabetes mellitus with hypoglycaemic coma C10E412 Unstable insulin dependent diabetes mellitus
C109D12 Type 2 diabetes mellitus with hypoglycaemic coma C10E500 Type 1 diabetes mellitus with ulcer
C109E00 Non-insulin depend diabetes mellitus with diabetic cataract C10E511 Type I diabetes mellitus with ulcer
C109E11 Type II diabetes mellitus with diabetic cataract C10E512 Insulin dependent diabetes mellitus with ulcer
C109E12 Type 2 diabetes mellitus with diabetic cataract C10E600 Type 1 diabetes mellitus with gangrene   
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A2.2 Diabetes Readcodes used to identify people who could have diabetes 
READCODE Description READCODE Description
C10E611 Type I diabetes mellitus with gangrene C10F011 Type II diabetes mellitus with renal complications
C10E612 Insulin dependent diabetes mellitus with gangrene C10F100 Type 2 diabetes mellitus with ophthalmic complications
C10E700 Type 1 diabetes mellitus with retinopathy C10F111 Type II diabetes mellitus with ophthalmic complications
C10E711 Type I diabetes mellitus with retinopathy C10F200 Type 2 diabetes mellitus with neurological complications
C10E712 Insulin dependent diabetes mellitus with retinopathy C10F211 Type II diabetes mellitus with neurological complications
C10E800 Type 1 diabetes mellitus - poor control C10F300 Type 2 diabetes mellitus with multiple complications
C10E811 Type I diabetes mellitus - poor control C10F311 Type II diabetes mellitus with multiple complications
C10E812 Insulin dependent diabetes mellitus - poor control C10F400 Type 2 diabetes mellitus with ulcer
C10E900 Type 1 diabetes mellitus maturity onset C10F411 Type II diabetes mellitus with ulcer
C10E911 Type I diabetes mellitus maturity onset C10F500 Type 2 diabetes mellitus with gangrene
C10E912 Insulin dependent diabetes maturity onset C10F511 Type II diabetes mellitus with gangrene
C10EA00 Type 1 diabetes mellitus without complication C10F600 Type 2 diabetes mellitus with retinopathy
C10EA11 Type I diabetes mellitus without complication C10F611 Type II diabetes mellitus with retinopathy
C10EA12 Insulin-dependent diabetes without complication C10F700 Type 2 diabetes mellitus - poor control
C10EB00 Type 1 diabetes mellitus with mononeuropathy C10F711 Type II diabetes mellitus - poor control
C10EB11 Type I diabetes mellitus with mononeuropathy C10F800 Reaven's syndrome
C10EB12 Insulin dependent diabetes mellitus with mononeuropathy C10F811 Metabolic syndrome X
C10EC00 Type 1 diabetes mellitus with polyneuropathy C10F900 Type 2 diabetes mellitus without complication
C10EC11 Type I diabetes mellitus with polyneuropathy C10F911 Type II diabetes mellitus without complication
C10EC12 Insulin dependent diabetes mellitus with polyneuropathy C10FA00 Type 2 diabetes mellitus with mononeuropathy
C10ED00 Type 1 diabetes mellitus with nephropathy C10FA11 Type II diabetes mellitus with mononeuropathy
C10ED11 Type I diabetes mellitus with nephropathy C10FB00 Type 2 diabetes mellitus with polyneuropathy
C10ED12 Insulin dependent diabetes mellitus with nephropathy C10FB11 Type II diabetes mellitus with polyneuropathy
C10EE00 Type 1 diabetes mellitus with hypoglycaemic coma C10FC00 Type 2 diabetes mellitus with nephropathy
C10EE11 Type I diabetes mellitus with hypoglycaemic coma C10FC11 Type II diabetes mellitus with nephropathy
C10EE12 Insulin dependent diabetes mellitus with hypoglycaemic coma C10FD00 Type 2 diabetes mellitus with hypoglycaemic coma
C10EF00 Type 1 diabetes mellitus with diabetic cataract C10FD11 Type II diabetes mellitus with hypoglycaemic coma
C10EF11 Type I diabetes mellitus with diabetic cataract C10FE00 Type 2 diabetes mellitus with diabetic cataract
C10EF12 Insulin dependent diabetes mellitus with diabetic cataract C10FE11 Type II diabetes mellitus with diabetic cataract
C10EG00 Type 1 diabetes mellitus with peripheral angiopathy C10FF00 Type 2 diabetes mellitus with peripheral angiopathy
C10EG11 Type I diabetes mellitus with peripheral angiopathy C10FF11 Type II diabetes mellitus with peripheral angiopathy
C10EG12 Insulin dependent diab mell with peripheral angiopathy C10FG00 Type 2 diabetes mellitus with arthropathy
C10EH00 Type 1 diabetes mellitus with arthropathy C10FG11 Type II diabetes mellitus with arthropathy
C10EH11 Type I diabetes mellitus with arthropathy C10FH00 Type 2 diabetes mellitus with neuropathic arthropathy
C10EH12 Insulin dependent diabetes mellitus with arthropathy C10FH11 Type II diabetes mellitus with neuropathic arthropathy
C10EJ00 Type 1 diabetes mellitus with neuropathic arthropathy C10FJ00 Insulin treated Type 2 diabetes mellitus
C10EJ11 Type I diabetes mellitus with neuropathic arthropathy C10FJ11 Insulin treated Type II diabetes mellitus
C10EJ12 Insulin dependent diab mell with neuropathic arthropathy C10FK00 Hyperosmolar non-ketotic state in type 2 diabetes mellitus
C10EK00 Type 1 diabetes mellitus with persistent proteinuria C10FL00 Type 2 diabetes mellitus with persistent proteinuria
C10EK11 Type I diabetes mellitus with persistent proteinuria C10FL11 Type II diabetes mellitus with persistent proteinuria
C10EL00 Type 1 diabetes mellitus with persistent microalbuminuria C10FM00 Type 2 diabetes mellitus with persistent microalbuminuria
C10EL11 Type I diabetes mellitus with persistent microalbuminuria C10FM11 Type II diabetes mellitus with persistent microalbuminuria
C10EM00 Type 1 diabetes mellitus with ketoacidosis C10FN00 Type 2 diabetes mellitus with ketoacidosis
C10EM11 Type I diabetes mellitus with ketoacidosis C10FN11 Type II diabetes mellitus with ketoacidosis
C10EN00 Type 1 diabetes mellitus with ketoacidotic coma C10FP00 Type 2 diabetes mellitus with ketoacidotic coma
C10EN11 Type I diabetes mellitus with ketoacidotic coma C10FP11 Type II diabetes mellitus with ketoacidotic coma
C10EP00 Type 1 diabetes mellitus with exudative maculopathy C10FQ00 Type 2 diabetes mellitus with exudative maculopathy
C10EP11 Type I diabetes mellitus with exudative maculopathy C10FQ11 Type II diabetes mellitus with exudative maculopathy
C10EQ00 Type 1 diabetes mellitus with gastroparesis C10FR00 Type 2 diabetes mellitus with gastroparesis
C10ER00 Latent autoimmune diabetes mellitus in adult C10FS00 Maternally inherited diabetes mellitus
C10F.00 Type 2 diabetes mellitus C10G.00 Secondary pancreatic diabetes mellitus
C10F.11 Type II diabetes mellitus C10G000 Secondary pancreatic diabetes mellitus without complication
C10F000 Type 2 diabetes mellitus with renal complications C10H.00 Diabetes mellitus induced by non-steroid drugs  
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READCODE Description READCODE Description
C10H000 DM induced by non-steroid drugs without complication F420500 Advanced diabetic retinal disease
C10J.00 Insulin autoimmune syndrome F420600 Non proliferative diabetic retinopathy
C10J000 Insulin autoimmune syndrome without complication F420700 High risk proliferative diabetic retinopathy
C10K.00 Type A insulin resistance F420800 High risk non proliferative diabetic retinopathy
C10K000 Type A insulin resistance without complication F420z00 Diabetic retinopathy NOS
C10L.00 Fibrocalculous pancreatopathy F440700 Diabetic iritis
C10L000 Fibrocalculous pancreatopathy without complication F464000 Diabetic cataract
C10M.00 Lipoatrophic diabetes mellitus G73y000 Diabetic peripheral angiopathy
C10M000 Lipoatrophic diabetes mellitus without complication K01x100 Nephrotic syndrome in diabetes mellitus
C10N.00 Secondary diabetes mellitus K01x111 Kimmelstiel - Wilson disease
C10N000 Secondary diabetes mellitus without complication Kyu0300 [X]Glomerular disorders in diabetes mellitus
C10N100 Cystic fibrosis related diabetes mellitus L180000 Diabetes mellitus - unspec whether in pregnancy/puerperium
C10y.00 Diabetes mellitus with other specified manifestation L180500 Pre-existing diabetes mellitus, insulin-dependent
C10y000 Diabetes mellitus, juvenile, + other specified manifestation L180600 Pre-existing diabetes mellitus, non-insulin-dependent
C10y100 Diabetes mellitus, adult, + other specified manifestation L180700 Pre-existing malnutrition-related diabetes mellitus
C10yy00 Other specified diabetes mellitus with other spec comps L180X00 Pre-existing diabetes mellitus, unspecified
C10yz00 Diabetes mellitus NOS with other specified manifestation L180z00 Diabetes mellitus in pregnancy/childbirth/puerperium NOS
C10z.00 Diabetes mellitus with unspecified complication Lyu2900 [X]Pre-existing diabetes mellitus, unspecified
C10z000 Diabetes mellitus, juvenile type, + unspecified complication M037200 Cellulitis in diabetic foot
C10z100 Diabetes mellitus, adult onset, + unspecified complication M21yC00 Insulin lipohypertrophy
C10zy00 Other specified diabetes mellitus with unspecified comps M21yC11 Insulin site lipohypertrophy
C10zz00 Diabetes mellitus NOS with unspecified complication M271000 Ischaemic ulcer diabetic foot
C113.00 Postsurgical hypoinsulinaemia M271100 Neuropathic diabetic ulcer - foot
C113000 Postpancreatectomy hyperglycaemia M271200 Mixed diabetic ulcer - foot
C113z00 Postsurgical hyperglycaemia NOS N030000 Diabetic cheiroarthropathy
C116000 Post-prandial hypoglycaemia N030011 Diabetic cheiropathy
C11y000 Steroid induced diabetes N030100 Diabetic Charcot arthropathy
C11y100 Drug-induced hypoglycaemia without coma R054200 [D]Gangrene of toe in diabetic
C1A..00 Insulin resistance R054300 [D]Widespread diabetic foot gangrene
C350011 Bronzed diabetes
Cyu2.00 [X]Diabetes mellitus
Cyu2000 [X]Other specified diabetes mellitus
Cyu2100 [X]Malnutrit-relat diabetes mellitus with other spec comps
Cyu2200 [X]Malnutrit-related diabetes mellitus with unspec complics
Cyu2300 [X]Unspecified diabetes mellitus with renal complications
F171100 Autonomic neuropathy due to diabetes
F345000 Diabetic mononeuritis multiplex
F35z000 Diabetic mononeuritis NOS
F372.00 Polyneuropathy in diabetes
F372.11 Diabetic polyneuropathy
F372.12 Diabetic neuropathy
F372000 Acute painful diabetic neuropathy
F372100 Chronic painful diabetic neuropathy
F372200 Asymptomatic diabetic neuropathy
F381300 Myasthenic syndrome due to diabetic amyotrophy
F381311 Diabetic amyotrophy
F3y0.00 Diabetic mononeuropathy
F420.00 Diabetic retinopathy
F420000 Background diabetic retinopathy
F420100 Proliferative diabetic retinopathy
F420200 Preproliferative diabetic retinopathy
F420300 Advanced diabetic maculopathy
F420400 Diabetic maculopathy  
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A2.3 ‘Readcode’ classification 
A. Diagnostic and label codes 
These types of labels (e.g. Type 1,Type 2, NIDDIM, IDDM) might be applied at diagnosis and then again whenever a patient is seen for a routine visit. Someone might come 
for an annual review and be given a code for ‘type two diabetes’ to indicate they had type 2 at this annual review. Another common use is for someone who has been treated 
with oral hypoglycaemic agents (OHA) for years and then starts insulin so they suddenly get a type 1 code which was more commonplace in the past but probably happens 
less often now.  
B. Diabetes review 
Any code which might be used for an annual review, an episode of assessment or diabetes monitoring. This includes O/E and codes that might suggest an assessment of 
some kind. Here we distinguish between a ‘diagnostic or label’ that would belong under group A and those that are about assessing a complication e.g. Type 1 with 
retinopathy. This category includes eye and foot screening, and indications of good and bad control. 
C. Medication review 
A code that suggests a change in medication, medication review, conversion to insulin or whether maximal tolerated therapy has been reached. 
D. Referral to another party 
A code where an assessment has been made and it’s considered that the person may need to be seen by a specialist, sent for education (e.g. DESMOND diabetes structured 
education) or an action to happen outside the surgery. 
 
E. Cared for by secondary care clinic 
A code which suggests the surgery has handed over care to a third party (e.g. shared care programme, community diabetes specialist clinic). 
F. Exemption codes 
For example a person is unsuitable for digital retinal photography, foot examination not indicated or they have been excluded from diabetes QOF indicators. 
G. Other:  All other Readcodes not categorised under A to F.
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Appendix 3 Additional tables  
A3.1 Consultations with doctors and practice nurses based on Vision allocation or Sole contact 
Year Practices (no.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 2350 1351 14 - 7672 1236 877 0 - 4625 2425 1380 15 - 7602 977 714 0 - 3561
2003 375 2223 1416 0 - 10402 1160 848 0 - 5182 2282 1448 0 - 10319 918 692 0 - 4084
2004 386 2287 1419 12 -9402 1225 905 0 - 6032 2339 1448 56 - 9431 964 743 0 - 4949
2005 427 2266 1387 173 - 9468 1251 931 0 - 6571 2312 1417 177 - 9222 982 760 0 - 5436
2006 441 2298 1368 5 - 7941 1290 980 0 - 5745 2335 1394 10 - 7889 1028 800 0 - 4737
2007 448 2357 1376 31 - 6804 1395 1073 0 - 5987 2413 1424 35 - 7387 1125 878 0 - 4996
2008 470 2336 1384 11 - 6835 1369 1069 0 - 6278 2381 1423 41 - 7435 1115 882 0 - 5068
2009 471 2348 1379 37 - 7212 1409 1098 0 - 7057 2395 1415 39 - 7851 1167 926 0 - 5595
2010 466 2334 1363 58 - 7021 1378 1081 0 - 6658 2383 1411 189 - 7592 1147 924 0 - 5735
2011 445 2353 1388 9 - 7461 1442 1099 0 - 6869 2394 1436 205 - 8120 1204 940 0 - 5666
2011/2012 434 2387 1405 0 -7919 1451 1107 0 - 6518 2432 1458 240 - 8583 1209 943 0 - 5268
% Change 1.6% 17.4% 0.3% 23.8%
Practice nurses (Sole contact)Doctors (Vision) Practice nurses (Vision) Doctors (Sole contact)
 
A3.2 Consultations with doctors and practice nurses (based on Vision allocation or Sole contact) as a percentage of all healthcare professional staff 
Year Practices (no.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 61.8 14.2 8.8 - 100.0 31.7 13.4 0.0 - 88.1 63.8 13.6 9.4 - 100.0 25.1 11.5 0.0 - 84.4
2003 375 61.4 14.8 0.0 - 100.0 31.9 14.0 0.0 - 100.0 63.0 14.3 0.0 - 99.8 25.2 12.1 0.0 - 100.0 
2004 386 61.0 15.3 1.4 - 100.0 31.4 14.3 0.0 - 94.7 62.3 14.9 11.5 - 99.9 24.5 11.7 0.0 - 76.8 
2005 427 60.1 15.6 17.7 - 100.0 31.5 14.4 0.0 - 74.7 61.0 15.2 18.8 - 99.5 24.5 11.6 0.0 - 63.9 
2006 441 59.9 16.5 0.7 - 100.0 31.0 15.0 0.0 - 98.2 60.7 16.0 1.3 - 99.8 24.6 12.3 0.0 - 83.6 
2007 448 58.7 16.8 5.2 - 100.0 31.5 15.1 0.0 - 92.8 59.7 16.2 5.8 - 99.5 25.4 12.5 0.0 - 79.5 
2008 470 58.1 15.9 7.2 - 100.0 31.5 14.6 0.0 - 90.9 59.1 15.5 10.6 - 99.8 25.6 12.3 0.0 - 70.3 
2009 471 57.6 16.7 2.3 - 100.0 31.6 14.9 0.0 - 97.7 58.5 16.3 2.5 - 99.7 26.1 12.7 0.0 - 78.9 
2010 466 58.1 16.2 4.0 - 100.0 31.2 14.9 0.0 - 96.1 59.0 15.7 16.3 - 100.0 25.8 12.4 0.0 - 68.9 
2011 445 57.1 16.0 0.6 - 100.0 32.2 14.7 0.0 - 99.3 57.8 15.5 20.6 - 100.0 26.8 12.5 0.0 - 62.3 
2011/2012 434 57.3 16.1 8.8 - 100.0 32.1 14.8 0.0 - 100.0 58.0 15.5 20.4 - 99.9 26.7 12.5 0.0 - 59.6 
% Change -7.3% 1.1% -9.1% 6.4%
Doctors (Sole contact) Practice nurses (Sole contact)Doctors (Vision) Practice nurses (Vision)
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A3.3 Number of times people with diabetes are seen per annum by doctors, practice nurses and healthcare professionals (based on Vision allocation or Sole 
contact) 
Practices (no.) Mean SD Range Mean SD Range Mean SD Range Mean SD Range Mean SD Range
2002 247 15.9 5.4 0.6 - 35.4 9.8 3.2 0.1 - 22.0 5.2 2.8 0.0 - 15.2 10.1 3.2 0.1 - 21.8 4.1 2.4 0.0 - 14.3
2003 375 15.2 5.1 0.0 - 32.9 9.2 3.0 0.0 - 21.8 5.0 2.7 0.0 - 14.5 9.5 3.0 0.0 - 22.5 3.9 2.2 0.0 - 11.7
2004 386 14.9 4.6 1.6 - 32.2 8.9 2.7 0.1 - 19.6 4.8 2.5 0.0 - 15.1 9.1 2.8 0.7 - 19.9 3.8 2.1 0.0 - 12.4
2005 427 14.3 4.3 4.1 - 32.4 8.4 2.7 2.1 - 23.7 4.6 2.5 0.0 - 15.0 8.5 2.7 2.3 - 23.6 3.6 2.1 0.0 - 12.4
2006 441 13.8 4.2 2.1 - 30.6 8.0 2.5 0.0 - 24.3 4.5 2.5 0.0 - 12.2 8.1 2.5 0.1 - 23.9 3.6 2.1 0.0 - 10.2
2007 448 13.6 4.2 1.2 - 29.1 7.7 2.4 0.2 - 24.9 4.5 2.5 0.0 - 12.7 7.9 2.5 0.2 - 24.1 3.6 2.1 0.0 - 11.6
2008 470 13.1 4.2 0.4 - 44.3 7.4 2.3 0.1 - 22.7 4.3 2.6 0.0 - 26.2 7.5 2.4 0.3 - 21.7 3.5 2.2 0.0 - 21.3
2009 471 12.7 4.0 2.0 - 35.5 7.0 2.1 0.2 - 17.3 4.2 2.5 0.0 - 21.1 7.2 2.2 0.2 - 16.5 3.5 2.2 0.0 - 17.0
2010 466 11.9 3.6 3.5 - 22.8 6.7 2.0 0.2 - 16.9 3.9 2.2 0.0 - 12.6 6.8 2.0 1.0 - 17.2 3.3 1.9 0.0 - 12.4
2011 445 11.5 3.4 2.6 - 21.6 6.4 1.9 0.0 - 17.4 3.9 2.1 0.0 - 11.9 6.4 1.9 1.4 - 17.4 3.3 1.9 0.0 - 11.5
2011/2012 434 11.5 3.3 2.7 - 21.2 6.4 1.9 0.0 - 17.3 3.8 2.1 0.0 - 11.8 6.5 1.9 1.4 - 17.2 3.2 1.9 0.0 - 11.0
% Change -28.1% -34.9% -25.6% -36.0% -21.1%
Practice nurses               
(Sole contact)
Doctors                        
(Vision)
Practice nurses            
(Vision)
All healthcare professionals 
(Vision)
Doctors                            
(Sole contact)
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A3.4 Multilevel model, HbA1c ≤7% - Findings for workforce variables (using nurse contact based on sole involvement
1
) 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Patients per healthcare professional -0.107 0.045 0.017 -0.049 0.024 0.038 -0.031 0.022 0.163 -0.033 0.020 0.109 -0.022 0.019 0.233
Nurse Contact - Sole involvement
  Low 0.025 0.090 0.780 -0.115 0.055 0.035 -0.097 0.053 0.064 -0.115 0.047 0.015 -0.025 0.047 0.589
  Medium -0.123 0.089 0.167 -0.123 0.056 0.029 -0.074 0.053 0.159 -0.073 0.047 0.124 -0.071 0.046 0.124
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.523 0.030 0.395 0.018 0.380 0.017 0.358 0.015 0.363 0.015
Global Tests χ2(2df) p χ
2
(2df) p χ
2
(2df) p χ
2
(2df) p χ
2
(2df) p
  Nurse Contact -Sole involvement 3.280 0.194 6.290 0.043 3.728 0.155 6.141 0.046 2.409 0.300
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Patients per healthcare professional 0.004 0.021 0.833 0.019 0.015 0.216 0.019 0.015 0.204 0.030 0.017 0.070 0.045 0.019 0.015 0.028 0.017 0.105
Nurse Contact - Sole involvement
  Low -0.089 0.049 0.066 -0.011 0.045 0.816 -0.090 0.047 0.055 -0.015 0.043 0.733 -0.059 0.045 0.186 -0.029 0.045 0.527
  Medium -0.084 0.048 0.077 0.015 0.044 0.728 -0.109 0.045 0.015 0.017 0.042 0.686 -0.020 0.042 0.628 -0.029 0.042 0.494
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.382 0.015 0.363 0.014 0.375 0.014 0.347 0.014 0.341 0.014 0.339 0.014
Global Tests χ2(2df) p χ
2
(2df) p χ
2
(2df) p χ
2
(2df) p χ
2
(2df) p χ
2
(2df) p
  Nurse Contact -Sole involvement 4.522 0.104 0.321 0.852 6.940 0.031 0.506 0.777 1.753 0.416 0.623 0.732
2011/12
2002 2003 2004 2005 2006
2007 2008 2009 2010 2011
 
1
 Nurse contact – sole involvement low <21%, medium 22-28%, high 29% and over 
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A3.5 Multilevel model, HbA1c ≤10% - Findings for workforce variables (using nurse contact based on sole involvement
1
)
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.187 0.071 0.008 -0.103 0.031 0.001 -0.040 0.025 0.107 -0.025 0.022 0.266 -0.014 0.022 0.523
Nurse Contact - Sole involvement
  Low -0.067 0.143 0.638 -0.145 0.071 0.042 -0.092 0.060 0.125 -0.050 0.052 0.338 -0.113 0.054 0.037
  Medium -0.203 0.141 0.152 -0.094 0.073 0.202 0.010 0.060 0.866 -0.040 0.052 0.451 -0.085 0.053 0.114
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.864 0.044 0.522 0.023 0.420 0.019 0.379 0.017 0.404 0.017
Global Tests (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - Sole involvement (2df) 2.158 0.340 4.267 0.118 3.589 0.166 1.030 0.598 4.827 0.090
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.011 0.023 0.628 -0.002 0.017 0.905 -0.015 0.017 0.373 -0.008 0.018 0.645 0.010 0.021 0.634 -0.016 0.020 0.420
Nurse Contact - Sole involvement
  Low -0.017 0.054 0.747 0.017 0.051 0.734 -0.032 0.052 0.537 -0.026 0.048 0.587 -0.088 0.050 0.082 -0.053 0.052 0.307
  Medium 0.012 0.052 0.826 0.009 0.049 0.858 -0.067 0.050 0.178 -0.001 0.047 0.975 0.006 0.048 0.900 -0.025 0.048 0.600
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.405 0.017 0.392 0.016 0.400 0.016 0.371 0.016 0.376 0.016 0.382 0.016
Global Tests (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - Sole involvement (2df) 0.271 0.873 0.116 0.944 1.823 0.402 0.353 0.838 3.867 0.145 1.059 0.589
2011/2012
2002 2003 2004 2005 2006
2007 2008 2009 2010 2011
 
1
 Nurse contact – sole involvement low <21%, medium 22-28%, high 29% and over 
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A3.6 Multilevel model, HbA1c ≤7% - Findings for workforce variables (using nurse contact based on Vision allocation
1
) 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.112 0.045 0.012 -0.047 0.024 0.048 -0.033 0.022 0.144 -0.034 0.020 0.092 -0.021 0.019 0.258
Nurse Contact - Vision
  Low 0.102 0.091 0.263 -0.140 0.055 0.011 -0.027 0.053 0.606 -0.084 0.048 0.079 -0.024 0.047 0.609
  Medium -0.077 0.089 0.384 -0.114 0.055 0.040 -0.035 0.053 0.510 -0.042 0.047 0.370 -0.071 0.046 0.126
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.523 0.030 0.394 0.018 0.382 0.017 0.360 0.015 0.363 0.015
Global Tests (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - Vision (2df) 4.123 0.127 7.434 0.024 0.481 0.786 3.099 0.212 2.412 0.299
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional 0.005 0.021 0.812 0.017 0.015 0.277 0.018 0.015 0.233 0.029 0.017 0.079 0.043 0.019 0.020 0.030 0.017 0.081
Nurse Contact - Vision
  Low -0.056 0.049 0.256 0.017 0.045 0.711 -0.012 0.046 0.793 -0.003 0.043 0.944 -0.053 0.043 0.216 -0.029 0.043 0.500
  Medium 0.002 0.047 0.963 0.009 0.045 0.848 0.020 0.046 0.666 0.012 0.043 0.786 -0.043 0.043 0.318 -0.002 0.043 0.966
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.383 0.015 0.363 0.014 0.377 0.015 0.348 0.014 0.341 0.014 0.339 0.014
Global Tests (degrees of freedom) χ2 p χ2 p χ2 p χ2 p χ2 p χ2 p
  Nurse Contact - Vision (2df) 1.741 0.419 0.137 0.934 0.459 0.795 0.126 0.939 1.796 0.408 0.533 0.766
2011/12
2002 2003 2004 2005 2006
2007 2008 2009 2010 2011
 
1
 Nurse contact – Vision allocation low <26%, medium 26-37%, high 38% and over 
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A3.7 Multilevel model, HbA1c ≤10% - Findings for workforce variables (using nurse contact based on Vision allocation
1
) 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.197 0.071 0.005 -0.107 0.031 0.001 -0.045 0.025 0.076 -0.023 0.022 0.306 -0.015 0.022 0.489
Nurse Contact - Vision
  Low 0.051 0.145 0.724 -0.171 0.071 0.017 -0.082 0.060 0.175 -0.049 0.053 0.352 -0.071 0.055 0.192
  Medium -0.197 0.142 0.164 -0.172 0.072 0.017 -0.070 0.060 0.239 -0.003 0.052 0.947 -0.054 0.054 0.313
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
Practice 0.862 0.044 0.519 0.023 0.421 0.019 0.379 0.017 0.406 0.017
Global Tests (degrees of freedom) χ
2
p χ
2
p χ
2
p χ
2
p χ
2
p
Nurse Contact - Vision (2df) 3.493 0.174 7.769 0.021 2.168 0.338 1.067 0.586 1.881 0.391
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Consultations per healthcare professional -0.012 0.023 0.585 -0.003 0.017 0.846 -0.016 0.017 0.346 -0.009 0.018 0.628 0.006 0.021 0.761 -0.019 0.020 0.335
Nurse Contact - Vision
  Low 0.010 0.054 0.850 0.056 0.050 0.266 0.051 0.050 0.311 0.021 0.047 0.651 -0.058 0.048 0.234 -0.026 0.050 0.596
  Medium 0.032 0.052 0.531 0.058 0.050 0.247 0.067 0.051 0.186 0.061 0.048 0.207 0.012 0.049 0.810 -0.030 0.050 0.546
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
Practice 0.405 0.017 0.391 0.016 0.400 0.016 0.371 0.016 0.377 0.016 0.383 0.016
Global Tests (degrees of freedom) χ
2
p χ
2
p χ
2
p χ
2
p χ
2
p χ
2
p
Nurse Contact - Vision (2df) 0.409 0.815 1.744 0.418 1.948 0.378 1.624 0.444 2.134 0.344 0.453 0.797
2011/12
2002 2003 2004 2005 2006
2007 2008 2009 2010 2011
 
1
 Nurse contact – Vision allocation low <26%, medium 26-37%, high 38% and over 
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A3.8 Multilevel model, HbA1c ≤7%, nurse contact based on any involvement
1
, 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.719 0.198 -0.296 0.124 -0.567 0.111 -0.590 0.101 -0.454 0.097
Age
  linear 0.510 0.014 <.001 0.495 0.010 <.001 0.524 0.010 <.001 0.528 0.009 <.001 0.530 0.008 <.001
  quadratic -0.108 0.012 <.001 -0.095 0.008 <.001 -0.096 0.008 <.001 -0.084 0.007 <.001 -0.104 0.007 <.001
Gender (Female) -0.120 0.021 <.001 -0.088 0.016 <.001 -0.066 0.015 <.001 -0.018 0.014 0.194 -0.011 0.013 0.381
Charlson -0.175 0.012 <.001 -0.166 0.009 <.001 -0.162 0.009 <.001 -0.179 0.008 <.001 -0.148 0.007 <.001
Obesity 0.124 0.023 <.001 0.069 0.017 <.001 0.044 0.016 0.005 0.010 0.014 0.467 0.000 0.013 0.976
Townsend
  1st - lowest 0.285 0.228 0.211 0.135 0.118 0.253 0.132 0.109 0.223 0.105 0.101 0.300 0.062 0.096 0.519
  2nd 0.212 0.228 0.351 0.099 0.117 0.400 0.104 0.108 0.338 0.041 0.101 0.686 0.025 0.096 0.793
  3th 0.198 0.228 0.385 0.066 0.117 0.575 0.054 0.108 0.620 0.042 0.100 0.676 -0.001 0.096 0.989
  4th 0.130 0.228 0.568 0.044 0.117 0.706 0.046 0.108 0.673 -0.011 0.100 0.910 -0.053 0.096 0.576
  5th - highest 0.146 0.228 0.521 0.036 0.117 0.757 0.013 0.108 0.906 -0.008 0.101 0.938 -0.052 0.096 0.585
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.318 0.254 0.211 -0.155 0.141 0.272 -0.001 0.133 0.996 0.079 0.123 0.524 0.001 0.118 0.992
  2nd -0.229 0.253 0.366 -0.135 0.141 0.340 0.021 0.133 0.877 0.107 0.123 0.387 0.030 0.118 0.798
  3th -0.338 0.253 0.182 -0.188 0.141 0.182 -0.011 0.132 0.935 0.069 0.123 0.573 0.004 0.118 0.973
  4th -0.289 0.254 0.255 -0.186 0.141 0.186 0.025 0.132 0.853 0.060 0.123 0.623 0.002 0.118 0.988
  5th - highest -0.245 0.254 0.333 -0.141 0.141 0.317 -0.002 0.133 0.986 0.087 0.123 0.480 0.014 0.118 0.905
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.020 0.261 0.940 -0.092 0.217 0.671 -0.048 0.204 0.812 -0.221 0.193 0.253 0.157 0.185 0.396
  Town & Fringe – Sparse 0.059 0.268 0.826 0.041 0.196 0.835 -0.135 0.158 0.392 -0.389 0.150 0.010 0.214 0.122 0.081
  Village, Hamlet & Isolated dwellings – Sparse 0.068 0.202 0.736 -0.170 0.153 0.268 -0.055 0.134 0.684 -0.296 0.127 0.020 0.005 0.117 0.968
  Urban >10k  - Less sparse 0.098 0.058 0.089 0.043 0.044 0.337 0.034 0.043 0.428 -0.004 0.039 0.924 0.051 0.037 0.171
  Town & Fringe – Less sparse -0.023 0.059 0.700 -0.023 0.045 0.608 -0.014 0.042 0.731 -0.038 0.040 0.339 0.004 0.038 0.924
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.032 0.041 0.436 -0.015 0.027 0.571 -0.013 0.025 0.588 -0.017 0.022 0.436 -0.037 0.021 0.082
Prevalence 0.188 0.063 0.003 0.135 0.034 <.001 0.112 0.031 0.000 0.085 0.025 0.001 0.082 0.024 0.001
Country
  England 0.098 0.157 0.533 -0.098 0.097 0.313 0.033 0.085 0.695 0.086 0.077 0.263 0.135 0.072 0.062
  Northern Ireland -0.184 0.378 0.626 -0.276 0.186 0.138 -0.050 0.174 0.773 0.322 0.156 0.040 0.315 0.150 0.036
  Scotland -0.564 0.362 0.120 -0.133 0.180 0.460 0.077 0.167 0.644 0.094 0.154 0.542 0.055 0.147 0.706
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.110 0.045 0.015 -0.047 0.024 0.047 -0.032 0.022 0.156 -0.035 0.020 0.080 -0.021 0.019 0.258
Nurse Contact - any involvement
  Low 0.042 0.091 0.646 -0.154 0.054 0.004 -0.047 0.051 0.360 -0.104 0.047 0.028 -0.032 0.047 0.493
  Medium -0.067 0.088 0.445 -0.113 0.056 0.045 -0.037 0.053 0.484 -0.090 0.047 0.054 -0.073 0.046 0.113
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.526 0.030 0.394 0.018 0.382 0.017 0.358 0.015 0.362 0.015
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 23.166 <.001 15.983 0.007 23.704 0.000 30.940 <.001 36.939 <.001
Percent White (5df) 10.554 0.032 4.212 0.378 2.146 0.709 3.125 0.537 1.901 0.754
Urban-Rural Classification (5df) 6.043 0.302 4.652 0.460 2.568 0.766 8.751 0.119 6.996 0.221
Country (3df) 4.423 0.219 2.599 0.458 1.108 0.775 6.034 0.110 8.969 0.030
Nurse Contact - any involvement  (2df) 1.547 0.461 8.853 0.012 0.941 0.625 5.929 0.052 2.516 0.284
2002 2003 2004 2005 2006
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
A3.9 Multilevel model, HbA1c ≤7%, nurse contact based on any involvement
1
 2007-2011/12 
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β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.470 0.096 -0.400 0.087 -0.402 0.087 -0.383 0.082 -0.363 0.084 -0.393 0.083
Age
  linear 0.584 0.008 <.001 0.590 0.008 <.001 0.593 0.008 <.001 0.596 0.008 <.001 0.596 0.007 <.001 0.570 0.008 <.001
  quadratic -0.094 0.007 <.001 -0.109 0.006 <.001 -0.107 0.006 <.001 -0.123 0.006 <.001 -0.111 0.006 <.001 -0.122 0.006 <.001
Gender (Female) 0.000 0.012 0.993 0.027 0.012 0.022 0.041 0.011 0.000 0.052 0.011 <.001 0.030 0.011 0.007 0.052 0.011 <.001
Charlson -0.121 0.006 <.001 -0.125 0.006 <.001 -0.131 0.005 <.001 -0.141 0.005 <.001 -0.153 0.005 <.001 -0.149 0.005 <.001
Obesity 0.000 0.013 0.983 0.002 0.012 0.881 -0.004 0.012 0.747 -0.009 0.011 0.449 -0.050 0.011 <.001 -0.119 0.011 <.001
Townsend
  1st - lowest 0.041 0.080 0.607 -0.015 0.073 0.840 -0.014 0.067 0.829 0.104 0.064 0.106 0.106 0.061 0.081 0.118 0.061 0.051
  2nd 0.011 0.080 0.889 -0.073 0.072 0.312 -0.060 0.066 0.367 0.083 0.064 0.192 0.077 0.060 0.201 0.093 0.060 0.122
  3th -0.016 0.080 0.845 -0.076 0.072 0.293 -0.088 0.066 0.186 0.044 0.064 0.494 0.068 0.060 0.261 0.090 0.060 0.137
  4th -0.027 0.080 0.734 -0.104 0.072 0.150 -0.105 0.066 0.115 0.012 0.064 0.854 0.052 0.060 0.386 0.069 0.060 0.251
  5th - highest -0.070 0.080 0.380 -0.122 0.072 0.092 -0.140 0.067 0.036 0.003 0.064 0.960 -0.006 0.061 0.926 0.036 0.061 0.555
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.057 0.103 0.582 0.032 0.095 0.733 -0.028 0.089 0.756 -0.208 0.086 0.016 -0.251 0.082 0.002 -0.244 0.082 0.003
  2nd -0.023 0.103 0.825 0.031 0.095 0.745 -0.012 0.089 0.890 -0.161 0.086 0.062 -0.192 0.083 0.020 -0.164 0.082 0.046
  3th -0.005 0.102 0.959 0.037 0.094 0.695 0.014 0.088 0.877 -0.156 0.086 0.069 -0.204 0.082 0.013 -0.183 0.081 0.025
  4th -0.021 0.102 0.839 0.036 0.094 0.704 -0.019 0.089 0.831 -0.154 0.086 0.073 -0.169 0.082 0.039 -0.163 0.082 0.046
  5th - highest -0.022 0.103 0.835 0.043 0.095 0.653 0.010 0.089 0.907 -0.159 0.086 0.065 -0.174 0.082 0.035 -0.162 0.082 0.048
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.190 0.182 0.296 0.234 0.176 0.185 -0.247 0.239 0.302 -0.181 0.230 0.431 -0.300 0.235 0.202 0.061 0.226 0.787
  Town & Fringe – Sparse 0.067 0.121 0.578 0.098 0.119 0.408 0.144 0.122 0.235 -0.003 0.118 0.976 0.008 0.119 0.948 0.063 0.118 0.591
  Village, Hamlet & Isolated dwellings – Sparse 0.120 0.113 0.288 0.159 0.110 0.147 0.077 0.114 0.500 0.000 0.111 1.000 -0.050 0.124 0.685 -0.029 0.123 0.813
  Urban >10k  - Less sparse 0.061 0.036 0.091 0.070 0.034 0.044 0.036 0.034 0.285 0.105 0.034 0.002 0.121 0.034 0.000 0.118 0.034 0.001
  Town & Fringe – Less sparse 0.053 0.036 0.150 0.052 0.035 0.137 0.035 0.034 0.300 0.072 0.033 0.030 0.037 0.034 0.278 0.030 0.035 0.383
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.043 0.022 0.054 -0.044 0.020 0.030 -0.032 0.021 0.122 -0.050 0.019 0.009 -0.034 0.019 0.082 -0.033 0.019 0.086
Prevalence 0.061 0.023 0.009 0.068 0.021 0.001 0.050 0.021 0.018 0.041 0.019 0.029 0.049 0.018 0.006 0.045 0.018 0.011
Country
  England 0.162 0.076 0.033 0.088 0.069 0.206 0.200 0.071 0.005 0.159 0.066 0.015 0.123 0.068 0.070 0.097 0.067 0.150
  Northern Ireland 0.294 0.147 0.045 0.081 0.143 0.572 0.235 0.140 0.094 0.084 0.130 0.519 0.024 0.128 0.849 -0.078 0.127 0.538
  Scotland 0.163 0.133 0.219 0.132 0.118 0.265 0.144 0.115 0.208 -0.026 0.108 0.812 -0.033 0.106 0.755 -0.076 0.105 0.469
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional 0.005 0.021 0.827 0.017 0.015 0.263 0.022 0.015 0.147 0.030 0.017 0.066 0.043 0.018 0.020 0.027 0.017 0.110
Nurse Contact - any involvement
  Low -0.063 0.048 0.195 0.008 0.044 0.850 -0.064 0.046 0.158 -0.040 0.042 0.339 -0.051 0.042 0.227 -0.018 0.043 0.672
  Medium -0.018 0.047 0.701 0.010 0.045 0.831 0.012 0.046 0.800 -0.016 0.043 0.710 -0.048 0.043 0.266 -0.035 0.044 0.427
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.383 0.015 0.364 0.014 0.376 0.014 0.347 0.014 0.341 0.014 0.339 0.014
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 25.193 <.001 31.185 <.001 41.467 <.001 36.497 <.001 29.351 <.001 17.911 0.003
Percent White (5df) 2.749 0.601 0.139 0.998 3.263 0.515 4.287 0.369 8.341 0.080 11.675 0.020
Urban-Rural Classification (5df) 3.993 0.550 5.822 0.324 4.558 0.472 11.269 0.046 17.228 0.004 14.997 0.010
Country (3df) 6.246 0.100 2.001 0.572 8.696 0.034 10.095 0.018 6.294 0.098 6.080 0.108
Nurse Contact - any involvement  (2df) 1.717 0.424 0.057 0.972 2.878 0.237 0.917 0.632 1.936 0.380 0.645 0.724
2011/122007 2008 2009 2010 2011
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.10 Multilevel model, HbA1c ≤10%, nurse contact based on any involvement
1
, 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.024 0.292 1.513 0.156 1.441 0.127 1.445 0.115 1.606 0.115
Age
  linear 0.411 0.013 <.001 0.403 0.011 <.001 0.437 0.012 <.001 0.470 0.011 <.001 0.466 0.011 <.001
  quadratic -0.134 0.010 <.001 -0.095 0.007 <.001 -0.068 0.007 <.001 -0.070 0.007 <.001 -0.081 0.007 <.001
Gender (Female) -0.154 0.022 <.001 -0.107 0.019 <.001 -0.163 0.019 <.001 -0.148 0.018 <.001 -0.167 0.017 <.001
Charlson -0.069 0.013 <.001 -0.070 0.011 <.001 -0.034 0.011 0.002 -0.073 0.010 <.001 -0.063 0.009 <.001
Obesity 0.467 0.026 <.001 0.424 0.021 <.001 0.360 0.021 <.001 0.348 0.019 <.001 0.353 0.018 <.001
Townsend
  1st - lowest 0.350 0.217 0.107 0.202 0.131 0.122 0.267 0.134 0.047 0.396 0.125 0.002 0.186 0.126 0.139
  2nd 0.281 0.217 0.195 0.175 0.130 0.180 0.223 0.134 0.096 0.330 0.125 0.008 0.158 0.126 0.207
  3th 0.209 0.217 0.336 0.066 0.130 0.611 0.119 0.134 0.372 0.196 0.125 0.116 0.062 0.125 0.621
  4th 0.146 0.217 0.501 -0.014 0.130 0.914 0.038 0.133 0.775 0.110 0.125 0.378 -0.044 0.125 0.725
  5th - highest 0.096 0.217 0.659 -0.064 0.130 0.624 -0.101 0.133 0.450 0.001 0.125 0.992 -0.145 0.125 0.248
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.332 0.249 0.182 -0.150 0.159 0.346 -0.213 0.163 0.191 -0.295 0.153 0.054 -0.139 0.153 0.365
  2nd -0.251 0.248 0.313 -0.089 0.160 0.578 -0.109 0.163 0.501 -0.208 0.153 0.175 -0.060 0.153 0.696
  3th -0.284 0.248 0.253 -0.111 0.159 0.486 -0.136 0.162 0.402 -0.192 0.153 0.209 -0.081 0.153 0.596
  4th -0.286 0.249 0.250 -0.091 0.160 0.570 -0.100 0.162 0.538 -0.171 0.152 0.261 -0.073 0.153 0.634
  5th - highest -0.277 0.250 0.267 0.031 0.160 0.847 0.002 0.163 0.992 -0.092 0.153 0.547 0.029 0.154 0.852
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.535 0.309 0.084 0.129 0.270 0.633 0.120 0.249 0.630 -0.128 0.238 0.590 -0.111 0.248 0.654
  Town & Fringe – Sparse 0.614 0.328 0.061 0.038 0.255 0.881 -0.093 0.203 0.646 -0.254 0.192 0.185 0.022 0.175 0.898
  Village, Hamlet & Isolated dwellings – Sparse 0.045 0.215 0.833 -0.187 0.190 0.326 -0.159 0.161 0.324 -0.054 0.160 0.734 -0.139 0.152 0.361
  Urban >10k  - Less sparse 0.071 0.063 0.262 0.009 0.054 0.864 0.028 0.055 0.615 0.053 0.053 0.315 0.009 0.050 0.864
  Town & Fringe – Less sparse 0.043 0.066 0.514 0.064 0.057 0.257 -0.041 0.057 0.475 -0.043 0.055 0.430 -0.021 0.053 0.684
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.059 0.064 0.361 0.003 0.034 0.934 -0.014 0.028 0.621 -0.002 0.024 0.932 -0.022 0.024 0.376
Prevalence 0.094 0.099 0.339 0.027 0.044 0.542 0.022 0.035 0.531 -0.007 0.028 0.791 0.037 0.027 0.169
Country
  England 0.238 0.249 0.339 -0.030 0.126 0.814 0.243 0.096 0.011 0.246 0.084 0.004 0.186 0.083 0.025
  Northern Ireland -0.186 0.508 0.715 -0.067 0.228 0.768 0.230 0.201 0.254 0.191 0.181 0.289 0.247 0.183 0.178
  Scotland -0.803 0.488 0.100 0.129 0.218 0.555 0.265 0.197 0.178 0.173 0.180 0.336 0.196 0.181 0.278
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.192 0.071 0.007 -0.107 0.030 <.001 -0.042 0.025 0.090 -0.024 0.022 0.273 -0.015 0.022 0.490
Nurse Contact - any involvement
  Low -0.029 0.145 0.844 -0.189 0.070 0.007 -0.094 0.058 0.108 -0.070 0.052 0.176 -0.089 0.054 0.100
  Medium -0.191 0.140 0.174 -0.174 0.073 0.018 -0.035 0.060 0.563 -0.052 0.052 0.311 -0.081 0.053 0.130
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.865 0.044 0.518 0.023 0.421 0.019 0.379 0.017 0.405 0.017
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 48.381 <.001 85.321 <.001 129.013 <.001 180.686 <.001 146.102 <.001
Percent White (5df) 3.094 0.542 12.508 0.014 16.809 0.002 15.475 0.004 13.774 0.008
Urban-Rural Classification (5df) 7.266 0.202 4.166 0.526 3.808 0.577 6.828 0.234 1.653 0.895
Country (3df) 6.725 0.081 1.452 0.693 6.556 0.088 8.667 0.034 5.253 0.154
Nurse Contact - any involvement  (2df) 2.173 0.337 9.046 0.011 2.621 0.270 2.027 0.363 3.455 0.178
2002 2003 2004 2005 2006
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 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.11 Multilevel model, HbA1c ≤10%, nurse contact based on any involvement
1
, 2007-2011/12 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.463 0.109 1.456 0.100 1.498 0.099 1.513 0.094 1.431 0.097 1.509 0.095
Age
  linear 0.483 0.010 <.001 0.480 0.010 <.001 0.484 0.010 <.001 0.510 0.009 <.001 0.547 0.009 <.001 0.500 0.009 <.001
  quadratic -0.076 0.006 <.001 -0.075 0.006 <.001 -0.089 0.006 <.001 -0.086 0.006 <.001 -0.081 0.006 <.001 -0.116 0.006 <.001
Gender (Female) -0.154 0.016 <.001 -0.148 0.016 <.001 -0.155 0.015 <.001 -0.142 0.015 <.001 -0.152 0.014 <.001 -0.132 0.014 <.001
Charlson -0.017 0.008 0.040 -0.026 0.008 0.001 -0.047 0.007 <.001 -0.039 0.007 <.001 -0.069 0.007 <.001 -0.071 0.007 <.001
Obesity 0.308 0.017 <.001 0.339 0.016 <.001 0.286 0.016 <.001 0.293 0.015 <.001 0.207 0.015 <.001 0.040 0.015 0.006
Townsend
  1st - lowest 0.382 0.102 <.001 0.236 0.095 0.013 0.237 0.087 0.007 0.315 0.082 <.001 0.268 0.075 <.001 0.285 0.073 <.001
  2nd 0.306 0.101 0.003 0.208 0.094 0.028 0.188 0.087 0.030 0.266 0.081 0.001 0.238 0.075 0.001 0.237 0.072 0.001
  3th 0.251 0.101 0.013 0.111 0.094 0.238 0.077 0.087 0.376 0.135 0.081 0.095 0.135 0.074 0.070 0.121 0.072 0.093
  4th 0.143 0.101 0.155 -0.025 0.094 0.789 -0.033 0.086 0.703 0.014 0.081 0.865 0.016 0.074 0.834 0.020 0.072 0.780
  5th - highest 0.018 0.101 0.861 -0.077 0.094 0.415 -0.133 0.087 0.123 -0.050 0.081 0.540 -0.129 0.074 0.083 -0.049 0.072 0.496
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.333 0.129 0.010 -0.162 0.121 0.182 -0.212 0.114 0.062 -0.344 0.108 0.001 -0.159 0.102 0.118 -0.224 0.099 0.023
  2nd -0.254 0.129 0.050 -0.097 0.122 0.424 -0.119 0.114 0.298 -0.281 0.108 0.009 -0.121 0.102 0.235 -0.198 0.099 0.045
  3th -0.256 0.129 0.047 -0.093 0.121 0.441 -0.071 0.113 0.533 -0.242 0.108 0.024 -0.137 0.101 0.175 -0.187 0.098 0.056
  4th -0.209 0.129 0.105 -0.075 0.121 0.533 -0.076 0.113 0.502 -0.268 0.108 0.013 -0.103 0.101 0.309 -0.134 0.098 0.173
  5th - highest -0.195 0.130 0.133 -0.052 0.122 0.668 -0.060 0.114 0.599 -0.193 0.108 0.075 -0.086 0.102 0.400 -0.143 0.099 0.148
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.037 0.235 0.874 -0.128 0.230 0.577 -0.247 0.308 0.422 0.119 0.308 0.699 0.257 0.306 0.400 0.463 0.300 0.122
  Town & Fringe – Sparse 0.021 0.166 0.898 0.309 0.170 0.070 -0.027 0.164 0.867 0.194 0.158 0.220 0.255 0.163 0.118 -0.038 0.152 0.804
  Village, Hamlet & Isolated dwellings – Sparse 0.049 0.155 0.750 0.126 0.154 0.412 -0.143 0.156 0.360 0.027 0.148 0.853 0.189 0.170 0.265 0.062 0.158 0.694
  Urban >10k  - Less sparse 0.053 0.048 0.273 0.048 0.046 0.295 0.085 0.045 0.061 0.193 0.044 <.0001 0.110 0.044 0.012 0.154 0.043 0.000
  Town & Fringe – Less sparse 0.027 0.050 0.587 0.016 0.048 0.738 0.028 0.047 0.542 0.118 0.045 0.009 0.008 0.046 0.861 0.092 0.046 0.043
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.030 0.024 0.222 -0.032 0.023 0.161 -0.032 0.023 0.155 -0.043 0.021 0.042 -0.030 0.022 0.177 -0.006 0.022 0.779
Prevalence -0.007 0.026 0.782 0.025 0.024 0.296 0.015 0.023 0.526 -0.002 0.021 0.931 0.004 0.020 0.838 -0.003 0.020 0.868
Country
  England 0.202 0.083 0.015 0.149 0.077 0.053 0.120 0.078 0.124 0.110 0.073 0.131 0.157 0.077 0.041 0.134 0.077 0.081
  Northern Ireland 0.127 0.169 0.452 0.047 0.168 0.780 0.117 0.163 0.472 0.040 0.151 0.793 0.213 0.150 0.155 0.116 0.147 0.433
  Scotland 0.071 0.155 0.646 0.208 0.142 0.142 0.178 0.136 0.188 0.103 0.127 0.419 0.188 0.124 0.132 0.145 0.122 0.237
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.011 0.023 0.643 -0.001 0.017 0.938 -0.012 0.017 0.489 -0.008 0.018 0.657 0.005 0.021 0.813 -0.022 0.020 0.276
Nurse Contact - any involvement
  Low -0.011 0.053 0.834 0.043 0.050 0.382 0.000 0.050 0.993 -0.022 0.047 0.640 -0.052 0.048 0.284 -0.022 0.049 0.661
  Medium 0.023 0.052 0.664 0.073 0.050 0.142 0.069 0.050 0.169 0.014 0.047 0.761 -0.008 0.049 0.873 -0.060 0.050 0.232
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.405 0.017 0.391 0.016 0.400 0.016 0.371 0.016 0.378 0.016 0.382 0.016
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 170.533 <.001 181.318 <.001 232.099 <.001 254.749 <.001 281.854 <.001 217.407 <.001
Percent White (5df) 10.179 0.038 6.410 0.171 15.752 0.003 12.703 0.013 3.655 0.455 5.043 0.283
Urban-Rural Classification (5df) 1.399 0.925 5.335 0.376 6.024 0.304 20.399 0.001 10.952 0.052 15.370 0.009
Country (3df) 6.710 0.082 5.619 0.132 2.876 0.411 2.615 0.455 4.457 0.216 3.143 0.370
Nurse Contact - any involvement  (2df) 0.383 0.826 2.225 0.329 2.328 0.312 0.537 0.765 1.235 0.539 1.428 0.490
2011/122007 2008 2009 2010 2011
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 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.12 Multilevel model, HbA1c ≤7%, nurse contact based on sole involvement, 2002-2006
1
 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.697 0.196 -0.310 0.125 -0.533 0.112 -0.597 0.100 -0.465 0.096
Age
  linear 0.510 0.014 <.001 0.495 0.010 <.001 0.524 0.010 <.001 0.528 0.009 <.001 0.530 0.008 <.001
  quadratic -0.108 0.012 <.001 -0.095 0.008 <.001 -0.096 0.008 <.001 -0.084 0.007 <.001 -0.104 0.007 <.001
Gender (Female) -0.120 0.021 <.001 -0.088 0.016 <.001 -0.066 0.015 <.001 -0.018 0.014 0.195 -0.011 0.013 0.386
Charlson -0.175 0.012 <.001 -0.166 0.009 <.001 -0.162 0.009 <.001 -0.179 0.008 <.001 -0.148 0.007 <.001
Obesity 0.124 0.023 <.001 0.069 0.017 <.001 0.044 0.016 0.005 0.010 0.014 0.471 0.000 0.013 0.980
Townsend
  1st - lowest 0.284 0.228 0.213 0.128 0.118 0.278 0.129 0.108 0.236 0.109 0.101 0.279 0.061 0.096 0.525
  2nd 0.211 0.228 0.353 0.092 0.117 0.433 0.100 0.108 0.354 0.045 0.101 0.651 0.024 0.096 0.799
  3th 0.197 0.228 0.388 0.059 0.117 0.616 0.050 0.108 0.641 0.047 0.100 0.643 -0.002 0.096 0.981
  4th 0.129 0.228 0.572 0.037 0.117 0.750 0.042 0.108 0.694 -0.006 0.100 0.950 -0.053 0.096 0.577
  5th - highest 0.146 0.228 0.523 0.029 0.117 0.802 0.010 0.108 0.927 -0.003 0.101 0.979 -0.053 0.096 0.579
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.313 0.254 0.217 -0.151 0.141 0.286 -0.001 0.132 0.997 0.071 0.123 0.564 0.004 0.118 0.973
  2nd -0.226 0.253 0.373 -0.127 0.141 0.369 0.019 0.133 0.886 0.098 0.123 0.427 0.032 0.118 0.788
  3th -0.335 0.253 0.185 -0.179 0.141 0.204 -0.012 0.132 0.930 0.061 0.123 0.621 0.005 0.118 0.966
  4th -0.287 0.254 0.258 -0.178 0.141 0.207 0.023 0.132 0.865 0.052 0.123 0.671 0.002 0.118 0.988
  5th - highest -0.245 0.253 0.333 -0.132 0.141 0.350 -0.005 0.132 0.972 0.079 0.123 0.522 0.014 0.118 0.907
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.016 0.261 0.951 -0.083 0.217 0.703 -0.051 0.203 0.800 -0.235 0.194 0.226 0.160 0.185 0.385
  Town & Fringe – Sparse 0.055 0.268 0.837 0.054 0.196 0.782 -0.138 0.157 0.381 -0.387 0.150 0.010 0.217 0.122 0.076
  Village, Hamlet & Isolated dwellings – Sparse 0.066 0.202 0.744 -0.160 0.153 0.297 -0.055 0.134 0.679 -0.295 0.127 0.020 0.006 0.117 0.956
  Urban >10k  - Less sparse 0.099 0.058 0.087 0.045 0.045 0.315 0.034 0.043 0.420 -0.003 0.039 0.936 0.050 0.037 0.182
  Town & Fringe – Less sparse -0.023 0.059 0.691 -0.023 0.045 0.600 -0.015 0.042 0.718 -0.038 0.040 0.333 0.002 0.038 0.960
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.033 0.041 0.416 -0.015 0.027 0.583 -0.012 0.025 0.624 -0.018 0.022 0.415 -0.037 0.021 0.083
Prevalence 0.180 0.063 0.004 0.137 0.034 <.001 0.115 0.031 <.001 0.087 0.025 0.001 0.082 0.024 0.001
Country
  England 0.085 0.156 0.586 -0.089 0.097 0.363 0.039 0.085 0.649 0.100 0.077 0.194 0.146 0.072 0.043
  Northern Ireland -0.182 0.377 0.628 -0.249 0.187 0.181 -0.043 0.173 0.802 0.315 0.156 0.044 0.319 0.150 0.034
  Scotland -0.531 0.360 0.140 -0.146 0.181 0.419 0.076 0.167 0.650 0.088 0.153 0.566 0.056 0.147 0.703
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.107 0.045 0.017 -0.049 0.024 0.038 -0.031 0.022 0.163 -0.033 0.020 0.109 -0.022 0.019 0.233
Nurse Contact -sole involvement
  Low 0.025 0.090 0.780 -0.115 0.055 0.035 -0.097 0.053 0.064 -0.115 0.047 0.015 -0.025 0.047 0.589
  Medium -0.123 0.089 0.167 -0.123 0.056 0.029 -0.074 0.053 0.159 -0.073 0.047 0.124 -0.071 0.046 0.124
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.523 0.030 0.395 0.018 0.380 0.017 0.358 0.015 0.363 0.015
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 23.103 <.001 15.931 0.007 23.411 <.001 30.743 <.001 36.529 <.001
Percent White (5df) 10.438 0.034 4.225 0.376 2.030 0.730 3.047 0.550 1.863 0.761
Urban-Rural Classification (5df) 6.154 0.292 4.791 0.442 2.699 0.746 8.773 0.119 7.087 0.214
Country (3df) 3.825 0.281 1.949 0.583 1.049 0.790 6.136 0.105 9.636 0.022
Nurse Contact - any involvement  (2df) 3.280 0.194 6.290 0.043 3.728 0.155 6.141 0.046 2.409 0.300
2002 2003 2004 2005 2006
 
1
 Nurse contact – sole involvement low <21%, medium 22-28%, high 29% and over 
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A3.13 Multilevel model, HbA1c ≤7%, nurse contact based on sole involvement
1
, 2007-2011/12 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.437 0.095 -0.397 0.087 -0.351 0.087 -0.398 0.082 -0.376 0.084 -0.392 0.083
Age
  linear 0.584 0.008 <.001 0.590 0.008 <.001 0.593 0.008 <.001 0.596 0.008 <.001 0.596 0.007 <.001 0.570 0.008 <.001
  quadratic -0.094 0.007 <.001 -0.109 0.006 <.001 -0.107 0.006 <.001 -0.123 0.006 <.001 -0.111 0.006 <.001 -0.122 0.006 <.001
Gender (Female) 0.000 0.012 0.997 0.027 0.012 0.022 0.041 0.011 <.001 0.052 0.011 <.001 0.030 0.011 0.008 0.052 0.011 <.001
Charlson -0.121 0.006 <.001 -0.125 0.006 <.001 -0.131 0.005 <.001 -0.141 0.005 <.001 -0.153 0.005 <.001 -0.149 0.005 <.001
Obesity 0.000 0.013 1.000 0.002 0.012 0.886 -0.004 0.012 0.738 -0.009 0.011 0.450 -0.050 0.011 <.001 -0.119 0.011 <.001
Townsend
  1st - lowest 0.038 0.080 0.639 -0.014 0.073 0.844 -0.014 0.067 0.831 0.104 0.064 0.106 0.106 0.061 0.079 0.119 0.061 0.049
  2nd 0.008 0.080 0.923 -0.073 0.072 0.316 -0.060 0.066 0.366 0.083 0.064 0.193 0.078 0.060 0.196 0.094 0.060 0.118
  3th -0.019 0.080 0.812 -0.075 0.072 0.299 -0.088 0.066 0.187 0.044 0.064 0.495 0.069 0.060 0.255 0.091 0.060 0.131
  4th -0.031 0.080 0.700 -0.103 0.072 0.155 -0.105 0.066 0.115 0.012 0.064 0.855 0.053 0.060 0.378 0.070 0.060 0.242
  5th - highest -0.073 0.080 0.358 -0.121 0.072 0.094 -0.140 0.067 0.036 0.003 0.064 0.964 -0.005 0.061 0.937 0.037 0.061 0.539
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.050 0.103 0.629 0.031 0.095 0.744 -0.029 0.089 0.748 -0.208 0.086 0.016 -0.252 0.082 0.002 -0.245 0.082 0.003
  2nd -0.017 0.103 0.868 0.029 0.095 0.761 -0.013 0.089 0.881 -0.160 0.086 0.063 -0.192 0.083 0.020 -0.166 0.082 0.043
  3th 0.000 0.102 0.999 0.035 0.094 0.712 0.013 0.088 0.884 -0.155 0.086 0.072 -0.204 0.082 0.013 -0.185 0.081 0.024
  4th -0.016 0.102 0.875 0.034 0.094 0.720 -0.020 0.089 0.817 -0.153 0.086 0.076 -0.170 0.082 0.039 -0.165 0.082 0.044
  5th - highest -0.017 0.103 0.865 0.041 0.095 0.668 0.008 0.089 0.931 -0.157 0.086 0.068 -0.174 0.082 0.035 -0.165 0.082 0.044
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.175 0.182 0.337 0.232 0.176 0.189 -0.272 0.239 0.255 -0.177 0.230 0.442 -0.300 0.235 0.201 0.055 0.227 0.810
  Town & Fringe – Sparse 0.069 0.121 0.566 0.096 0.119 0.420 0.142 0.122 0.242 -0.002 0.118 0.985 0.008 0.119 0.948 0.059 0.118 0.620
  Village, Hamlet & Isolated dwellings – Sparse 0.120 0.113 0.288 0.157 0.109 0.153 0.076 0.114 0.503 0.001 0.111 0.995 -0.051 0.125 0.685 -0.034 0.123 0.783
  Urban >10k  - Less sparse 0.063 0.036 0.082 0.070 0.034 0.044 0.037 0.034 0.274 0.105 0.034 0.002 0.120 0.034 0.000 0.117 0.034 0.001
  Town & Fringe – Less sparse 0.053 0.036 0.145 0.052 0.035 0.133 0.034 0.034 0.319 0.072 0.033 0.030 0.037 0.034 0.276 0.031 0.035 0.376
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.039 0.022 0.082 -0.044 0.020 0.029 -0.026 0.021 0.205 -0.051 0.019 0.008 -0.035 0.019 0.064 -0.035 0.019 0.067
Prevalence 0.061 0.023 0.009 0.069 0.021 0.001 0.051 0.021 0.014 0.039 0.019 0.034 0.052 0.018 0.004 0.046 0.018 0.009
Country
  England 0.157 0.075 0.037 0.090 0.069 0.193 0.195 0.071 0.006 0.155 0.066 0.018 0.128 0.068 0.059 0.098 0.067 0.146
  Northern Ireland 0.289 0.146 0.048 0.078 0.143 0.583 0.212 0.140 0.129 0.086 0.130 0.508 0.028 0.128 0.828 -0.087 0.127 0.491
  Scotland 0.155 0.133 0.242 0.132 0.118 0.266 0.131 0.115 0.254 -0.028 0.108 0.798 -0.036 0.107 0.739 -0.081 0.106 0.446
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional 0.004 0.021 0.833 0.019 0.015 0.216 0.019 0.015 0.204 0.030 0.017 0.070 0.045 0.019 0.015 0.028 0.017 0.105
Nurse Contact -sole involvement
  Low -0.089 0.049 0.066 -0.011 0.045 0.816 -0.090 0.047 0.055 -0.015 0.043 0.733 -0.059 0.045 0.186 -0.029 0.045 0.527
  Medium -0.084 0.048 0.077 0.015 0.044 0.728 -0.109 0.045 0.015 0.017 0.042 0.686 -0.020 0.042 0.628 -0.029 0.042 0.494
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.382 0.015 0.363 0.014 0.375 0.014 0.347 0.014 0.341 0.014 0.339 0.014
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 25.072 <.001 30.814 <.001 41.540 <.001 36.637 <.001 29.285 <.001 17.778 <.001
Percent White (5df) 2.574 0.632 0.138 0.998 3.265 0.515 4.463 0.347 8.352 0.080 11.487 0.022
Urban-Rural Classification (5df) 4.028 0.545 5.786 0.328 4.847 0.435 11.245 0.047 17.048 0.004 14.816 0.011
Country (3df) 6.112 0.106 2.092 0.554 8.231 0.042 9.809 0.020 6.880 0.076 6.425 0.093
Nurse Contact - any involvement  (2df) 4.522 0.104 0.321 0.852 6.940 0.031 0.506 0.777 1.753 0.416 0.623 0.732
2011/122007 2008 2009 2010 2011
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 Nurse contact – sole involvement low <21%, medium 22-28%, high 29% and over 
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A3.14 Multilevel model, HbA1c ≤10%, nurse contact based on sole involvement
1
, 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.024 0.289 1.458 0.157 1.410 0.128 1.432 0.114 1.612 0.114
Age
  linear 0.411 0.013 <.001 0.403 0.011 <.001 0.437 0.012 <.001 0.470 0.011 <.001 0.466 0.011 <.001
  quadratic -0.134 0.010 <.001 -0.095 0.007 <.001 -0.068 0.007 <.001 -0.070 0.007 <.001 -0.081 0.007 <.001
Gender (Female) -0.154 0.022 <.001 -0.107 0.019 <.001 -0.163 0.019 <.001 -0.148 0.018 <.001 -0.167 0.017 <.001
Charlson -0.069 0.013 <.001 -0.070 0.011 <.001 -0.034 0.011 0.002 -0.073 0.010 <.001 -0.063 0.009 <.001
Obesity 0.467 0.026 <.001 0.424 0.021 <.001 0.360 0.021 <.001 0.349 0.019 <.001 0.353 0.018 <.001
Townsend
  1st - lowest 0.351 0.217 0.107 0.197 0.131 0.133 0.259 0.135 0.054 0.397 0.125 0.002 0.215 0.125 0.086
  2nd 0.282 0.217 0.194 0.169 0.131 0.196 0.215 0.134 0.109 0.331 0.125 0.008 0.186 0.125 0.135
  3th 0.210 0.217 0.334 0.060 0.130 0.645 0.111 0.134 0.406 0.197 0.125 0.114 0.090 0.124 0.472
  4th 0.147 0.217 0.499 -0.020 0.130 0.878 0.030 0.134 0.822 0.111 0.125 0.371 -0.016 0.124 0.895
  5th - highest 0.097 0.217 0.655 -0.070 0.130 0.591 -0.109 0.134 0.415 0.002 0.125 0.984 -0.116 0.124 0.350
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.330 0.249 0.185 -0.148 0.159 0.353 -0.203 0.163 0.213 -0.297 0.153 0.052 -0.165 0.153 0.281
  2nd -0.250 0.248 0.315 -0.084 0.160 0.597 -0.099 0.163 0.542 -0.210 0.153 0.170 -0.087 0.153 0.567
  3th -0.284 0.248 0.253 -0.106 0.160 0.505 -0.126 0.162 0.437 -0.193 0.153 0.206 -0.109 0.152 0.474
  4th -0.287 0.249 0.249 -0.086 0.160 0.592 -0.090 0.162 0.578 -0.173 0.152 0.256 -0.102 0.152 0.502
  5th - highest -0.280 0.250 0.262 0.038 0.161 0.813 0.011 0.163 0.948 -0.093 0.153 0.542 0.000 0.153 0.998
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.531 0.309 0.086 0.137 0.270 0.612 0.128 0.249 0.608 -0.135 0.238 0.572 -0.160 0.248 0.520
  Town & Fringe – Sparse 0.616 0.328 0.060 0.052 0.255 0.839 -0.085 0.202 0.676 -0.250 0.192 0.192 0.017 0.175 0.923
  Village, Hamlet & Isolated dwellings – Sparse 0.045 0.215 0.835 -0.177 0.191 0.354 -0.152 0.161 0.345 -0.053 0.160 0.740 -0.140 0.152 0.357
  Urban >10k  - Less sparse 0.070 0.063 0.268 0.010 0.054 0.857 0.030 0.055 0.594 0.053 0.053 0.316 0.008 0.050 0.881
  Town & Fringe – Less sparse 0.043 0.066 0.518 0.065 0.057 0.250 -0.040 0.057 0.488 -0.044 0.055 0.426 -0.025 0.053 0.642
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.061 0.064 0.342 -0.001 0.035 0.978 -0.017 0.028 0.553 -0.003 0.024 0.886 -0.022 0.024 0.367
Prevalence 0.084 0.099 0.396 0.033 0.044 0.449 0.025 0.035 0.479 -0.007 0.028 0.797 0.039 0.027 0.150
Country
  England 0.240 0.249 0.334 -0.001 0.127 0.991 0.260 0.096 0.007 0.251 0.084 0.003 0.194 0.083 0.019
  Northern Ireland -0.154 0.507 0.762 -0.044 0.229 0.847 0.247 0.201 0.218 0.184 0.181 0.309 0.217 0.182 0.235
  Scotland -0.746 0.486 0.125 0.132 0.220 0.549 0.283 0.197 0.151 0.168 0.179 0.349 0.162 0.180 0.367
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.187 0.071 0.008 -0.103 0.031 0.001 -0.040 0.025 0.107 -0.025 0.022 0.266 -0.014 0.022 0.523
Nurse Contact -sole involvement
  Low -0.067 0.143 0.638 -0.145 0.071 0.042 -0.092 0.060 0.125 -0.050 0.052 0.338 -0.113 0.054 0.037
  Medium -0.203 0.141 0.152 -0.094 0.073 0.202 0.010 0.060 0.866 -0.040 0.052 0.451 -0.085 0.053 0.114
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.864 0.044 0.522 0.023 0.420 0.019 0.379 0.017 0.404 0.017
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 48.227 <.001 85.400 <.001 129.114 <.001 180.410 <.001 146.075 <.001
Percent White (5df) 3.057 0.548 13.113 0.011 16.753 0.002 15.487 0.004 13.358 0.010
Urban-Rural Classification (5df) 7.231 0.204 4.138 0.530 3.781 0.581 6.816 0.235 1.832 0.872
Country (3df) 6.188 0.103 1.068 0.785 7.485 0.058 9.154 0.027 5.688 0.128
Nurse Contact - any involvement  (2df) 2.158 0.340 4.267 0.118 3.589 0.166 1.030 0.598 4.827 0.090
2002 2003 2004 2005 2006
 
1
 Nurse contact – sole involvement low <21%, medium 22-28%, high 29% and over 
 
123 
 
A3.15 Multilevel model, HbA1c ≤10%, nurse contact based on sole involvement
1
, 2007-2011/12 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.470 0.109 1.484 0.101 1.554 0.099 1.522 0.094 1.427 0.097 1.486 0.096
Age
  linear 0.483 0.010 <.001 0.480 0.010 <.001 0.484 0.010 <.001 0.510 0.009 <.001 0.547 0.009 <.001 0.500 0.009 <.001
  quadratic -0.076 0.006 <.001 -0.075 0.006 <.001 -0.089 0.006 <.001 -0.086 0.006 <.001 -0.082 0.006 <.001 -0.116 0.006 <.001
Gender (Female) -0.154 0.016 <.001 -0.148 0.016 <.001 -0.155 0.015 <.001 -0.142 0.015 <.001 -0.152 0.014 <.001 -0.132 0.014 <.001
Charlson -0.017 0.008 0.040 -0.026 0.008 0.001 -0.047 0.007 <.001 -0.039 0.007 <.001 -0.069 0.007 <.001 -0.071 0.007 <.001
Obesity 0.308 0.017 <.001 0.339 0.016 <.0001 0.286 0.016 <.001 0.293 0.015 <.001 0.207 0.015 <.001 0.040 0.015 0.006
Townsend
  1st - lowest 0.380 0.102 <.001 0.237 0.095 0.013 0.238 0.087 0.006 0.315 0.082 <.001 0.268 0.075 <.001 0.272 0.073 <.001
  2nd 0.305 0.101 0.003 0.208 0.094 0.028 0.189 0.087 0.030 0.266 0.081 0.001 0.239 0.075 0.001 0.224 0.073 0.002
  3th 0.249 0.101 0.014 0.112 0.094 0.236 0.078 0.087 0.368 0.135 0.081 0.094 0.136 0.074 0.068 0.109 0.072 0.133
  4th 0.142 0.101 0.160 -0.025 0.094 0.793 -0.032 0.086 0.712 0.014 0.081 0.862 0.017 0.074 0.824 0.008 0.072 0.916
  5th - highest 0.016 0.101 0.872 -0.076 0.094 0.417 -0.133 0.087 0.126 -0.049 0.081 0.542 -0.128 0.074 0.085 -0.061 0.072 0.398
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.331 0.129 0.010 -0.162 0.122 0.182 -0.213 0.114 0.062 -0.346 0.108 0.001 -0.159 0.102 0.119 -0.213 0.099 0.031
  2nd -0.252 0.129 0.051 -0.098 0.122 0.423 -0.119 0.114 0.296 -0.282 0.108 0.009 -0.121 0.102 0.237 -0.187 0.099 0.059
  3th -0.255 0.129 0.048 -0.094 0.121 0.436 -0.071 0.113 0.534 -0.244 0.108 0.024 -0.137 0.101 0.175 -0.174 0.098 0.076
  4th -0.206 0.129 0.109 -0.078 0.121 0.521 -0.078 0.114 0.495 -0.270 0.107 0.012 -0.103 0.101 0.307 -0.121 0.098 0.219
  5th - highest -0.193 0.130 0.136 -0.055 0.122 0.655 -0.063 0.114 0.585 -0.194 0.108 0.072 -0.087 0.102 0.395 -0.127 0.099 0.197
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.049 0.235 0.834 -0.137 0.230 0.554 -0.265 0.308 0.389 0.118 0.308 0.703 0.263 0.306 0.389 0.444 0.299 0.138
  Town & Fringe – Sparse 0.017 0.166 0.918 0.311 0.170 0.068 -0.027 0.165 0.870 0.193 0.158 0.222 0.258 0.163 0.114 -0.040 0.152 0.792
  Village, Hamlet & Isolated dwellings – Sparse 0.045 0.155 0.772 0.127 0.154 0.410 -0.140 0.156 0.370 0.027 0.148 0.857 0.191 0.170 0.262 0.049 0.158 0.754
  Urban >10k  - Less sparse 0.052 0.048 0.275 0.048 0.046 0.295 0.086 0.045 0.058 0.193 0.044 <.001 0.109 0.044 0.014 0.156 0.043 <.001
  Town & Fringe – Less sparse 0.027 0.050 0.586 0.015 0.048 0.749 0.026 0.047 0.571 0.117 0.045 0.009 0.007 0.046 0.883 0.096 0.046 0.036
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.030 0.025 0.223 -0.027 0.023 0.227 -0.026 0.023 0.254 -0.042 0.021 0.046 -0.028 0.022 0.187 -0.009 0.022 0.679
Prevalence -0.007 0.026 0.795 0.026 0.024 0.276 0.016 0.023 0.500 -0.002 0.021 0.934 0.007 0.020 0.724 0.000 0.020 0.983
Country
  England 0.200 0.083 0.015 0.151 0.077 0.050 0.115 0.078 0.141 0.109 0.073 0.135 0.166 0.077 0.031 0.152 0.077 0.049
  Northern Ireland 0.129 0.169 0.446 0.038 0.168 0.821 0.093 0.163 0.566 0.031 0.151 0.836 0.214 0.149 0.152 0.153 0.148 0.299
  Scotland 0.072 0.155 0.641 0.211 0.142 0.137 0.171 0.136 0.207 0.098 0.127 0.440 0.185 0.125 0.137 0.173 0.123 0.159
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.011 0.023 0.628 -0.002 0.017 0.905 -0.015 0.017 0.373 -0.008 0.018 0.645 0.010 0.021 0.634 -0.016 0.020 0.420
Nurse Contact -sole involvement
  Low -0.017 0.054 0.747 0.017 0.051 0.734 -0.032 0.052 0.537 -0.026 0.048 0.587 -0.088 0.050 0.082 -0.053 0.052 0.307
  Medium 0.012 0.052 0.826 0.009 0.049 0.858 -0.067 0.050 0.178 -0.001 0.047 0.975 0.006 0.048 0.900 -0.025 0.048 0.600
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.405 0.017 0.392 0.016 0.400 0.016 0.371 0.016 0.376 0.016 0.382 0.016
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 170.303 <.001 180.955 <.001 231.849 <.001 254.704 <.001 281.635 <.001 216.514 <.001
Percent White (5df) 10.149 0.038 6.189 0.186 15.695 0.004 12.745 0.013 3.571 0.467 5.331 0.255
Urban-Rural Classification (5df) 1.419 0.922 5.476 0.361 6.243 0.283 20.459 0.001 10.870 0.054 15.687 0.008
Country (3df) 6.617 0.085 5.993 0.112 2.805 0.423 2.624 0.453 4.868 0.182 4.008 0.261
Nurse Contact - any involvement  (2df) 0.271 0.873 0.116 0.944 1.823 0.402 0.353 0.838 3.867 0.145 1.059 0.589
2011/20122007 2008 2009 2010 2011
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 Nurse contact – sole involvement low <21%, medium 22-28%, high 29% and over 
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A3.16 Multilevel model, HbA1c ≤7%, nurse contact based on Vision allocation
1
, 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.729 0.197 -0.311 0.123 -0.573 0.112 -0.616 0.102 -0.458 0.097
Age
  linear 0.510 0.014 <.001 0.495 0.010 <.001 0.524 0.010 <.001 0.528 0.009 <.001 0.530 0.008 <.001
  quadratic -0.108 0.012 <.001 -0.095 0.008 <.001 -0.096 0.008 <.001 -0.084 0.007 <.001 -0.104 0.007 <.001
Gender (Female) -0.120 0.021 <.001 -0.088 0.016 <.001 -0.066 0.015 <.001 -0.018 0.014 0.197 -0.011 0.013 0.383
Charlson -0.175 0.012 <.001 -0.166 0.009 <.001 -0.162 0.009 <.001 -0.179 0.008 <.001 -0.148 0.007 <.001
Obesity 0.124 0.023 <.001 0.069 0.017 <.001 0.044 0.016 0.005 0.010 0.014 0.470 0.000 0.013 0.977
Townsend
  1st - lowest 0.285 0.228 0.211 0.127 0.118 0.281 0.135 0.109 0.215 0.107 0.101 0.290 0.057 0.096 0.549
  2nd 0.212 0.228 0.351 0.091 0.117 0.436 0.106 0.108 0.326 0.043 0.101 0.671 0.020 0.096 0.831
  3th 0.198 0.228 0.385 0.058 0.117 0.619 0.056 0.108 0.603 0.044 0.100 0.664 -0.006 0.096 0.952
  4th 0.130 0.228 0.568 0.037 0.117 0.755 0.048 0.108 0.656 -0.009 0.100 0.925 -0.058 0.096 0.545
  5th - highest 0.146 0.228 0.522 0.029 0.117 0.807 0.015 0.108 0.888 -0.006 0.101 0.953 -0.057 0.096 0.555
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.317 0.254 0.211 -0.149 0.141 0.292 -0.002 0.133 0.986 0.075 0.123 0.545 0.008 0.118 0.946
  2nd -0.227 0.253 0.370 -0.126 0.141 0.371 0.020 0.133 0.881 0.103 0.123 0.402 0.037 0.118 0.756
  3th -0.336 0.253 0.184 -0.178 0.141 0.207 -0.011 0.132 0.932 0.067 0.123 0.588 0.010 0.118 0.930
  4th -0.286 0.254 0.259 -0.175 0.141 0.214 0.024 0.133 0.856 0.059 0.123 0.630 0.008 0.118 0.948
  5th - highest -0.243 0.254 0.339 -0.131 0.141 0.354 -0.003 0.133 0.984 0.086 0.123 0.486 0.020 0.118 0.866
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.023 0.261 0.930 -0.088 0.217 0.686 -0.043 0.204 0.833 -0.217 0.194 0.263 0.153 0.185 0.407
  Town & Fringe – Sparse 0.058 0.268 0.829 0.043 0.196 0.826 -0.131 0.158 0.406 -0.377 0.151 0.012 0.211 0.122 0.085
  Village, Hamlet & Isolated dwellings – Sparse 0.068 0.202 0.737 -0.168 0.153 0.273 -0.053 0.134 0.694 -0.287 0.128 0.025 0.002 0.117 0.985
  Urban >10k  - Less sparse 0.099 0.058 0.088 0.043 0.045 0.329 0.033 0.043 0.433 -0.003 0.039 0.940 0.050 0.037 0.178
  Town & Fringe – Less sparse -0.024 0.059 0.681 -0.023 0.045 0.600 -0.015 0.042 0.719 -0.038 0.040 0.343 0.003 0.038 0.946
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.031 0.041 0.447 -0.014 0.027 0.603 -0.013 0.025 0.592 -0.020 0.022 0.375 -0.037 0.021 0.079
Prevalence 0.186 0.063 0.003 0.133 0.034 <.001 0.110 0.031 <.001 0.083 0.025 0.001 0.082 0.024 0.001
Country
  England 0.088 0.156 0.574 -0.088 0.097 0.363 0.031 0.085 0.714 0.092 0.077 0.234 0.136 0.072 0.060
  Northern Ireland -0.215 0.377 0.568 -0.252 0.186 0.176 -0.055 0.173 0.752 0.319 0.157 0.042 0.325 0.150 0.031
  Scotland -0.601 0.362 0.096 -0.114 0.180 0.526 0.072 0.167 0.666 0.096 0.154 0.534 0.059 0.147 0.686
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.112 0.045 0.012 -0.047 0.024 0.048 -0.033 0.022 0.144 -0.034 0.020 0.092 -0.021 0.019 0.258
Nurse Contact - Vision
  Low 0.102 0.091 0.263 -0.140 0.055 0.011 -0.027 0.053 0.606 -0.084 0.048 0.079 -0.024 0.047 0.609
  Medium -0.077 0.089 0.384 -0.114 0.055 0.040 -0.035 0.053 0.510 -0.042 0.047 0.370 -0.071 0.046 0.126
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.523 0.030 0.394 0.018 0.382 0.017 0.360 0.015 0.363 0.015
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 23.174 <.001 15.900 0.007 23.777 <.001 31.023 <.001 36.893 <.001
Percent White (5df) 10.697 0.030 4.039 0.401 2.160 0.706 3.035 0.552 1.897 0.755
Urban-Rural Classification (5df) 6.156 0.291 4.739 0.449 2.532 0.772 8.293 0.141 6.924 0.226
Country (3df) 4.711 0.194 2.223 0.527 1.081 0.782 5.902 0.117 9.303 0.026
Nurse Contact - any involvement  (2df) 4.123 0.127 7.434 0.024 0.481 0.786 3.099 0.212 2.412 0.299
2002 2003 2004 2005 2006
 
1
 Nurse contact – Vision allocation low <26%, medium 26-37%, high 38% and over 
A3.17 Multilevel model, HbA1c ≤7%, nurse contact based on Vision allocation, 2007-2011/12 
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β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.481 0.096 -0.403 0.088 -0.419 0.088 -0.396 0.083 -0.365 0.084 <.0001 -0.399 0.083
Age
  linear 0.584 0.008 <.001 0.590 0.008 <.001 0.593 0.008 <.001 0.596 0.008 <.001 0.596 0.007 <.001 0.570 0.008 <.001
  quadratic -0.094 0.007 <.001 -0.109 0.006 <.001 -0.107 0.006 <.001 -0.123 0.006 <.001 -0.111 0.006 <.001 -0.122 0.006 <.001
Gender (Female) 0.000 0.012 0.990 0.027 0.012 0.022 0.041 0.011 <.001 0.052 0.011 <.001 0.030 0.011 0.007 0.052 0.011 <.001
Charlson -0.121 0.006 <.001 -0.125 0.006 <.001 -0.131 0.005 <.001 -0.141 0.005 <.001 -0.153 0.005 <.001 -0.149 0.005 <.001
Obesity 0.000 0.013 0.989 0.002 0.012 0.892 -0.004 0.012 0.751 -0.008 0.011 0.461 -0.050 0.011 <.001 -0.119 0.011 <.001
Townsend
  1st - lowest 0.042 0.080 0.603 -0.014 0.073 0.842 -0.016 0.067 0.809 0.118 0.064 0.067 0.108 0.061 0.075 0.119 0.061 0.050
  2nd 0.012 0.080 0.885 -0.073 0.072 0.310 -0.062 0.066 0.351 0.097 0.064 0.128 0.079 0.060 0.189 0.094 0.060 0.119
  3th -0.015 0.080 0.848 -0.076 0.072 0.295 -0.090 0.066 0.178 0.057 0.064 0.368 0.070 0.060 0.246 0.090 0.060 0.134
  4th -0.027 0.080 0.735 -0.103 0.072 0.153 -0.106 0.066 0.109 0.025 0.064 0.693 0.055 0.060 0.364 0.070 0.060 0.246
  5th - highest -0.070 0.080 0.384 -0.122 0.072 0.092 -0.142 0.067 0.033 0.017 0.064 0.796 -0.003 0.061 0.956 0.036 0.061 0.552
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.057 0.103 0.577 0.032 0.095 0.732 -0.026 0.089 0.773 -0.231 0.086 0.007 -0.255 0.082 0.002 -0.246 0.082 0.003
  2nd -0.022 0.103 0.828 0.031 0.095 0.745 -0.009 0.089 0.919 -0.184 0.086 0.033 -0.196 0.083 0.018 -0.166 0.082 0.043
  3th -0.005 0.102 0.958 0.037 0.094 0.694 0.018 0.088 0.841 -0.178 0.086 0.038 -0.207 0.082 0.012 -0.184 0.081 0.024
  4th -0.020 0.102 0.844 0.036 0.094 0.704 -0.015 0.089 0.868 -0.176 0.086 0.041 -0.172 0.082 0.036 -0.164 0.082 0.044
  5th - highest -0.020 0.103 0.845 0.043 0.095 0.651 0.014 0.089 0.873 -0.181 0.086 0.036 -0.177 0.082 0.032 -0.163 0.082 0.046
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.193 0.182 0.290 0.235 0.176 0.183 -0.245 0.239 0.305 -0.126 0.230 0.582 -0.290 0.235 0.216 0.058 0.226 0.797
  Town & Fringe – Sparse 0.070 0.121 0.566 0.098 0.118 0.407 0.146 0.122 0.230 0.025 0.118 0.832 0.011 0.119 0.925 0.062 0.118 0.600
  Village, Hamlet & Isolated dwellings – Sparse 0.122 0.113 0.281 0.159 0.109 0.146 0.079 0.114 0.486 0.024 0.111 0.826 -0.046 0.124 0.712 -0.031 0.123 0.801
  Urban >10k  - Less sparse 0.061 0.036 0.089 0.070 0.034 0.043 0.037 0.034 0.282 0.110 0.034 0.001 0.121 0.034 0.000 0.119 0.034 0.001
  Town & Fringe – Less sparse 0.053 0.036 0.143 0.052 0.035 0.137 0.035 0.034 0.305 0.076 0.033 0.023 0.037 0.034 0.273 0.031 0.035 0.368
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.044 0.022 0.047 -0.044 0.020 0.029 -0.034 0.021 0.108 -0.050 0.019 0.009 -0.034 0.019 0.076 -0.036 0.019 0.060
Prevalence 0.060 0.023 0.010 0.068 0.021 0.001 0.048 0.021 0.023 0.040 0.019 0.032 0.050 0.018 0.005 0.046 0.018 0.010
Country
  England 0.165 0.076 0.029 0.087 0.069 0.209 0.195 0.071 0.006 0.156 0.066 0.018 0.125 0.068 0.065 0.096 0.067 0.151
  Northern Ireland 0.296 0.146 0.043 0.080 0.143 0.574 0.237 0.140 0.091 0.073 0.130 0.573 0.027 0.128 0.835 -0.079 0.127 0.536
  Scotland 0.166 0.132 0.212 0.131 0.118 0.268 0.145 0.115 0.207 -0.045 0.108 0.677 -0.033 0.106 0.755 -0.079 0.105 0.454
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional 0.005 0.021 0.812 0.017 0.015 0.277 0.018 0.015 0.233 0.029 0.017 0.079 0.043 0.019 0.020 0.030 0.017 0.081
Nurse Contact - Vision
  Low -0.056 0.049 0.256 0.017 0.045 0.711 -0.012 0.046 0.793 -0.003 0.043 0.944 -0.053 0.043 0.216 -0.029 0.043 0.500
  Medium 0.002 0.047 0.963 0.009 0.045 0.848 0.020 0.046 0.666 0.012 0.043 0.786 -0.043 0.043 0.318 -0.002 0.043 0.966
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.383 0.015 0.363 0.014 0.377 0.015 0.348 0.014 0.341 0.014 0.339 0.014
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 25.207 <.001 31.091 <.001 41.583 <.001 37.121 <.001 29.274 <.001 17.984 0.003
Percent White (5df) 2.807 0.591 0.146 0.998 3.404 0.493 4.426 0.351 8.376 0.079 11.755 0.019
Urban-Rural Classification (5df) 4.070 0.539 5.871 0.319 4.586 0.469 11.550 0.042 17.056 0.004 15.224 0.009
Country (3df) 6.425 0.093 1.976 0.577 8.271 0.041 10.622 0.014 6.535 0.088 6.175 0.103
Nurse Contact - any involvement  (2df) 1.741 0.419 0.137 0.934 0.459 0.795 0.126 0.939 1.796 0.408 0.533 0.766
2011/122007 2008 2009 2010 2011
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A3.18 Multilevel model, HbA1c ≤10%, nurse contact based on Vision allocation
1
, 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.005 0.290 1.492 0.155 1.460 0.128 1.415 0.115 1.596 0.116
Age
  linear 0.411 0.013 <.001 0.403 0.011 <.001 0.437 0.012 <.001 0.470 0.011 <.001 0.466 0.011 <.001
  quadratic -0.134 0.010 <.001 -0.095 0.007 <.001 -0.068 0.007 <.001 -0.070 0.007 <.001 -0.081 0.007 <.001
Gender (Female) -0.154 0.022 <.001 -0.107 0.019 <.001 -0.163 0.019 <.001 -0.148 0.018 <.001 -0.167 0.017 <.001
Charlson -0.069 0.013 <.001 -0.070 0.011 <.001 -0.034 0.011 0.002 -0.073 0.010 <.001 -0.063 0.009 <.001
Obesity 0.467 0.026 <.001 0.424 0.021 <.001 0.360 0.021 <.001 0.349 0.019 <.001 0.353 0.018 <.001
Townsend
  1st - lowest 0.350 0.217 0.107 0.194 0.131 0.139 0.272 0.134 0.042 0.396 0.125 0.002 0.223 0.125 0.075
  2nd 0.281 0.217 0.195 0.166 0.131 0.203 0.228 0.134 0.088 0.330 0.125 0.008 0.194 0.125 0.120
  3th 0.209 0.217 0.336 0.058 0.130 0.658 0.125 0.133 0.350 0.196 0.125 0.115 0.097 0.124 0.437
  4th 0.146 0.217 0.501 -0.023 0.130 0.862 0.044 0.133 0.743 0.110 0.125 0.377 -0.009 0.124 0.939
  5th - highest 0.096 0.217 0.660 -0.073 0.130 0.578 -0.095 0.133 0.475 0.002 0.125 0.989 -0.109 0.124 0.379
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.332 0.249 0.182 -0.143 0.159 0.369 -0.222 0.163 0.172 -0.297 0.153 0.052 -0.175 0.153 0.251
  2nd -0.249 0.248 0.316 -0.080 0.160 0.617 -0.118 0.163 0.466 -0.209 0.153 0.173 -0.096 0.153 0.530
  3th -0.282 0.248 0.255 -0.100 0.160 0.529 -0.144 0.162 0.374 -0.191 0.152 0.210 -0.117 0.152 0.444
  4th -0.285 0.249 0.253 -0.078 0.160 0.626 -0.109 0.162 0.501 -0.171 0.152 0.262 -0.108 0.152 0.476
  5th - highest -0.276 0.250 0.269 0.043 0.160 0.788 -0.008 0.163 0.962 -0.091 0.153 0.554 -0.006 0.153 0.970
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.536 0.309 0.083 0.132 0.270 0.626 0.121 0.249 0.629 -0.121 0.238 0.610 -0.152 0.248 0.541
  Town & Fringe – Sparse 0.617 0.328 0.060 0.037 0.255 0.884 -0.096 0.203 0.636 -0.242 0.192 0.208 0.019 0.175 0.912
  Village, Hamlet & Isolated dwellings – Sparse 0.046 0.215 0.829 -0.184 0.190 0.332 -0.161 0.161 0.317 -0.046 0.160 0.773 -0.141 0.152 0.354
  Urban >10k  - Less sparse 0.070 0.063 0.263 0.011 0.054 0.834 0.029 0.055 0.598 0.054 0.053 0.307 0.008 0.050 0.866
  Town & Fringe – Less sparse 0.041 0.066 0.531 0.066 0.057 0.247 -0.041 0.057 0.470 -0.044 0.055 0.427 -0.023 0.053 0.668
  Village, Hamlet & Isolated dwelling – Less sparse0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.060 0.065 0.355 0.005 0.035 0.883 -0.011 0.028 0.702 -0.004 0.024 0.874 -0.023 0.024 0.352
Prevalence 0.090 0.099 0.365 0.026 0.044 0.551 0.018 0.035 0.604 -0.009 0.028 0.754 0.037 0.027 0.176
Country
  England 0.228 0.248 0.357 -0.013 0.126 0.917 0.233 0.095 0.015 0.252 0.084 0.003 0.184 0.083 0.027
  Northern Ireland -0.226 0.508 0.656 -0.039 0.228 0.864 0.212 0.201 0.292 0.190 0.181 0.294 0.208 0.183 0.254
  Scotland -0.847 0.488 0.083 0.155 0.218 0.479 0.249 0.197 0.205 0.178 0.180 0.321 0.156 0.180 0.386
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.197 0.071 0.005 -0.107 0.031 0.001 -0.045 0.025 0.076 -0.023 0.022 0.306 -0.015 0.022 0.489
Nurse Contact - Vision
  Low 0.051 0.145 0.724 -0.171 0.071 0.017 -0.082 0.060 0.175 -0.049 0.053 0.352 -0.071 0.055 0.192
  Medium -0.197 0.142 0.164 -0.172 0.072 0.017 -0.070 0.060 0.239 -0.003 0.052 0.947 -0.054 0.054 0.313
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.862 0.044 0.519 0.023 0.421 0.019 0.379 0.017 0.406 0.017
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 48.369 <.001 85.435 <.001 128.877 <.001 180.791 <.001 146.793 <.001
Percent White (5df) 3.181 0.528 12.888 0.012 16.768 0.002 15.943 0.003 13.994 0.007
Urban-Rural Classification (5df) 7.302 0.199 4.165 0.526 3.956 0.556 6.774 0.238 1.804 0.876
Country (3df) 7.116 0.068 1.437 0.697 6.053 0.109 9.155 0.027 5.073 0.167
Nurse Contact - any involvement  (2df) 3.493 0.174 7.769 0.021 2.168 0.338 1.067 0.586 1.881 0.391
2002 2003 2004 2005 2006
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 Nurse contact – Vision allocation low <26%, medium 26-37%, high 38% and over 
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A3.19 Multilevel model, HbA1c ≤10%, nurse contact based on Vision allocation
1
, 2007-2011/12 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.452 0.109 1.457 0.101 1.483 0.100 1.488 0.094 1.423 0.097 1.483 0.096
Age
  linear 0.483 0.010 <.001 0.480 0.010 <.001 0.484 0.010 <.001 0.510 0.009 <.001 0.547 0.009 <.001 0.500 0.009 <.001
  quadratic -0.076 0.006 <.001 -0.075 0.006 <.001 -0.089 0.006 <.001 -0.086 0.006 <.001 -0.082 0.006 <.001 -0.116 0.006 <.001
Gender (Female) -0.154 0.016 <.001 -0.148 0.016 <.001 -0.155 0.015 <.001 -0.142 0.015 <.001 -0.152 0.014 <.001 -0.132 0.014 <.001
Charlson -0.017 0.008 0.040 -0.026 0.008 0.001 -0.047 0.007 <.001 -0.039 0.007 <.001 -0.069 0.007 <.001 -0.071 0.007 <.001
Obesity 0.308 0.017 <.001 0.339 0.016 <.001 0.286 0.016 <.001 0.293 0.015 <.001 0.207 0.015 <.001 0.040 0.015 0.006
Townsend
  1st - lowest 0.380 0.102 <.001 0.238 0.095 0.012 0.236 0.087 0.007 0.315 0.082 <.001 0.268 0.075 <.001 0.272 0.073 <.001
  2nd 0.305 0.101 0.003 0.209 0.094 0.027 0.187 0.087 0.031 0.266 0.081 0.001 0.238 0.075 0.001 0.224 0.073 0.002
  3th 0.249 0.101 0.014 0.113 0.094 0.230 0.076 0.087 0.381 0.135 0.081 0.095 0.135 0.074 0.069 0.109 0.072 0.133
  4th 0.142 0.101 0.160 -0.023 0.094 0.806 -0.034 0.086 0.694 0.013 0.081 0.867 0.016 0.074 0.830 0.007 0.072 0.919
  5th - highest 0.016 0.101 0.874 -0.075 0.094 0.426 -0.134 0.087 0.120 -0.050 0.081 0.535 -0.129 0.074 0.083 -0.062 0.072 0.392
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.331 0.129 0.011 -0.164 0.121 0.177 -0.212 0.114 0.062 -0.344 0.108 0.001 -0.160 0.102 0.117 -0.212 0.099 0.031
  2nd -0.252 0.129 0.052 -0.099 0.122 0.417 -0.117 0.114 0.306 -0.279 0.108 0.010 -0.122 0.102 0.233 -0.186 0.099 0.060
  3th -0.255 0.129 0.048 -0.095 0.121 0.432 -0.068 0.113 0.550 -0.240 0.108 0.026 -0.138 0.101 0.173 -0.174 0.098 0.076
  4th -0.205 0.129 0.111 -0.078 0.121 0.520 -0.073 0.113 0.521 -0.265 0.108 0.014 -0.104 0.101 0.307 -0.120 0.098 0.221
  5th - highest -0.192 0.130 0.139 -0.054 0.122 0.658 -0.057 0.114 0.617 -0.189 0.108 0.081 -0.086 0.102 0.399 -0.127 0.099 0.198
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.037 0.235 0.876 -0.120 0.230 0.604 -0.260 0.308 0.398 0.129 0.308 0.674 0.245 0.305 0.421 0.457 0.299 0.127
  Town & Fringe – Sparse 0.022 0.166 0.894 0.316 0.170 0.064 -0.031 0.164 0.849 0.195 0.158 0.215 0.254 0.163 0.119 -0.037 0.152 0.806
  Village, Hamlet & Isolated dwellings – Sparse 0.051 0.155 0.743 0.133 0.154 0.388 -0.141 0.156 0.368 0.027 0.148 0.853 0.186 0.170 0.274 0.055 0.158 0.729
  Urban >10k  - Less sparse 0.053 0.048 0.273 0.049 0.046 0.289 0.087 0.045 0.056 0.193 0.044 <.001 0.110 0.044 0.013 0.157 0.043 <.001
  Town & Fringe – Less sparse 0.028 0.050 0.580 0.016 0.048 0.741 0.029 0.047 0.542 0.118 0.045 0.008 0.007 0.046 0.870 0.096 0.046 0.035
  Village, Hamlet & Isolated dwelling – Less sparse0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.030 0.024 0.215 -0.031 0.023 0.176 -0.034 0.023 0.138 -0.046 0.021 0.030 -0.030 0.022 0.165 -0.009 0.022 0.679
Prevalence -0.008 0.026 0.769 0.025 0.024 0.288 0.013 0.023 0.569 -0.004 0.021 0.864 0.006 0.020 0.774 -0.002 0.020 0.914
Country
  England 0.200 0.083 0.015 0.148 0.077 0.055 0.113 0.078 0.147 0.103 0.073 0.156 0.161 0.077 0.036 0.150 0.077 0.051
  Northern Ireland 0.134 0.169 0.428 0.043 0.167 0.797 0.111 0.162 0.494 0.041 0.151 0.785 0.219 0.150 0.143 0.150 0.148 0.309
  Scotland 0.073 0.155 0.637 0.205 0.142 0.149 0.178 0.136 0.190 0.101 0.127 0.426 0.191 0.124 0.124 0.178 0.123 0.148
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.012 0.023 0.585 -0.003 0.017 0.846 -0.016 0.017 0.346 -0.009 0.018 0.628 0.006 0.021 0.761 -0.019 0.020 0.335
Nurse Contact - Vision
  Low 0.010 0.054 0.850 0.056 0.050 0.266 0.051 0.050 0.311 0.021 0.047 0.651 -0.058 0.048 0.234 -0.026 0.050 0.596
  Medium 0.032 0.052 0.531 0.058 0.050 0.247 0.067 0.051 0.186 0.061 0.048 0.207 0.012 0.049 0.810 -0.030 0.050 0.546
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.405 0.017 0.391 0.016 0.400 0.016 0.371 0.016 0.377 0.016 0.383 0.016
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 170.700 <.001 181.350 <.001 232.534 <.001 255.251 <.001 281.404 <.001 216.947 <.001
Percent White (5df) 10.352 0.035 6.443 0.168 16.484 0.002 13.243 0.010 3.665 0.453 5.318 0.256
Urban-Rural Classification (5df) 1.395 0.925 5.468 0.361 6.240 0.284 20.430 0.001 10.880 0.054 15.892 0.007
Country (3df) 6.632 0.085 5.553 0.136 2.702 0.440 2.300 0.513 4.702 0.195 3.978 0.264
Nurse Contact - any involvement  (2df) 0.409 0.815 1.744 0.418 1.948 0.378 1.624 0.444 2.134 0.344 0.453 0.797
2011/122007 2008 2009 2010 2011
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 Nurse contact – Vision allocation low <26%, medium 26-37%, high 38% and over 
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A3.20 Multilevel model (including whether previous years threshold was achieved), HbA1c ≤7%, 
nurse contact based on any involvement
1
, 2003-2007 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -1.190 0.127 -1.589 0.117 -1.627 0.106 -1.530 0.102 -1.544 0.100
Age
  linear 0.409 0.013 <.001 0.423 0.012 <.001 0.401 0.011 <.001 0.399 0.010 <.001 0.451 0.010 <.001
  quadratic -0.055 0.011 <.001 -0.054 0.010 <.001 -0.059 0.009 <.001 -0.091 0.009 <.001 -0.064 0.008 <.001
Gender (Female) -0.053 0.021 0.011 -0.037 0.018 0.044 0.013 0.017 0.451 0.009 0.016 0.592 0.005 0.015 0.732
Charlson -0.099 0.012 <.001 -0.083 0.010 <.001 -0.106 0.009 <.001 -0.067 0.008 <.001 -0.063 0.007 <.001
Obesity 0.022 0.022 0.326 -0.001 0.019 0.956 -0.011 0.018 0.550 -0.022 0.016 0.181 -0.004 0.016 0.794
Townsend
  1st - lowest -0.070 0.158 0.659 0.115 0.130 0.374 -0.020 0.120 0.871 0.030 0.116 0.793 -0.017 0.097 0.864
  2nd -0.053 0.158 0.738 0.114 0.129 0.380 -0.069 0.120 0.568 0.018 0.116 0.875 -0.038 0.096 0.695
  3th -0.087 0.158 0.583 0.071 0.129 0.580 -0.049 0.120 0.681 -0.013 0.115 0.914 -0.042 0.096 0.664
  4th -0.085 0.158 0.589 0.065 0.129 0.615 -0.091 0.120 0.446 -0.028 0.116 0.805 -0.023 0.096 0.814
  5th - highest -0.053 0.158 0.738 0.057 0.129 0.658 -0.061 0.120 0.614 -0.017 0.116 0.883 -0.068 0.096 0.477
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.021 0.183 0.908 0.030 0.157 0.848 0.162 0.147 0.269 -0.085 0.142 0.551 -0.029 0.124 0.816
  2nd -0.014 0.183 0.939 0.032 0.157 0.837 0.176 0.146 0.230 -0.051 0.142 0.721 0.001 0.124 0.994
  3th -0.031 0.183 0.864 0.035 0.156 0.823 0.161 0.146 0.269 -0.059 0.141 0.677 0.032 0.123 0.793
  4th -0.015 0.182 0.935 0.065 0.156 0.677 0.136 0.146 0.351 -0.042 0.141 0.767 0.013 0.123 0.913
  5th - highest -0.019 0.182 0.916 -0.010 0.157 0.948 0.179 0.146 0.220 -0.038 0.142 0.786 0.015 0.123 0.900
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.222 0.245 0.366 -0.149 0.232 0.522 -0.327 0.219 0.137 0.177 0.212 0.404 0.284 0.207 0.169
  Town & Fringe – Sparse 0.103 0.227 0.651 -0.177 0.177 0.318 -0.300 0.170 0.078 0.350 0.140 0.012 -0.126 0.140 0.367
  Village, Hamlet & Isolated dwellings – Sparse -0.242 0.179 0.177 -0.109 0.153 0.479 -0.442 0.145 0.002 0.062 0.135 0.648 0.175 0.129 0.177
  Urban >10k  - Less sparse 0.026 0.055 0.640 -0.017 0.051 0.736 -0.046 0.047 0.331 0.065 0.045 0.149 0.014 0.043 0.754
  Town & Fringe – Less sparse -0.045 0.057 0.423 -0.022 0.051 0.661 -0.046 0.049 0.340 0.004 0.046 0.935 0.017 0.044 0.709
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.025 0.025 0.317 0.000 0.024 0.999 -0.003 0.021 0.889 -0.038 0.020 0.062 -0.038 0.021 0.072
Prevalence 0.130 0.033 <.001 0.081 0.031 0.008 0.056 0.025 0.024 0.048 0.023 0.034 0.025 0.022 0.261
Country
  England -0.075 0.093 0.423 0.076 0.083 0.361 0.090 0.075 0.232 0.163 0.070 0.020 0.110 0.072 0.123
  Northern Ireland -0.212 0.216 0.326 -0.023 0.185 0.901 0.539 0.167 0.001 0.235 0.162 0.147 0.195 0.153 0.203
  Scotland 0.074 0.208 0.722 -0.012 0.182 0.947 0.142 0.167 0.396 0.048 0.161 0.768 0.137 0.143 0.336
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.041 0.024 0.086 0.010 0.022 0.635 -0.037 0.020 0.065 -0.028 0.018 0.124 0.022 0.020 0.259
Nurse Contact - any involvement
  Low -0.101 0.052 0.052 -0.055 0.050 0.278 -0.090 0.046 0.050 0.047 0.045 0.298 -0.018 0.046 0.687
  Medium -0.051 0.054 0.348 -0.030 0.052 0.565 -0.094 0.045 0.039 0.006 0.044 0.899 0.027 0.045 0.540
  High 0.000 0.000 0.000 0.000 0.000
Hba1c ≤ 7% (previous year) 2.072 0.022 <.001 2.133 0.019 <.001 2.229 0.017 <.001 2.291 0.016 <.001 2.259 0.015 <.001
Random Variance
  Practice 0.344 0.018 0.352 0.017 0.326 0.015 0.328 0.015 0.343 0.015
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 2.100 0.835 5.972 0.309 7.664 0.176 6.543 0.257 4.445 0.487
Percent White (5df) 0.245 0.993 3.469 0.483 1.793 0.774 1.643 0.801 2.655 0.617
Urban-Rural Classification (5df) 5.272 0.384 1.226 0.942 9.650 0.086 9.719 0.084 6.108 0.296
Country (3df) 4.526 0.210 1.206 0.752 16.830 0.001 8.373 0.039 2.884 0.410
Nurse Contact - any involvement  (2df) 3.792 0.150 1.187 0.552 5.581 0.061 1.230 0.541 0.922 0.631
2003 2004 2005 2006 2007
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.21 Multilevel model (including whether previous years threshold was achieved), HbA1c ≤7%, 
nurse contact based on any involvement
1
, 2008-2011 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -1.457 0.088 -1.523 0.090 -1.463 0.081 -1.486 0.082
Age
  linear 0.436 0.010 <.001 0.426 0.009 <.001 0.430 0.009 <.001 0.434 0.009 <.001
  quadratic -0.097 0.008 <.001 -0.083 0.008 <.001 -0.102 0.008 <.001 -0.080 0.008 <.001
Gender (Female) 0.034 0.014 0.019 0.051 0.014 <.001 0.054 0.014 <.001 0.009 0.014 0.496
Charlson -0.070 0.007 <.001 -0.073 0.007 <.001 -0.083 0.006 <.001 -0.097 0.006 <.001
Obesity -0.027 0.015 0.071 -0.043 0.014 0.003 -0.034 0.014 0.016 -0.069 0.014 <.001
Townsend
  1st - lowest -0.066 0.090 0.461 -0.032 0.083 0.703 0.124 0.079 0.119 0.049 0.076 0.520
  2nd -0.130 0.090 0.148 -0.049 0.083 0.551 0.136 0.079 0.086 0.032 0.075 0.666
  3th -0.112 0.090 0.210 -0.086 0.083 0.295 0.107 0.079 0.175 0.046 0.075 0.540
  4th -0.129 0.089 0.148 -0.090 0.082 0.276 0.070 0.079 0.378 0.060 0.075 0.426
  5th - highest -0.121 0.090 0.179 -0.118 0.083 0.155 0.098 0.079 0.219 0.001 0.076 0.992
  Unknown 0.000 0.000 0.000 0.000
Percent White
  1st - lowest 0.118 0.116 0.310 0.032 0.110 0.772 -0.276 0.105 0.009 -0.166 0.102 0.103
  2nd 0.102 0.116 0.383 0.035 0.110 0.748 -0.228 0.105 0.030 -0.145 0.102 0.154
  3th 0.090 0.116 0.439 0.065 0.109 0.550 -0.235 0.105 0.025 -0.172 0.101 0.090
  4th 0.081 0.116 0.484 0.027 0.109 0.803 -0.226 0.105 0.031 -0.120 0.101 0.236
  5th - highest 0.111 0.116 0.340 0.061 0.110 0.579 -0.247 0.105 0.019 -0.102 0.101 0.312
  Unknown 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.006 0.194 0.975 -0.413 0.274 0.131 0.038 0.254 0.880 -0.377 0.260 0.147
  Town & Fringe – Sparse -0.069 0.132 0.602 0.004 0.137 0.974 -0.136 0.129 0.290 0.079 0.128 0.536
  Village, Hamlet & Isolated dwellings – Sparse 0.038 0.123 0.756 -0.071 0.131 0.586 0.005 0.122 0.970 0.028 0.134 0.835
  Urban >10k  - Less sparse 0.059 0.041 0.147 -0.024 0.040 0.558 0.145 0.040 <.001 0.084 0.040 0.034
  Town & Fringe – Less sparse 0.052 0.043 0.223 -0.029 0.041 0.485 0.089 0.040 0.027 -0.010 0.041 0.807
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000
Practice List Size -0.033 0.018 0.067 -0.015 0.019 0.432 -0.039 0.016 0.015 -0.026 0.016 0.103
Prevalence 0.064 0.019 0.001 0.028 0.019 0.151 0.022 0.016 0.162 0.032 0.015 0.035
Country
  England 0.004 0.061 0.954 0.185 0.065 0.004 0.066 0.055 0.230 0.084 0.056 0.134
  Northern Ireland -0.067 0.146 0.649 0.313 0.145 0.031 -0.045 0.130 0.730 -0.045 0.127 0.725
  Scotland 0.155 0.127 0.224 0.144 0.124 0.245 -0.145 0.113 0.201 -0.028 0.111 0.800
  Wales 0.000 0.000 0.000 0.000
Consultations per healthcare professional 0.010 0.014 0.479 0.012 0.014 0.391 0.029 0.014 0.036 0.030 0.015 0.051
Nurse Contact - any involvement
  Low 0.029 0.039 0.453 -0.042 0.042 0.317 -0.014 0.035 0.688 -0.054 0.035 0.122
  Medium -0.009 0.039 0.812 0.021 0.042 0.612 -0.009 0.035 0.809 -0.035 0.036 0.324
  High 0.000 0.000 0.000 0.000
Hba1c ≤ 7% (previous year) 2.300 0.014 <.001 2.303 0.014 <.001 2.308 0.014 <.001 2.331 0.014 <.001
Random Variance
  Practice 0.294 0.013 0.324 0.014 0.262 0.012 0.256 0.012
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p
Townsend (5df) 11.956 0.035 14.813 0.011 11.365 0.045 6.944 0.225
Percent White (5df) 1.536 0.820 2.449 0.654 3.441 0.487 5.202 0.267
Urban-Rural Classification (5df) 3.143 0.678 2.922 0.712 16.702 0.005 11.704 0.039
Country (3df) 6.356 0.096 11.134 0.011 6.472 0.091 3.624 0.305
Nurse Contact - any involvement  (2df) 0.972 0.615 2.075 0.354 0.166 0.920 2.545 0.280
2008 2009 2010 2011
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.22 Multilevel model (including whether previous years threshold was achieved), HbA1c ≤10%,  
nurse contact based on any involvement
1
, 2003-2007 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.178 0.158 1.112 0.127 1.056 0.115 1.242 0.119 1.069 0.112
Age
  linear 0.351 0.013 <.001 0.378 0.013 <.001 0.391 0.012 <.001 0.384 0.011 <.001 0.387 0.011 <.001
  quadratic -0.094 0.009 <.001 -0.054 0.008 <.001 -0.064 0.008 <.001 -0.084 0.007 <.001 -0.069 0.007 <.001
Gender (Female) -0.097 0.021 <.001 -0.159 0.021 <.001 -0.166 0.020 <.001 -0.164 0.019 <.001 -0.171 0.018 <.001
Charlson -0.024 0.012 0.055 0.013 0.012 0.288 -0.029 0.011 0.009 -0.022 0.010 0.029 0.018 0.009 0.044
Obesity 0.423 0.025 <.001 0.329 0.023 <.001 0.332 0.021 <.001 0.340 0.020 <.001 0.314 0.019 <.001
Townsend
  1st - lowest 0.136 0.158 0.390 0.274 0.142 0.053 0.412 0.135 0.002 0.271 0.134 0.044 0.424 0.109 0.000
  2nd 0.110 0.158 0.484 0.250 0.141 0.077 0.327 0.134 0.015 0.245 0.134 0.067 0.347 0.109 0.001
  3th 0.010 0.157 0.947 0.148 0.141 0.292 0.204 0.134 0.128 0.128 0.134 0.340 0.322 0.109 0.003
  4th -0.071 0.157 0.651 0.067 0.141 0.632 0.109 0.134 0.415 0.045 0.134 0.735 0.213 0.109 0.050
  5th - highest -0.134 0.158 0.396 -0.079 0.141 0.575 0.007 0.134 0.957 -0.071 0.134 0.594 0.070 0.108 0.517
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.010 0.187 0.958 -0.243 0.173 0.159 -0.229 0.164 0.162 -0.254 0.164 0.123 -0.330 0.140 0.019
  2nd 0.043 0.188 0.818 -0.123 0.173 0.477 -0.165 0.164 0.312 -0.164 0.164 0.320 -0.245 0.141 0.082
  3th 0.009 0.187 0.961 -0.152 0.172 0.377 -0.148 0.163 0.366 -0.170 0.164 0.301 -0.260 0.140 0.063
  4th 0.019 0.187 0.919 -0.126 0.172 0.464 -0.133 0.163 0.413 -0.137 0.164 0.401 -0.220 0.140 0.115
  5th - highest 0.162 0.188 0.389 -0.038 0.172 0.826 -0.038 0.163 0.817 -0.064 0.164 0.699 -0.192 0.141 0.173
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.147 0.288 0.611 0.118 0.259 0.648 -0.241 0.243 0.323 -0.085 0.257 0.742 -0.153 0.240 0.523
  Town & Fringe – Sparse -0.054 0.274 0.843 -0.013 0.210 0.952 -0.147 0.201 0.466 0.133 0.186 0.473 -0.010 0.176 0.955
  Village, Hamlet & Isolated dwellings – Sparse -0.280 0.203 0.167 -0.168 0.167 0.315 -0.108 0.164 0.511 0.009 0.161 0.956 0.055 0.162 0.734
  Urban >10k  - Less sparse -0.031 0.061 0.619 0.001 0.060 0.990 0.030 0.057 0.596 0.011 0.054 0.840 0.003 0.052 0.947
  Town & Fringe – Less sparse 0.035 0.065 0.591 -0.047 0.062 0.446 -0.044 0.060 0.460 -0.015 0.057 0.787 -0.043 0.054 0.431
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.010 0.034 0.771 -0.009 0.027 0.726 0.011 0.023 0.633 -0.016 0.024 0.510 -0.023 0.024 0.338
Prevalence 0.005 0.043 0.910 -0.001 0.034 0.978 -0.019 0.027 0.473 0.020 0.027 0.448 -0.024 0.025 0.351
Country
  England -0.038 0.125 0.759 0.275 0.091 0.003 0.270 0.082 0.001 0.205 0.082 0.012 0.176 0.080 0.028
  Northern Ireland -0.187 0.244 0.444 0.225 0.201 0.263 0.326 0.184 0.076 0.156 0.188 0.407 0.071 0.173 0.680
  Scotland 0.148 0.236 0.530 0.212 0.200 0.288 0.282 0.185 0.126 0.165 0.188 0.381 0.033 0.161 0.835
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.140 0.030 <.001 -0.021 0.024 0.373 -0.015 0.022 0.498 -0.011 0.022 0.608 -0.009 0.022 0.693
Nurse Contact - any involvement
  Low -0.171 0.069 0.013 -0.103 0.056 0.066 -0.081 0.051 0.111 -0.058 0.053 0.279 0.013 0.052 0.808
  Medium -0.160 0.072 0.026 -0.031 0.058 0.589 -0.068 0.050 0.175 -0.051 0.053 0.329 0.037 0.050 0.461
  High 0.000 0.000 0.000 0.000 0.000
Hba1c ≤ 7% (previous year) 1.004 0.029 <.001 1.102 0.027 <.001 1.160 0.025 <.001 1.100 0.023 <.001 1.179 0.021 <.001
Random Variance
  Practice 0.493 0.023 0.387 0.019 0.353 0.017 0.389 0.018 0.383 0.017
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 63.809 <.001 104.228 <.001 157.475 <.001 129.680 <.001 135.772 <.001
Percent White (5df) 11.189 0.025 14.856 0.005 12.162 0.016 13.540 0.009 9.282 0.054
Urban-Rural Classification (5df) 4.855 0.434 2.704 0.746 3.829 0.574 1.098 0.954 1.987 0.851
Country (3df) 3.536 0.316 9.220 0.027 11.184 0.011 6.315 0.097 5.645 0.130
Nurse Contact - any involvement  (2df) 7.700 0.021 3.491 0.175 3.026 0.220 1.468 0.480 0.550 0.759
2003 2004 2005 2006 2007
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 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.23 Multilevel model (including whether previous years threshold was achieved), HbA1c ≤10%, nurse contact based on any involvement
1
, 2008-2011 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.117 0.104 1.131 0.101 1.177 0.097 1.045 0.098
Age
  linear 0.373 0.011 <.001 0.372 0.010 <.001 0.396 0.010 <.001 0.437 0.010 <.001
  quadratic -0.078 0.007 <.001 -0.091 0.006 <.001 -0.084 0.006 <.001 -0.075 0.006 <.001
Gender (Female) -0.156 0.017 <.001 -0.167 0.016 <.001 -0.155 0.016 <.001 -0.176 0.016 <.001
Charlson 0.010 0.008 0.221 -0.012 0.008 0.140 0.000 0.008 0.979 -0.030 0.008 <.001
Obesity 0.321 0.018 <.001 0.268 0.017 <.001 0.289 0.017 <.001 0.204 0.016 <.001
Townsend
  1st - lowest 0.201 0.105 0.055 0.294 0.094 0.002 0.306 0.090 0.001 0.262 0.083 0.002
  2nd 0.178 0.104 0.088 0.265 0.094 0.005 0.268 0.089 0.003 0.243 0.082 0.003
  3th 0.067 0.104 0.522 0.148 0.094 0.115 0.147 0.089 0.100 0.137 0.082 0.093
  4th -0.069 0.104 0.508 0.032 0.094 0.729 0.001 0.089 0.990 0.032 0.082 0.695
  5th - highest -0.120 0.104 0.250 -0.078 0.094 0.408 -0.053 0.089 0.554 -0.126 0.082 0.126
  Unknown 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.099 0.134 0.460 -0.264 0.124 0.033 -0.343 0.119 0.004 -0.083 0.112 0.457
  2nd -0.032 0.135 0.812 -0.170 0.124 0.171 -0.295 0.119 0.013 -0.088 0.112 0.435
  3th -0.036 0.134 0.789 -0.138 0.123 0.264 -0.277 0.118 0.019 -0.115 0.111 0.301
  4th -0.011 0.134 0.936 -0.142 0.123 0.249 -0.293 0.118 0.013 -0.073 0.111 0.514
  5th - highest 0.009 0.135 0.944 -0.121 0.124 0.329 -0.207 0.119 0.081 -0.043 0.112 0.699
  Unknown 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.230 0.232 0.323 -0.299 0.316 0.344 0.228 0.313 0.468 0.177 0.313 0.573
  Town & Fringe – Sparse 0.287 0.176 0.103 -0.044 0.168 0.791 0.327 0.167 0.050 0.316 0.168 0.060
  Village, Hamlet & Isolated dwellings – Sparse 0.080 0.160 0.619 -0.149 0.161 0.356 0.047 0.155 0.763 0.269 0.176 0.127
  Urban >10k  - Less sparse 0.020 0.049 0.687 0.078 0.048 0.103 0.187 0.047 <.001 0.046 0.047 0.332
  Town & Fringe – Less sparse -0.013 0.052 0.798 0.008 0.050 0.868 0.104 0.048 0.031 -0.043 0.049 0.380
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000
Practice List Size -0.021 0.022 0.359 -0.017 0.022 0.434 -0.029 0.020 0.156 -0.022 0.021 0.284
Prevalence 0.017 0.024 0.473 0.001 0.022 0.951 -0.008 0.020 0.677 -0.007 0.019 0.713
Country
  England 0.097 0.076 0.198 0.097 0.075 0.194 0.049 0.070 0.483 0.138 0.073 0.058
  Northern Ireland 0.015 0.174 0.930 0.098 0.165 0.556 -0.028 0.155 0.854 0.194 0.151 0.199
  Scotland 0.220 0.150 0.143 0.116 0.140 0.409 0.047 0.132 0.723 0.165 0.128 0.197
  Wales 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.003 0.017 0.839 -0.022 0.016 0.180 -0.016 0.018 0.370 -0.012 0.020 0.551
Nurse Contact - any involvement
  Low 0.063 0.049 0.194 0.016 0.048 0.740 -0.007 0.045 0.873 -0.040 0.046 0.381
  Medium 0.077 0.049 0.115 0.065 0.049 0.178 0.023 0.045 0.617 0.001 0.047 0.991
  High 0.000 0.000 0.000 0.000
Hba1c ≤ 7% (previous year) 1.164 0.020 <.001 1.148 0.019 <.001 1.206 0.019 <.001 1.226 0.019 <.001
Random Variance
  Practice 0.374 0.016 0.375 0.016 0.344 0.015 0.345 0.015
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p
Townsend (5df) 166.839 <.001 209.508 <.001 224.439 <.001 231.473 <.001
Percent White (5df) 5.944 0.203 12.594 0.013 9.227 0.056 3.246 0.518
Urban-Rural Classification (5df) 5.182 0.394 5.945 0.312 18.994 0.002 8.671 0.123
Country (3df) 5.066 0.167 1.743 0.627 1.019 0.797 3.843 0.279
Nurse Contact - any involvement  (2df) 2.936 0.230 1.888 0.389 0.427 0.808 0.929 0.629
2008 2009 2010 2011
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over  
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A3.24 Multilevel Model, Longitudinal Practice Cohort, HbA1c ≤ 7% (nurse contact based on any involvement), 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.852 0.236 -0.302 0.185 -0.597 0.179 0.166 0.001 -0.458 0.157
Age
  linear 0.525 0.016 <.001 0.490 0.014 <.001 0.533 0.013 <.001 0.536 0.012 <.001 0.541 0.012 <.001
  quadratic -0.117 0.013 <.001 -0.105 0.012 <.001 -0.092 0.011 <.001 -0.074 0.010 <.001 -0.098 0.010 <.001
Gender (Female) -0.127 0.024 <.001 -0.073 0.021 <.001 -0.068 0.020 0.001 -0.037 0.019 0.055 -0.039 0.018 0.033
Charlson -0.179 0.014 <.001 -0.173 0.012 <.001 -0.157 0.012 <.001 -0.184 0.011 <.001 -0.152 0.010 <.001
Obesity 0.149 0.026 <.001 0.068 0.023 0.003 0.064 0.022 0.003 0.022 0.020 0.267 -0.001 0.019 0.977
Townsend
  1st - lowest 0.346 0.280 0.217 0.120 0.204 0.555 0.212 0.190 0.265 -0.088 0.174 0.614 -0.055 0.167 0.740
  2nd 0.263 0.280 0.347 0.120 0.204 0.554 0.192 0.190 0.312 -0.164 0.174 0.347 -0.101 0.167 0.544
  3th 0.264 0.280 0.347 0.113 0.204 0.578 0.154 0.190 0.418 -0.167 0.174 0.338 -0.149 0.167 0.371
  4th 0.198 0.280 0.479 0.086 0.204 0.671 0.134 0.190 0.479 -0.234 0.174 0.178 -0.170 0.166 0.307
  5th - highest 0.210 0.281 0.453 0.083 0.204 0.683 0.115 0.190 0.546 -0.181 0.174 0.300 -0.180 0.167 0.281
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.186 0.321 0.563 -0.227 0.244 0.352 -0.062 0.230 0.786 0.254 0.212 0.230 0.051 0.201 0.799
  2nd -0.112 0.322 0.728 -0.179 0.244 0.463 -0.050 0.230 0.827 0.278 0.213 0.190 0.116 0.201 0.564
  3th -0.223 0.322 0.489 -0.274 0.244 0.262 -0.109 0.230 0.636 0.239 0.212 0.261 0.084 0.201 0.675
  4th -0.159 0.322 0.622 -0.243 0.245 0.322 -0.057 0.231 0.805 0.243 0.213 0.254 0.072 0.202 0.720
  5th - highest -0.138 0.323 0.669 -0.180 0.245 0.463 -0.089 0.231 0.701 0.272 0.213 0.202 0.111 0.202 0.584
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.069 0.368 0.851 0.203 0.313 0.516 0.039 0.299 0.897 -0.010 0.285 0.973 -0.088 0.275 0.750
  Town & Fringe – Sparse 0.057 0.319 0.859 0.033 0.269 0.903 -0.166 0.261 0.526 -0.498 0.250 0.046 0.087 0.232 0.707
  Village, Hamlet & Isolated dwellings – Sparse 0.141 0.276 0.610 0.114 0.237 0.632 -0.108 0.234 0.645 -0.076 0.220 0.728 -0.142 0.216 0.511
  Urban >10k  - Less sparse 0.110 0.066 0.092 0.034 0.058 0.558 0.085 0.055 0.124 -0.015 0.052 0.773 0.015 0.050 0.759
  Town & Fringe – Less sparse -0.015 0.066 0.815 -0.066 0.059 0.267 0.034 0.056 0.542 -0.066 0.054 0.215 -0.052 0.051 0.310
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.037 0.050 0.456 0.017 0.038 0.659 -0.013 0.036 0.730 0.018 0.035 0.613 -0.015 0.033 0.642
Prevalence 0.214 0.074 0.004 0.180 0.052 0.001 0.147 0.047 0.002 0.120 0.043 0.005 0.139 0.041 0.001
Country
  England 0.082 0.170 0.629 0.009 0.128 0.945 0.054 0.125 0.666 0.132 0.117 0.261 0.283 0.115 0.014
  Northern Ireland -0.091 0.452 0.841 -0.257 0.338 0.447 -0.100 0.324 0.757 0.637 0.299 0.033 0.551 0.290 0.057
  Scotland -0.403 0.439 0.359 -0.269 0.326 0.410 -0.032 0.308 0.918 0.421 0.286 0.141 0.310 0.280 0.269
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.152 0.056 0.007 -0.080 0.044 0.069 -0.005 0.042 0.902 -0.024 0.039 0.540 0.034 0.041 0.416
Nurse Contact - any involvement
  Low -0.020 0.114 0.862 -0.068 0.084 0.421 -0.119 0.085 0.164 -0.202 0.084 0.016 -0.098 0.078 0.212
  Medium -0.126 0.107 0.239 -0.168 0.081 0.038 -0.082 0.076 0.280 -0.168 0.070 0.017 -0.060 0.072 0.400
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.561 0.038 0.413 0.027 0.401 0.026 0.376 0.024 0.375 0.024
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 16.714 0.005 2.000 0.849 9.698 0.084 22.467 0.000 20.930 0.001
Percent White (5df) 7.213 0.125 7.532 0.110 2.795 0.593 1.684 0.794 4.183 0.382
Urban-Rural Classification (5df) 5.348 0.375 4.252 0.514 3.597 0.609 6.516 0.259 3.446 0.632
Country (3df) 1.686 0.640 0.994 0.803 0.449 0.930 4.682 0.197 7.243 0.065
Nurse Contact - any involvement  (2df) 1.638 0.441 4.338 0.114 2.229 0.328 7.979 0.019 1.708 0.426
20062002 2003 2004 2005
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.25 Multilevel Model, Longitudinal Practice Cohort, HbA1c ≤ 7% (nurse contact based on any involvement), 2007-20011/12 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept -0.422 0.158 -0.537 0.147 -0.480 0.146 -0.479 0.139 -0.467 0.136 -0.416 0.137
Age
  linear 0.578 0.012 <.001 0.593 0.012 <.001 0.582 0.011 <.001 0.580 0.011 <.001 0.592 0.011 <.001 0.564 0.011 <.001
  quadratic -0.093 0.010 <.001 -0.102 0.010 <.001 -0.097 0.009 <.001 -0.109 0.009 <.001 -0.118 0.009 <.001 -0.127 0.009 <.001
Gender (Female) -0.004 0.018 0.806 0.030 0.017 0.081 0.028 0.017 0.097 0.041 0.016 0.012 0.026 0.016 0.099 0.038 0.016 0.015
Charlson -0.120 0.009 <.001 -0.127 0.008 <.001 -0.139 0.008 <.001 -0.137 0.008 <.001 -0.157 0.008 <.001 -0.156 0.008 <.001
Obesity 0.005 0.018 0.782 0.022 0.018 0.226 -0.003 0.017 0.880 -0.003 0.017 0.878 -0.045 0.016 0.006 -0.106 0.016 <.001
Townsend
  1st - lowest 0.015 0.168 0.929 -0.015 0.162 0.927 0.007 0.149 0.961 0.255 0.147 0.083 0.142 0.142 0.319 0.163 0.139 0.242
  2nd -0.003 0.168 0.984 -0.053 0.162 0.742 -0.016 0.149 0.912 0.241 0.147 0.101 0.097 0.142 0.494 0.115 0.139 0.408
  3th -0.040 0.168 0.811 -0.056 0.162 0.730 -0.032 0.149 0.832 0.211 0.147 0.150 0.105 0.142 0.458 0.134 0.139 0.334
  4th -0.025 0.167 0.879 -0.090 0.162 0.576 -0.051 0.148 0.732 0.183 0.147 0.211 0.106 0.142 0.455 0.108 0.139 0.438
  5th - highest -0.090 0.168 0.590 -0.121 0.162 0.456 -0.106 0.149 0.477 0.156 0.147 0.288 0.027 0.142 0.848 0.074 0.139 0.595
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.126 0.197 0.523 0.063 0.189 0.739 -0.059 0.173 0.735 -0.257 0.169 0.128 -0.291 0.161 0.072 -0.357 0.158 0.024
  2nd -0.090 0.198 0.650 0.089 0.189 0.639 -0.005 0.173 0.977 -0.197 0.168 0.243 -0.210 0.161 0.193 -0.247 0.157 0.117
  3th -0.018 0.198 0.928 0.067 0.189 0.724 0.007 0.173 0.970 -0.201 0.168 0.232 -0.197 0.161 0.221 -0.272 0.157 0.084
  4th -0.068 0.198 0.730 0.078 0.189 0.679 -0.016 0.174 0.927 -0.203 0.169 0.230 -0.167 0.161 0.300 -0.228 0.158 0.148
  5th - highest -0.053 0.198 0.790 0.093 0.189 0.623 -0.014 0.174 0.936 -0.207 0.169 0.220 -0.146 0.162 0.365 -0.214 0.158 0.175
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.414 0.283 0.144 0.135 0.270 0.618 -0.340 0.275 0.217 -0.150 0.265 0.571 -0.366 0.263 0.164 0.156 0.257 0.544
  Town & Fringe – Sparse -0.242 0.240 0.312 -0.007 0.232 0.977 -0.052 0.236 0.825 0.179 0.227 0.430 -0.163 0.221 0.460 0.180 0.217 0.406
  Village, Hamlet & Isolated dwellings – Sparse -0.509 0.217 0.019 -0.170 0.206 0.410 -0.119 0.209 0.569 -0.056 0.201 0.779 -0.186 0.196 0.344 -0.022 0.193 0.909
  Urban >10k  - Less sparse 0.052 0.049 0.285 0.037 0.047 0.431 -0.019 0.046 0.680 0.044 0.045 0.323 0.117 0.044 0.007 0.114 0.043 0.008
  Town & Fringe – Less sparse -0.027 0.050 0.594 -0.020 0.048 0.684 -0.075 0.047 0.110 -0.006 0.046 0.898 -0.011 0.044 0.811 0.030 0.044 0.494
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.013 0.035 0.709 -0.045 0.033 0.178 -0.020 0.034 0.549 -0.044 0.031 0.161 -0.024 0.030 0.431 -0.012 0.031 0.702
Prevalence 0.096 0.043 0.027 0.076 0.040 0.055 0.040 0.040 0.319 0.029 0.037 0.426 0.056 0.034 0.101 0.064 0.034 0.061
Country
  England 0.254 0.126 0.043 0.157 0.120 0.189 0.275 0.125 0.028 0.147 0.117 0.211 0.144 0.115 0.210 0.110 0.117 0.347
  Northern Ireland 0.501 0.300 0.094 0.380 0.287 0.185 0.318 0.284 0.262 0.178 0.273 0.514 0.272 0.265 0.304 0.100 0.265 0.707
  Scotland 0.052 0.290 0.858 0.195 0.274 0.475 0.087 0.269 0.748 -0.213 0.259 0.412 -0.069 0.251 0.784 -0.035 0.252 0.889
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional 0.104 0.045 0.022 0.116 0.042 0.006 0.100 0.050 0.045 0.039 0.031 0.216 0.123 0.039 0.002 0.075 0.036 0.036
Nurse Contact - any involvement
  Low -0.141 0.085 0.096 0.009 0.080 0.912 -0.041 0.085 0.632 -0.086 0.080 0.279 0.006 0.078 0.944 0.034 0.079 0.670
  Medium 0.021 0.078 0.789 0.133 0.074 0.073 0.125 0.076 0.101 0.034 0.073 0.648 0.018 0.072 0.807 -0.011 0.073 0.876
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.409 0.026 0.392 0.024 0.412 0.025 0.396 0.025 0.384 0.024 0.394 0.024
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 11.030 0.051 12.222 0.032 13.298 0.021 15.264 0.009 15.139 0.010 10.881 0.054
Percent White (5df) 6.361 0.174 1.048 0.902 3.108 0.540 3.362 0.499 10.263 0.036 14.498 0.006
Urban-Rural Classification (5df) 9.657 0.086 3.622 0.605 4.524 0.477 3.618 0.606 15.870 0.007 9.364 0.095
Country (3df) 6.418 0.093 2.540 0.468 5.449 0.142 4.513 0.211 3.313 0.346 1.304 0.728
Nurse Contact - any involvement  (2df) 3.676 0.159 3.657 0.161 4.190 0.123 2.168 0.338 0.061 0.970 0.311 0.856
2011/122007 2008 2009 2010 2011
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 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.26 Multilevel Model, Longitudinal Practice Cohort, HbA1c ≤ 10% (nurse contact based on any involvement), 2002-2006 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 0.735 0.329 1.565 0.224 1.395 0.206 1.511 0.200 1.589 0.196
Age
  linear 0.427 0.015 <.001 0.440 0.016 <.001 0.478 0.016 <.001 0.493 0.016 <.001 0.476 0.015 <.001
  quadratic -0.144 0.011 <.001 -0.091 0.010 <.001 -0.057 0.010 <.001 -0.052 0.010 <.001 -0.066 0.010 <.001
Gender (Female) -0.160 0.026 <.001 -0.122 0.025 <.001 -0.176 0.026 <.001 -0.145 0.026 <.001 -0.159 0.025 <.001
Charlson -0.068 0.015 <.001 -0.071 0.015 <.001 -0.037 0.015 0.015 -0.056 0.015 <.001 -0.055 0.013 <.001
Obesity 0.490 0.030 <.001 0.445 0.029 <.001 0.371 0.029 <.001 0.351 0.027 <.001 0.365 0.026 <.001
Townsend
  1st - lowest 0.473 0.246 0.054 0.173 0.204 0.396 -0.066 0.249 0.791 0.230 0.233 0.325 0.225 0.224 0.315
  2nd 0.426 0.246 0.083 0.154 0.204 0.451 -0.101 0.249 0.684 0.154 0.233 0.507 0.200 0.223 0.370
  3th 0.334 0.245 0.173 0.049 0.203 0.810 -0.237 0.248 0.341 0.005 0.232 0.984 0.059 0.223 0.793
  4th 0.268 0.245 0.274 -0.027 0.203 0.893 -0.293 0.248 0.237 -0.080 0.232 0.731 -0.019 0.223 0.934
  5th - highest 0.201 0.246 0.413 -0.062 0.204 0.761 -0.439 0.248 0.077 -0.112 0.232 0.629 -0.127 0.223 0.569
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.197 0.291 0.499 -0.191 0.255 0.454 0.289 0.291 0.321 -0.242 0.277 0.382 -0.251 0.267 0.346
  2nd -0.132 0.292 0.651 -0.135 0.256 0.598 0.363 0.292 0.215 -0.155 0.278 0.578 -0.124 0.268 0.642
  3th -0.168 0.292 0.565 -0.137 0.256 0.592 0.347 0.292 0.235 -0.134 0.278 0.630 -0.178 0.267 0.506
  4th -0.158 0.293 0.590 -0.144 0.257 0.574 0.366 0.292 0.211 -0.062 0.278 0.823 -0.195 0.268 0.467
  5th - highest -0.173 0.294 0.555 -0.002 0.258 0.995 0.521 0.293 0.075 0.011 0.279 0.970 0.009 0.268 0.974
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.732 0.464 0.115 0.197 0.397 0.619 0.241 0.383 0.530 0.346 0.388 0.372 0.224 0.395 0.571
  Town & Fringe – Sparse 0.641 0.390 0.100 0.005 0.332 0.989 0.005 0.350 0.989 -0.389 0.325 0.230 0.239 0.354 0.499
  Village, Hamlet & Isolated dwellings – Sparse 0.244 0.359 0.497 -0.114 0.311 0.714 -0.300 0.291 0.302 0.367 0.333 0.272 -0.080 0.301 0.791
  Urban >10k  - Less sparse 0.089 0.072 0.219 0.030 0.072 0.672 0.118 0.073 0.106 0.134 0.071 0.059 0.049 0.069 0.477
  Town & Fringe – Less sparse 0.077 0.074 0.299 0.046 0.076 0.544 0.022 0.078 0.774 -0.025 0.075 0.742 -0.023 0.072 0.746
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.069 0.080 0.389 0.048 0.048 0.312 -0.021 0.043 0.615 0.015 0.042 0.725 0.008 0.041 0.843
Prevalence 0.047 0.117 0.688 0.022 0.065 0.731 0.018 0.055 0.745 -0.020 0.051 0.693 0.044 0.051 0.378
Country
  England 0.190 0.270 0.482 -0.021 0.162 0.897 0.126 0.145 0.385 0.215 0.140 0.124 0.216 0.142 0.127
  Northern Ireland -0.287 0.582 0.623 -0.457 0.389 0.240 0.393 0.390 0.313 0.261 0.373 0.484 0.008 0.368 0.983
  Scotland -0.756 0.565 0.181 -0.546 0.374 0.144 0.628 0.376 0.095 0.006 0.357 0.988 -0.087 0.357 0.808
  Wales 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional -0.268 0.088 0.003 -0.083 0.055 0.133 -0.036 0.049 0.462 0.016 0.047 0.732 0.032 0.051 0.534
Nurse Contact - any involvement
  Low -0.079 0.182 0.664 -0.137 0.107 0.199 -0.163 0.099 0.100 -0.121 0.100 0.228 -0.083 0.097 0.388
  Medium -0.224 0.172 0.192 -0.212 0.103 0.039 -0.169 0.089 0.056 -0.063 0.085 0.460 -0.047 0.089 0.596
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.925 0.056 0.528 0.034 0.459 0.031 0.443 0.030 0.458 0.030
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 44.214 <.001 39.875 <.001 74.059 <.001 79.307 <.001 80.189 <.001
Percent White (5df) 1.732 0.785 7.839 0.098 10.952 0.027 11.715 0.020 20.589 <.001
Urban-Rural Classification (5df) 5.255 0.386 1.124 0.952 6.478 0.262 12.679 0.027 2.551 0.769
Country (3df) 3.923 0.270 2.687 0.442 2.910 0.406 2.994 0.393 2.990 0.393
Nurse Contact - any involvement  (2df) 1.776 0.412 4.446 0.108 4.466 0.107 1.499 0.473 0.789 0.674
20062002 2003 2004 2005
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A3.27 Multilevel Model, Longitudinal Practice Cohort, HbA1c ≤ 10% (nurse contact based on any involvement), 2007-20011/12 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intercept 1.544 0.191 1.315 0.178 1.458 0.173 1.453 0.164 1.392 0.166 1.538 0.165
Age
  linear 0.479 0.015 <.001 0.475 0.015 <.001 0.470 0.014 <.001 0.512 0.014 <.001 0.535 0.013 <.001 0.485 0.013 <.001
  quadratic -0.073 0.009 <.001 -0.069 0.009 <.001 -0.093 0.009 <.001 -0.081 0.009 <.001 -0.097 0.008 <.001 -0.130 0.008 <.001
Gender (Female) -0.164 0.024 <.001 -0.152 0.023 <.001 -0.182 0.022 <.001 -0.154 0.021 <.001 -0.152 0.021 <.001 -0.148 0.020 <.001
Charlson -0.014 0.012 0.241 -0.023 0.011 0.046 -0.040 0.011 <.001 -0.029 0.011 0.006 -0.057 0.010 <.001 -0.060 0.010 <.001
Obesity 0.314 0.025 <.001 0.350 0.024 <.001 0.296 0.023 <.001 0.319 0.022 <.001 0.201 0.021 <.001 0.040 0.021 0.057
Townsend
  1st - lowest 0.402 0.217 0.064 0.075 0.209 0.719 0.139 0.190 0.462 0.210 0.177 0.236 0.271 0.168 0.106 0.494 0.157 0.002
  2nd 0.353 0.217 0.104 0.067 0.209 0.749 0.120 0.189 0.526 0.143 0.177 0.420 0.254 0.167 0.129 0.434 0.157 0.006
  3th 0.265 0.217 0.221 -0.041 0.209 0.844 -0.010 0.189 0.958 0.032 0.177 0.856 0.187 0.167 0.263 0.339 0.156 0.030
  4th 0.146 0.216 0.500 -0.216 0.209 0.301 -0.149 0.189 0.430 -0.149 0.177 0.397 0.032 0.167 0.850 0.180 0.156 0.249
  5th - highest 0.050 0.216 0.819 -0.210 0.209 0.315 -0.196 0.189 0.301 -0.209 0.177 0.238 -0.102 0.167 0.542 0.135 0.156 0.388
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.370 0.254 0.146 0.077 0.242 0.751 -0.136 0.221 0.537 -0.145 0.205 0.479 -0.271 0.193 0.160 -0.542 0.181 0.003
  2nd -0.314 0.255 0.218 0.154 0.242 0.526 -0.026 0.221 0.905 -0.075 0.205 0.716 -0.202 0.193 0.294 -0.483 0.181 0.008
  3th -0.269 0.254 0.291 0.187 0.242 0.439 0.012 0.220 0.956 -0.020 0.204 0.921 -0.155 0.192 0.421 -0.451 0.180 0.012
  4th -0.224 0.255 0.380 0.249 0.243 0.304 0.018 0.221 0.937 -0.079 0.205 0.699 -0.158 0.193 0.413 -0.402 0.181 0.026
  5th - highest -0.226 0.256 0.376 0.264 0.243 0.276 0.025 0.221 0.909 -0.035 0.205 0.866 -0.146 0.193 0.451 -0.421 0.181 0.020
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.022 0.366 0.952 0.233 0.364 0.522 -0.196 0.357 0.583 0.292 0.359 0.415 0.521 0.357 0.144 0.596 0.342 0.081
  Town & Fringe – Sparse -0.089 0.333 0.789 0.004 0.338 0.991 -0.154 0.322 0.632 0.241 0.319 0.450 0.358 0.314 0.254 -0.074 0.281 0.793
  Village, Hamlet & Isolated dwellings – Sparse -0.293 0.277 0.291 -0.146 0.275 0.596 -0.135 0.283 0.634 0.338 0.285 0.235 0.578 0.302 0.056 0.221 0.256 0.386
  Urban >10k  - Less sparse 0.091 0.066 0.169 0.018 0.064 0.778 0.087 0.063 0.165 0.168 0.059 0.005 0.121 0.058 0.036 0.200 0.055 0.000
  Town & Fringe – Less sparse 0.042 0.069 0.549 -0.091 0.066 0.172 -0.017 0.065 0.793 0.065 0.062 0.294 -0.027 0.060 0.653 0.138 0.058 0.017
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.020 0.042 0.628 -0.026 0.040 0.520 -0.029 0.039 0.465 -0.050 0.037 0.179 -0.017 0.037 0.651 0.007 0.038 0.859
Prevalence -0.023 0.052 0.655 -0.012 0.048 0.807 -0.044 0.046 0.345 -0.051 0.043 0.240 -0.047 0.042 0.255 -0.023 0.042 0.581
Country
  England 0.105 0.148 0.481 0.179 0.144 0.212 0.149 0.145 0.305 0.084 0.137 0.543 0.197 0.140 0.158 0.147 0.141 0.297
  Northern Ireland 0.295 0.370 0.425 0.355 0.352 0.313 0.190 0.340 0.575 0.314 0.325 0.334 0.413 0.321 0.198 0.085 0.315 0.788
  Scotland -0.128 0.356 0.719 0.158 0.337 0.639 -0.009 0.322 0.978 -0.029 0.306 0.925 -0.094 0.301 0.755 -0.132 0.298 0.657
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Consultations per healthcare professional 0.031 0.054 0.568 0.048 0.051 0.352 0.033 0.058 0.577 -0.008 0.037 0.826 0.072 0.047 0.128 0.002 0.043 0.969
Nurse Contact - any involvement
  Low -0.017 0.101 0.866 0.077 0.096 0.421 0.076 0.099 0.441 -0.018 0.094 0.849 0.045 0.095 0.639 0.017 0.096 0.856
  Medium 0.033 0.092 0.722 0.155 0.089 0.083 0.187 0.089 0.036 0.116 0.087 0.182 0.158 0.088 0.073 -0.027 0.089 0.758
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.477 0.031 0.464 0.030 0.471 0.030 0.459 0.029 0.464 0.029 0.474 0.030
Global Tests (degrees of Freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend (5df) 84.024 <.001 94.245 <.001 108.936 <.001 163.638 <.001 128.974 <.001 138.024 <.001
Percent White (5df) 5.261 0.262 8.591 0.072 9.035 0.060 6.296 0.178 5.567 0.234 5.957 0.202
Urban-Rural Classification (5df) 3.942 0.558 5.250 0.386 4.814 0.439 9.548 0.089 12.839 0.025 16.346 0.006
Country (3df) 2.015 0.569 1.990 0.575 1.423 0.700 1.635 0.652 4.513 0.211 2.116 0.549
Nurse Contact - any involvement  (2df) 0.232 0.890 3.022 0.221 4.418 0.110 2.457 0.293 3.311 0.191 0.207 0.902
2011/122007 2008 2009 2010 2011
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.28 Multilevel model, HbA1c ≤7% - effect of diabetic review 2002 – 2006
1
 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intecept -0.847 0.190 -0.500 0.122 -0.622 0.109 -0.673 0.099 -0.453 0.095
Age
  linear 0.510 0.014 <.001 0.495 0.010 <.001 0.524 0.010 <.001 0.528 0.009 <.001 0.530 0.008 <.001
  quadratic -0.109 0.012 <.001 -0.094 0.008 <.001 -0.096 0.008 <.001 -0.084 0.007 <.001 -0.104 0.007 <.001
Gender (Female) -0.118 0.021 <.001 -0.089 0.016 <.001 -0.066 0.015 <.001 -0.017 0.014 0.202 -0.012 0.013 0.365
Charlson -0.177 0.012 <.001 -0.167 0.009 <.001 -0.162 0.009 <.001 -0.179 0.008 <.001 -0.147 0.007 <.001
Obesity 0.123 0.023 <.001 0.069 0.017 <.001 0.044 0.016 0.005 0.011 0.014 0.436 0.001 0.013 0.951
Townsend
  1st - lowest 0.241 0.242 0.318 0.131 0.117 0.264 0.133 0.108 0.219 0.114 0.101 0.257 0.065 0.096 0.498
  2nd 0.165 0.241 0.495 0.093 0.117 0.425 0.105 0.108 0.332 0.051 0.101 0.613 0.028 0.096 0.768
  3th 0.154 0.241 0.523 0.064 0.117 0.581 0.055 0.108 0.610 0.052 0.100 0.604 0.002 0.096 0.987
  4th 0.083 0.241 0.731 0.043 0.117 0.713 0.047 0.108 0.663 -0.003 0.100 0.975 -0.051 0.096 0.596
  5th - highest 0.101 0.242 0.678 0.034 0.117 0.772 0.014 0.108 0.898 0.001 0.101 0.991 -0.048 0.096 0.617
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.268 0.266 0.314 -0.148 0.141 0.295 0.000 0.132 0.997 0.071 0.123 0.564 0.008 0.118 0.948
  2nd -0.191 0.265 0.471 -0.128 0.141 0.364 0.021 0.132 0.872 0.101 0.123 0.410 0.036 0.118 0.758
  3th -0.300 0.265 0.258 -0.184 0.141 0.191 -0.013 0.132 0.924 0.063 0.123 0.608 0.009 0.118 0.938
  4th -0.244 0.266 0.358 -0.184 0.141 0.192 0.020 0.132 0.881 0.049 0.123 0.692 0.007 0.118 0.953
  5th - highest -0.202 0.266 0.447 -0.141 0.141 0.319 -0.007 0.132 0.958 0.073 0.123 0.556 0.021 0.118 0.862
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.024 0.258 0.926 -0.069 0.216 0.748 -0.046 0.203 0.822 -0.202 0.193 0.295 0.165 0.184 0.371
  Town & Fringe – Sparse 0.111 0.266 0.677 0.075 0.195 0.700 -0.118 0.157 0.452 -0.354 0.150 0.018 0.205 0.122 0.094
  Village, Hamlet & Isolated dwellings – Sparse 0.080 0.200 0.691 -0.152 0.153 0.322 -0.043 0.133 0.750 -0.269 0.127 0.034 -0.002 0.117 0.987
  Urban >10k  - Less sparse 0.097 0.058 0.092 0.037 0.045 0.406 0.033 0.043 0.434 -0.004 0.039 0.912 0.047 0.037 0.205
  Town & Fringe – Less sparse -0.025 0.059 0.675 -0.027 0.045 0.552 -0.014 0.042 0.739 -0.039 0.040 0.330 0.003 0.038 0.938
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.023 0.039 0.563 -0.049 0.027 0.068 -0.029 0.025 0.257 -0.032 0.022 0.144 -0.038 0.021 0.074
Prevalence 0.161 0.061 0.008 0.129 0.034 0.000 0.111 0.031 <.001 0.080 0.025 0.001 0.080 0.023 0.001
Country
  England 0.113 0.150 0.453 -0.003 0.096 0.972 0.062 0.084 0.463 0.127 0.076 0.096 0.163 0.072 0.024
  Northern Ireland -0.130 0.378 0.731 -0.232 0.186 0.213 -0.048 0.172 0.781 0.319 0.156 0.041 0.334 0.151 0.026
  Scotland -0.358 0.384 0.351 -0.030 0.180 0.868 0.108 0.166 0.514 0.128 0.153 0.405 0.104 0.147 0.478
  Wales 0.000 0.000 0.000 0.000 0.000
Reviews with a healthcare professional 0.131 0.034 <.001 0.082 0.023 <.001 0.038 0.021 0.064 0.040 0.018 0.029 0.006 0.019 0.760
% Practice nurse reviews
  Low 0.139 0.087 0.113 -0.026 0.055 0.640 -0.046 0.054 0.393 -0.077 0.050 0.118 -0.133 0.049 0.006
  Medium 0.029 0.086 0.732 0.062 0.055 0.262 0.031 0.052 0.551 0.001 0.046 0.989 -0.090 0.045 0.044
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.501 0.029 0.389 0.018 0.379 0.017 0.356 0.015 0.360 0.015
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p
Townsend(5df) 23.567 <.001 14.994 0.010 23.611 0.000 31.610 <.001 36.725 <.001
Percent White(5df) 10.010 0.040 4.372 0.358 2.171 0.704 3.421 0.490 1.952 0.745
Urban-Rural Classification(5df) 6.238 0.284 4.364 0.498 2.337 0.801 7.504 0.186 6.582 0.254
Country(3df) 2.322 0.508 2.892 0.409 2.034 0.565 6.095 0.107 9.411 0.024
% Practice nurse reviews(2df) 2.729 0.256 2.481 0.289 1.982 0.371 3.028 0.220 8.593 0.014
2002 2003 2004 2005 2006
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.29 Multilevel model, HbA1c ≤7% - effect of diabetic review 2007 – 20011/12
1
 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intecept -0.489 0.094 -0.369 0.087 -0.387 0.086 -0.358 0.082 -0.333 0.084 -0.352 0.083
Age
  linear 0.583 0.008 <.001 0.591 0.008 <.001 0.593 0.008 <.001 0.595 0.008 <.001 0.596 0.007 <.001 0.570 0.008 <.001
  quadratic -0.094 0.007 <.001 -0.109 0.006 <.001 -0.107 0.006 <.001 -0.123 0.006 <.001 -0.111 0.006 <.001 -0.122 0.006 <.001
Gender (Female) 0.001 0.012 0.953 0.026 0.012 0.024 0.042 0.011 <.001 0.052 0.011 <.001 0.030 0.011 0.008 0.053 0.011 <.001
Charlson -0.120 0.006 <.001 -0.125 0.006 <.001 -0.131 0.005 <.001 -0.141 0.005 <.001 -0.153 0.005 <.001 -0.149 0.005 <.001
Obesity -0.001 0.013 0.952 0.002 0.012 0.854 -0.004 0.012 0.738 -0.010 0.011 0.368 -0.049 0.011 <.001 -0.119 0.011 <.001
Townsend
  1st - lowest 0.051 0.080 0.529 -0.021 0.073 0.771 -0.014 0.067 0.829 0.104 0.064 0.105 0.108 0.061 0.076 0.119 0.061 0.051
  2nd 0.020 0.080 0.801 -0.079 0.072 0.275 -0.060 0.066 0.364 0.084 0.064 0.190 0.079 0.060 0.191 0.094 0.060 0.120
  3th -0.009 0.080 0.913 -0.081 0.072 0.261 -0.089 0.066 0.178 0.043 0.064 0.500 0.070 0.060 0.249 0.090 0.060 0.136
  4th -0.020 0.080 0.807 -0.109 0.072 0.133 -0.106 0.066 0.111 0.012 0.064 0.851 0.054 0.060 0.370 0.069 0.060 0.250
  5th - highest -0.064 0.080 0.427 -0.128 0.072 0.078 -0.141 0.067 0.034 0.003 0.064 0.962 -0.004 0.061 0.954 0.034 0.061 0.570
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.060 0.103 0.558 0.037 0.095 0.699 -0.026 0.089 0.773 -0.202 0.086 0.019 -0.250 0.082 0.002 -0.243 0.082 0.003
  2nd -0.026 0.103 0.798 0.033 0.095 0.727 -0.010 0.089 0.910 -0.157 0.086 0.069 -0.194 0.083 0.019 -0.166 0.082 0.043
  3th -0.007 0.103 0.944 0.041 0.095 0.662 0.016 0.089 0.854 -0.153 0.086 0.074 -0.207 0.082 0.012 -0.186 0.081 0.022
  4th -0.021 0.103 0.838 0.040 0.095 0.672 -0.018 0.089 0.838 -0.152 0.086 0.078 -0.173 0.082 0.035 -0.168 0.082 0.040
  5th - highest -0.018 0.103 0.860 0.047 0.095 0.623 0.010 0.089 0.912 -0.154 0.086 0.075 -0.179 0.082 0.030 -0.167 0.082 0.041
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.201 0.182 0.271 0.216 0.177 0.222 -0.261 0.239 0.275 -0.186 0.230 0.419 -0.317 0.235 0.177 0.052 0.226 0.818
  Town & Fringe – Sparse 0.078 0.121 0.518 0.086 0.119 0.467 0.138 0.122 0.256 -0.014 0.118 0.904 0.000 0.119 0.999 0.065 0.118 0.582
  Village, Hamlet & Isolated dwellings – Sparse 0.130 0.113 0.249 0.149 0.110 0.175 0.075 0.114 0.512 -0.009 0.111 0.936 -0.060 0.124 0.632 -0.028 0.123 0.819
  Urban >10k  - Less sparse 0.065 0.036 0.071 0.070 0.035 0.043 0.035 0.034 0.310 0.102 0.034 0.003 0.121 0.034 0.000 0.118 0.034 0.001
  Town & Fringe – Less sparse 0.055 0.037 0.135 0.048 0.035 0.175 0.030 0.034 0.376 0.067 0.034 0.049 0.037 0.034 0.281 0.030 0.035 0.387
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.046 0.023 0.043 -0.045 0.021 0.030 -0.035 0.021 0.098 -0.047 0.019 0.014 -0.037 0.019 0.051 -0.031 0.019 0.110
Prevalence 0.056 0.024 0.016 0.071 0.021 0.001 0.047 0.021 0.024 0.043 0.019 0.023 0.047 0.018 0.008 0.045 0.018 0.009
Country
  England 0.164 0.075 0.029 0.082 0.069 0.235 0.190 0.071 0.008 0.134 0.065 0.040 0.096 0.068 0.157 0.081 0.067 0.225
  Northern Ireland 0.309 0.146 0.035 0.083 0.145 0.566 0.236 0.140 0.093 0.064 0.131 0.627 -0.013 0.130 0.920 -0.103 0.128 0.422
  Scotland 0.181 0.133 0.173 0.130 0.118 0.271 0.136 0.115 0.234 -0.051 0.108 0.634 -0.070 0.106 0.509 -0.100 0.105 0.341
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Reviews with a healthcare professional -0.021 0.020 0.285 -0.002 0.019 0.904 0.001 0.019 0.966 -0.009 0.019 0.617 -0.004 0.019 0.823 -0.004 0.020 0.842
% Practice nurse reviews
  Low -0.083 0.050 0.097 -0.042 0.047 0.362 -0.054 0.047 0.242 -0.005 0.044 0.901 -0.033 0.047 0.477 -0.041 0.046 0.375
  Medium -0.001 0.047 0.979 -0.032 0.044 0.462 -0.030 0.045 0.513 -0.056 0.042 0.180 -0.063 0.041 0.121 -0.072 0.040 0.073
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.383 0.015 0.365 0.014 0.378 0.015 0.347 0.014 0.342 0.014 0.336 0.014
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend(5df) 26.439 <.001 30.497 <.001 42.380 <.001 36.615 <.001 29.281 <.001 18.452 0.002
Percent White(5df) 2.841 0.585 0.183 0.996 3.329 0.504 3.952 0.413 7.596 0.108 10.792 0.029
Urban-Rural Classification(5df) 4.468 0.484 5.506 0.357 4.407 0.493 10.395 0.065 17.579 0.004 15.059 0.010
Country(3df) 6.515 0.089 1.824 0.610 7.999 0.046 8.515 0.037 5.471 0.140 6.006 0.111
% Practice nurse reviews(2df) 3.174 0.205 1.014 0.602 1.413 0.493 1.917 0.383 2.459 0.292 3.307 0.191
2011/20122007 2008 2009 2010 2011
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.30 Multilevel model, HbA1c ≤10% - effect of diabetic review 2002 – 2006
1
  
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intecept 0.775 0.275 1.175 0.151 1.381 0.124 1.366 0.111 1.550 0.113
Age
  linear 0.411 0.013 <.001 0.404 0.011 <.001 0.437 0.012 <.001 0.471 0.011 <.001 0.466 0.011 <.001
  quadratic -0.134 0.010 <.001 -0.095 0.008 <.001 -0.067 0.007 <.001 -0.070 0.007 <.001 -0.081 0.007 <.001
Gender (Female) -0.154 0.022 <.001 -0.110 0.019 <.001 -0.163 0.019 <.001 -0.148 0.018 <.001 -0.168 0.017 <.001
Charlson -0.070 0.013 <.001 -0.070 0.011 <.001 -0.035 0.011 0.002 -0.074 0.010 <.001 -0.064 0.009 <.001
Obesity 0.468 0.026 <.001 0.425 0.021 <.001 0.360 0.021 <.001 0.349 0.019 <.001 0.354 0.018 <.001
Townsend
  1st - lowest 0.482 0.227 0.034 0.202 0.130 0.121 0.270 0.134 0.044 0.390 0.125 0.002 0.218 0.125 0.081
  2nd 0.413 0.226 0.068 0.171 0.130 0.188 0.226 0.134 0.090 0.325 0.125 0.009 0.188 0.124 0.130
  3th 0.339 0.226 0.134 0.064 0.130 0.621 0.123 0.133 0.355 0.190 0.125 0.127 0.093 0.124 0.453
  4th 0.274 0.226 0.225 -0.015 0.129 0.906 0.042 0.133 0.752 0.102 0.124 0.410 -0.012 0.124 0.920
  5th - highest 0.221 0.227 0.330 -0.065 0.130 0.613 -0.096 0.133 0.469 -0.005 0.125 0.969 -0.112 0.124 0.368
  Unknown 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.462 0.257 0.072 -0.127 0.159 0.424 -0.216 0.162 0.184 -0.286 0.153 0.061 -0.180 0.152 0.238
  2nd -0.386 0.256 0.131 -0.065 0.159 0.685 -0.114 0.162 0.483 -0.198 0.153 0.194 -0.105 0.152 0.491
  3th -0.421 0.256 0.100 -0.093 0.159 0.558 -0.141 0.162 0.384 -0.182 0.152 0.233 -0.127 0.152 0.404
  4th -0.425 0.257 0.098 -0.079 0.159 0.622 -0.114 0.162 0.481 -0.170 0.152 0.264 -0.122 0.152 0.422
  5th - highest -0.413 0.257 0.108 0.043 0.160 0.790 -0.013 0.163 0.937 -0.095 0.153 0.535 -0.022 0.153 0.887
  Unknown 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse 0.539 0.306 0.078 0.150 0.267 0.574 0.154 0.248 0.534 -0.136 0.236 0.564 -0.124 0.246 0.615
  Town & Fringe – Sparse 0.682 0.325 0.036 0.120 0.253 0.634 -0.035 0.202 0.862 -0.197 0.190 0.300 0.047 0.174 0.787
  Village, Hamlet & Isolated dwellings – Sparse0.058 0.214 0.785 -0.161 0.189 0.396 -0.121 0.161 0.453 -0.022 0.159 0.891 -0.122 0.152 0.421
  Urban >10k  - Less sparse 0.074 0.063 0.237 -0.001 0.054 0.989 0.030 0.055 0.584 0.056 0.052 0.282 0.012 0.050 0.811
  Town & Fringe – Less sparse 0.048 0.066 0.469 0.058 0.057 0.307 -0.039 0.057 0.489 -0.044 0.055 0.420 -0.019 0.053 0.718
  Village, Hamlet & Isolated dwelling – Less sparse0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000
Practice List Size 0.029 0.061 0.640 -0.053 0.034 0.119 -0.031 0.029 0.279 -0.020 0.024 0.421 -0.037 0.024 0.135
Prevalence 0.046 0.094 0.624 0.019 0.042 0.654 0.016 0.034 0.651 -0.010 0.027 0.726 0.037 0.027 0.170
Country
  England 0.301 0.233 0.196 0.125 0.122 0.306 0.257 0.094 0.006 0.265 0.082 0.001 0.199 0.082 0.015
  Northern Ireland -0.290 0.490 0.554 0.004 0.224 0.986 0.206 0.199 0.301 0.199 0.179 0.266 0.226 0.182 0.214
  Scotland -0.725 0.507 0.153 0.312 0.216 0.148 0.281 0.196 0.150 0.189 0.178 0.289 0.153 0.179 0.394
  Wales 0.000 0.000 0.000 0.000 0.000
Reviews with a healthcare professional 0.268 0.053 <.001 0.183 0.029 <.001 0.081 0.024 0.001 0.071 0.020 <.001 0.073 0.022 0.001
% Practice nurse reviews
  Low 0.110 0.136 0.419 0.029 0.070 0.677 0.006 0.061 0.922 0.058 0.054 0.288 0.008 0.056 0.890
  Medium -0.040 0.134 0.765 0.075 0.071 0.285 -0.021 0.058 0.724 0.006 0.050 0.911 0.008 0.051 0.877
  High 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.809 0.043 0.497 0.022 0.416 0.019 0.372 0.017 0.398 0.017
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p
Townsend(5df) 51.506 <.001 84.721 <.001 128.436 <.001 182.116 <.001 144.373 <.001
Percent White(5df) 2.764 0.598 12.021 0.017 15.540 0.004 14.031 0.007 12.667 0.013
Urban-Rural Classification(5df) 8.105 0.151 4.216 0.519 3.578 0.612 6.756 0.239 1.701 0.889
Country(3df) 7.177 0.067 4.412 0.220 7.830 0.050 10.537 0.015 6.187 0.103
% Practice nurse reviews(2df) 1.255 0.534 1.149 0.563 0.213 0.899 1.285 0.526 0.031 0.984
2002 2003 2004 2005 2006
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
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A3.31 Multilevel model, HbA1c ≤10% - effect of diabetic review 2007 – 2011/12
1
 
β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t β SE(β) prob<t
Intecept 1.444 0.106 1.459 0.099 1.477 0.097 1.483 0.093 1.415 0.095 1.431 0.095
Age
  linear 0.484 0.010 <.001 0.480 0.010 <.001 0.484 0.010 <.001 0.510 0.009 <.001 0.547 0.009 <.001 0.500 0.009 <.001
  quadratic -0.076 0.006 <.001 -0.075 0.006 <.001 -0.089 0.006 <.001 -0.085 0.006 <.001 -0.082 0.006 <.001 -0.116 0.006 <.001
Gender (Female) -0.155 0.016 <.001 -0.148 0.016 <.001 -0.155 0.015 <.001 -0.142 0.015 <.001 -0.153 0.014 <.001 -0.131 0.014 <.001
Charlson -0.018 0.008 0.034 -0.026 0.008 0.001 -0.048 0.007 <.001 -0.039 0.007 <.001 -0.069 0.007 <.001 -0.071 0.007 <.001
Obesity 0.308 0.017 <.001 0.339 0.016 <.001 0.286 0.016 <.001 0.292 0.015 <.001 0.207 0.015 <.001 0.040 0.015 0.007
Townsend
  1st - lowest 0.376 0.102 <.001 0.237 0.095 0.013 0.238 0.087 0.006 0.315 0.082 <.001 0.265 0.075 <.001 0.273 0.073 <.001
  2nd 0.300 0.101 0.003 0.206 0.095 0.030 0.189 0.087 0.030 0.267 0.081 0.001 0.235 0.075 0.002 0.225 0.073 0.002
  3th 0.242 0.101 0.017 0.110 0.094 0.243 0.077 0.086 0.373 0.136 0.081 0.093 0.132 0.074 0.077 0.108 0.072 0.134
  4th 0.137 0.101 0.173 -0.025 0.094 0.789 -0.033 0.086 0.704 0.015 0.081 0.856 0.013 0.074 0.864 0.008 0.072 0.913
  5th - highest 0.010 0.101 0.923 -0.077 0.094 0.416 -0.133 0.086 0.124 -0.050 0.081 0.540 -0.132 0.074 0.077 -0.063 0.072 0.387
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Percent White
  1st - lowest -0.334 0.130 0.010 -0.158 0.122 0.195 -0.203 0.114 0.075 -0.345 0.108 0.001 -0.153 0.102 0.133 -0.216 0.099 0.028
  2nd -0.261 0.130 0.044 -0.096 0.122 0.430 -0.111 0.114 0.329 -0.279 0.108 0.010 -0.117 0.102 0.250 -0.190 0.099 0.055
  3th -0.265 0.129 0.040 -0.094 0.121 0.438 -0.066 0.113 0.561 -0.243 0.108 0.024 -0.136 0.101 0.179 -0.178 0.098 0.069
  4th -0.219 0.129 0.089 -0.082 0.121 0.497 -0.076 0.113 0.504 -0.270 0.108 0.012 -0.103 0.101 0.309 -0.128 0.098 0.191
  5th - highest -0.207 0.130 0.111 -0.067 0.122 0.581 -0.064 0.114 0.575 -0.192 0.108 0.075 -0.088 0.102 0.389 -0.134 0.099 0.176
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Urban-Rural Classification
  Urban >10k – Sparse -0.021 0.234 0.928 -0.147 0.229 0.521 -0.227 0.306 0.458 0.141 0.307 0.647 0.283 0.304 0.352 0.477 0.298 0.110
  Town & Fringe – Sparse 0.037 0.166 0.824 0.317 0.170 0.062 -0.019 0.164 0.905 0.191 0.157 0.226 0.263 0.162 0.104 -0.030 0.151 0.840
  Village, Hamlet & Isolated dwellings – Sparse 0.062 0.155 0.690 0.124 0.154 0.420 -0.136 0.155 0.380 0.028 0.148 0.847 0.194 0.169 0.251 0.058 0.157 0.710
  Urban >10k  - Less sparse 0.059 0.048 0.223 0.045 0.046 0.322 0.084 0.045 0.066 0.197 0.044 <.001 0.110 0.044 0.012 0.157 0.043 <.001
  Town & Fringe – Less sparse 0.037 0.051 0.460 0.012 0.048 0.810 0.024 0.047 0.606 0.118 0.046 0.009 0.005 0.046 0.907 0.095 0.046 0.038
  Village, Hamlet & Isolated dwelling – Less sparse 0.000 0.000 0.000 0.000 0.000 0.000
  Unknown 0.000 0.000 0.000 0.000 0.000 0.000
Practice List Size -0.041 0.025 0.097 -0.045 0.023 0.047 -0.042 0.023 0.065 -0.046 0.021 0.030 -0.037 0.021 0.081 -0.020 0.022 0.357
Prevalence -0.009 0.026 0.731 0.027 0.024 0.262 0.015 0.023 0.505 -0.001 0.021 0.946 0.005 0.020 0.799 0.001 0.020 0.958
Country
  England 0.211 0.081 0.009 0.162 0.075 0.032 0.130 0.076 0.088 0.119 0.072 0.097 0.168 0.075 0.025 0.174 0.076 0.022
  Northern Ireland 0.127 0.168 0.450 0.064 0.168 0.705 0.126 0.161 0.434 0.051 0.151 0.738 0.243 0.149 0.103 0.193 0.148 0.191
  Scotland 0.064 0.155 0.681 0.206 0.141 0.144 0.185 0.134 0.168 0.113 0.126 0.371 0.193 0.123 0.115 0.205 0.121 0.092
  Wales 0.000 0.000 0.000 0.000 0.000 0.000
Reviews with a healthcare professional 0.064 0.022 0.004 0.074 0.021 <.001 0.092 0.021 <.001 0.056 0.021 0.007 0.082 0.021 <.001 0.091 0.023 <.001
% Practice nurse reviews
  Low 0.072 0.054 0.182 0.058 0.051 0.254 0.087 0.050 0.081 0.058 0.049 0.230 -0.043 0.052 0.402 -0.007 0.053 0.898
  Medium 0.048 0.051 0.346 0.072 0.048 0.136 0.056 0.049 0.250 0.022 0.046 0.638 -0.047 0.045 0.300 -0.026 0.046 0.574
  High 0.000 0.000 0.000 0.000 0.000 0.000
Random Variance
  Practice 0.401 0.017 0.386 0.016 0.391 0.016 0.368 0.016 0.369 0.015 0.375 0.016
Global Tests (degress of freedom) 2 p 2 p 2 p 2 p 2 p 2 p
Townsend(5df) 171.204 <.001 180.127 <.001 233.026 <.001 254.604 <.001 281.664 <.001 219.227 <.001
Percent White(5df) 8.631 0.071 4.929 0.295 14.517 0.006 13.064 0.011 3.176 0.529 4.907 0.297
Urban-Rural Classification(5df) 1.631 0.897 5.725 0.334 5.864 0.320 21.028 0.001 11.526 0.042 16.089 0.007
Country(3df) 7.846 0.049 6.116 0.106 3.405 0.333 3.128 0.372 5.424 0.143 5.422 0.143
% Practice nurse reviews(2df) 2.003 0.367 2.611 0.271 3.305 0.192 1.449 0.485 1.353 0.508 0.321 0.852
2011/20122007 2008 2009 2010 2011
 
1
 Nurse contact – Any involvement low <26%, medium 26-35%, high 35% and over 
 
                                                                                                                                                                                                                              
 
140 
 
Appendix 4 Read codes (activity labels) 
A4.1a Doctors - Readcode entries (%) on the Vision System – Diagnosis or label 
Readcode 
classification Readcode label 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Diabetes mellitus 20.45 15.14 12.26 11.04 8.01 5.45 4.92 4.41 3.76 2.90 2.63
Diabetes mellitus with ketoacidosis 0.13 0.06 0.04 0.04 0.03 0.05 0.05 0.04 0.05 0.04 0.04
Diabetic on diet only 0.17 0.29 0.26 0.26 0.28 0.23 0.22 0.22 0.19 0.15 0.12
Diabetic on insulin 0.12 0.13 0.17 0.12 0.08 0.10 0.07 0.10 0.12 0.06 0.05
Diabetic on oral treatment 0.34 0.65 0.61 0.42 0.38 0.49 0.56 0.66 0.45 0.29 0.23
H/O: diabetes mellitus 0.65 0.50 0.49 0.60 0.80 0.79 0.89 0.48 0.35 0.29 0.28
H/O: insulin therapy 0.06 0.10 0.08 0.07 0.12 0.11 0.12 0.13 0.11 0.08 0.07
IDDM-Insulin dependent diabetes mellitus 0.29 0.25 0.23 0.22 0.14 0.14 0.11 0.08 0.08 0.05 0.04
Insulin dependent diabetes mellitus 1.46 1.02 0.63 0.40 0.32 0.22 0.16 0.14 0.14 0.13 0.13
Insulin treated Type 2 diabetes mellitus 0.19 0.24 0.16 0.20 0.23 0.16 0.16 0.17 0.15 0.11 0.09
Maturity onset diabetes 0.27 0.24 0.17 0.13 0.11 0.07 0.03 0.06 0.03 0.03 0.03
NIDDM - Non-insulin dependent diabetes mellitus 0.13 0.09 0.26 0.24 0.20 0.13 0.12 0.10 0.10 0.06 0.07
Non-insulin dependent diabetes mellitus 9.01 6.79 3.84 2.61 1.84 1.33 0.91 0.60 0.71 0.59 0.56
Type 1 diabetes mellitus 0.58 0.84 0.97 0.97 1.40 1.38 1.34 1.18 1.01 0.88 0.70
Type 2 diabetes mellitus 7.84 11.83 13.32 14.54 19.69 21.02 21.04 20.10 19.28 15.40 13.74
Type II diabetes mellitus 0.14 0.09 0.04 0.05 0.07 0.08 0.08 0.06 0.07 0.07 0.07
All 41.90 38.40 33.67 32.11 33.85 31.90 30.93 28.70 26.75 21.25 18.95
Diagnosis or label
 
Note: only Readcode labels that represent ≥0.01% of all Readcode entries for one or more years during 
the study period are listed in this appendix 
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A4.1b Doctors – Readcode entries (%) on the Vision System – Annual review 
Readcode 
classification Readcode label 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Annual diabetic blood test 0.04 0.02 0.02 0.05 0.07 0.11 0.09 0.07 0.07 0.13 0.12
Attending diabetes clinic 0.39 0.27 0.28 0.19 0.28 0.27 0.30 0.24 0.18 0.17 0.15
Attends diabetes monitoring 0.82 0.49 0.35 0.28 0.34 0.35 0.42 0.61 0.41 0.20 0.21
Background diabetic retinopathy 0.06 0.11 0.07 0.08 0.07 0.12 0.12 0.13 0.13 0.08 0.06
DNA - Did not attend diabetic clinic 0.01 0.04 0.09 0.17 0.15 0.20 0.29 0.21 0.22 0.19 0.24
Declined diabetic retinop scrn 0.00 0.04 0.18 0.20 0.14
Diabetes care plan agreed 0.00 0.01 0.02 0.03 0.14 0.10 0.49 0.93 1.04
Diabetes clinic administration 0.23 0.11 0.05 0.13 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Diabetes clinical management plan 0.04 0.05 0.09 0.24 0.16
Diabetes management plan given 0.50 0.67 0.79 0.97 1.31 1.74 2.79 3.24 3.22 2.92 2.83
Diabetes mellitus with neuropathy 0.39 0.32 0.23 0.22 0.22 0.22 0.18 0.16 0.18 0.15 0.15
Diabetes mellitus with no mention of complication 0.20 0.07 0.06 0.05 0.09 0.07 0.02 0.03 0.00 0.01 0.01
Diabetes monitor.verbal invite 0.00 0.00 0.03 0.01 0.02 0.02 0.05 0.14 0.14 0.10 0.10
Diabetes monitored 0.11 0.41 0.37 0.46 0.18 0.11 0.48 0.53 0.53 0.44 0.41
Diabetes monitoring 1st letter 0.00 0.44 0.67 0.73 0.21 0.13 0.15 0.40 0.24 0.48
Diabetes monitoring 2nd letter 0.00 0.09 0.07 0.10 0.05 0.07 0.05 0.15 0.05 0.08
Diabetes monitoring admin. 29.07 28.03 23.55 20.24 18.22 17.66 18.02 18.93 16.69 12.42 10.99
Diabetes monitoring admin.NOS 0.02 0.01 0.01 0.06 0.14 0.10 0.01 0.02 0.05 0.13 0.13
Diabetes type 2 review 0.00 0.23 0.65 0.94 1.09 1.19 1.19
Diabetes: practice programme 0.83 1.12 1.31 1.44 1.39 0.85 1.07 1.47 1.67 1.38 1.35
Diabetic - good control 0.85 0.70 0.55 0.47 0.44 0.42 0.75 0.76 0.78 0.61 0.55
Diabetic - poor control 3.79 3.26 2.71 2.76 2.42 2.43 2.36 2.35 2.39 2.02 1.85
Diabetic 6 month review 0.00 0.00 0.01 0.10 0.80 0.79 1.11 1.27 1.18 1.12
Diabetic annual review 2.67 2.93 3.57 2.98 4.31 4.35 4.57 4.11 3.60 2.35 2.24
Diabetic foot examination 0.02 0.18 0.10 0.13 0.05 0.03 0.07 0.11 0.13 0.13
Diabetic foot screen 0.01 1.73 3.19 2.06 1.14
Diabetic leaflet given 0.01 0.01 0.00 0.21 0.12 0.01 0.01 0.01 0.04 0.01 0.00
Diabetic monitoring 8.15 10.19 11.58 12.21 13.20 15.03 13.92 13.15 13.87 11.54 10.41
Diabetic monitoring NOS 2.58 2.25 1.96 2.22 2.26 2.41 2.73 2.60 2.40 1.64 1.47
Diabetic neuropathy 0.16 0.15 0.13 0.15 0.17 0.27 0.17 0.14 0.15 0.14 0.12
Diabetic peripheral neuropathy screening 0.12 1.45 1.81 1.25 1.02 0.65 0.33 0.29 0.41 0.65
Diabetic retinopathy 0.48 0.42 0.29 0.27 0.23 0.23 0.23 0.27 0.19 0.16 0.14
Diabetic retinopathy screening 0.16 0.80 1.08 0.90 0.30 0.43 0.38 0.36 0.38 0.30 0.25
Diabetic retinopathy screening refused 0.00 0.08 0.06 0.17 0.19 0.12 0.06 0.02 0.01
Follow-up diabetic assessment 0.82 1.66 2.24 2.10 2.61 1.70 1.69 1.70 1.86 1.49 1.28
Fundoscopy - diabetic check 0.01 0.10 0.11 0.06 0.01 0.01 0.00 0.00 0.00 0.00
Hb. A1C - diabetic control 0.20 0.30 0.25 0.48 0.60 0.66 0.52 0.55 0.53 0.34 0.25
HbA1 - diabetic control 0.04 0.04 0.04 0.06 0.06 0.10 0.11 0.08 0.05 0.04 0.04
Health education - diabetes 0.01 0.02 0.04 0.04 0.05 0.14 0.11 0.18 0.12 0.16
Injection sites - diabetic 0.02 0.04 0.11 0.09 0.07 0.08 0.09 0.09 0.07 0.07 0.05
Non-insulin dependent diabetes mellitus - poor control 0.02 0.03 0.12 0.14 0.18 0.20 0.02 0.03 0.02 0.02 0.01
O/E - Left diabetic foot at high risk 0.01 0.06 0.04 0.06 0.07 0.09 0.08 0.08 0.43 0.59
O/E - Left diabetic foot at low risk 0.04 0.14 0.57 0.60 0.57 0.80 0.92 0.99 1.07 9.19 11.96
O/E - Left diabetic foot at moderate risk 0.03 0.13 0.12 0.23 0.41 0.37 0.36 0.32 2.04 2.78
O/E - Right diabetic foot at high risk 0.01 0.07 0.05 0.06 0.06 0.07 0.07 0.08 0.45 0.61
O/E - Right diabetic foot at low risk 0.04 0.15 0.61 0.66 0.58 0.81 0.93 1.00 1.10 9.46 12.29
O/E - Right diabetic foot at moderate risk 0.03 0.15 0.13 0.24 0.41 0.39 0.36 0.33 2.13 2.84
Pt advised re diabetic diet 0.04 0.07 0.06 0.08 0.09 0.19 0.14 0.14 0.13 0.10 0.08
Seen in diabetic clinic 3.60 3.64 2.51 3.23 2.64 3.40 3.42 3.30 3.26 2.33 2.10
Type 2 diabetes mellitus with persistent microalbuminuria 0.00 0.06 0.21 0.28 0.33 0.30 0.26 0.18 0.22 0.15 0.13
Type 2 diabetes mellitus with persistent proteinuria 0.02 0.07 0.05 0.07 0.14 0.14 0.09 0.08 0.07 0.07
All 57.50 60.30 59.91 58.69 58.11 60.78 62.45 64.64 65.36 73.42 76.42
Annual review
 
Note: only Readcode labels that represent ≥0.01% of all Readcode entries for one or more years during 
the study period are listed in this appendix 
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A4.1c Doctors - Readcode entries (%) on the Vision System – medication review, referral to 
another party, care for by secondary clinic and exemption codes 
Readcode 
classification Readcode label 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Medication review Conversion to insulin 0.15 0.11 0.10 0.08 0.09 0.08 0.09 0.08 0.07 0.04 0.03
Diabetes medication review 0.02 0.54 1.38 0.81 1.09 1.04 0.73 0.98 1.02 0.69 0.60
Diabetic treatment changed 0.09 0.07 0.07 0.05 0.09 0.15 0.16 0.12 0.13 0.10 0.09
Patient on maximal tolerated therapy for diabetes 0.02 0.81 1.38 1.31 1.34 1.23 1.51 2.36 1.50 1.20
All 0.27 0.74 2.36 2.32 2.59 2.62 2.24 2.74 3.61 2.37 1.98
Referral to another Refer to diabetic foot screener . 0.00 0.01 0.27 0.16 0.12 0.18 0.19 0.14 0.08 0.06
party Refer, diabetic liaison nurse 0.10 0.10 0.08 0.09 0.08 0.07 0.09 0.07 0.13 0.10 0.10
Referral to DESMOND diabetes structured education 
programme
0.00 0.06 0.12 0.08 0.07 0.04
Referral to community diabetes specialist nurse 0.05 0.05 0.07 0.10 0.10 0.12
All 0.16 0.15 0.14 0.43 0.36 0.39 0.54 0.62 0.64 0.54 0.47
Care for by Diabetes: shared care programme 0.12 0.22 0.24 0.11 0.07 0.10 0.12 0.18 0.20 0.15 0.15
secondary clinic Seen in community diabetes specialist clinic 0.00 0.01 0.00 0.02 0.02 0.17 0.15
Under care of diabetic foot screener 0.00 0.07 1.67 3.54 2.17 1.53 1.48 1.38 1.24 0.65 0.58
All 0.14 0.33 2.03 3.71 2.30 1.69 1.73 1.68 1.52 1.02 0.92
Exemption codes Diabetic foot examination not indicated 0.21 0.25 0.27 0.25 0.14 0.10 0.09 0.04 0.03
Diabetic patient unsuitable for digital retinal photography 0.01 0.07 0.14 0.11 0.11 0.11 0.10 0.09
Diabetic retinopathy screening not indicated 0.00 0.14 0.22 0.13 0.06 0.06 0.06 0.05 0.03 0.02
Excepted from diabetes qual indicators: Patient unsuitable 0.02 1.06 1.65 1.66 1.44 1.08 0.83 1.17 0.74 0.68
Excepted from diabetes quality indicators: Informed dissent 0.03 0.45 0.58 0.64 0.64 0.55 0.49 0.63 0.43 0.41
All 0.00 0.07 1.88 2.74 2.79 2.54 1.98 1.60 2.08 1.36 1.24
Other Did not attend diabetic retinopathy clinic 0.00 0.06 0.14 0.02 0.03 0.02 0.01
All 0.03 0.02 0.00 0.01 0.01 0.07 0.15 0.03 0.04 0.05 0.03
 
Note: only Readcode labels that represent ≥0.01% of all Readcode entries for one or more years during 
the study period are listed in this appendix 
 
A4.2a Practice nurses - Readcode entries (%) on the Vision System – Diagnosis or label 
Readcode 
classification Readcode label 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Diagnosis or label Diabetes mellitus 4.51 4.19 3.08 1.96 1.51 1.03 0.75 0.66 0.60 0.56 0.49
Diabetic on diet only 0.29 0.47 0.70 0.51 0.36 0.44 0.58 0.65 0.47 0.30 0.27
Diabetic on insulin 0.06 0.11 0.36 0.28 0.27 0.43 0.43 0.43 0.30 0.19 0.19
Diabetic on insulin and oral treatment 0.01 0.04 0.05 0.08 0.12 0.18 0.29 0.32 0.19 0.10 0.09
Diabetic on oral treatment 0.48 0.88 1.06 1.01 0.87 1.10 1.40 1.60 1.15 0.75 0.68
H/O: diabetes mellitus 0.13 0.12 0.09 0.12 0.08 0.05 0.04 0.04 0.02 0.01 0.01
H/O: insulin therapy 0.06 0.08 0.27 0.22 0.22 0.29 0.22 0.17 0.12 0.05 0.06
Insulin dependent diabetes mellitus 0.19 0.24 0.12 0.09 0.05 0.03 0.02 0.01 0.01 0.01 0.01
Insulin treated Type 2 diabetes mellitus 0.08 0.16 0.15 0.13 0.13 0.16 0.16 0.06 0.05 0.04 0.03
Maturity onset diabetes 0.16 0.12 0.06 0.05 0.03 0.00 0.00 0.00 0.00 0.00
Non-insulin dependent diabetes mellitus 1.16 1.61 0.73 0.61 0.41 0.19 0.05 0.02 0.01 0.02 0.02
Type 1 diabetes mellitus 0.17 0.30 0.28 0.21 0.26 0.27 0.18 0.17 0.14 0.11 0.10
Type 2 diabetes mellitus 3.29 4.95 4.93 4.07 5.54 5.08 4.60 4.52 3.79 2.61 2.39
Type II diabetes mellitus 0.14 0.13 0.03 0.02 0.02 0.01 0.01 0.04 0.01 0.02 0.02
All 10.85 13.46 11.99 9.40 9.91 9.28 8.74 8.71 6.90 4.91 4.49
 
Note: only Readcode labels that represent ≥0.01% of all Readcode entries for one or more years during 
the study period are listed in this appendix 
  
                                                                                                                                                                                                                              
 
143 
 
A4.2b Practice nurses - Readcode entries (%) on the Vision System – Annual review 
Readcode 
classification Readcode label 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Annual review Annual diabetic blood test 0.10 0.04 0.05 0.04 0.03 0.05 0.24 0.25 0.23 0.12 0.07
Attending diabetes clinic 0.02 0.03 0.13 0.10 0.02 0.02 0.02 0.01 0.01 0.32 0.32
Attends diabetes monitoring 2.97 2.60 2.48 2.57 2.37 2.38 1.99 1.21 0.94 0.75 0.64
DNA - Did not attend diabetic clinic 0.10 0.41 0.93 0.92 1.07 1.33 1.04 0.79 0.96 0.56 0.45
Declined diabetic retinop scrn 0.00 0.03 0.14 0.11 0.12
Diabetes care plan agreed 0.00 0.01 0.10 0.27 0.41 0.93 0.86 1.00
Diabetes clinic administration 0.40 0.28 0.34 0.34 0.43 0.32 0.01 0.02 0.02 0.01 0.01
Diabetes clinical management plan 0.00 0.00 0.01 0.22 0.29
Diabetes management plan given 0.22 0.35 0.60 0.99 1.17 0.95 1.47 1.49 1.51 1.19 1.23
Diabetes monitor. check done 0.59 1.02 0.61 0.83 0.93 1.42 0.94 0.24 0.53 0.43 0.37
Diabetes monitor.phone invite 0.01 0.01 0.05 0.06 0.07 0.04 0.09 0.18 0.27 0.08 0.05
Diabetes monitor.verbal invite 0.01 0.02 0.03 0.02 0.02 0.01 0.03 0.29 0.25 0.12 0.10
Diabetes monitored 0.29 0.41 0.09 0.10 0.16 0.18 0.12 0.15 0.08 0.04 0.03
Diabetes monitoring 1st letter 0.72 0.41 0.27 0.19 0.46 0.49 0.60 1.10 0.98 0.50 0.34
Diabetes monitoring 2nd letter 0.00 0.04 0.03 0.08 0.13 0.14 0.13 0.19 0.19 0.10 0.05
Diabetes monitoring admin. 59.14 53.79 40.77 36.83 34.01 32.81 30.62 29.68 26.58 17.28 15.12
Diabetes monitoring admin.NOS 0.00 0.00 0.01 0.16 0.08 0.01 0.01 0.01 0.00 0.02 0.02
Diabetes type 2 review 0.00 0.15 0.43 0.42 0.66 0.75 0.68
Diabetes: practice programme 1.09 1.86 3.34 3.55 3.28 2.56 2.95 2.83 2.80 2.25 1.97
Diabetic - follow-up default 0.02 0.04 0.00 0.00 0.33 0.13 0.08 0.04 0.00 0.00 0.01
Diabetic - good control 0.10 0.17 0.20 0.11 0.09 0.19 0.42 0.42 0.23 0.15 0.11
Diabetic - poor control 0.48 0.74 0.47 0.27 0.29 0.24 0.21 0.22 0.31 0.25 0.24
Diabetic 6 month review 0.02 0.37 0.82 1.34 1.16 1.28 0.93 0.91
Diabetic annual review 1.83 1.80 4.25 4.46 5.12 5.31 4.74 5.03 3.90 2.46 2.35
Diabetic diet - good compliance 0.06 0.45 0.27 0.17 0.25 0.42 0.34 0.15 0.04 0.05
Diabetic foot examination 0.11 0.43 0.32 0.20 0.08 0.13 0.10 0.08 0.14 0.19
Diabetic foot examination declined 0.01 0.11 0.16 0.15 0.16 0.14 0.17 0.13 0.13
Diabetic foot risk assessment 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.20 0.08
Diabetic foot screen 0.03 4.99 9.94 6.21 4.00
Diabetic leaflet given 0.05 0.04 0.02 0.05 0.07 0.02 0.04 0.06 0.11 0.02 0.02
Diabetic monitoring 7.93 6.82 9.14 9.90 12.47 13.15 14.92 14.90 17.94 12.58 10.44
Diabetic monitoring NOS 1.92 1.59 1.55 1.88 2.32 2.48 2.25 2.12 1.51 0.83 0.77
Diabetic neuropathy 0.15 0.04 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Diabetic peripheral neuropathy screening 0.00 0.14 1.70 1.97 1.27 1.33 1.17 1.29 1.31 1.28 1.47
Diabetic retinopathy 0.07 0.09 0.05 0.03 0.04 0.08 0.06 0.11 0.09 0.07 0.07
Diabetic retinopathy screening 0.79 1.07 1.17 0.99 0.38 0.34 0.13 0.09 0.12 0.08 0.07
Diabetic retinopathy screening refused 0.02 0.10 0.16 0.09 0.15 0.14 0.06 0.01 0.01
Follow-up diabetic assessment 2.23 3.62 4.76 4.73 5.37 5.64 5.36 4.42 3.73 2.44 2.02
Fundoscopy - diabetic check 0.05 0.14 0.03 0.00 0.00 0.00 0.00
Hb. A1C - diabetic control 0.17 0.31 0.73 0.77 0.94 0.75 0.72 0.63 0.53 0.32 0.26
Health education - diabetes 0.22 0.06 0.08 0.10 0.28 0.19 0.13 0.07 0.11
Initial diabetic assessment 0.32 0.43 0.34 0.35 0.29 0.32 0.30 0.29 0.25 0.14 0.12
Injection sites - diabetic 0.09 0.26 0.36 0.36 0.35 0.32 0.31 0.26 0.19 0.15 0.15
O/E - Left diabetic foot at high risk 0.00 0.06 0.09 0.04 0.03 0.13 0.07 0.07 0.52 0.68
O/E - Left diabetic foot at low risk 0.01 0.03 0.44 0.84 0.59 0.65 1.03 0.90 1.20 13.63 17.47
O/E - Left diabetic foot at moderate risk 0.00 0.01 0.10 0.19 0.14 0.11 0.29 0.20 0.27 2.59 3.45
O/E - Right diabetic foot at high risk 0.00 0.06 0.10 0.04 0.03 0.13 0.06 0.07 0.53 0.70
O/E - Right diabetic foot at low risk 0.01 0.03 0.46 0.95 0.64 0.71 1.07 0.90 1.27 13.85 17.68
O/E - Right diabetic foot at moderate risk 0.00 0.01 0.11 0.24 0.15 0.13 0.31 0.21 0.28 2.64 3.46
Patient held diabetic record issued 0.03 0.03 0.13 0.30 0.15 0.07 0.29 0.25 0.23
Pt advised re diabetic diet 0.13 0.16 0.47 0.56 0.41 0.37 0.88 1.21 1.08 0.81 0.54
Referral for diabetic retinopathy screening 0.00 0.08 0.08 0.10 0.11 0.07 0.07
Seen in diabetic clinic 6.27 5.99 3.70 3.21 3.06 2.64 2.84 1.94 1.56 0.95 0.57
Type 2 diabetes mellitus with persistent proteinuria 0.01 0.07 0.11 0.07 0.07 0.05 0.04 0.03
All 88.82 85.64 81.76 80.37 80.66 80.63 81.97 82.79 86.15 90.65 91.81
 
Note: only Readcode labels that represent ≥0.01% of all Readcode entries for one or more years during 
the study period are listed in this appendix 
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A4.2c Practice nurses - Readcode entries (%) on the Vision System – medication review, referral 
to another party, care for by secondary clinic and exemption codes 
Readcode 
classification Readcode label 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2011/12
Medication review Conversion to insulin 0.15 0.13 0.27 0.22 0.17 0.13 0.11 0.08 0.05 0.05 0.04
Diabetes medication review 0.00 0.03 0.49 0.44 0.42 0.54 0.63 0.29 0.15 0.13 0.12
Patient on maximal tolerated therapy for diabetes 0.21 0.29 0.25 0.45 0.37 0.39 0.58 0.34 0.26
All 0.16 0.18 0.98 0.97 0.86 1.15 1.18 0.89 0.86 0.58 0.46
Referral to another Refer to diabetic foot screener
0.01 0.03 0.84 0.83 0.63 0.69 0.64 0.47 0.34 0.32
party Referral to DESMOND diabetes structured education 
programme
0.00 0.09 0.28 0.22 0.15 0.14
Referral to diabetes structured education programme 0.02 0.06 0.10 0.22 0.19 0.26 0.13 0.08
All 0.07 0.10 0.10 0.93 0.95 0.84 1.13 1.26 1.12 0.78 0.70
Care for by Diabetes care by hospital only 0.03 0.11 0.06 0.09 0.03 0.03 0.02 0.06 0.03 0.02 0.02
secondary clinic Diabetes: shared care programme 0.06 0.28 0.36 0.32 0.26 0.18 0.18 0.15 0.15 0.11 0.10
Seen by diabetic liaison nurse 0.01 0.00 0.00 0.00 0.04 0.27 0.16 0.00 0.00
Subcutaneous injection of insulin 0.00 0.02 0.10 0.43 0.22 0.19 0.04 0.03 0.02 0.02 0.02
Under care of diabetic foot screener 0.18 3.58 6.08 5.85 6.29 5.35 4.66 3.68 2.29 1.85
All 0.09 0.59 4.10 6.93 6.37 6.69 5.64 5.23 4.13 2.52 2.07
Exemption codes Diabetic foot examination not indicated 0.00 0.29 0.32 0.18 0.30 0.43 0.37 0.11 0.07 0.06
Diabetic retinopathy screening not indicated 0.15 0.17 0.07 0.05 0.05 0.02 0.03 0.00 0.00
Excepted from diabetes qual indicators: Patient unsuitable 0.01 0.40 0.50 0.53 0.49 0.30 0.22 0.21 0.14 0.13
Excepted from diabetes quality indicators: Informed dissent 0.01 0.21 0.40 0.41 0.47 0.41 0.36 0.36 0.24 0.19
All 0.01 0.03 1.06 1.40 1.25 1.38 1.28 1.08 0.81 0.54 0.44
Other All 0.00 0.01 0.01 0.01 0.01 0.02 0.05 0.03 0.03 0.03 0.04
 
Note: only Readcode labels that represent ≥0.01% of all Readcode entries for one or more years during 
the study period are listed in this appendix 
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Appendix 5.  Algorithm for removing weight outliers 
 
All records with inconceivable body mass index (BMI) measurements (age ≥ 16 and BMI <13 or BMI 
>150), missing weights, weights of zero or less and missing event (measurement) dates were removed. 
This reduced the number of observations from 4,706,621 to 4,603,058. An inspection of a sample of 
weight histories suggested that a pragmatic approach should be used to further reduce the number of 
outliers. 
Initially each weight measurement (subscript 0) was compared with the two measurements that preceded 
it (subscripts -1, -2) and the two that followed (subscripts 1, 2). Note this approach was adapted for short 
series of weight measurements and for the beginning and end of a series of measurements. Eight change 
values were computed: 
 (t0 – t-2)/t-2, (t0 – t-1)/t-1, (t1 – t0)/t0 and (t2 – t0)/t0 
and their corresponding counterparts 
(t-2 – t0)/t0, (t-1 – t0)/t0, (t0 – t1)/t1 and (t0 – t2)/t2 
Where there was a difference of at least a year between measurements the change value was adjusted 
downwards so for two measurements two years apart the change value was divided by 2. If the selected 
measurement differed by 50% or more from the measurements immediately before (t-1, t0) and after (t0, t1) 
and by at least 25% from both the two outer values {(t-2 , t0) (t0 , t2)} then it was defined as an outlier. This 
process removed many of the solitary outliers that were grossly different from the rest of a person’s 
weights. 
At the second stage the criteria for defining an outlier were tightened. If the selected measurement 
differed by 20% or more from the measurement immediately before (t-1, t0) or after (t0, t1), and (t-1 ,t-2), (t1 
,t2) and (t-1 ,t1) all differed by less than 10% the measurement was deemed to be an outlier and removed. 
This was repeated two more times. In the final stage, measurements that still differed by 20% or more 
from measurements immediately before and after were selected for visual inspection. The whole process 
reduced the number of useable weights down to 4,534,221. The cleaned weight histories were then used 
to create a time varying obesity index based on the threshold for obesity (BMI ≥ 30). It was therefore 
possible for some people to fluctuate above and below the obesity threshold as their weight changed over 
time. 
                                                                                                                                                                                                                              
 
146 
 
Appendix 6.  Practice survey questionnaire 
 
THIN Practice Questionnaire 
   
Contact details  
(This information will be used by THIN for administrative and research/audit purposes only) 
Vision User No: «User_Number»  
 
Name ........................................................ Position in practice................................................. 
Phone number: ........................................... Fax number:......................................................... 
E-mail.................................................................................................................................... 
Address:................................................................................................................................. 
............................................................................................................................................. 
.............................................................................................................................................. 
PCT/HB....................................................... SHA..................................................................... 
Practice Opening Hours:.............................................................. 
Please circle the answers below as appropriate 
 
1. Number of GP WTEs (Whole Time Equivalents)  ………………………………………… 
 
2. Number of GP principals (If different from above)  ………………………………………… 
 
3. Are you a Training practice:     Yes / No  
4. Are you a VES site?      Yes / No / Coming (date:      /          /          ) 
If “Yes” who is your provider?  ……………………………………………. 
 
5. How long have you had Vision?  Less than a year / 1-2 years / 2+ years 
 
6. Which system, if any, did you use before Vision?  ………………………………………… 
                                                                                                                                                                                                                              
 
147 
 
 
7. Do the GPs use paper medical records?          Regularly / Occasionally / Rarely or never 
 
8. Do the practice nurses use paper records?  Regularly/ Occasionally/ Rarely or never 
9. Do you receive electronic Pathology Results? Yes / No  
If “Yes” are they:  Histology Microbiology Chemistry Haematology Others 
10. Do you scan in hospital correspondence?   Yes / No  
11. In which type of area is the practice   Rural / Urban / Inner city 
12. Are you a dispensing practice?    Yes / No   
P.T.O. 
13. Please give the full name of all GPs and tick whether they are full-time, part-time or trainee: 
Name Sex 
Full-
time 
Part-
time 
Trainee 
     
     
     
     
     
     
     
     
     
 
14. Do you contribute data to any other research data scheme(s)?  Yes / No   
If yes, which scheme(s)? ……………………………………………………………… 
15. As a THIN member you have the opportunity to earn extra money for “follow-up” studies through 
THIN’s Additional Information Services Department (AIS).  Payments start from £30 per patient 
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request.  If you do not already undertake AIS studies, and are willing to be contacted in the 
future with no obligation to participate, please complete the following:- 
Are you interested in finding out more?   Yes / No    
If “Yes” please provide contact details: 
 Name:……………………………………………….  Position: ………………………………………………… 
 Telephone:……………………………………………    Email………………………………………… 
16.  Please list the number of staff employed by the practice, according their job title (as Whole Time 
Equivalents). 
 WTE 
Practice nurse  
Consultant Nurse  
Nurse Practitioner  
Advanced Nurse Practitioner  
Other registered nurse (please describe)  
 
 
 
Practice manager (clinical background e.g. RN)   
Practice manager (non-clinical background)  
Nursing assistant  
Clinical support worker  
Receptionist  
Other (please describe)  
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17. How many nursing staff (as Whole Time Equivalents) are employed on the following pay bands or 
their equivalent (excluding London weighting)?  
 WTE 
Band 2 (£13,903 - £17,003)  
Band 3 (£15,860 - £18,827)  
Band 4 (£18,402 - £21,798)  
Band 5 (£21,176 - £27,625)  
Band 6 (£25,528 - £34,189)  
Band 7 (£30,460 - £40,157)  
Band 8 (£38,851 - £80,810)  
 
18. Do any of the nurses providing care to patients with diabetes hold a post graduate qualification 
relating to diabetic care from a Higher Education Institute?   
Yes / No 
19. How is the care of people with diabetes generally managed? (Please tick all that apply) 
a) By GPs  (but none specialise in this)  
b) By a designated GP (or GPS) who specialises in diabetes   
c) By practice nurses  (but none specialise in this)  
d) By a designated nurse (or nurses) who specialises in diabetes  
e) Shared between the practice and hospital / community based 
consultants  
f) By hospital / community based specialists   
g) Other (please describe)  
 
20. Which of the above is the main approach to managing care of people with diabetes? 
 
(please write one number)  __________ 
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21. How do patients with diabetes typically receive the majority of their diabetes related care and 
assessment? (Please tick all that apply) 
 
Appointments as and when needed   
Routinely scheduled appointments  
Through regularly held clinics specifically for diabetic patients  
Other (please specify) 
 
 
 
22. Who initiates patient’s treatment with insulin? 
 
GP  
Practice Nurse  
Community Diabetic Nurse Specialist   
Outpatient diabetes mellitus clinic  
Other (please specify) 
 
 
 
THIN Ref: «THIN_Ref» 
 
 
 
Thank you for your time. 
 
